<SEC-DOCUMENT>0001628280-23-014622.txt : 20230501
<SEC-HEADER>0001628280-23-014622.hdr.sgml : 20230501
<ACCEPTANCE-DATETIME>20230501164731
ACCESSION NUMBER:		0001628280-23-014622
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		47
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230501
DATE AS OF CHANGE:		20230501

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		23874530

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>med-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:ebea4200-127d-4056-af39-00ad362d0793,g:908e033e-f9bd-4981-9c22-7aad939362db,d:7237206793d54e1ba85313ed02bd1f82--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns="http://www.w3.org/1999/xhtml" xmlns:med="http://www.medifast1.com/20230331" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>med-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8yNi0xLTEtMS02Mzk5Mg_7d59d532-8aa0-4c2c-8f9c-59eacdcadf6a">0000910329</ix:nonNumeric><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8yNy0xLTEtMS02Mzk5Mg_df7a4d75-554b-4bcd-9629-f24318334143">12-31</ix:nonNumeric><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8yOC0xLTEtMS02Mzk5Mg_b14ea012-8b55-46c6-ba4b-3a24b8d88429">2023</ix:nonNumeric><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8yOS0xLTEtMS02Mzk5Mg_87424297-bbee-4f5e-b865-ab518f2e55c0">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8zMC0xLTEtMS02Mzk5Mg_7271a5a7-53cf-4b57-9c39-dc57e964e4d8">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="med-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73efc58548364e9da276fb4aee70585f_I20230424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d62bc40011a4e969ffff01db87cd897_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14276493cdda4b5297135c9e43430126_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fbf2e6d85424505bb1df89b807899f0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37fc307c3fff4012b03412aba9187bf6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic21acf6f41c44ed8a91b90def6137e1b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib645712f743642f7b14f17858412b113_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7a98f37c1e44fa184ad39aef19462ae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f0ba66dcb054c298b2f1218f9d34e61_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9003a88c4844e8cbd52972e24a1d8e7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i760c27790b4a43b18f0947b1de071b7c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25bf64baa4f84f3c91994cf68921d605_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff775d4fc8d945b78ba54e784502dc6f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31b8f688eea24545a396eeb0611d6e1b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90030857661f4a4dbc4ccc740b7b79c0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8914dfcaa1404cf9af3e00a8b215faad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i892b2a6455a84efea48207042eb47ebc_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c9ff89193a54598a41c53bc8a2c8707_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddbcc131b7564ee995939796a3d726ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16778ba2b0e747a695b14af615208230_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad93c89a7e443da95e864cdcaff958e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i021a1b09c09b4f149bc661efb55a8579_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae2a9532cbe94c05a12c15c043307bc3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3245c01aff3346e8b0e93c38786ba422_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09b1a76e8224a0f8f66a0f0d89c5f8e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia03cb5ed3f53442c810b63d75610adee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefab9b282eab46b6b9feb116dacd81f1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aa7a26927a042ddb0c4efddb86c5947_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4d87af6ad34ece906c185c57bc0f27_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d859544afec4409b2dc5203bc73948f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63601fd2318848348fc1c8b45cb1f3a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13e17fd77c1a47b9b50510f8f141dfae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic44f166aec324147a4cca9c573b540dd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieba1e7bde05646528901c22163e8367a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9b32ff21de445638831a1796f077b25_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae296ff6c0a4ed29838c825beaa94bb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id59c14c148de496880d6652176a2c999_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a735cd0fee4e528a997870d8f0f709_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb9683758726458fb14c1d50b204c772_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia309ad2ca0aa4222af27696fc0425511_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6188f0dd58ad41dfb34e2a2f9bee3259_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3dd7f52bc934c60b57c8561a32e45d5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9a5bf52113ef41b2935708b735e9ee0f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91137ee67f7f41ce9748d8db7d981c22_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffbabdce70a34f2d8c8f4369464e6bf9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5a00a160b774d91807d91918cf7ee46_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b24326b642845e8b3857f0d21d79d19_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie316187f7c484420a923ed9f350e11ca_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i720156933c7242888d839f8f81c4decf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f68ff9d37804516a004fa3fefa6e941_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4b5d53cd7024ad8b562648072669881_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if84394c44eed4092ac896bf455a72df7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia665c39f19eb4a6a9d485acd05a18124_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f1aab26e7984ccaba10e7aa1ad24c41_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab840a0209b94086be8b0d816f977bc2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dba0507dc5141659a87360e36adc332_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7752400214154be7a3da22c4ede6da41_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i584845803f224e90963b306cfaa8a708_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaca1e5bf2df0432fbcfc2e5ee7e5e7d6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17778c8c21984c959271d0d7cbc7d47a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if51850419cba458da16f0e96e36a1e6c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c0fd591c6d54c788d05c4d43bfe45e2_I20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i813dd19e7bc04cd4b34c1ac0e2f5b4fc_I20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e4639f404b746da9129538a34b70a01_I20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">med:UncommittedIncrementalFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0292eae6d68435581e1a1cb655cb025_D20210413-20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-13</xbrli:startDate><xbrli:endDate>2021-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcfc7ba03ed44069a73caf1bc4436006_D20210413-20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-13</xbrli:startDate><xbrli:endDate>2021-04-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9c24ad6f6bc453d97165b16303e0845_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">med:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87cc27821ccd42ed968755b54c044371_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55a3deca29144b558d038563d063d0e5_I20210413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf71ad0c5ed640be905a819b87cf32f5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7237206793d54e1ba85313ed02bd1f82_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:21.6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzI4_73de853a-8123-4601-9a72-9e5a1bbed852">10-Q</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE5_9314749c-ab07-4ca8-ba78-d4c625b739b7">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMTk5MDIzMjU3OTI3_02e9b07f-7499-42aa-b40b-46baeef864f2">March 31, 2023</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE0_9c37b092-8fd2-495f-ba7b-33f785331dda">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the transition period from________ to ________.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE1_210130d2-1b8e-449c-b7a4-19ae7f22c560">001-31573</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzI2_608172ba-98ef-4f7a-9bad-14fd3585a567">Medifast, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.607%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6MmQ2ZWYxM2RhMDA1NGE5OWEyNGFjNzAyYTUxY2U4NzYvdGFibGVyYW5nZToyZDZlZjEzZGEwMDU0YTk5YTI0YWM3MDJhNTFjZTg3Nl8wLTAtMS0xLTYzOTky_8775ffae-d185-4027-90e7-8ae0110a64cf">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6MmQ2ZWYxM2RhMDA1NGE5OWEyNGFjNzAyYTUxY2U4NzYvdGFibGVyYW5nZToyZDZlZjEzZGEwMDU0YTk5YTI0YWM3MDJhNTFjZTg3Nl8wLTItMS0xLTYzOTky_34a65007-bf92-49a9-80e6-5d5c1a56cb8f">13-3714405</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzIx_e2ad1c01-86de-4aa7-ad2f-abc18ce13cbe">100 International Drive</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzIw_a0630ebf-67c9-46ee-a6c5-44d33ff5b319">Baltimore</ix:nonNumeric>, <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzIy_55cc72a2-b25b-4e53-9222-4702da197281">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzI3_eee42992-50bc-47c9-94a5-b95577b4512c">21202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Telephone Number: (<ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzIz_d723f645-fbe2-4db2-96d5-528826de4aa0">410</ix:nonNumeric>) <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE2_f9ee492b-1c49-42bf-ba10-f7618b86723a">581-8042</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices, Zip Code and Telephone Number, Including Area Code)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 3.28pt;text-align:center;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 3.28pt;text-align:center;text-indent:-7.2pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6NzVhYWFhYTIwNWE3NGIwY2I5ODcwZDVmYjc5NWVhOTAvdGFibGVyYW5nZTo3NWFhYWFhMjA1YTc0YjBjYjk4NzBkNWZiNzk1ZWE5MF8xLTAtMS0xLTYzOTky_92005520-a506-4e54-b0e1-a6c4896ac9a4">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6NzVhYWFhYTIwNWE3NGIwY2I5ODcwZDVmYjc5NWVhOTAvdGFibGVyYW5nZTo3NWFhYWFhMjA1YTc0YjBjYjk4NzBkNWZiNzk1ZWE5MF8xLTItMS0xLTYzOTky_59ba41b7-94ca-44f8-8963-9d588f12c50c">MED</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6NzVhYWFhYTIwNWE3NGIwY2I5ODcwZDVmYjc5NWVhOTAvdGFibGVyYW5nZTo3NWFhYWFhMjA1YTc0YjBjYjk4NzBkNWZiNzk1ZWE5MF8xLTQtMS0xLTYzOTky_9abcc6b0-a884-4518-a025-e3b459befd6c">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE3_a1024229-8d82-4158-acb8-417b348bfed9">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE4_bc5b342d-2c3e-435f-8e74-250e4d19b4f3">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6ODhkOTMxOGRhYWUxNGYzNmIyMWNjMGU4MDc4ZjdjMGQvdGFibGVyYW5nZTo4OGQ5MzE4ZGFhZTE0ZjM2YjIxY2MwZTgwNzhmN2MwZF8wLTAtMS0xLTYzOTky_8618b89a-4454-4faa-b7b9-e9628a422097">Large accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Non-accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6ODhkOTMxOGRhYWUxNGYzNmIyMWNjMGU4MDc4ZjdjMGQvdGFibGVyYW5nZTo4OGQ5MzE4ZGFhZTE0ZjM2YjIxY2MwZTgwNzhmN2MwZF8xLTMtMS0xLTYzOTky_bf21a535-7351-418d-b144-032aea609cb0">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Emerging growth company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6ODhkOTMxOGRhYWUxNGYzNmIyMWNjMGU4MDc4ZjdjMGQvdGFibGVyYW5nZTo4OGQ5MzE4ZGFhZTE0ZjM2YjIxY2MwZTgwNzhmN2MwZF8yLTEtMS0xLTYzOTky_70c127bc-8d81-4010-bff0-ffdac8d7c51e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by checkmark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzI1_81c992ed-3231-4446-8ff3-d20dcff71177">x</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding at April&#160;24, 2023 was <ix:nonFraction unitRef="shares" contextRef="i73efc58548364e9da276fb4aee70585f_I20230424" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yNzQ4Nzc5MDcxNzk0_e2e3e16f-df5c-479a-99d4-dac9997c6d74">10,887,193</ix:nonFraction>.</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:4pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medifast, Inc. and Subsidiaries</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_10">Part 1 &#8211; Financial Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_13">Item 1 &#8211; Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16">Condensed Consolidated Statements of Income (unaudited) for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_16">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_16">2</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19">Condensed Consolidated Statements of Comprehensive Income (unaudited) for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_19">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_19">3</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22">Condensed Consolidated Balance Sheets (unaudited) as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22"> and December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_22">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_22">4</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25">Condensed Consolidated Statements of Cash Flows (unaudited) for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25">Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_25">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_25">5</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28">Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity (unaudited) for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28">Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28">March</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28"> 3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_28">2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_28">6</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_31">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_31">7</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_61">Item 2 &#8211; Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_61">13</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_85">Item 3 &#8211; Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_85">18</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_88">Item 4 &#8211; Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_88">18</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_91">Part II &#8211; Other Information</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_94">Item 1 &#8211; Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_94">19</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_97">Item 1A &#8211; Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_97">19</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_100">Item 2 &#8211; Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_100">19</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_103">Item 6 &#8211; Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i7237206793d54e1ba85313ed02bd1f82_103">20</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div id="i7237206793d54e1ba85313ed02bd1f82_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:115%"> </span></div><div id="i7237206793d54e1ba85313ed02bd1f82_16"></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except per share amounts &amp; dividend data)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:59.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.132%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMy0xLTEtMS02Mzk5Mg_3d3a8270-bf8a-48fe-8ca5-021cf4b5c3e0">348,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMy0zLTEtMS02Mzk5Mg_df0ccb29-9921-4818-93e4-af4c1f845964">417,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNC0xLTEtMS02Mzk5Mg_478cd8d2-9b77-48ae-9575-9e5cc6b30a96">102,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNC0zLTEtMS02Mzk5Mg_5f675a83-623f-48d0-ba09-7550e2372965">115,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNS0xLTEtMS02Mzk5Mg_637e3f14-31e8-413e-b470-b48b7f9428c2">246,390</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNS0zLTEtMS02Mzk5Mg_938c6ee4-0b51-4a43-b744-4b5596b62135">302,286</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNy0xLTEtMS02Mzk5Mg_b990372f-65ff-4f29-b4d4-0f787806509f">192,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNy0zLTEtMS02Mzk5Mg_b5d54661-4b93-4307-a627-6d99623cf218">247,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfOS0xLTEtMS02Mzk5Mg_d90b3836-670a-4186-b5e1-16164b77b558">53,511</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfOS0zLTEtMS02Mzk5Mg_7c4af8b6-fd76-4ccc-b574-5d75438c894a">55,087</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTItMS0xLTEtNjM5OTI_8b24865c-80b9-49ee-88ac-9e58d901a2ce">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTItMy0xLTEtNjM5OTI_921ec4c0-411d-489a-b66a-bf38c5230d86">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTMtMS0xLTEtNjM5OTI_030a933e-8863-480c-a251-5442a02249b6">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTMtMy0xLTEtNjM5OTI_d843f77c-657c-4e65-bf58-b023efad8d8a">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTQtMS0xLTEtNjM5OTI_289a875d-c1b6-4996-9871-dfd6274ac048">182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTQtMy0xLTEtNjM5OTI_1c7ab039-1a2e-4a5d-a4c9-34d9d3819f71">111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTYtMS0xLTEtNjM5OTI_14c1acc4-19ca-406b-bc1d-930bffdf7a84">53,329</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTYtMy0xLTEtNjM5OTI_b34a1770-8974-4f28-962f-636fad04b72a">54,976</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTgtMS0xLTEtNjM5OTI_1b79cbf3-309a-47e1-b0af-b89d3fcafc5e">13,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTgtMy0xLTEtNjM5OTI_65accea5-3b40-422b-b403-d253884f3c12">13,195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjAtMS0xLTEtNjM5OTI_31bd1787-9090-454a-b1ca-a50813b8339f">39,968</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjAtMy0xLTEtNjM5OTI_4584fb0a-4671-4421-8757-7a7080ab0e83">41,781</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjItMS0xLTEtNjM5OTI_9551a1d4-775f-43e1-932f-d16245db4593">3.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjItMy0xLTEtNjM5OTI_231644da-ffb0-4e4c-8685-f5d8e04c65b6">3.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjQtMS0xLTEtNjM5OTI_4efc5fbf-b521-4a5f-b826-169048c51514">3.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjQtMy0xLTEtNjM5OTI_66175a81-5dab-457d-9952-5e76882579ef">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjctMS0xLTEtNjM5OTI_7a7ef509-8a68-41f9-961d-52fd0320ba41">10,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjctMy0xLTEtNjM5OTI_bcda701f-c36d-4fa5-bc50-5bb0057d35b5">11,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjgtMS0xLTEtNjM5OTI_3aef1bb5-3fc5-4407-b37b-d007b3bba388">10,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjgtMy0xLTEtNjM5OTI_b3e93f9a-44cb-4c82-a38a-3a40089e1334">11,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash dividends declared per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMzAtMS0xLTEtNjM5OTI_317c59b5-f332-48a9-9ef0-437b9be0211e">1.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMzAtMy0xLTEtNjM5OTI_5703fcb7-f75c-497f-8b41-59d1e6cb72ea">1.64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"></td><td style="width:59.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfMy0xLTEtMS02Mzk5Mg_0a72357a-f0b3-4bd4-92fa-106282798265">39,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfMy0zLTEtMS02Mzk5Mg_b2788f62-0095-4f08-8c03-e88224ae37a0">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other comprehensive income, net of tax:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfNi0xLTEtMS02Mzk5Mg_10adf817-f636-4561-ba13-fd2be34852ec">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfNi0zLTEtMS02Mzk5Mg_5f11737d-96d1-4a99-b408-7ede65a02ba6">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Unrealized losses on investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfNy0xLTEtMS02Mzk5Mg_8a5d796e-afa8-4942-8725-a040d159f256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfNy0zLTEtMS02Mzk5Mg_416c9423-5b0b-4ccc-9085-dc5afed31577">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfOC0xLTEtMS02Mzk5Mg_f86f5aad-ad13-4b02-980e-b8030d520592">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfOC0zLTEtMS02Mzk5Mg_eb9100ab-8569-42eb-a068-05c413cde11c">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfMTAtMS0xLTEtNjM5OTI_1fe250bf-699b-4945-90eb-1c75c1d6bf81">39,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfMTAtMy0xLTEtNjM5OTI_4b1773c4-e3bf-42b8-b519-36d2e19fae71">41,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except par value)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:58.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,<br/>2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNC0xLTEtMS02Mzk5Mg_9a7a820f-8aa6-4fda-9f06-df1dffef501a">123,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:-1.19pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNC0zLTEtMS02Mzk5Mg_ff783136-0cff-4572-a432-0ef369d81f2d">87,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNS0xLTEtMS02Mzk5Mg_963fd2ca-1244-4786-a684-0e4c081168b3">96,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNS0zLTEtMS02Mzk5Mg_26e29e0c-37ee-4cba-94c3-9eaa06d637a2">118,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfOC0xLTEtMS02Mzk5Mg_054469f0-1d7f-402f-b4eb-be2d6ab02e95">9,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfOC0zLTEtMS02Mzk5Mg_8bbb05ae-fa16-4f9c-8db6-4aef1edc7ecb">16,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfOS0xLTEtMS02Mzk5Mg_d0aab91c-fbd3-40bc-a887-8a06113bf05a">230,318</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfOS0zLTEtMS02Mzk5Mg_b554e86e-0662-4ec2-bc3b-54b2bced9f87">222,784</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Property, plant and equipment - net of accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTEtMS0xLTEtNjM5OTI_88743e38-9613-4d19-9409-48e076bb35a7">55,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTEtMy0xLTEtNjM5OTI_3ed2b7df-8d67-463c-81e3-b6cb000aceac">57,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTItMS0xLTEtNjM5OTI_71850aab-b420-479d-9995-3d6e93e722fb">17,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTItMy0xLTEtNjM5OTI_577177bc-5c22-4b5e-abc7-c354dd54edf0">18,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTMtMS0xLTEtNjM5OTI_92cd8066-de0e-4a79-817d-57b8735f0d68">13,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTMtMy0xLTEtNjM5OTI_f7b30885-3e4c-4157-bdf9-6e3d32c87485">12,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTQtMS0xLTEtNjM5OTI_8282350d-2e3b-440d-88c2-d2a9b8e6fcab">4,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTQtMy0xLTEtNjM5OTI_0191bc8d-9f64-48e9-b285-3ec1c90dcbc2">5,328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL ASSETS</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTctMS0xLTEtNjM5OTI_a2e25404-2a49-4a32-be44-e570e3459db6">321,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTctMy0xLTEtNjM5OTI_74ddaeea-5988-4e33-b346-3abb88337d95">316,213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjEtMS0xLTEtNjM5OTI_b307491f-cc12-4f2f-a278-4330f2f7e0bd">113,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt;text-indent:-1.19pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjEtMy0xLTEtNjM5OTI_e904bbff-1ae4-4f7b-a7f5-d0db04ff728c">134,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income taxes payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjItMS0xLTEtNjM5OTI_512b3214-a831-451a-a765-08f4765013cb">13,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjItMy0xLTEtNjM5OTI_88b63932-f6db-4b07-b399-c0b0828ac012">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;Current lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjMtMS0xLTEtNjM5OTI_3c61553b-9532-4607-967f-ae3a97378f13">5,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjMtMy0xLTEtNjM5OTI_ffb24791-14df-4558-be53-1b464117f94d">5,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjQtMS0xLTEtNjM5OTI_a9c7a19a-db56-4114-81a7-d7076698e3cd">131,742</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjQtMy0xLTEtNjM5OTI_5d2b401c-45b2-41a6-bdcb-db47fc2c0743">140,894</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;Lease obligations, net of current lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjYtMS0xLTEtNjM5OTI_f30594be-2836-4d9e-aab7-42159cf110a4">18,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjYtMy0xLTEtNjM5OTI_c1bc0b10-d16d-48ca-8725-34ab230f8d30">20,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjktMS0xLTEtNjM5OTI_a0e06746-f4b3-4d93-9351-d7a2ae91c853">150,706</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjktMy0xLTEtNjM5OTI_09c19af2-8ea2-44a4-9c1d-924affa98c62">161,169</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzItMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo4N2QzMDQwMGM0OTE0NWY0YmRlZGM2YmRjZDFiMmNhN18yNzQ4Nzc5MDY5NTA0_12500503-ecfd-411c-ad26-4cefec08323a"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzItMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo4N2QzMDQwMGM0OTE0NWY0YmRlZGM2YmRjZDFiMmNhN18yNzQ4Nzc5MDY5NTA0_51e1baa2-ddac-48a2-93c2-486c18533c2c">0.001</ix:nonFraction></ix:nonFraction> per share: <ix:nonFraction unitRef="shares" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzItMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo4N2QzMDQwMGM0OTE0NWY0YmRlZGM2YmRjZDFiMmNhN18yNzQ4Nzc5MDY5NTA4_43d7dd85-3dad-4012-ae0f-f4c6a7ede8cf"><ix:nonFraction unitRef="shares" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzItMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo4N2QzMDQwMGM0OTE0NWY0YmRlZGM2YmRjZDFiMmNhN18yNzQ4Nzc5MDY5NTA4_96d1439e-deb6-4a80-8a67-ff4f6fcddf97">20,000</ix:nonFraction></ix:nonFraction> shares authorized;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzMtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo0MDVlYzJkZGE5MGY0Yzk1YmQwODhlMDNmMWRjOTkwZl8yNzQ4Nzc5MDY5NDg3_31b300a6-06c2-4efc-859c-934e44eb7bcf">10,887</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzMtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo0MDVlYzJkZGE5MGY0Yzk1YmQwODhlMDNmMWRjOTkwZl8yNzQ4Nzc5MDY5NDkx_7d2f9bc6-79cf-48ba-b8e6-be11332fa484">10,928</ix:nonFraction> issued and <ix:nonFraction unitRef="shares" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzMtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo0MDVlYzJkZGE5MGY0Yzk1YmQwODhlMDNmMWRjOTkwZl8yNzQ4Nzc5MDY5NDk1_fcfa163d-ab9b-419c-99e1-051cca402425">10,887</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzMtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo0MDVlYzJkZGE5MGY0Yzk1YmQwODhlMDNmMWRjOTkwZl8yNzQ4Nzc5MDY5NDk5_4e312e5b-6b6c-451d-b7bf-9aece52661a9">10,873</ix:nonFraction> outstanding</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">at March&#160;31, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzQtMS0xLTEtNjM5OTI_cc426644-64d8-4fcd-b262-b0094810898d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzQtMy0xLTEtNjM5OTI_6ff8e73e-a57c-4cd1-9999-c8e502f8f757">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzUtMS0xLTEtNjM5OTI_f5442d5b-4340-465d-8902-11b7dfa0ee1e">19,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzUtMy0xLTEtNjM5OTI_de9facc0-39de-45a6-9eb3-a5d97e5a3e45">21,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzYtMS0xLTEtNjM5OTI_8fdc6bd2-97bd-4200-b3af-bd6380deaf25">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzYtMy0xLTEtNjM5OTI_2ee6f1eb-1119-43ae-a6d1-33990c840a8a">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Retained earnings </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzctMS0xLTEtNjM5OTI_853886a3-ac0f-4082-bc9c-0f3f5f4e8e4a">151,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzctMy0xLTEtNjM5OTI_e3e25bc6-494c-477e-9e15-f1a271aa7f9d">139,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: treasury stock at cost, 0 and <ix:nonFraction unitRef="shares" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzgtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjphMjUxMjMyNjY5OTc0NzZmODk1N2UyOGJmZTk1NDA0NV8yNzQ4Nzc5MDY5NTQw_5991846f-bfd8-4fcc-b4d9-254d7c502443">54</ix:nonFraction> shares at March&#160;31, 2023 and December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzgtMS0xLTEtNjM5OTI_01a3750b-5ee6-486f-8f17-93b61c937b35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt;text-indent:-1.19pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzgtMy0xLTEtNjM5OTI_123f9c50-16b0-4002-b375-b0e44015158e">6,398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzktMS0xLTEtNjM5OTI_861088e2-6825-485d-92de-c7e8d65cbfef">170,900</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzktMy0xLTEtNjM5OTI_d654e57a-c3d9-48ba-9b48-97dfcd3b1725">155,044</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNDEtMS0xLTEtNjM5OTI_f26defd5-e62f-40fd-acce-5e9f23a98459">321,606</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNDEtMy0xLTEtNjM5OTI_ed5cbf86-e4e3-4d04-855b-bcd82ac2b9cc">316,213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollar in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:57.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.286%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNC0xLTEtMS02Mzk5Mg_b0ccff7a-6ead-45f3-b704-b0c1e53da282">39,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNC0zLTEtMS02Mzk5Mg_84d1d39a-875f-48ba-b0c1-f8914d3d4971">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net income to cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNi0xLTEtMS02Mzk5Mg_43e9b1ce-7197-4ea2-9682-f9aa60f0e361">2,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNi0zLTEtMS02Mzk5Mg_978f7c78-fde8-4918-bf37-5d73f9310305">2,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-cash lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="med:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNy0xLTEtMS02Mzk5Mg_3f7e0757-5de4-4530-bfd0-9ede5be979b5">1,369</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="med:OperatingLeaseExpenseNonCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNy0zLTEtMS02Mzk5Mg_304bc540-7605-4e3a-b0b0-eb819ef2943d">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfOC0xLTEtMS02Mzk5Mg_c37f886b-0f82-48e7-bd03-b2f288e59777">606</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfOC0zLTEtMS02Mzk5Mg_7701b607-3d87-426c-883b-22928bdace4a">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Amortization of premium on investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTAtMS0xLTEtNjM5OTI_8a144b96-db41-4582-857e-a2ad08ae2dfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTAtMy0xLTEtNjM5OTI_e667710a-6c22-488f-beb9-816dd0acb9de">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTEtMS0xLTEtNjM5OTI_4d6c749b-9b3f-46f5-9bac-34d30c1fe173">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTEtMy0xLTEtNjM5OTI_a18b9c05-5319-4f09-8d3f-40c202ec44f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 17.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTQtMS0xLTEtNjM5OTI_1777d0d6-2ab4-4cfe-ad54-7b3b07f0b11b">21,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTQtMy0xLTEtNjM5OTI_6846ac6d-64e6-4627-9627-63e3396eb364">8,929</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTYtMS0xLTEtNjM5OTI_75a183e9-766b-4ba5-9839-4aa78ca1c226">6,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTYtMy0xLTEtNjM5OTI_6f4a74a7-7bb9-4431-9ce3-779310df1aea">3,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTctMS0xLTEtNjM5OTI_f8227183-5f0d-4712-83dc-28eb6a067c3b">887</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTctMy0xLTEtNjM5OTI_de58e2a9-c5a9-414a-82b8-3d366bcf99c5">6,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable and accrued expenses </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTgtMS0xLTEtNjM5OTI_0aadea2c-8116-45f0-95d1-8ee1474b2d49">21,897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTgtMy0xLTEtNjM5OTI_71682c55-27a1-4bbe-aa80-76824e69c521">6,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTktMS0xLTEtNzY2NTU_f8ead574-66e5-428e-b624-1cdfc0424fbd">12,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTktMy0xLTEtNzY2NTU_47866b21-82aa-4386-8d77-485a501f4707">14,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTktMS0xLTEtNjM5OTI_f88e4897-4524-497b-9804-405899fd81ca">64,059</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTktMy0xLTEtNjM5OTI_33099b27-57c8-4dac-ac25-e1bb2b94de6b">43,673</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Investing Activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Sale and maturities of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjItMS0xLTEtNjM5OTI_b2c459ea-a086-4319-b721-8f23b8b001db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjItMy0xLTEtNjM5OTI_3f71ef3d-d05a-4d2b-a5ff-167432d8bb09">1,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjMtMS0xLTEtNjM5OTI_a8852608-bd47-43fa-b667-b2b0ee59ce17">2,115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjMtMy0xLTEtNjM5OTI_25418300-a1c4-4ff3-bbbb-c240d26e6455">3,009</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjQtMS0xLTEtNjM5OTI_79098ceb-f41c-4613-b0af-e15f68a4967e">2,115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjQtMy0xLTEtNjM5OTI_e6600952-564d-4310-933d-6e0f1aa0d225">1,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Financing Activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Options exercised by directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="med:ProceedsFromStockOptionsExercisedDirectors" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjgtMS0xLTEtNjM5OTI_95223a8d-09db-42a5-b816-3564d5d374d9">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="med:ProceedsFromStockOptionsExercisedDirectors" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjgtMy0xLTEtNjM5OTI_25a8e1f7-f300-49d6-a25b-cfa9fd595a23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net shares repurchased for taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfOtherEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjktMS0xLTEtNjM5OTI_00f5abe2-fa73-4fb5-9417-8ba96a9f7071">3,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfOtherEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjktMy0xLTEtNjM5OTI_bdbb00f1-27b9-4ecf-908a-8e54f015d8ff">1,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash dividends paid to stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzAtMS0xLTEtNjM5OTI_8a5e67e1-5605-4e72-8809-f4eae5b6d761">19,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzAtMy0xLTEtNjM5OTI_a71e9a7b-d4b3-47b4-9563-32017e903c66">16,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock repurchases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzEtMS0xLTEtNjM5OTI_2ba40afc-2f48-4eaa-889d-aa6855df69da">3,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzEtMy0xLTEtNjM5OTI_d15257c2-f8e6-40eb-a5e6-64c9730cb634">10,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash flow used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzMtMS0xLTEtNjM5OTI_11c5586c-92ef-428b-be13-9279577fdc4e">25,896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzMtMy0xLTEtNjM5OTI_20a3b045-24a8-4466-8c2e-a607a7656673">28,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Foreign currency impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzUtMS0xLTEtNjM5OTI_fbaa2ba1-3cba-4240-a526-8ed919bcc4e3">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzUtMy0xLTEtNjM5OTI_4ac2e723-f6c7-4d03-b710-afe5f843c869">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzctMS0xLTEtNjM5OTI_49ca4a65-7c56-405e-aed2-f7ddbee1c762">36,057</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzctMy0xLTEtNjM5OTI_2afc89bd-555d-402a-b8f6-356c2f203eeb">13,820</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents - beginning of the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzgtMS0xLTEtNjM5OTI_4b21977d-4a0c-4010-9ecd-7533a5de6995">87,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14276493cdda4b5297135c9e43430126_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzgtMy0xLTEtNjM5OTI_9c075dfc-6dea-4b91-a72f-6e906ecd6857">104,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents - end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzktMS0xLTEtNjM5OTI_3cc8edb3-b29c-4289-bd7d-7940e0e67fe0">123,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzktMy0xLTEtNjM5OTI_ef8ed78b-a45e-4591-96a4-c1e59ce5e700">118,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes (refunded) paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNDItMS0xLTEtNjM5OTI_e7450ae4-0e2f-4d23-b097-1fc6caea474f">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNDItMy0xLTEtNjM5OTI_dd4f97c7-253d-4506-a900-15687a3f7854">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Dividends declared included in accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNDMtMS0xLTEtNjM5OTI_2dad5770-f76a-4e27-ae0c-be7a63022d87">18,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNDMtMy0xLTEtNjM5OTI_f1ff7976-1726-4cbf-8551-8d75d447655f">19,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS&#8217; EQUITY (UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:30.030%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.444%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.563%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.983%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of<br/>Shares Issued</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Common Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Additional Paid-In <br/>Capital</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated Other <br/>Comprehensive Income</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Retained <br/>Earnings</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Treasury Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37fc307c3fff4012b03412aba9187bf6_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy0xLTEtMS02Mzk5Mg_4677a4c8-9aeb-4189-97f1-41662e6e1019">10,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fc307c3fff4012b03412aba9187bf6_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy0zLTEtMS02Mzk5Mg_6405a5c5-a437-414d-a973-9bb5671976a0">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21acf6f41c44ed8a91b90def6137e1b_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy01LTEtMS02Mzk5Mg_e618c08e-9e5f-4b48-8602-d38db2124ee5">21,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib645712f743642f7b14f17858412b113_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy03LTEtMS02Mzk5Mg_24594794-5c05-4e7a-9157-73f20746d441">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7a98f37c1e44fa184ad39aef19462ae_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy05LTEtMS02Mzk5Mg_89580fd7-94b9-4bbe-9cc4-6452590ea32d">139,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f0ba66dcb054c298b2f1218f9d34e61_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy0xMS0xLTEtNjM5OTI_b98d876c-ecd4-4a16-a8b0-c83716a68a73">6,398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy0xMy0xLTEtNjM5OTI_81a69ea0-1022-4fff-8649-bb107d1b1ecf">155,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9003a88c4844e8cbd52972e24a1d8e7_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNC05LTEtMS02Mzk5Mg_32ef50f0-a991-4d9c-ad87-c7d9a9faf30b">39,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNC0xMy0xLTEtNjM5OTI_e781d84c-0675-4872-8e33-1bfcdc88acb4">39,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNS0xLTEtMS02Mzk5Mg_029d9c5a-0c8e-4208-9c78-85136ac05159">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i760c27790b4a43b18f0947b1de071b7c_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNS01LTEtMS02Mzk5Mg_bb9fdeff-8c63-4d01-a8ef-35f84f933984">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNS0xMy0xLTEtNjM5OTI_95e4ddb2-c2bc-4783-bfc1-7831dcfd1c8a">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Options exercised by directors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi0xLTEtMS03MDA3NA_379c606f-8a5a-4be6-9fa9-cbaf98b8e575">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i760c27790b4a43b18f0947b1de071b7c_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi01LTEtMS03MDA3NA_40769683-e0e4-478c-8b74-fbc6439df8ad">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi0xMy0xLTEtNzAwNzQ_e6fb8a97-97d7-4a27-86a6-790bd48731a0">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for employee taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi0xLTEtMS02Mzk5Mg_4b02c1a0-fb5b-4e6c-bbc8-811037cc7ff3">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i760c27790b4a43b18f0947b1de071b7c_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi01LTEtMS02Mzk5Mg_158b1284-3a2e-4b43-bc8b-df945394ab89">3,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi0xMy0xLTEtNjM5OTI_f98091ad-f712-4519-9f91-742674df68da">3,236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25bf64baa4f84f3c91994cf68921d605_D20230101-20230331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNy0xMS0xLTEtNjM5OTI_f7128d7e-2916-4ec8-9923-b5286437e116">3,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNy0xMy0xLTEtNjM5OTI_5c787114-26e1-4d67-89cb-26b31e2e1827">3,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOC0xLTEtMS02Mzk5Mg_cdc17470-9e29-4b9f-84c8-504d0d4318a5">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9003a88c4844e8cbd52972e24a1d8e7_D20230101-20230331" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOC05LTEtMS02Mzk5Mg_43b286fa-ef41-4c13-9f45-dbd065dbc83a">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25bf64baa4f84f3c91994cf68921d605_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOC0xMS0xLTEtNjM5OTI_bc0298cc-8ea4-43d2-90ec-e150fc6bb3aa">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOC0xMy0xLTEtNjM5OTI_41103495-13ff-4e0f-be5d-174eabe67709">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff775d4fc8d945b78ba54e784502dc6f_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOS03LTEtMS02Mzk5Mg_3e1bffe8-0ed8-495b-ad91-7a7824a48653">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOS0xMy0xLTEtNjM5OTI_6931d6b1-64ae-486a-83a3-6b6b267f1c29">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9003a88c4844e8cbd52972e24a1d8e7_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTAtOS0xLTEtNjM5OTI_fe033119-0325-4010-be5d-2acfa3a9bd76">17,994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTAtMTMtMS0xLTYzOTky_2ce9551c-2893-4e85-b73d-12deb54eae36">17,994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31b8f688eea24545a396eeb0611d6e1b_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItMS0xLTEtNjM5OTI_cb4597e1-259f-4039-83cd-2e47fdd9aa11">10,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31b8f688eea24545a396eeb0611d6e1b_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItMy0xLTEtNjM5OTI_e18ce72d-b4fa-4c88-91f2-78c73dd9ebbf">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90030857661f4a4dbc4ccc740b7b79c0_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItNS0xLTEtNjM5OTI_6add389d-1fd0-49c0-a95e-57cad15d8c51">19,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8914dfcaa1404cf9af3e00a8b215faad_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItNy0xLTEtNjM5OTI_bac5aad6-5a49-47d8-b960-df0d9895ea43">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892b2a6455a84efea48207042eb47ebc_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItOS0xLTEtNjM5OTI_67df1006-a099-4a6e-9a60-b00d97f59011">151,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c9ff89193a54598a41c53bc8a2c8707_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItMTEtMS0xLTYzOTky_033a68e0-1948-41cf-945c-cd3f7c1da03a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItMTMtMS0xLTYzOTky_a4b42104-4f92-431d-9ac2-2972858a0c60">170,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three months ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of <br/>Shares Issued</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Common Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Additional Paid-In <br/>Capital</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Accumulated Other<br/>Comprehensive Income</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Retained <br/>Earnings</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Treasury Stock</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iddbcc131b7564ee995939796a3d726ad_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy0xLTEtMS02Mzk5Mg_a562ce85-15ad-4a16-9537-ca646b2695c3">11,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddbcc131b7564ee995939796a3d726ad_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy0zLTEtMS02Mzk5Mg_98980542-cfa4-41a8-bb4e-f0fbe21e6d24">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16778ba2b0e747a695b14af615208230_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy01LTEtMS02Mzk5Mg_97402bde-dac1-4fc7-b7a9-ba2fad696338">12,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad93c89a7e443da95e864cdcaff958e_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy03LTEtMS02Mzk5Mg_e77354c7-daa2-4a4f-ba10-4b2f9370af48">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i021a1b09c09b4f149bc661efb55a8579_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy05LTEtMS02Mzk5Mg_c39cd724-aadc-4032-9cfd-3c9261359ca6">190,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae2a9532cbe94c05a12c15c043307bc3_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy0xMS0xLTEtNjM5OTI_f31b1d84-221e-4d3d-93cd-cc1fe400f7a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14276493cdda4b5297135c9e43430126_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy0xMy0xLTEtNjM5OTI_d35d8c91-8f66-4a04-98ef-d234fc4648b3">202,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3245c01aff3346e8b0e93c38786ba422_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNC05LTEtMS02Mzk5Mg_9ac36722-e849-47de-95d4-2ca402767e69">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNC0xMy0xLTEtNjM5OTI_d5edf2a4-d679-45f7-a5d6-63cefdcba6a0">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib09b1a76e8224a0f8f66a0f0d89c5f8e_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNS0xLTEtMS02Mzk5Mg_72d3a75e-7140-4c7a-810e-10199f52bf92">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia03cb5ed3f53442c810b63d75610adee_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNS01LTEtMS02Mzk5Mg_9446d89f-2764-4864-b962-456f241382e3">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNS0xMy0xLTEtNjM5OTI_a1929e53-32f8-42e1-a495-72586ac9223e">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Net shares repurchased for employee taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib09b1a76e8224a0f8f66a0f0d89c5f8e_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNi0xLTEtMS02Mzk5Mg_2c364179-9fcb-44b2-96c3-dcf23ccbfbb5">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia03cb5ed3f53442c810b63d75610adee_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNi01LTEtMS02Mzk5Mg_694ea316-7537-4816-be43-39b4824531c8">1,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNi0xMy0xLTEtNjM5OTI_89c54c36-cc3e-4508-87e9-f27a2d011248">1,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock from stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iefab9b282eab46b6b9feb116dacd81f1_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNy0xMS0xLTEtNjM5OTI_311fddb9-f161-4605-8143-e67a7c90ce98">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNy0xMy0xLTEtNjM5OTI_f8fbaef6-836d-4ca7-b70f-2f06cb1287be">10,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Treasury stock retired from stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib09b1a76e8224a0f8f66a0f0d89c5f8e_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockSharesRetired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOC0xLTEtMS02Mzk5Mg_32b88def-0998-4d12-9f60-db5f929a4183">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3245c01aff3346e8b0e93c38786ba422_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOC05LTEtMS02Mzk5Mg_f825c24d-81c0-43de-b0b9-e50ce1334bf7">10,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefab9b282eab46b6b9feb116dacd81f1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOC0xMS0xLTEtNjM5OTI_3225903b-8eec-4ffd-ba8e-e29be318acf6">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:TreasuryStockRetiredCostMethodAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOC0xMy0xLTEtNjM5OTI_da337b19-073b-435c-b3f0-1a449eb0d388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aa7a26927a042ddb0c4efddb86c5947_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOS03LTEtMS03MDI4MA_28ef177c-658b-4596-a21d-20cb12b955fb">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOS0xMy0xLTEtNzAyODA_d638b980-ed2c-4309-9d94-a1cecf8bd98b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash dividends declared to stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3245c01aff3346e8b0e93c38786ba422_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOS05LTEtMS02Mzk5Mg_632e8fc4-5780-4be2-bac2-8dbcb55f50f2">19,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOS0xMy0xLTEtNjM5OTI_9766fb65-04ae-4f21-ad06-d5d264c93486">19,063</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifc4d87af6ad34ece906c185c57bc0f27_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItMS0xLTEtNjM5OTI_4b6e339e-9052-440e-826d-cc969052af23">11,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc4d87af6ad34ece906c185c57bc0f27_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItMy0xLTEtNjM5OTI_bdacbab6-3542-4a27-be91-70b9e55c2d45">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d859544afec4409b2dc5203bc73948f_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItNS0xLTEtNjM5OTI_c99b9bba-ed8b-464a-a871-06cf7489bd53">12,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63601fd2318848348fc1c8b45cb1f3a2_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItNy0xLTEtNjM5OTI_cac3c333-d1ac-4551-907b-57d22093e163">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13e17fd77c1a47b9b50510f8f141dfae_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItOS0xLTEtNjM5OTI_7d87ce73-60da-4abe-b643-7200dab3a8ae">203,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic44f166aec324147a4cca9c573b540dd_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItMTEtMS0xLTYzOTky_7fe12809-86ab-4edf-9527-5eaff7bb0362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItMTMtMS0xLTYzOTky_7fe3ffa8-ecfb-46dc-a996-33fb20c60721">216,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwMw_d3c34013-98f4-4eeb-b744-b949151e8651" continuedAt="i6d157f5a903044b899e58c82d1713a8b" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i6d157f5a903044b899e58c82d1713a8b"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwNA_a59e548a-e5ae-452e-adfe-9cf32280bd8d" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2022 has been derived from the 2022 audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (&#8220;2022 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2023. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2022 Form 10-K.</span></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzQ5OQ_4db03143-752c-4256-b658-a5d338846e47" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span></ix:nonNumeric></div><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwMA_364beb42-62b1-4bb9-9f12-db53f8ac6fbd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span></ix:nonNumeric></div><div style="margin-top:12pt;text-align:justify"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwMQ_015393d6-c4ba-4ec1-a257-0c5dc88ff65e" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwMg_c3869add-dc95-412f-a9ee-4e31791a7964" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not adopted any new accounting standards during the three months ended March 31, 2023. There are no recently issued accounting pronouncements that are expected to have a material effect on the Company&#8217;s financial position, results of operations, cash flows, or disclosures.</span></div></ix:nonNumeric></ix:continuation><div id="i7237206793d54e1ba85313ed02bd1f82_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RleHRyZWdpb246MzZiMTM2NTkwYmRhNDcxYzg1ZDM4Mzc5ZjgxMDNkODRfOTYy_66addeec-2695-4797-8579-c85d87b5a808" continuedAt="i2fca2374b66946efbef48df887c49e22" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="i2fca2374b66946efbef48df887c49e22"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#8217;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.</span></div><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RleHRyZWdpb246MzZiMTM2NTkwYmRhNDcxYzg1ZDM4Mzc5ZjgxMDNkODRfOTYx_cb0786aa-ad51-4caf-b3fc-0360de380da2" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfMi0xLTEtMS02Mzk5Mg_354d5120-cbf9-4bf1-94ec-592c3538f6ae">12,932</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfMi0zLTEtMS02Mzk5Mg_4f60997b-1d1f-4d20-ade5-8bd35b5c500b">12,670</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfMy0xLTEtMS02Mzk5Mg_3e226d2c-a6ea-4ccf-9726-c2e036fcdaed">4,296</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfMy0zLTEtMS02Mzk5Mg_2123c8f9-7e6a-4358-8659-f2b0ce604d26">3,611</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="med:InventoryNonFoodFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNC0xLTEtMS02Mzk5Mg_52db9456-928e-4e4f-ba85-75553694d3b2">7,032</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="med:InventoryNonFoodFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNC0zLTEtMS02Mzk5Mg_d597cc3b-bec8-4221-bc53-cae0fad40de0">8,738</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNS0xLTEtMS02Mzk5Mg_04c929a9-a402-4263-aeff-c87b7b5ad97e">78,825</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNS0zLTEtMS02Mzk5Mg_715e551f-a354-4a66-82d7-100c17d0e2d0">97,675</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNi0xLTEtMS02Mzk5Mg_5be3dbc1-d478-4f85-9246-5d801ed4a864">6,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNi0zLTEtMS02Mzk5Mg_dc070661-6a30-45e2-9753-5d4258985331">3,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNy0xLTEtMS02Mzk5Mg_bb48ca6e-0d85-49d6-9bc4-53e639b8368b">96,896</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNy0zLTEtMS02Mzk5Mg_da67312b-add8-4be2-9d6f-efa95c83cb07">118,856</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_40"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RleHRyZWdpb246NGFjNGIyYTc5MWNlNDM0NTlmZGYwODdmNjUxM2Y2ZGRfOTI0_b627ce7b-49d8-4929-8f03-4da4d188926f" continuedAt="i9d0923c092a849f5879988f134e3d3ef" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i9d0923c092a849f5879988f134e3d3ef" continuedAt="i2c40ec8f23bf4bbcaee31bbb96196bc5"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) computations are calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.</span></div><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RleHRyZWdpb246NGFjNGIyYTc5MWNlNDM0NTlmZGYwODdmNjUxM2Y2ZGRfOTIz_39a534bd-e3ac-4918-95d8-c6ce4b6dbf09" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:60.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.668%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfNC0xLTEtMS02Mzk5Mg_f4bbc9ec-5f7a-40c0-b57d-51aa37fa39fb">39,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfNC0zLTEtMS02Mzk5Mg_11aaddd7-aa59-481b-bb7f-171855ed1290">41,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfNy0xLTEtMS02Mzk5Mg_3c18fa10-50ed-4f2b-a3f5-2476724465d9">10,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfNy0zLTEtMS02Mzk5Mg_085122ee-ecd1-4a46-836b-6325d795b1e2">11,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfOC0xLTEtMS02Mzk5Mg_ca00e473-49f0-40b8-aad6-0dcefc93219e">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfOC0zLTEtMS02Mzk5Mg_c4d2a3d1-21cc-4aeb-b163-6e3bfebb9cac">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfOS0xLTEtMS02Mzk5Mg_4bb25aea-f751-46b8-9575-5a1a8918857c">10,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfOS0zLTEtMS02Mzk5Mg_c1a27197-0f32-453f-87f3-a5f4efcc291b">11,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfMTEtMS0xLTEtNjM5OTI_b4af2bf5-9b4e-47ad-b96f-26d71986fab9">3.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfMTEtMy0xLTEtNjM5OTI_6c2bca71-8cae-431a-87bc-8920cf384fb3">3.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfMTMtMS0xLTEtNjM5OTI_173a58bb-f9fa-4189-af9d-ebd80064b368">3.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfMTMtMy0xLTEtNjM5OTI_2def848c-1b0d-47ce-a0e4-4f988163e449">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2c40ec8f23bf4bbcaee31bbb96196bc5">The calculation of diluted EPS excluded <ix:nonFraction unitRef="shares" contextRef="ieba1e7bde05646528901c22163e8367a_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RleHRyZWdpb246NGFjNGIyYTc5MWNlNDM0NTlmZGYwODdmNjUxM2Y2ZGRfMjc0ODc3OTA3MDY2NQ_70488a0c-94ac-4dde-b827-86da997d5bce">13</ix:nonFraction> thousand and <ix:nonFraction unitRef="shares" contextRef="if9b32ff21de445638831a1796f077b25_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RleHRyZWdpb246NGFjNGIyYTc5MWNlNDM0NTlmZGYwODdmNjUxM2Y2ZGRfMjc0ODc3OTA3MDY2OQ_8204db4a-efb1-4254-88ca-ffa1fff74139">0</ix:nonFraction> thousand antidilutive restricted stock awards for the three months ended March 31, 2023 and 2022, respectively.</ix:continuation> </span></div><div id="i7237206793d54e1ba85313ed02bd1f82_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1Nw_956e7c5c-a1a2-482f-ac09-4acfb6067464" continuedAt="i1cb49427e25642f89295c13a4c77f044" escape="true">SHARE-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="i1cb49427e25642f89295c13a4c77f044" continuedAt="ifb4c2e0dd5a944ad87dc192978d51c74"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#8217;s common stock, and dividend yield. Options outstanding as of March&#160;31, 2023 generally vest over a period of <ix:nonNumeric contextRef="i7ae296ff6c0a4ed29838c825beaa94bb_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzQz_13823048-211d-412d-b9eb-024cb8f83ab1">3</ix:nonNumeric> years and expire <ix:nonNumeric contextRef="i7ae296ff6c0a4ed29838c825beaa94bb_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzQ3_5e8be6a0-da3f-42b4-9066-cf76e7bbea54">10</ix:nonNumeric> years from the date of grant. The exercise price of these options ranges from $<ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzUx_caa73177-03b8-45e7-8894-a50d13a3547f">26.52</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzU1_211830ef-c109-4c38-9a21-92f3468b8dc8">66.68</ix:nonFraction>. Due to the Company&#8217;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#8217;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the three months ended March 31, 2023 and 2022, the Company did <ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMTMyNw_bb7b5284-8e18-4b47-ad49-eb3550e69724"><ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMTMyNw_bc1a1ee7-9919-4182-8f8f-8605531b5e0d">no</ix:nonFraction></ix:nonFraction>t grant stock options. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><ix:continuation id="ifb4c2e0dd5a944ad87dc192978d51c74" continuedAt="ia982255653404b0083af46f15b353840"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1OA_9d2a79c5-38f8-4790-8f46-e6f47405bce7" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNC0xLTEtMS02Mzk5Mg_1704be9d-324c-4549-8589-0ef2f0124f14">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNC0zLTEtMS02Mzk5Mg_1f44176a-81c0-4918-b30f-d208e33e4625">54.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i14276493cdda4b5297135c9e43430126_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNC01LTEtMS02Mzk5Mg_8262a643-f8e1-478b-a860-4a3eb98362f2">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i14276493cdda4b5297135c9e43430126_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNC03LTEtMS02Mzk5Mg_020439f7-e22a-4118-b65b-f8a445a2bb0e">54.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNS0xLTEtMS02Mzk5Mg_deedf08f-fca7-427f-b701-1603d3a57cd7">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNS0zLTEtMS02Mzk5Mg_e3c1af7b-3c1b-479d-9770-6f20d0ed1922">27.18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNS01LTEtMS02Mzk5Mg_44b720b0-239a-4834-bfe0-2a18e43930c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNS03LTEtMS02Mzk5Mg_768c628a-29d5-423a-a833-4c8a1a8d22ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNi0xLTEtMS02Mzk5Mg_15905334-5296-467d-9072-e34ab7725892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNi0zLTEtMS02Mzk5Mg_5f2216c5-c697-443f-a5a6-0f3ab2722c88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNi01LTEtMS02Mzk5Mg_3658f182-45d7-4d04-a3d4-b6287616ce85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNi03LTEtMS02Mzk5Mg_26d50138-0d7c-47a5-a516-d07f4e71ffdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNy0xLTEtMS02Mzk5Mg_73b80b2f-ddf5-4c6a-95d1-d0d2fbde38cb">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNy0zLTEtMS02Mzk5Mg_a30ca2f2-e788-4775-a603-6707d1c608a5">58.65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNy01LTEtMS02Mzk5Mg_3b4be272-f992-40cc-b7d4-c290cb1da8ce">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNy03LTEtMS02Mzk5Mg_98bea1ae-5397-419b-8459-74879ee1c224">54.98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfOC0xLTEtMS02Mzk5Mg_8ea91b31-5305-4900-9913-e3259488e9ae">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfOC0zLTEtMS02Mzk5Mg_70116585-8c44-4437-90ea-7b7750eb876b">58.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfOC01LTEtMS02Mzk5Mg_a8a152ee-9e1e-4e88-b283-dbbc8aaf1ea6">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfOC03LTEtMS02Mzk5Mg_95ac87d2-6559-42aa-8a14-4932f39a38f7">52.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the weighted-average remaining contractual life for both the outstanding stock options and exercisable stock options was <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzY4_eb2d3463-0b50-4d2a-a3d8-7dabff25bf69"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzY4_eed523e7-9b2b-45a3-9bf2-be0165594b77">4.3</ix:nonNumeric></ix:nonNumeric> years with an aggregate intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzcy_29fbe8c2-9b07-428c-b910-112c5adec660"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzcy_aa852117-a50b-4aa4-819c-da9fc78a67ac">1.3</ix:nonFraction></ix:nonFraction> million. The compensation expense calculated under the fair value method for stock options was fully recognized as of March&#160;31, 2023. For the three months ended March 31, 2023, the Company received $<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDUy_d19ee621-ea39-4253-9487-e859e29c85b9">0.1</ix:nonFraction> million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the three months ended March 31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDU2_1fbb28b1-63de-4ea3-83cb-8efdba6f5dde">0.3</ix:nonFraction> million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to <ix:nonNumeric contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDcw_ae3b6a06-7a0c-467d-a7b2-410c3d92febd">5</ix:nonNumeric> years after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#8217;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.</span></div><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1Mw_27513e4a-82df-4ee5-b863-70ef957aa73c" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.617%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3a735cd0fee4e528a997870d8f0f709_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNC0xLTEtMS02Mzk5Mg_39d57b66-a1bc-45d2-9074-f313518b8f6a">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id3a735cd0fee4e528a997870d8f0f709_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNC0zLTEtMS02Mzk5Mg_17e4e69e-55a9-4023-84bc-3bf3f15ec09b">187.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb9683758726458fb14c1d50b204c772_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNC01LTEtMS02Mzk5Mg_b4cea386-64fe-4fff-80f6-e05a80fb96c6">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibb9683758726458fb14c1d50b204c772_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNC03LTEtMS02Mzk5Mg_f20089ba-a110-4c9c-a2e8-a24c4ea0375f">183.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNS0xLTEtMS02Mzk5Mg_af025444-3732-4822-bf16-c17ac9fc1991">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNS0zLTEtMS02Mzk5Mg_aa8e903f-9ebf-44a2-b7b9-c6880f7c628e">102.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNS01LTEtMS02Mzk5Mg_960b7779-6087-41f1-9541-c2e4eab240d3">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNS03LTEtMS02Mzk5Mg_177d5ce8-7a63-46e7-974e-07425e94b06e">175.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNi0xLTEtMS02Mzk5Mg_d83f5a09-d4b3-4850-b29d-13e8c2bb900c">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNi0zLTEtMS02Mzk5Mg_09b18f6d-d806-4955-a9e8-ee6176f9b331">163.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNi01LTEtMS02Mzk5Mg_50e588ae-9e7b-4c37-b40c-30151f40c1db">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNi03LTEtMS02Mzk5Mg_aa8d5adf-8b47-49ba-bb3b-7933a48edc38">149.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNy0xLTEtMS02Mzk5Mg_91c13cee-4b8f-421d-8a8c-18190a1df1a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNy0zLTEtMS02Mzk5Mg_7ec113f6-ce21-4229-aabc-80a347bbe57f">190.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNy01LTEtMS02Mzk5Mg_cd709c73-5f1f-4cec-8668-032e66cf0729">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNy03LTEtMS02Mzk5Mg_cb6a1bb3-a2ea-43af-a1fb-02ad3756e90f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia309ad2ca0aa4222af27696fc0425511_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfOC0xLTEtMS02Mzk5Mg_bfb3b322-a0a2-41ba-9e79-96e90c62f639">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia309ad2ca0aa4222af27696fc0425511_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfOC0zLTEtMS02Mzk5Mg_ed877922-e4f2-4a75-b011-36d33eb86d73">138.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6188f0dd58ad41dfb34e2a2f9bee3259_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfOC01LTEtMS02Mzk5Mg_62dddfeb-8e12-4f21-81de-237ee24213d0">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6188f0dd58ad41dfb34e2a2f9bee3259_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfOC03LTEtMS02Mzk5Mg_bf822a5f-1d24-468a-94bd-da3b1337c259">190.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company withheld approximately <ix:nonFraction unitRef="shares" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDc0_e7e95f8c-50bb-4e71-9f4a-194f783145bd">9</ix:nonFraction> thousand shares and <ix:nonFraction unitRef="shares" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDgy_df5caeed-6e9f-4ce1-83fb-d597901ac123">8</ix:nonFraction> thousand shares of the Company&#8217;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the three months ended March 31, 2023 and 2022, respectively. The total fair value of restricted stock awards vested during the three months ended March 31, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDkw_5baa649e-0597-45f0-abac-cc6a48c4f0f7">2.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNTAz_b372e6eb-faf7-42bd-8520-ca3a729745f7">3.2</ix:nonFraction> million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Performance-based Share Awards</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between <ix:nonFraction unitRef="number" contextRef="ic3dd7f52bc934c60b57c8561a32e45d5_D20230101-20230331" decimals="INF" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMzEyMg_3aa6a5fd-7a13-4ef6-9e26-7871a1dc5c69">0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9a5bf52113ef41b2935708b735e9ee0f_D20230101-20230331" decimals="INF" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMzEyOQ_c042b390-cab2-462a-b62e-142743122292">250</ix:nonFraction>% of the target number depending upon both the Company&#8217;s total stockholder return (&#8220;TSR&#8221;) and the Company&#8217;s performance against predetermined performance goals over a <ix:nonNumeric contextRef="i91137ee67f7f41ce9748d8db7d981c22_D20230101-20230331" name="med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1NA_b4539acc-919f-46df-8ee1-57822c19231e">three-year</ix:nonNumeric> performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#8217;s TSR are valued using the Monte Carlo method and are recognized ratably as expense over the award&#8217;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#8217;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period. In the event that management determines that the Company will not reach the lower threshold of the predetermined performance goals established in the grant agreement, any previously recognized expense is reversed in the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><ix:continuation id="ia982255653404b0083af46f15b353840" continuedAt="icd0a5cf524d54411afdfb8150e87af9d"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period in which such a determination is made. As of March 31, 2023, management determined that the market and performance-based share awards granted in 2022 would not reach the lower threshold of the predetermined performance goal resulting in a $<ix:nonFraction unitRef="usd" contextRef="iffbabdce70a34f2d8c8f4369464e6bf9_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMTA5OTUxMTYzOTQ5Nw_a52cc90a-c786-4ca4-b998-5c089457fd13">1.4</ix:nonFraction>&#160;million decrease in the Company&#8217;s share-based compensation expense for the three months ended March 31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for all types of awards granted is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1NQ_a887929d-4caf-4a4a-98ac-7de6e6990f48" continuedAt="i80fd5593b13a4ab4b4ff6ab1c7d44966" escape="true">The total expense during the three months ended March 31, 2023 and 2022  as follows (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i80fd5593b13a4ab4b4ff6ab1c7d44966"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ib5a00a160b774d91807d91918cf7ee46_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfMy0xLTEtMS02Mzk5Mg_2a6c5c18-5808-437b-9aec-4a9faa886764">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib5a00a160b774d91807d91918cf7ee46_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfMy0zLTEtMS02Mzk5Mg_078b00fc-ace5-41e7-a1c5-bfc5541f710f">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9b24326b642845e8b3857f0d21d79d19_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfMy01LTEtMS02Mzk5Mg_cd8b0935-d169-4c74-aef3-bdeb10769b1d">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9b24326b642845e8b3857f0d21d79d19_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfMy03LTEtMS02Mzk5Mg_51bac862-dd4a-451f-880a-3bc52951252e">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ie316187f7c484420a923ed9f350e11ca_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNC0xLTEtMS02Mzk5Mg_e22f48b3-8e81-42d8-9b21-d5c71b2c5e72">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie316187f7c484420a923ed9f350e11ca_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNC0zLTEtMS02Mzk5Mg_a7869d11-d6fd-42df-8cad-1af830a85ff4">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i720156933c7242888d839f8f81c4decf_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNC01LTEtMS02Mzk5Mg_9e8851e8-82c9-4f05-99b0-e92cb134a58c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i720156933c7242888d839f8f81c4decf_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNC03LTEtMS02Mzk5Mg_b8ecf4c2-e714-41fd-a73b-162d207a1cc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iffbabdce70a34f2d8c8f4369464e6bf9_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNS0xLTEtMS02Mzk5Mg_9ab6962b-d8cb-47ad-abf9-8f2e203c9b91">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="iffbabdce70a34f2d8c8f4369464e6bf9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNS0zLTEtMS02Mzk5Mg_32bb01ff-7578-42d8-81d9-0884101e623c">1,388</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i2f68ff9d37804516a004fa3fefa6e941_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNS01LTEtMS02Mzk5Mg_43673f1f-5a31-4fde-ad10-8022d78d5f56">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2f68ff9d37804516a004fa3fefa6e941_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNS03LTEtMS02Mzk5Mg_3291b098-5c53-4797-a932-63fc99ba6139">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ia4b5d53cd7024ad8b562648072669881_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNi0xLTEtMS02Mzk5Mg_38b2dba5-5747-4d96-9cf7-d057de4eb056">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia4b5d53cd7024ad8b562648072669881_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNi0zLTEtMS02Mzk5Mg_ec589d79-002b-4837-a80a-aa1728e18887">640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if84394c44eed4092ac896bf455a72df7_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNi01LTEtMS02Mzk5Mg_ac8befbf-b8cf-496c-9b66-36892339a3eb">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if84394c44eed4092ac896bf455a72df7_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNi03LTEtMS02Mzk5Mg_48513b63-d4e7-4dd4-bb24-ec4f534b45bb">640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ia665c39f19eb4a6a9d485acd05a18124_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNy0xLTEtMS02Mzk5Mg_3bade896-aed0-4c95-bc5f-8e9b3df9f993">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia665c39f19eb4a6a9d485acd05a18124_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNy0zLTEtMS02Mzk5Mg_fb481938-4601-4195-a8da-51928468c8b0">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i3f1aab26e7984ccaba10e7aa1ad24c41_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNy01LTEtMS02Mzk5Mg_c9f0d78b-d249-469c-9755-7c5e17fcd310">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3f1aab26e7984ccaba10e7aa1ad24c41_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNy03LTEtMS02Mzk5Mg_d8cdd3c5-5f34-48ca-b094-716583e44491">469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfOC0xLTEtMS02Mzk5Mg_d2407c31-fda7-4da6-932d-cd5aed6e4676">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfOC0zLTEtMS02Mzk5Mg_19e76b58-ce1b-46ed-922e-726d5c74046e">606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfOC01LTEtMS02Mzk5Mg_5d104555-f34c-4b82-b4b7-e90b7f59b725">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfOC03LTEtMS02Mzk5Mg_e5a2c696-7bdc-442d-b5d2-e606936b984e">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><ix:continuation id="icd0a5cf524d54411afdfb8150e87af9d"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company withheld approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="iab840a0209b94086be8b0d816f977bc2_D20230101-20230331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjc0ODc3OTA4MDUxMg_8a107ab8-07b6-4dcc-a582-e4068f521c4a">21</ix:nonFraction> thousand shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company&#8217;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of market and performance-based share awards for the three months ended March 31, 2023. <ix:nonFraction unitRef="shares" contextRef="i6dba0507dc5141659a87360e36adc332_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjE5OTAyMzI2NzI0OA_ffe7f003-6ad7-4419-98ac-eaa1d9f417af">No</ix:nonFraction> market and performance-based share awards vested and <ix:nonFraction unitRef="shares" contextRef="i6dba0507dc5141659a87360e36adc332_D20220101-20220331" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjE5OTAyMzI2NzIzOA_c770babf-9b86-4f34-925e-96c41ba4ba4d">no</ix:nonFraction> shares were withheld to cover minimum tax liability withholding obligations for the three months ended March 31, 2022. The total fair value of market and performance-based share awards vested during the three months ended March 31, 2023 and 2022 was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iab840a0209b94086be8b0d816f977bc2_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjc0ODc3OTA4MDUyNQ_04723b81-1053-49bf-8cb2-9188e3f3e0f0">5.3</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $<ix:nonFraction unitRef="usd" contextRef="i6dba0507dc5141659a87360e36adc332_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjc0ODc3OTA4MDUzMw_dcab1ba7-1d3d-495d-936a-5c8bea9d1ce0">0</ix:nonFraction>, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was $<ix:nonFraction unitRef="usd" contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIyNTg3_cf1db5f7-1116-4684-bcec-980f1e28218a">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIyNTc5_bc36fa5c-6418-4e64-90e1-4d6ed1817d3e">0.5</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was $<ix:nonFraction unitRef="usd" contextRef="ia309ad2ca0aa4222af27696fc0425511_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjMz_3af864b2-bd38-4a0e-a906-8bc997293b33">11.7</ix:nonFraction> million of total unrecognized compensation cost related to restricted stock awards as of March&#160;31, 2023, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjQ5_1819a1e4-b6c2-4a71-a2bc-13bbf0b7abeb">2.4</ix:nonNumeric> years. There was $<ix:nonFraction unitRef="usd" contextRef="i7752400214154be7a3da22c4ede6da41_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjY1_96c3d790-49d4-4c74-829f-267c1e565efa">10.5</ix:nonFraction> million of unrecognized compensation costs related to the <ix:nonFraction unitRef="shares" contextRef="i91137ee67f7f41ce9748d8db7d981c22_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjY5_3788c82e-ea6a-411d-a5ce-715141994636">91</ix:nonFraction> thousand market and performance-based shares presented in the table above as of March&#160;31, 2023, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i91137ee67f7f41ce9748d8db7d981c22_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjYx_cab9d7d0-847d-4d34-b691-af42edcb6c23">2.2</ix:nonNumeric> years.</span></div></ix:continuation><div id="i7237206793d54e1ba85313ed02bd1f82_46"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMTM4Mg_1ea2f3c9-c2ad-4d6c-be2f-a0f4d2de1d5b" continuedAt="i26128d901b77411eafa6a05136d4e0f7" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i26128d901b77411eafa6a05136d4e0f7" continuedAt="i62e51c11e2e8427292215c31f38b9c16"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#8217;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of March&#160;31, 2023 and 2022, respectively, or for the three-month periods then ended, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases relating to office and warehouse space have lease terms of <ix:nonNumeric contextRef="i584845803f224e90963b306cfaa8a708_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg1MQ_82fe2616-b494-43e6-8a34-1abed71521a9">19</ix:nonNumeric> months to <ix:nonNumeric contextRef="iaca1e5bf2df0432fbcfc2e5ee7e5e7d6_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg1NQ_5be92ac0-f46d-47b8-a500-317d4573dc3e">122</ix:nonNumeric> months. Our leases relating to equipment have lease terms of <ix:nonNumeric contextRef="i17778c8c21984c959271d0d7cbc7d47a_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg1OQ_b70864ad-acf9-4f33-8c8b-34cf36e5496a">24</ix:nonNumeric> months to <ix:nonNumeric contextRef="if51850419cba458da16f0e96e36a1e6c_I20230331" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg2Mw_ad7e46c9-1e98-4f37-8ad9-c6c6def4bb5f">203</ix:nonNumeric> months, with certain of them having automatic renewal clauses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are recognized as expenses when they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg2Nw_eb398716-08ef-40ef-a23c-7a6c9a07bed9">1.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg3MQ_bcbe1ee7-77b4-44d6-ad5d-c3dac97bacab">1.8</ix:nonFraction>&#160;million for the three months ended March 31, 2023 and 2022, respectively.</span></div><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMTM4NA_61bef8cf-e89e-4dbc-91f4-e7a2f8f83427" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:63.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.905%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOmE5MzViNDAwNjFjODQ4YWJhZjlhMTZlNWZjNDY0OTk3L3RhYmxlcmFuZ2U6YTkzNWI0MDA2MWM4NDhhYmFmOWExNmU1ZmM0NjQ5OTdfNC0xLTEtMS02Mzk5Mg_d9703362-b703-4633-86e6-91c5da143e3b">1,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOmE5MzViNDAwNjFjODQ4YWJhZjlhMTZlNWZjNDY0OTk3L3RhYmxlcmFuZ2U6YTkzNWI0MDA2MWM4NDhhYmFmOWExNmU1ZmM0NjQ5OTdfNC0zLTEtMS02Mzk5Mg_01d5c35e-1b83-4935-8cdd-83a7914dde8b">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOmE5MzViNDAwNjFjODQ4YWJhZjlhMTZlNWZjNDY0OTk3L3RhYmxlcmFuZ2U6YTkzNWI0MDA2MWM4NDhhYmFmOWExNmU1ZmM0NjQ5OTdfNy0xLTEtMS02Mzk5Mg_558eb29b-aba9-48fd-ac07-43e2ed574d2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOmE5MzViNDAwNjFjODQ4YWJhZjlhMTZlNWZjNDY0OTk3L3RhYmxlcmFuZ2U6YTkzNWI0MDA2MWM4NDhhYmFmOWExNmU1ZmM0NjQ5OTdfNy0zLTEtMS02Mzk5Mg_5ec2bed0-0d44-4c36-bb38-b121ec6480db">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the weighted average remaining lease term was <ix:nonNumeric contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDkzMA_59da69de-63ed-4fa3-9e45-40a8bf216bf1">4 years, 7 months</ix:nonNumeric> and the weighted average discount rate was <ix:nonFraction unitRef="number" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDk1NQ_8e7229df-0f77-41e7-86a3-4978efc2ee8d">2.00</ix:nonFraction>%.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><ix:continuation id="i62e51c11e2e8427292215c31f38b9c16"><ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMTM4NQ_c8b21171-9fbc-4c25-bcf1-6201a16415cd" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of March&#160;31, 2023 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:81.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023 (excluding the three months ended March&#160;31, 2023)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfMC0xLTEtMS02Mzk5Mg_2b9b611b-b501-49ac-8c4e-e7b1a5c6fb28">4,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfMS0xLTEtMS02Mzk5Mg_2f89c93b-874f-4b38-a850-0d2105d9479b">5,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfMi0xLTEtMS02Mzk5Mg_cb909eb8-991c-4066-9bfd-1c09694adaac">5,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfMy0xLTEtMS02Mzk5Mg_6250f3fb-be56-4276-aeed-0eab644f51cb">4,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfNC0xLTEtMS02Mzk5Mg_2c1f2081-815b-4367-8dd1-fd126dd613bc">2,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="med:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfNS0xLTEtMS02Mzk5Mg_79da8014-91e8-4ef3-9bae-8a32f65bfd05">2,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfNi0xLTEtMS02Mzk5Mg_e63d8b20-1570-4dad-b361-cddd02b2f667">25,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfNy0xLTEtMS02Mzk5Mg_fdea9399-f676-4294-9397-ca740d7b7d61">1,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfOC0xLTEtMS02Mzk5Mg_361f7dea-c2cc-4aff-a449-3a22b8a3ed4d">24,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i7237206793d54e1ba85313ed02bd1f82_49"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80OS9mcmFnOjlhN2RmM2IyOGM1NTQxMGM4ODE2Mzg0NjNmY2QyNDE1L3RleHRyZWdpb246OWE3ZGYzYjI4YzU1NDEwYzg4MTYzODQ2M2ZjZDI0MTVfMTgw_813ce9b1-1dc8-4a5a-bdd9-b46630c68246" continuedAt="ib305a731a5c249dfae813d2b01ae26ce" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib305a731a5c249dfae813d2b01ae26ce">Accumulated other comprehensive income, net of tax, was comprised of $<ix:nonFraction unitRef="usd" contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80OS9mcmFnOjlhN2RmM2IyOGM1NTQxMGM4ODE2Mzg0NjNmY2QyNDE1L3RleHRyZWdpb246OWE3ZGYzYjI4YzU1NDEwYzg4MTYzODQ2M2ZjZDI0MTVfMTIwOTQ2Mjc5MDYxMDE_ba453692-97f7-4893-8310-0a60e404d95c">33</ix:nonFraction> thousand of foreign currency translation as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80OS9mcmFnOjlhN2RmM2IyOGM1NTQxMGM4ODE2Mzg0NjNmY2QyNDE1L3RleHRyZWdpb246OWE3ZGYzYjI4YzU1NDEwYzg4MTYzODQ2M2ZjZDI0MTVfMTIwOTQ2Mjc5MDYwNzM_8e6af25c-57d7-42d7-ae9b-ec6486fe3e54">24</ix:nonFraction> thousand of foreign currency translation as of December&#160;31, 2022.</ix:continuation></span></div><div id="i7237206793d54e1ba85313ed02bd1f82_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMzQ0MA_9b52ca52-dfdd-4d78-8fc4-fa9a1c0c658c" continuedAt="ib148cab9d2d849aeb14e5edf167b0175" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="ib148cab9d2d849aeb14e5edf167b0175"><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement (the &#8220;Credit Agreement&#8221;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (&#8220;SOFR&#8221;), from London Inter-Bank Offered Rate (LIBOR) (the &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement provides for a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i7c0fd591c6d54c788d05c4d43bfe45e2_I20210413" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzAyNw_b5652277-8c3c-4c2e-8ed6-2de668f8a8ea">225.0</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> senior secured revolving credit facility with a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i813dd19e7bc04cd4b34c1ac0e2f5b4fc_I20210413" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA0MQ_ff4c8891-1867-440c-be1f-f3e23d4c49d1">20.0</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="i7e4639f404b746da9129538a34b70a01_I20210413" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA0OQ_fcc2b213-5a63-468b-9e8a-53fd4b55462e">100.0</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Amended Credit Agreement matures on April&#160;13, 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from <ix:nonFraction unitRef="number" contextRef="ie0292eae6d68435581e1a1cb655cb025_D20210413-20210413" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA1Nw_f888990f-6440-41b2-be9e-638905c545c6">0.20</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="idcfc7ba03ed44069a73caf1bc4436006_D20210413-20210413" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA2OA_4da8f3eb-b4d1-43b9-b184-843f388ae30d">0.40</ix:nonFraction>% per annum depending on the Company&#8217;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#8217;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#8217;s Total Net Leverage Ratio. As of March&#160;31, 2023, the Applicable Rate for Term SOFR Loans is <ix:nonFraction unitRef="number" contextRef="ia9c24ad6f6bc453d97165b16303e0845_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA3Mg_6e02750d-3050-40b5-aeaa-27ecb6f9e279">1.25</ix:nonFraction>% per annum and the Applicable Rate for ABR Loans is <ix:nonFraction unitRef="number" contextRef="i87cc27821ccd42ed968755b54c044371_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA3Ng_c3c9b51d-6c26-4618-b673-dc4c561267eb">0.25</ix:nonFraction>% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than <ix:nonFraction unitRef="number" contextRef="i55a3deca29144b558d038563d063d0e5_I20210413" decimals="INF" name="med:MaximumTotalNetLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA4MA_1a7929eb-9690-465c-b2b5-8242e3d5d643">2.75</ix:nonFraction> to 1.00 and an Interest Coverage Ratio of at least <ix:nonFraction unitRef="number" contextRef="i55a3deca29144b558d038563d063d0e5_I20210413" decimals="INF" name="med:MinimumInterestCoverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA4OA_28206700-ed69-46ad-835c-fb8976be1371">3.50</ix:nonFraction> to 1.00.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="usd" contextRef="idf71ad0c5ed640be905a819b87cf32f5_I20230331" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMzM2OQ_62dcfe8d-2ec2-42c7-b9a4-fb45a4ed8c49">no</ix:nonFraction> borrowings outstanding under the Amended Credit Agreement as of March&#160;31, 2023.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note Regarding Forward-Looking Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information in this report contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Act&#8221;). These forward-looking statements generally can be identified by use of phrases or terminology such as &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;expect&#8221; or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of our management and are subject to certain events, risks, uncertainties and other factors. These risks and uncertainties include, but are not limited to, those described in our 2022 Form 10-K and those described from time to time in our future reports filed with the SEC. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this report. All of the forward-looking statements contained herein speak only as of the date of this report.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and related notes appearing elsewhere herein.</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medifast is the global company behind one of the fastest-growing health and wellness communities, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which offers Lifelong Transformation, One Healthy Habit at a Time</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company&#8217;s growth over the past few years is a reflection of its unique Coach-driven approach, which stands out in a world where health and wellbeing is too often a difficult and lonely journey.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medifast is often compared to diet and weight loss-only companies or to multi-level marketing companies, but our model is different. In November 2022, we announced that Medifast's </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA program was named the #1 weight loss program in the U.S. by revenue for 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We believe our growth is demonstrated by strong financial performance over the last several years. We generated revenue of $1,599 billion in 2022, $1,526 billion in 2021 and $934.8 million in 2020, representing year-over-year increases of 4.8% in 2022 and 63.2% in 2021. Income from operations was $184.8 million in 2022, $216.2 million in 2021 and $134.2 million in 2020, representing a year-over-year decrease of 14.5% in 2022 and increase of 61.2% in 2021.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA brand offers a highly competitive and effective lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The program is built around four key components:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Independent OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Coaches: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provide individualized support and guidance to customers on the path to optimal health and wellbeing.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Community</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Community of like-hearted people providing each other with real-time connection and support.</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">The Habits of Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Transformational System:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A proprietary system which offers easy steps to a sustainably healthy lifestyle. </span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Products &amp; Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clinically proven plans and scientifically developed products, called &#8220;Fuelings,&#8221; backed by dietitians, scientists and physicians.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We help customers achieve their health goals through a network of approximately 58,700 independent active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches, about 90% of whom were customers first, and have impacted more than 3 million lives to date. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches introduce customers to a set of healthy habits, in most cases starting with the habit of healthy eating, and offer exclusive </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA-branded Fuelings. Fuelings are nutrient-dense, portion-controlled, nutritionally interchangeable and simple to use. They are formulated with high-quality ingredients and are fortified with probiotic BC30&#8482; cultures, vitamins and minerals, as well as other nutrients essential for good health. Our products support the process of integrating healthy habits into our customers&#8217; day-to-day lives.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> Source Euromonitor International Limited; based on custom research conducted in Q2 2022; value sales for structured weight loss and meal replacement programs in 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA coaching model is customer-centric and boasts an energized health and wellness community. It promotes holistic health and wellness and positions healthy weight as a catalyst to greater lifestyle changes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches provide personalized support to customers and motivate them by sharing their passion for healthy living and lifestyle transformation. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The entrepreneurial spirit of our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches is another key to our success, as they create a continuous cycle of growth, activating new customers, many of whom go on to become </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches. We offer economic incentives designed to support each </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach&#8217;s long-term success, which we believe plays an important role in their financial wellness, providing the opportunity to improve their finances while changing the health trajectory of families, communities and generations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches are independent contractors, not employees, who support customers and market our products and services primarily through word of mouth, email and social media channels such as Facebook, Instagram, Twitter and video conferencing platforms. As entrepreneurs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches market our products to friends, family and other acquaintances.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA products are shipped directly to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA customers who are working with an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coach. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches do not handle inventory or deliver merchandise to customers. This arrangement frees our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches from having to manage inventory and allows them to maintain an arms-length transactional relationship while focusing their attention on support and encouragement.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure our success by the results our customers are able to achieve. The more </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches we have, the more customers we can serve. We believe our Coach-based model is scalable and drives both customer success and growth. We expect our continued investment in fostering a robust community around our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA brand and Coaching Model will continue to drive a sustainable, repeatable business rhythm focused on our mission of offering the world Lifelong Transformation, One Healthy Habit at a Time.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are conducted through our wholly owned subsidiaries, Jason Pharmaceuticals, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Seven Crondall Associates, LLC, Corporate Events, Inc., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA (Hong Kong) Limited, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA (Singapore) PTE. LTD and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Health Consultation (Shanghai) Co., Ltd.</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Macroeconomic Conditions </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Global economic challenges including the impact of rising inflation, adverse labor market conditions, the war in Ukraine and the continuing impact of the COVID-19 pandemic have caused macroeconomic uncertainty and volatility in markets where we, our suppliers and our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches operate. These uncertainties make it challenging for our management to estimate our future business performance.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to market risks from changes in commodity or other raw material prices. Rising inflation could impact our cost structure and put pressure on consumer spending. Increases in commodity prices or food costs, including as a result of inflation, could affect the global and U.S. economies and could also adversely impact our business, financial condition or results of operations. Our variable cost structure can be utilized to adapt to changing market conditions with potential actions including adjustments to our manufacturing, distribution and customer support infrastructure. In addition, adverse labor market conditions could constrain our ability to manufacture and deliver products or increase the associated costs. We continue to take steps to attract, train, and develop personnel. As a response, we may periodically take incremental pricing actions to offset supply chain costs, inflationary pressures, and adverse labor market conditions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, beginning in February 2022, the war in Ukraine and corresponding events have had, and could continue to have, adverse effects on regional and global markets. While our operations are not directly impacted by the war in Ukraine, the duration of hostilities and the vast array of sanctions and related events (including cyberattacks) cannot be predicted. As a result, those events present uncertainty and risk. To date, the war in Ukraine has had no material impact on our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and the related adverse public health developments have adversely affected workforces, economics, and financial markets globally, leading to uncertainty and an economic downturn. Our manufacturing and distribution facilities remained fully operational during the pandemic, and we have not experienced any meaningful disruption to our worldwide supply chain due to the pandemic. However, management continues to monitor the situation.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:115%;position:relative;top:-2.8pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA makes no guarantee of financial success. Success with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA results from successful sales efforts, which require hard work, diligence, skill, persistence, competence, and leadership. Please see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA Income Disclosure Statement (http://bit.ly/ids</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">VIA) for statistics on actual earnings of Coaches.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to changing macroeconomic conditions, the Company may take further actions that alter its business operations as may be required by governmental authorities, or that are determined to be in the best interests of employees, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIA Coaches and customers.</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of our financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Management develops, and changes periodically, these estimates and assumptions based on historical experience and on various other factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. There were no significant changes in our critical estimates during the first three months of 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited condensed consolidated financial statements are prepared in accordance with GAAP. Our significant accounting policies are described in Note 2 to the audited consolidated financial statements included in the 2022 Form 10-K. We consider all of our significant accounting policies and estimates to be critical. During Q1 2023 we made a change to our customer terms and conditions (&#8220;Customer T&amp;Cs&#8221;) that resulted in a change to our revenue recognition policy which is described below. There were no other significant changes in our critical accounting policies during the first three months of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue Recognition: Our revenue is derived primarily from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other healthy living products. Prior to a change in our Customer T&amp;Cs in the first quarter of 2023, revenue was recognized upon receipt by the customer and net of discounts, rebates, promotional adjustments, price adjustments, allocated consideration to loyalty programs, and estimated returns. Upon the change of our Customer T&amp;Cs, revenue is now recognized upon delivery to the shipping carrier and net of discounts, rebates, promotional adjustments, price adjustments, allocated consideration to loyalty programs, and estimated returns. The impact of this change to the quarter ended March 31, 2023 is an increase of approximately $9.1 million in revenue and $2.8 million of income from operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue is recognized when control of the promised products is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for transferring those products. When determining whether the customer has obtained control of the products, we consider any future performance obligations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers. A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, each performance obligation is satisfied. Our contracts have performance obligations to fulfill and deliver products from the point of sale transaction along with the related customer reward programs.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our performance obligations are satisfied at a point in time. Revenue from products transferred to customers at a point in time accounted for substantially all of our revenue for the three months ended March 31, 2023 and 2022. Revenue on these contracts is recognized when the obligations under the terms of the contract with our customer are satisfied. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our return policy allows for customer returns of consumable products within 30 days of purchase and upon our authorization. We adjust revenues for the products expected to be returned and a liability is recognized for expected refunds to customers. We estimate expected returns based on historical levels and project this experience into the future.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our sales contracts may give customers the option to purchase additional products priced at a discount. Options to acquire additional products at a discount can come in many forms, such as customer reward programs and incentive offerings including pricing arrangements, and promotions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We reduce the transaction price for certain customer reward programs and incentive offerings including pricing arrangements, promotions, and incentives that represent variable consideration and separate performance obligations. The Company accounts for sales rewards that provide the customer with a material right as a separate performance obligation of the transactions, and therefore allocates consideration between the initial sale of products and the customer reward program and incentive offering.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amounts billed to customers for shipping and handling activities are treated as a promised service performance obligation and are recorded as revenue in our Consolidated Statements of Income upon fulfillment of the performance obligation. Shipping and handling costs incurred by the Company for the delivery of products to customers are considered a cost to fulfill the contract and are included in cost of sales in our Consolidated Statements of Income.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We expense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">VIA Coach compensation and credit card fees during the period in which the corresponding revenue is earned. These costs are recorded in selling, general and administrative expense in our Consolidated Statements of Income.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Results of Operations</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product sales accounted for approximately 98% of our revenues for each of the three months ended March 31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables reflect our income statements (in thousands, except percentages):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$ Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">% Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">348,983</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">417,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68,617)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">102,593</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">115,314</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">246,390</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">302,286</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(55,896)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(18.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">192,879</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">247,199</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,320)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">53,511</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">55,087</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,576)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(181)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(95)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other expense</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(16)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(182)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(111)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">53,329</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">54,976</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,647)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(3.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">13,361</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">13,195</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">39,968</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">41,781</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,813)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%;text-decoration:underline">% of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Revenue:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Revenue decreased $68.6 million, or 16.4%, to $349.0 million for the three months ended March 31, 2023 from $417.6 million for the three months ended March 31, 2022. The average revenue per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">VIA Coach was $5,945 for the three months ended March 31, 2023 compared to $6,536 for the three months ended March 31, 2022. The decline in revenue for the three months ended March 31, 2023 was primarily driven by a decrease in the number of active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">VIA Coaches to 58,700 as of March&#160;31, 2023 from 63,900 as of March&#160;31, 2022 and the decline in the productivity per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">VIA Coach, partially offset by a $9.1 million impact from a timing difference related to changes in the Company&#8217;s sales order terms and conditions with its customers. The decrease in productivity per active earning </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OPTA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">VIA Coach for the quarter was driven by continued pressure on customer acquisition, partially offset by a price increase implemented in November 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of sales:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cost of sales decreased $12.7 million, or 11.0%, to $102.6 million from $115.3 million for the three months ended March 31, 2023 from the corresponding period in 2022. The decrease in cost of sales for the three months ended March 31, 2023 was primarily driven by decreased volumes, partially offset by higher product costs resulting from inflationary pressures on raw ingredient costs, shipping costs, and labor costs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross profit:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended March 31, 2023, gross profit decreased $55.9 million, or 18.5%, to $246.4 million from $302.3 million for the three months ended March 31, 2022. The decrease in gross profit for the three months ended March 31, 2023 was due to lower revenue as well as cost inflation from raw ingredient costs, shipping costs, and labor costs. As a percentage of revenue, gross profit decreased 178 basis points to 70.6% for the three months ended March 31, 2023 from 72.4% </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the corresponding period in 2022. The decrease in gross profit as a percentage of revenue for the three months ended March 31, 2023 is due to deleveraging of fixed costs due to lower volumes, product cost inflation, and the impact of a program in January aimed at driving customer acquisition.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Selling, general, and administrative:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SG&amp;A expenses were $192.9 million for the three months ended March 31, 2023, a decrease of $54.3 million, or 22.0%, as compared to $247.2 million from the corresponding period in 2022. As a percentage of revenue, SG&amp;A expenses were 55.3% for the three months ended March 31, 2023 as compared to 59.2% for the corresponding period in 2022. SG&amp;A expenses included research and development costs of $1.0 million and $0.9 million for the three months ended March 31, 2023 and 2022, respectively, in connection with the development of new products, programs and clinical research activities. The decrease in SG&amp;A expenses for the three months ended March 31, 2023 was primarily due to progress on several cost reduction and optimization initiatives as well as decrease Coach compensation due to lower volumes and fewer active earning Coaches.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income from operations:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the three months ended March 31, 2023, income from operations decreased $1.6 million to $53.5 million from $55.1 million for the corresponding period in 2022 primarily as a result of decreased gross profit partially offset by decreased SG&amp;A expenses. Income from operations as a percentage of revenue increased to 15.3% for the three months ended March 31, 2023 from 13.2% for the corresponding period in 2022 due to the factors described above impacting revenue and SG&amp;A expenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Provision for income taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> For the three months ended March 31, 2023, the Company recorded $13.4 million in income tax expense, an effective tax rate of 25.1%, as compared to $13.2 million in income tax expense, an effective tax rate of 24.0%, for the three months ended March 31, 2022. The increase in the effective tax rate for the three months ended March 31, 2023 was primarily driven by an increase in the limitations on executive compensation and meals and entertainment costs as well as other items partially offset by an increase in the tax benefit for research and development tax costs.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net income: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net income was $40.0 million, or $3.67 per diluted share for the three months ended March 31, 2023 as compared to $41.8 million, or $3.59 per diluted share, for the three months ended March 31, 2022. The period-over-period changes were driven by the factors described above in the section titled &#8220;Income from operations.&#8221;</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_82"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company had stockholders&#8217; equity of $170.9&#160;million and working capital of $98.6&#160;million at March&#160;31, 2023 as compared with $155.0&#160;million and $81.9&#160;million at December&#160;31, 2022, respectively. The $15.9&#160;million net increase in stockholders&#8217; equity reflects $40.0&#160;million in net income for the three months ended March 31, 2023 offset by $3.6 million used for repurchases of the Company&#8217;s common stock and $18.0&#160;million for declared dividends paid to holders of the Company&#8217;s common stock as well as the other equity transactions described in the &#8220;Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity&#8221; included in this report. On March 16, 2023, the Company declared a quarterly dividend of $1.65 per share payable on May 9, 2023, to stockholders of record as of March 28, 2023. While we intend to continue the dividend program and believe we will have sufficient liquidity to do so, we can provide no assurance that we will be able to continue to declare and pay dividends. The Company&#8217;s cash, and cash equivalents increased from $87.7&#160;million at December&#160;31, 2022 to $123.7&#160;million at March&#160;31, 2023. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash provided by operating activities increased by $20.4&#160;million to $64.1&#160;million for the three months ended March 31, 2023 from $43.7&#160;million for the three months ended March 31, 2022 primarily driven by a $30.9&#160;million increase related to changes in  inventory balances, a $3.5&#160;million increase in prepaid expenses and other current assets and a $5.7&#160;million increase in other assets, partially offset by a reduction in net income, a $1.7 million reduction in share-based compensation, a $15.8 million reduction in accounts payable and accrued expenses and a $1.5&#160;million reduction in income taxes payable. We decreased our inventory purchases during the period ended March&#160;31, 2023 to align with sales demand. Accounts payable and accrued expenses decreased due to the timing of payments.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in investing activities was $2.1 million for the three months ended March 31, 2023 as compared to $1.8 million for the three months ended March 31, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Net cash used in financing activities decreased by $2.2&#160;million to $25.9 million for the three months ended March 31, 2023 from $28.1 million for the three months ended March 31, 2022. This decrease was primarily due to a $6.4&#160;million decrease in repurchases of the Company's common stock, partially offset by a $1.8 million increase in net shares repurchased for employee taxes and a $2.5 million increase in cash dividends paid to stockholders. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In pursuing its business strategy, the Company may require additional cash for operating and investing activities. The Company expects future cash requirements, if any, to be funded from operating cash flow and financing activities.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time the Company evaluates potential acquisitions that complement our business. If consummated, any such transactions may use a portion of our working capital or require the issuance of equity or debt. We have no present understandings, commitments or agreements with respect to any material acquisitions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on SOFR, from LIBOR (the &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement provides for a $225.0&#160;million senior secured revolving credit facility with a $20.0&#160;million letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to $100.0&#160;million. The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to credit facilities. As of March&#160;31, 2023, the Company had no borrowings under the credit facility and was in compliance with all of its debt covenants.</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Market risk is the potential loss arising from adverse changes in market rates and prices, such as interest rates and a decline in the stock market. The Company does not enter into derivatives, foreign exchange transactions or other financial instruments for trading or speculative purposes.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is exposed to market risk related to changes in interest rates and market pricing impacting our credit facility. The Company does not have any outstanding borrowings or investments at March&#160;31, 2023, and therefore it would not expect its operating results or cash flows to be affected to any significant degree by the effect of a change in market conditions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes to our market risk exposure since December&#160;31, 2022.</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_88"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Management, including our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Act, as amended, as of March&#160;31, 2023. Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Act is recorded, processed, summarized and reported accurately and on a timely basis. Based on this evaluation performed in accordance with the criteria established in the 2013 Internal Control &#8211; Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission, our management concluded that the Company&#8217;s disclosure controls and procedures are effective at the reasonable assurance level as of the end of the period covered by this report.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Act) during the fiscal quarter ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:21.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Part II Other Information</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_94"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is, from time to time, subject to a variety of litigation and similar proceedings that arise out of the ordinary course of its business. Based upon the Company&#8217;s experience, current information and applicable law, it does not believe that these proceedings and claims will have a material adverse effect on its results of operations, financial position or liquidity. However, the results of legal actions cannot be predicted with certainty. Therefore, it is possible that the Company&#8217;s results of operations, financial condition or cash flows could be materially adversely affected in any particular period by the unfavorable resolution of one or more legal actions.</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_97"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There have been no material changes to the risk factors set forth in Part I, Item 1A of the 2022 Form 10-K.</span></div><div id="i7237206793d54e1ba85313ed02bd1f82_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:19.826%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.264%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.488%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Average Price Paid per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total Number of Shares Purchased<br/>as Part of a Publicly Announced<br/>Plan or Program</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Maximum Number of Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Yet Be Purchased Under the Plans or Programs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:115%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 1 - January 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,265&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,323,568</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 1 - February 28</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,323,568</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1 - March 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,323,568</span></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Also included are shares of common stock surrendered by employees and directors to the Company to cover minimum tax liability withholding obligations upon the exercise of stock options or the vesting of shares of restricted stock and performance-based share awards previously granted to such employees and directors.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">At the outset of the quarter ended March&#160;31, 2023, there were 1,353,833 shares of the Company&#8217;s common stock eligible for repurchase under the stock repurchase authorization dated September 16, 2014 (the "Stock Repurchase Plan").</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March&#160;31, 2023, there were 1,323,568 shares of the Company&#8217;s common stock eligible for repurchase under the Stock Repurchase Plan. There can be no assurances as to the amount, timing or prices of repurchases, which may vary based on market conditions and other factors. The Stock Repurchase Plan does not have an expiration date and can be modified or terminated by the Board of Directors at any time.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Description of Exhibit</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/910329/000114420415012727/v402962_ex3-1.htm">Restated and Amended Certificate of Incorporation of Medifast, Inc. (incorporated by reference to Exhibit 3.1 of the Company&#8217;s Current Report on Form 8-K (File No. 001-31573) filed February 27, 2015).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/910329/000110465919069652/tm1923867d1_ex3-1.htm">Amended and Restated Bylaws of Medifast, Inc. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Amendment No. 1 Current Report on Form 8-K (File No. 001-31573) filed on December 4, 2019).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20230131xexx311.htm">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20230131xexx312.htm">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20230131xexx321.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20230131xexx321.htm"> (fu</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20230131xexx321.htm">rnished herewith)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="med-20230131xexx321.htm">.</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The following financial statements from Medifast, Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2023 filed May&#160;1, 2023, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Income, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Cash Flows, (v) Condensed Consolidated Statements of Changes in Stockholders&#8217; Equity, and (vi) Notes to the Condensed Consolidated Financial Statements (filed herewith).</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC Release No. 33-8238, Exhibit 32.1 is being furnished and not filed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><div id="i7237206793d54e1ba85313ed02bd1f82_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:21.6pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i7237206793d54e1ba85313ed02bd1f82_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medifast, Inc.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ DANIEL R. CHARD</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Daniel R. Chard</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">May 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ JAMES P. MALONEY</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">James P. Maloney</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Dated:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>med-20230131xexx311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i117710c636004d88a02827538ee0ac07_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel R. Chard, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this report on Form 10-Q of Medifast, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Daniel R. Chard</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel R. Chard</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>med-20230131xexx312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i50d0ec3df43b4324a4adbc8f42a18670_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James P. Maloney, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this report on Form 10-Q of Medifast, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.052%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;James P. Maloney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>med-20230131xexx321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1cb75f0de7df445e8fed3023c7b6330d_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC.</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q (the &#8220;Report&#8221;) for the quarter ended March 31, 2023 of Medifast, Inc. (the &#8220;Company&#8221;), as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Daniel R. Chard, Chief Executive Officer and I, James P. Maloney, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.778%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DANIEL R. CHARD</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel R. Chard</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JAMES P. MALONEY</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 8.2pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>med-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ebea4200-127d-4056-af39-00ad362d0793,g:908e033e-f9bd-4981-9c22-7aad939362db-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:med="http://www.medifast1.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medifast1.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medifast1.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.medifast1.com/role/INVENTORIES">
        <link:definition>0000009 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARE">
        <link:definition>0000010 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATION" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION">
        <link:definition>0000011 - Disclosure - SHARE-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.medifast1.com/role/LEASES">
        <link:definition>0000012 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOME" roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME">
        <link:definition>0000013 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.medifast1.com/role/DEBT">
        <link:definition>0000014 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.medifast1.com/role/INVENTORIESTables">
        <link:definition>0000016 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARETables">
        <link:definition>0000017 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONTables" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables">
        <link:definition>0000018 - Disclosure - SHARE-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.medifast1.com/role/LEASESTables">
        <link:definition>0000019 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.medifast1.com/role/INVENTORIESDetails">
        <link:definition>0000020 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails">
        <link:definition>0000021 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARENarrativeDetails" roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails">
        <link:definition>0000022 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONNarrativeDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>0000023 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails">
        <link:definition>0000024 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails">
        <link:definition>0000025 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails">
        <link:definition>0000026 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails">
        <link:definition>0000027 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESSupplementalCashFlowInformationDetails" roleURI="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails">
        <link:definition>0000028 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESFutureMinimumLeaseCommitmentsDetails" roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails">
        <link:definition>0000029 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESFutureMinimumLeaseCommitmentsDetails_1" roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1">
        <link:definition>0000029 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails">
        <link:definition>0000030 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTDetails" roleURI="http://www.medifast1.com/role/DEBTDetails">
        <link:definition>0000031 - Disclosure - DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="med_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_GrantedIn2022Member" abstract="true" name="GrantedIn2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="med_ProceedsFromStockOptionsExercisedDirectors" abstract="false" name="ProceedsFromStockOptionsExercisedDirectors" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_MinimumInterestCoverageRatio" abstract="false" name="MinimumInterestCoverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="med_OptionsAndRestrictedStockMember" abstract="true" name="OptionsAndRestrictedStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_MaximumTotalNetLeverageRatio" abstract="false" name="MaximumTotalNetLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="med_UncommittedIncrementalFacilityMember" abstract="true" name="UncommittedIncrementalFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_DenominatorAbstract" abstract="true" name="DenominatorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="med_GrantedIn2021Member" abstract="true" name="GrantedIn2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_OperatingLeaseArrangementForEquipmentMember" abstract="true" name="OperatingLeaseArrangementForEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_GrantedIn2023Member" abstract="true" name="GrantedIn2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_OperatingLeaseExpenseNonCash" abstract="false" name="OperatingLeaseExpenseNonCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_InventoryNonFoodFinishedGoods" abstract="false" name="InventoryNonFoodFinishedGoods" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="med_NumeratorAbstract" abstract="true" name="NumeratorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="med_GrantedIn2020Member" abstract="true" name="GrantedIn2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_OperatingLeaseArrangementForRealEstateMember" abstract="true" name="OperatingLeaseArrangementForRealEstateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="med_MarketAndPerformanceBasedShareMember" abstract="true" name="MarketAndPerformanceBasedShareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>med-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ebea4200-127d-4056-af39-00ad362d0793,g:908e033e-f9bd-4981-9c22-7aad939362db-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_80c5e0fb-3557-477f-ab50-a36841c0ef50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5f4fc4af-bc3c-4733-b55d-1acb6ec24059" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_80c5e0fb-3557-477f-ab50-a36841c0ef50" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5f4fc4af-bc3c-4733-b55d-1acb6ec24059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_2662fb2a-9b58-4e9f-a33c-fef7214132e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_80c5e0fb-3557-477f-ab50-a36841c0ef50" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_2662fb2a-9b58-4e9f-a33c-fef7214132e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c079ad51-ced0-46dc-8bf1-7ce453040aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_af1050ea-2360-42b7-acec-5b28895aa0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c079ad51-ced0-46dc-8bf1-7ce453040aa3" xlink:to="loc_us-gaap_OperatingIncomeLoss_af1050ea-2360-42b7-acec-5b28895aa0c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_bdfdd6ed-7738-4683-b6ec-59f5d6abec5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c079ad51-ced0-46dc-8bf1-7ce453040aa3" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_bdfdd6ed-7738-4683-b6ec-59f5d6abec5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_140e0428-1c70-4c3f-90e9-4ad524cba950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_bf029813-af8b-443c-a56a-604a7de148fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_140e0428-1c70-4c3f-90e9-4ad524cba950" xlink:to="loc_us-gaap_GrossProfit_bf029813-af8b-443c-a56a-604a7de148fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c58b5b5b-6cc9-4258-a29f-8bcdd616e231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_140e0428-1c70-4c3f-90e9-4ad524cba950" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c58b5b5b-6cc9-4258-a29f-8bcdd616e231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_33c11813-987d-4f2b-8371-1c137b6ed6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43f4e3ca-5edc-4392-be2c-26fa57be0a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_33c11813-987d-4f2b-8371-1c137b6ed6ea" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_43f4e3ca-5edc-4392-be2c-26fa57be0a2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_7b3082e0-74d5-47d6-96e1-75a14e7e5e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_33c11813-987d-4f2b-8371-1c137b6ed6ea" xlink:to="loc_us-gaap_CostOfRevenue_7b3082e0-74d5-47d6-96e1-75a14e7e5e0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5d4418fe-d502-4875-b295-e8b55d959c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_edf80a28-2a72-4c99-9945-ffa5c7d31b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5d4418fe-d502-4875-b295-e8b55d959c8d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_edf80a28-2a72-4c99-9945-ffa5c7d31b5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a3e89158-422e-4ecc-84c4-59d203294f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5d4418fe-d502-4875-b295-e8b55d959c8d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a3e89158-422e-4ecc-84c4-59d203294f8d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f4e02fb-9c18-4d31-b5dd-7e7048c2591a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_563d9999-91da-438f-ac48-83dbdd2a840f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f4e02fb-9c18-4d31-b5dd-7e7048c2591a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_563d9999-91da-438f-ac48-83dbdd2a840f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c3282c87-9419-465f-9f34-5878ade2089d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1f4e02fb-9c18-4d31-b5dd-7e7048c2591a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c3282c87-9419-465f-9f34-5878ade2089d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_59c9a39a-076b-4bc3-b6b6-c97717c79915" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b9131865-167c-4d58-aa24-87d245c7fa99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_59c9a39a-076b-4bc3-b6b6-c97717c79915" xlink:to="loc_us-gaap_NetIncomeLoss_b9131865-167c-4d58-aa24-87d245c7fa99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3ee2c94a-0509-4384-938b-475f80a847d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_59c9a39a-076b-4bc3-b6b6-c97717c79915" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3ee2c94a-0509-4384-938b-475f80a847d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ba172c92-1344-4568-b332-e53653b0c9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9385428c-41b8-4254-9f89-10519a1e07b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ba172c92-1344-4568-b332-e53653b0c9e1" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9385428c-41b8-4254-9f89-10519a1e07b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_42e18d3d-aed1-455d-9a4b-f56b3f7cf389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ba172c92-1344-4568-b332-e53653b0c9e1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_42e18d3d-aed1-455d-9a4b-f56b3f7cf389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_2061c946-54b2-4274-b866-f8673889745d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ba172c92-1344-4568-b332-e53653b0c9e1" xlink:to="loc_us-gaap_TaxesPayableCurrent_2061c946-54b2-4274-b866-f8673889745d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c4b75fbc-75ae-464b-b60a-9421c8291ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2abf9088-ea4f-43af-814b-577acb5915d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c4b75fbc-75ae-464b-b60a-9421c8291ec1" xlink:to="loc_us-gaap_InventoryNet_2abf9088-ea4f-43af-814b-577acb5915d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7eef5253-1aa7-4bcc-91ed-4d736e7b1c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c4b75fbc-75ae-464b-b60a-9421c8291ec1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7eef5253-1aa7-4bcc-91ed-4d736e7b1c83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d9c629c5-09f3-4b07-a7e3-9f23956f7aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c4b75fbc-75ae-464b-b60a-9421c8291ec1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d9c629c5-09f3-4b07-a7e3-9f23956f7aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_aea0404f-726a-47a7-a566-32d682f50d75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a37260d6-8dbc-4128-91bb-b5365a65e861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aea0404f-726a-47a7-a566-32d682f50d75" xlink:to="loc_us-gaap_AssetsCurrent_a37260d6-8dbc-4128-91bb-b5365a65e861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7a792dc7-3442-4a4e-a569-04ec7432f4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aea0404f-726a-47a7-a566-32d682f50d75" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7a792dc7-3442-4a4e-a569-04ec7432f4db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a8de4fab-fd04-4c6f-b740-d652cc8aad00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aea0404f-726a-47a7-a566-32d682f50d75" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a8de4fab-fd04-4c6f-b740-d652cc8aad00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_926bf4dc-00e1-4ecc-9eb0-e92277072d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aea0404f-726a-47a7-a566-32d682f50d75" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_926bf4dc-00e1-4ecc-9eb0-e92277072d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e7bf64e3-7a9b-4a22-bb00-a8264f7ad3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_aea0404f-726a-47a7-a566-32d682f50d75" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e7bf64e3-7a9b-4a22-bb00-a8264f7ad3ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2bb67c4b-4505-48f2-aee7-74168687fd87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d59b959d-51d2-477f-a2da-679555723034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2bb67c4b-4505-48f2-aee7-74168687fd87" xlink:to="loc_us-gaap_Liabilities_d59b959d-51d2-477f-a2da-679555723034" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a53c385f-625a-4359-8ec5-968611ddbf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_2bb67c4b-4505-48f2-aee7-74168687fd87" xlink:to="loc_us-gaap_StockholdersEquity_a53c385f-625a-4359-8ec5-968611ddbf3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_76d89b04-dad6-436a-952a-f2d09dd713b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_de66a469-262e-41de-a523-dfedfcd6817a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_76d89b04-dad6-436a-952a-f2d09dd713b0" xlink:to="loc_us-gaap_AdditionalPaidInCapital_de66a469-262e-41de-a523-dfedfcd6817a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_25a9d99b-ead4-4c5c-958b-971b354ebad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_76d89b04-dad6-436a-952a-f2d09dd713b0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_25a9d99b-ead4-4c5c-958b-971b354ebad5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4577eadf-fe99-4405-8904-ce1524c7b376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_76d89b04-dad6-436a-952a-f2d09dd713b0" xlink:to="loc_us-gaap_CommonStockValue_4577eadf-fe99-4405-8904-ce1524c7b376" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a5c848e0-b2b4-4342-8932-10026dd78060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_76d89b04-dad6-436a-952a-f2d09dd713b0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a5c848e0-b2b4-4342-8932-10026dd78060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_a2b9cae9-24cb-4543-af4b-9a6140ad7508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_76d89b04-dad6-436a-952a-f2d09dd713b0" xlink:to="loc_us-gaap_TreasuryStockCommonValue_a2b9cae9-24cb-4543-af4b-9a6140ad7508" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_48ab7642-070c-4cc2-9ecc-2ceec0e7e39e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2222d8ae-c88a-4eb9-bdf8-28eff71866ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_48ab7642-070c-4cc2-9ecc-2ceec0e7e39e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2222d8ae-c88a-4eb9-bdf8-28eff71866ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6f1669ed-ce5b-4d80-980f-4b88bf71c1c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_48ab7642-070c-4cc2-9ecc-2ceec0e7e39e" xlink:to="loc_us-gaap_LiabilitiesCurrent_6f1669ed-ce5b-4d80-980f-4b88bf71c1c1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c92cdf31-f8a4-46d3-96b4-ae0ee88ef5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_311e706a-33d2-4dc4-a15d-59c8f7687eed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c92cdf31-f8a4-46d3-96b4-ae0ee88ef5a3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_311e706a-33d2-4dc4-a15d-59c8f7687eed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_abe6b5e9-d4b0-4ed2-acd4-b08e445431ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c92cdf31-f8a4-46d3-96b4-ae0ee88ef5a3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_abe6b5e9-d4b0-4ed2-acd4-b08e445431ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_35c47e3c-a4b1-4d7a-b04b-3bca0197304c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c92cdf31-f8a4-46d3-96b4-ae0ee88ef5a3" xlink:to="loc_us-gaap_PaymentsOfDividends_35c47e3c-a4b1-4d7a-b04b-3bca0197304c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ProceedsFromStockOptionsExercisedDirectors_a9a5f234-1cc5-45d5-a05a-dc8ec531a2ae" xlink:href="med-20230331.xsd#med_ProceedsFromStockOptionsExercisedDirectors"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c92cdf31-f8a4-46d3-96b4-ae0ee88ef5a3" xlink:to="loc_med_ProceedsFromStockOptionsExercisedDirectors_a9a5f234-1cc5-45d5-a05a-dc8ec531a2ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a896e83-920d-4f16-959e-a8a330c6f223" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_38897c46-4a02-4a61-aa4d-0c6dd1af4db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a896e83-920d-4f16-959e-a8a330c6f223" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_38897c46-4a02-4a61-aa4d-0c6dd1af4db6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ecc50453-46b9-4e58-9edc-ec0c250879eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a896e83-920d-4f16-959e-a8a330c6f223" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ecc50453-46b9-4e58-9edc-ec0c250879eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baeb3e61-a1ab-487e-b721-dfd1ea242961" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a896e83-920d-4f16-959e-a8a330c6f223" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_baeb3e61-a1ab-487e-b721-dfd1ea242961" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e1e979d4-356e-46d2-8e97-295627f42672" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a896e83-920d-4f16-959e-a8a330c6f223" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e1e979d4-356e-46d2-8e97-295627f42672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6570bbca-c5fb-473f-89dc-0a54f7c5c303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_53c4c002-c227-4d15-9d70-76704a8b78ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6570bbca-c5fb-473f-89dc-0a54f7c5c303" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_53c4c002-c227-4d15-9d70-76704a8b78ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb307fef-3958-4aca-ba1a-c6f5e67bc806" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6570bbca-c5fb-473f-89dc-0a54f7c5c303" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb307fef-3958-4aca-ba1a-c6f5e67bc806" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_4656c780-052a-4bb1-844d-f17c86d4c614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_4656c780-052a-4bb1-844d-f17c86d4c614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_81d4279b-abdc-4c99-817e-017f615b53c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_81d4279b-abdc-4c99-817e-017f615b53c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b30f4231-89e5-483b-97ab-6f7b55b0fb01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b30f4231-89e5-483b-97ab-6f7b55b0fb01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_764e6112-27cd-4f97-9068-e8b96380543c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_764e6112-27cd-4f97-9068-e8b96380543c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9b7ad2da-a6f8-426d-b3c2-356d5ed6ce66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9b7ad2da-a6f8-426d-b3c2-356d5ed6ce66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e336e529-1428-4f4b-939b-0311f788e9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e336e529-1428-4f4b-939b-0311f788e9b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_4625f734-914f-44aa-b244-eb7c5028af38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_4625f734-914f-44aa-b244-eb7c5028af38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_31e0eb16-04a3-4d88-a281-dc3aa4f04540" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_NetIncomeLoss_31e0eb16-04a3-4d88-a281-dc3aa4f04540" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5a2b7d07-dbf9-44b7-bd84-c9e3332094ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5a2b7d07-dbf9-44b7-bd84-c9e3332094ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ffd6dfce-f101-4c95-8e41-33394c5bd140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_us-gaap_ShareBasedCompensation_ffd6dfce-f101-4c95-8e41-33394c5bd140" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash_e7c60b78-7c49-45bc-b8dc-d0c7087cc602" xlink:href="med-20230331.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad6636ab-b304-4672-bf77-217cb03866ce" xlink:to="loc_med_OperatingLeaseExpenseNonCash_e7c60b78-7c49-45bc-b8dc-d0c7087cc602" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="med-20230331.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_61985ff4-02c0-4249-b778-ba4db77b25fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_4a53a4da-8e26-4187-9b75-e75a8819690d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_61985ff4-02c0-4249-b778-ba4db77b25fa" xlink:to="loc_us-gaap_InventoryRawMaterials_4a53a4da-8e26-4187-9b75-e75a8819690d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_751f05c0-779c-4e11-9711-b42c2003834c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_61985ff4-02c0-4249-b778-ba4db77b25fa" xlink:to="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_751f05c0-779c-4e11-9711-b42c2003834c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods_351565a3-0ed5-426c-9b3c-94df0543a094" xlink:href="med-20230331.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_61985ff4-02c0-4249-b778-ba4db77b25fa" xlink:to="loc_med_InventoryNonFoodFinishedGoods_351565a3-0ed5-426c-9b3c-94df0543a094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_f6fa48aa-c387-4cca-85c7-3fb1c4f993b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_61985ff4-02c0-4249-b778-ba4db77b25fa" xlink:to="loc_us-gaap_InventoryFinishedGoods_f6fa48aa-c387-4cca-85c7-3fb1c4f993b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_e12030bc-9fcf-4372-940d-723c1e11998d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_61985ff4-02c0-4249-b778-ba4db77b25fa" xlink:to="loc_us-gaap_InventoryValuationReserves_e12030bc-9fcf-4372-940d-723c1e11998d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="med-20230331.xsd#EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a10d51e5-5298-49bc-a528-15a5620c7d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc030bae-f60c-415c-8e8c-1d4a5e4ed79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a10d51e5-5298-49bc-a528-15a5620c7d7b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cc030bae-f60c-415c-8e8c-1d4a5e4ed79d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e04227de-2625-481b-b415-c1b1489e2ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a10d51e5-5298-49bc-a528-15a5620c7d7b" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_e04227de-2625-481b-b415-c1b1489e2ed5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="med-20230331.xsd#LEASESFutureMinimumLeaseCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d10cb13a-44e6-438d-9a5a-8a91e2515e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2ecf48eb-a7ca-4878-9fb9-dba2bed2c60a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d10cb13a-44e6-438d-9a5a-8a91e2515e1d" xlink:to="loc_us-gaap_OperatingLeaseLiability_2ecf48eb-a7ca-4878-9fb9-dba2bed2c60a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5d98d84b-6dd7-479f-b348-0d2152758c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d10cb13a-44e6-438d-9a5a-8a91e2515e1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5d98d84b-6dd7-479f-b348-0d2152758c1e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="med-20230331.xsd#LEASESFutureMinimumLeaseCommitmentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dda2dccb-252e-4900-8f61-ca69b50ff107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_fe11b946-3fd4-4ffc-939f-feda6008e6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dda2dccb-252e-4900-8f61-ca69b50ff107" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_fe11b946-3fd4-4ffc-939f-feda6008e6b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_66bf3a02-fa41-4084-83da-3a29c142592f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dda2dccb-252e-4900-8f61-ca69b50ff107" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_66bf3a02-fa41-4084-83da-3a29c142592f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b0454264-3aa6-4ee7-b984-9d790c9b1032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dda2dccb-252e-4900-8f61-ca69b50ff107" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b0454264-3aa6-4ee7-b984-9d790c9b1032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_673a9e1b-b146-4aee-b642-31b93aea3032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dda2dccb-252e-4900-8f61-ca69b50ff107" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_673a9e1b-b146-4aee-b642-31b93aea3032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9059d537-e97b-470b-908a-60576e342e55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dda2dccb-252e-4900-8f61-ca69b50ff107" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9059d537-e97b-470b-908a-60576e342e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_5d12b4a6-68f5-429a-8043-a9805b1fde42" xlink:href="med-20230331.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_dda2dccb-252e-4900-8f61-ca69b50ff107" xlink:to="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_5d12b4a6-68f5-429a-8043-a9805b1fde42" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>med-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ebea4200-127d-4056-af39-00ad362d0793,g:908e033e-f9bd-4981-9c22-7aad939362db-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="extended" id="i5658637a3e244579ae245c9d60cae958_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_33b71bb7-481a-4770-a937-66a17397abdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_33b71bb7-481a-4770-a937-66a17397abdc" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_bd5bb954-be59-43cb-93de-43f98a024737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_CommonStockSharesIssued_bd5bb954-be59-43cb-93de-43f98a024737" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ccb02334-930f-446b-ac58-ae7747e1c255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_StockholdersEquity_ccb02334-930f-446b-ac58-ae7747e1c255" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_100d59a3-861d-49b3-aad4-d44e6a489acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_NetIncomeLoss_100d59a3-861d-49b3-aad4-d44e6a489acb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_77452f10-fec2-40ce-929d-0e2fe54e7bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_77452f10-fec2-40ce-929d-0e2fe54e7bd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_ad138d65-5e07-4289-a346-88d75fd4caed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_ad138d65-5e07-4289-a346-88d75fd4caed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_35d0c526-5fae-4c19-8003-18133a53359b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_35d0c526-5fae-4c19-8003-18133a53359b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1360013e-0ee4-400c-bfbf-88368a1d5f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1360013e-0ee4-400c-bfbf-88368a1d5f82" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_be91edca-6bc5-4f39-930c-f1a371675792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_be91edca-6bc5-4f39-930c-f1a371675792" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b76195fc-634a-448a-8cd4-de83e3d61360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b76195fc-634a-448a-8cd4-de83e3d61360" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_75edd241-87cc-4566-a307-5e3c07faf5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_75edd241-87cc-4566-a307-5e3c07faf5e6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_61453f9a-2d1e-4da0-9aff-973e124b77de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_61453f9a-2d1e-4da0-9aff-973e124b77de" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_69a441da-b600-47e8-a0b9-d57fad10df07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_69a441da-b600-47e8-a0b9-d57fad10df07" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0a39198e-e53b-4387-a491-be36a09165b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0a39198e-e53b-4387-a491-be36a09165b3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_920979db-5523-4ab5-a481-2e352a4d12e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_DividendsCommonStockCash_920979db-5523-4ab5-a481-2e352a4d12e3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6ea54088-75ec-410b-9077-d5a07761f203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_12ab5a5a-3cf0-4254-9235-803434378ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_13a489aa-880f-4606-a321-3bd942b3390c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_33b71bb7-481a-4770-a937-66a17397abdc" xlink:to="loc_us-gaap_StatementTable_13a489aa-880f-4606-a321-3bd942b3390c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_13a489aa-880f-4606-a321-3bd942b3390c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9" xlink:to="loc_us-gaap_EquityComponentDomain_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9" xlink:to="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_53862e55-2c21-4de8-a8c8-42b6b3554c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_CommonStockMember_53862e55-2c21-4de8-a8c8-42b6b3554c9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6b02d742-de17-4793-af7e-0bbdfb5dc3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6b02d742-de17-4793-af7e-0bbdfb5dc3a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc310c0e-2bbf-41c9-97a1-78c8d404e0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc310c0e-2bbf-41c9-97a1-78c8d404e0c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7cfce479-4992-4e98-8854-41f986a55853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_RetainedEarningsMember_7cfce479-4992-4e98-8854-41f986a55853" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_ec9ded9d-8f6d-4287-bdc5-590e99a1a82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_TreasuryStockCommonMember_ec9ded9d-8f6d-4287-bdc5-590e99a1a82a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="med-20230331.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended" id="i898bb07a439a49aeba4afbc580487baa_EARNINGSPERSHARENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c422e704-9f07-4998-bf52-36ac0a115bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_17c72ac5-3c45-4648-9dbf-2aac2be2f8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c422e704-9f07-4998-bf52-36ac0a115bf3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_17c72ac5-3c45-4648-9dbf-2aac2be2f8df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c4fe40f0-10ad-401f-8d88-4e58b26282a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c422e704-9f07-4998-bf52-36ac0a115bf3" xlink:to="loc_us-gaap_StatementTable_c4fe40f0-10ad-401f-8d88-4e58b26282a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c4fe40f0-10ad-401f-8d88-4e58b26282a9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_336d6da0-a31f-4187-ae57-2f329242d913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_336d6da0-a31f-4187-ae57-2f329242d913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_32b35d21-f3d9-473b-9ee9-cdd7dc37c8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_336d6da0-a31f-4187-ae57-2f329242d913" xlink:to="loc_us-gaap_RestrictedStockMember_32b35d21-f3d9-473b-9ee9-cdd7dc37c8f0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="ida1e17632f1e4ee8961306dc4a46cff5_SHAREBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_71a968ee-0bc4-41d5-8c48-81716cc89680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_71a968ee-0bc4-41d5-8c48-81716cc89680" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dcef8842-b3cc-46e7-8aeb-ab39faacbd99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dcef8842-b3cc-46e7-8aeb-ab39faacbd99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_35a25aa0-8eeb-400a-b30a-07d8807857d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_35a25aa0-8eeb-400a-b30a-07d8807857d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_6ea8a15c-154d-479c-b04c-553bd27e8b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_6ea8a15c-154d-479c-b04c-553bd27e8b40" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_87808962-2939-4cc6-88c9-bc6e7bb7e989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_87808962-2939-4cc6-88c9-bc6e7bb7e989" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2a4aba66-5748-46f1-a7ab-719cfd2c2bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2a4aba66-5748-46f1-a7ab-719cfd2c2bcc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e856b366-1a48-4bf9-99a7-58dd83364761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e856b366-1a48-4bf9-99a7-58dd83364761" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e876563a-3893-42ec-b7c5-f932cad9eaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e876563a-3893-42ec-b7c5-f932cad9eaa8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0463df0b-b94f-48db-8e89-bc18ac400bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0463df0b-b94f-48db-8e89-bc18ac400bff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1b247551-172f-4b3a-9f98-bf521309eec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1b247551-172f-4b3a-9f98-bf521309eec1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a6c1e4aa-a740-44e2-a66a-8ac435baed7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a6c1e4aa-a740-44e2-a66a-8ac435baed7d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0a27f6c8-c5a4-4ff8-84f0-2a540a39f8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0a27f6c8-c5a4-4ff8-84f0-2a540a39f8eb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_499108f1-c9d9-4814-afbd-fdca6250ef26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_499108f1-c9d9-4814-afbd-fdca6250ef26" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_54330195-6928-43cb-b735-ec2462ae81cc" xlink:href="med-20230331.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_54330195-6928-43cb-b735-ec2462ae81cc" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_8bf130aa-fd4d-4458-b9d9-6c277e2d642f" xlink:href="med-20230331.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_8bf130aa-fd4d-4458-b9d9-6c277e2d642f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_774ff544-23a6-45ae-9a75-e080088aee40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_774ff544-23a6-45ae-9a75-e080088aee40" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_261862ff-931e-4166-926a-1ed74914c1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_261862ff-931e-4166-926a-1ed74914c1db" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cd6ef992-ae2c-41fa-995e-a624b8ae7ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cd6ef992-ae2c-41fa-995e-a624b8ae7ef7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e83181ab-fb28-4a05-b520-95ca690bae8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e83181ab-fb28-4a05-b520-95ca690bae8f" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d535c0de-2edc-4308-94ea-8af8223ce99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d535c0de-2edc-4308-94ea-8af8223ce99a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_14a5c2c5-ee2b-416a-b3f2-e64ab843056e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_14a5c2c5-ee2b-416a-b3f2-e64ab843056e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:to="loc_us-gaap_AwardTypeAxis_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_610e24f1-0561-45f3-a8cd-057427ed157a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:to="loc_us-gaap_EmployeeStockOptionMember_610e24f1-0561-45f3-a8cd-057427ed157a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9819da95-9c83-4888-9480-e0e67bbe37a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:to="loc_us-gaap_RestrictedStockMember_9819da95-9c83-4888-9480-e0e67bbe37a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3e51e9d3-d74f-4a8d-995b-f083fcecfcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:to="loc_us-gaap_PerformanceSharesMember_3e51e9d3-d74f-4a8d-995b-f083fcecfcf1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceBasedShareMember_69890925-4a07-4e57-ab61-95638034a3c2" xlink:href="med-20230331.xsd#med_MarketAndPerformanceBasedShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:to="loc_med_MarketAndPerformanceBasedShareMember_69890925-4a07-4e57-ab61-95638034a3c2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5252c7cf-225b-424a-8cb7-c9f71653dff2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:to="loc_srt_RangeAxis_5252c7cf-225b-424a-8cb7-c9f71653dff2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5252c7cf-225b-424a-8cb7-c9f71653dff2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5252c7cf-225b-424a-8cb7-c9f71653dff2" xlink:to="loc_srt_RangeMember_5252c7cf-225b-424a-8cb7-c9f71653dff2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47ebb973-7204-43fe-849f-c13e5cf5f5c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5252c7cf-225b-424a-8cb7-c9f71653dff2" xlink:to="loc_srt_RangeMember_47ebb973-7204-43fe-849f-c13e5cf5f5c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_19cc551f-4f44-46d2-aae9-8dbcd11a20de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_47ebb973-7204-43fe-849f-c13e5cf5f5c1" xlink:to="loc_srt_MinimumMember_19cc551f-4f44-46d2-aae9-8dbcd11a20de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3fe4e62f-954e-48cc-9325-778502e6f289" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_47ebb973-7204-43fe-849f-c13e5cf5f5c1" xlink:to="loc_srt_MaximumMember_3fe4e62f-954e-48cc-9325-778502e6f289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_bf3c6a77-414d-4767-8891-2a9777a35f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:to="loc_us-gaap_AwardDateAxis_bf3c6a77-414d-4767-8891-2a9777a35f49" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_bf3c6a77-414d-4767-8891-2a9777a35f49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_bf3c6a77-414d-4767-8891-2a9777a35f49" xlink:to="loc_us-gaap_AwardDateDomain_bf3c6a77-414d-4767-8891-2a9777a35f49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_e424e09e-c794-49a9-8869-cc144e27efce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_bf3c6a77-414d-4767-8891-2a9777a35f49" xlink:to="loc_us-gaap_AwardDateDomain_e424e09e-c794-49a9-8869-cc144e27efce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member_666041a9-f91c-4cbe-a772-8bf7d2103063" xlink:href="med-20230331.xsd#med_GrantedIn2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_e424e09e-c794-49a9-8869-cc144e27efce" xlink:to="loc_med_GrantedIn2022Member_666041a9-f91c-4cbe-a772-8bf7d2103063" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="extended" id="i0b1bf73aa2614297a2d2b466137bbeaa_SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12b3032a-95c2-4777-9fff-6ca180942f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12b3032a-95c2-4777-9fff-6ca180942f51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f970d304-cab9-42c2-8777-ed1739f92326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f970d304-cab9-42c2-8777-ed1739f92326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_45342bf8-d424-4a96-993d-eb5a01308bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_45342bf8-d424-4a96-993d-eb5a01308bc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3e19f72c-a9ea-485e-82ca-4523384ae5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3e19f72c-a9ea-485e-82ca-4523384ae5bc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b79007a0-e531-41d7-93c9-614002917d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b79007a0-e531-41d7-93c9-614002917d35" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_074e257c-bf85-4194-9a16-25a12f34f420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12b3032a-95c2-4777-9fff-6ca180942f51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6ea9aac-50ac-4c46-b596-48bf30a8f929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6ea9aac-50ac-4c46-b596-48bf30a8f929" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ffb87adb-1cb1-414b-81db-2bdedc078131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ffb87adb-1cb1-414b-81db-2bdedc078131" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_abd855db-38a0-4ed6-84af-e9a4bd53af6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_abd855db-38a0-4ed6-84af-e9a4bd53af6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e83fac7b-8afd-4882-a09e-40ad3cdd066a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e83fac7b-8afd-4882-a09e-40ad3cdd066a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_64e6f1b5-669f-463d-98f0-49d41b9b1f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82869a23-4c74-43b1-9037-d9eb5460ca88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12b3032a-95c2-4777-9fff-6ca180942f51" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82869a23-4c74-43b1-9037-d9eb5460ca88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f9d76acf-809f-47d3-b6e5-6629ae34e53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82869a23-4c74-43b1-9037-d9eb5460ca88" xlink:to="loc_us-gaap_AwardTypeAxis_f9d76acf-809f-47d3-b6e5-6629ae34e53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9d76acf-809f-47d3-b6e5-6629ae34e53c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f9d76acf-809f-47d3-b6e5-6629ae34e53c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9d76acf-809f-47d3-b6e5-6629ae34e53c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d44b045e-74d8-4107-892a-6ad6d7accbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f9d76acf-809f-47d3-b6e5-6629ae34e53c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d44b045e-74d8-4107-892a-6ad6d7accbd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_bdea4b42-5173-475f-b1ad-a43895230073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d44b045e-74d8-4107-892a-6ad6d7accbd7" xlink:to="loc_us-gaap_RestrictedStockMember_bdea4b42-5173-475f-b1ad-a43895230073" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="extended" id="ied8d907323c1444783f5ca02e9937832_SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fdffc6ca-6dc9-4daf-9057-8026c85a1af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e48527ae-34ac-46b1-98fa-e2f77dc1894b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fdffc6ca-6dc9-4daf-9057-8026c85a1af5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e48527ae-34ac-46b1-98fa-e2f77dc1894b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7ac60563-8a38-42a8-9c0f-2739c8cc7ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fdffc6ca-6dc9-4daf-9057-8026c85a1af5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7ac60563-8a38-42a8-9c0f-2739c8cc7ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fdffc6ca-6dc9-4daf-9057-8026c85a1af5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9fd0af59-f426-4cc6-a6e8-808daf4c38cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:to="loc_us-gaap_AwardTypeAxis_9fd0af59-f426-4cc6-a6e8-808daf4c38cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd0af59-f426-4cc6-a6e8-808daf4c38cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9fd0af59-f426-4cc6-a6e8-808daf4c38cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fd0af59-f426-4cc6-a6e8-808daf4c38cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9fd0af59-f426-4cc6-a6e8-808daf4c38cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember_5b8ec7b9-058f-4646-921f-fad94a8f2b1d" xlink:href="med-20230331.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:to="loc_med_OptionsAndRestrictedStockMember_5b8ec7b9-058f-4646-921f-fad94a8f2b1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceBasedShareMember_51b74b50-e976-4fb6-b9dd-62193cd4d677" xlink:href="med-20230331.xsd#med_MarketAndPerformanceBasedShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:to="loc_med_MarketAndPerformanceBasedShareMember_51b74b50-e976-4fb6-b9dd-62193cd4d677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3a7d3154-fe9b-4049-adde-0fb9c2cc8cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:to="loc_us-gaap_PerformanceSharesMember_3a7d3154-fe9b-4049-adde-0fb9c2cc8cd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_b2c5a7ef-60f5-4553-923d-389024eb52af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:to="loc_us-gaap_AwardDateAxis_b2c5a7ef-60f5-4553-923d-389024eb52af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_b2c5a7ef-60f5-4553-923d-389024eb52af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_b2c5a7ef-60f5-4553-923d-389024eb52af" xlink:to="loc_us-gaap_AwardDateDomain_b2c5a7ef-60f5-4553-923d-389024eb52af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_b2c5a7ef-60f5-4553-923d-389024eb52af" xlink:to="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2023Member_3ccd19cf-883a-445c-bd25-7e9ecba632e7" xlink:href="med-20230331.xsd#med_GrantedIn2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:to="loc_med_GrantedIn2023Member_3ccd19cf-883a-445c-bd25-7e9ecba632e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member_d7422236-a5de-48dc-8ac6-509cca7c9505" xlink:href="med-20230331.xsd#med_GrantedIn2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:to="loc_med_GrantedIn2022Member_d7422236-a5de-48dc-8ac6-509cca7c9505" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member_bfa9b7fc-872c-4b2e-9672-851bea6838ca" xlink:href="med-20230331.xsd#med_GrantedIn2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:to="loc_med_GrantedIn2021Member_bfa9b7fc-872c-4b2e-9672-851bea6838ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member_a0ec5623-54ca-4d31-a4d4-a3f930efa943" xlink:href="med-20230331.xsd#med_GrantedIn2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:to="loc_med_GrantedIn2020Member_a0ec5623-54ca-4d31-a4d4-a3f930efa943" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="med-20230331.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="extended" id="ia6fb986f0563445c975d126941dab5c6_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e063fed4-e17c-4e08-82a5-a4383b9ab3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e063fed4-e17c-4e08-82a5-a4383b9ab3f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_91299667-8b8a-4d6e-9c8f-2e38ff58c8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_OperatingLeaseExpense_91299667-8b8a-4d6e-9c8f-2e38ff58c8c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c11c0d8f-47a1-45ac-a7a4-1ba36ed97a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c11c0d8f-47a1-45ac-a7a4-1ba36ed97a98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_482b315d-3a34-4e00-9fa3-f0af6fcabc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_482b315d-3a34-4e00-9fa3-f0af6fcabc2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f87b7c5a-bad3-4206-9497-1cc50310de70" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:to="loc_srt_RangeAxis_f87b7c5a-bad3-4206-9497-1cc50310de70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f87b7c5a-bad3-4206-9497-1cc50310de70_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f87b7c5a-bad3-4206-9497-1cc50310de70" xlink:to="loc_srt_RangeMember_f87b7c5a-bad3-4206-9497-1cc50310de70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b391e7c-eba9-4b08-b976-3aabfd21f8bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f87b7c5a-bad3-4206-9497-1cc50310de70" xlink:to="loc_srt_RangeMember_4b391e7c-eba9-4b08-b976-3aabfd21f8bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_42a5af51-b336-4e9e-9b5c-0b29ceec0b89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4b391e7c-eba9-4b08-b976-3aabfd21f8bf" xlink:to="loc_srt_MinimumMember_42a5af51-b336-4e9e-9b5c-0b29ceec0b89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_065f14b3-a2ab-4b34-ab39-2b11ca0d2d14" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4b391e7c-eba9-4b08-b976-3aabfd21f8bf" xlink:to="loc_srt_MaximumMember_065f14b3-a2ab-4b34-ab39-2b11ca0d2d14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7042f4c1-e74c-43e8-9658-22ea016e71a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7042f4c1-e74c-43e8-9658-22ea016e71a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7042f4c1-e74c-43e8-9658-22ea016e71a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7042f4c1-e74c-43e8-9658-22ea016e71a3" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7042f4c1-e74c-43e8-9658-22ea016e71a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3783b23-8922-41bd-bdbf-ccb18a7be198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7042f4c1-e74c-43e8-9658-22ea016e71a3" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3783b23-8922-41bd-bdbf-ccb18a7be198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember_bcd4c428-83dd-4780-acc0-1b79b687fcb6" xlink:href="med-20230331.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3783b23-8922-41bd-bdbf-ccb18a7be198" xlink:to="loc_med_OperatingLeaseArrangementForRealEstateMember_bcd4c428-83dd-4780-acc0-1b79b687fcb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember_29507567-c339-45c2-a724-3e6296197873" xlink:href="med-20230331.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3783b23-8922-41bd-bdbf-ccb18a7be198" xlink:to="loc_med_OperatingLeaseArrangementForEquipmentMember_29507567-c339-45c2-a724-3e6296197873" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBTDetails" xlink:type="simple" xlink:href="med-20230331.xsd#DEBTDetails"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/DEBTDetails" xlink:type="extended" id="ife7065561e8f424eab36635dc5e64e1f_DEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0827b100-999c-4f47-8b32-da691885b4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0827b100-999c-4f47-8b32-da691885b4ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_9b947f7a-89b9-4597-b342-fe72b5d30bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_9b947f7a-89b9-4597-b342-fe72b5d30bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8d3e0923-8cb5-4c22-83bf-4654118c6986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8d3e0923-8cb5-4c22-83bf-4654118c6986" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio_b752c591-052c-4b44-bc56-41bd0a5ff200" xlink:href="med-20230331.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_med_MaximumTotalNetLeverageRatio_b752c591-052c-4b44-bc56-41bd0a5ff200" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio_2c59faa4-4607-49bf-8670-b6e8e910d55e" xlink:href="med-20230331.xsd#med_MinimumInterestCoverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_med_MinimumInterestCoverageRatio_2c59faa4-4607-49bf-8670-b6e8e910d55e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_01b01d96-cf31-43f7-9b92-687a990c1dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_01b01d96-cf31-43f7-9b92-687a990c1dbb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_CreditFacilityAxis_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6" xlink:to="loc_us-gaap_CreditFacilityDomain_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6" xlink:to="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_666bd25d-3925-4659-8057-d4faaca7ed3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_666bd25d-3925-4659-8057-d4faaca7ed3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_25355d5e-5b80-40c5-98a2-742d174bf51d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:to="loc_us-gaap_LetterOfCreditMember_25355d5e-5b80-40c5-98a2-742d174bf51d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_UncommittedIncrementalFacilityMember_3d74ba4b-e5b0-4b4b-a85b-fdd69d541b53" xlink:href="med-20230331.xsd#med_UncommittedIncrementalFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:to="loc_med_UncommittedIncrementalFacilityMember_3d74ba4b-e5b0-4b4b-a85b-fdd69d541b53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ad02d068-f23d-4651-aecc-1af9212d3963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_DebtInstrumentAxis_ad02d068-f23d-4651-aecc-1af9212d3963" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ad02d068-f23d-4651-aecc-1af9212d3963_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ad02d068-f23d-4651-aecc-1af9212d3963" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ad02d068-f23d-4651-aecc-1af9212d3963_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc57210c-c475-4d2c-b797-e070d7d49df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ad02d068-f23d-4651-aecc-1af9212d3963" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc57210c-c475-4d2c-b797-e070d7d49df4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember_22e5bd55-ce58-48f2-9081-608fcfa0e6d2" xlink:href="med-20230331.xsd#med_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc57210c-c475-4d2c-b797-e070d7d49df4" xlink:to="loc_med_CreditAgreementMember_22e5bd55-ce58-48f2-9081-608fcfa0e6d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_02f8a658-3f42-4d4f-9de0-c55831ebb4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_02f8a658-3f42-4d4f-9de0-c55831ebb4cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_02f8a658-3f42-4d4f-9de0-c55831ebb4cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02f8a658-3f42-4d4f-9de0-c55831ebb4cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_02f8a658-3f42-4d4f-9de0-c55831ebb4cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4decd117-7aed-4659-95bd-56b3868e7bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02f8a658-3f42-4d4f-9de0-c55831ebb4cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4decd117-7aed-4659-95bd-56b3868e7bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e8aefc3f-1ce8-490d-b3bc-2555211386ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4decd117-7aed-4659-95bd-56b3868e7bc7" xlink:to="loc_us-gaap_LineOfCreditMember_e8aefc3f-1ce8-490d-b3bc-2555211386ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bda61963-4cdd-4939-b875-8c23a831d88d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_srt_RangeAxis_bda61963-4cdd-4939-b875-8c23a831d88d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bda61963-4cdd-4939-b875-8c23a831d88d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bda61963-4cdd-4939-b875-8c23a831d88d" xlink:to="loc_srt_RangeMember_bda61963-4cdd-4939-b875-8c23a831d88d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4abea239-70e5-4358-8926-d43d0df1f355" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bda61963-4cdd-4939-b875-8c23a831d88d" xlink:to="loc_srt_RangeMember_4abea239-70e5-4358-8926-d43d0df1f355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fa4ea4e2-d83e-40f1-ace6-25800cfdcfeb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4abea239-70e5-4358-8926-d43d0df1f355" xlink:to="loc_srt_MinimumMember_fa4ea4e2-d83e-40f1-ace6-25800cfdcfeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2c064561-1fc4-403e-97e5-58d4fc5ba3fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4abea239-70e5-4358-8926-d43d0df1f355" xlink:to="loc_srt_MaximumMember_2c064561-1fc4-403e-97e5-58d4fc5ba3fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_8713493c-e386-4fd8-bd6a-0340262a60ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_VariableRateAxis_8713493c-e386-4fd8-bd6a-0340262a60ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8713493c-e386-4fd8-bd6a-0340262a60ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_8713493c-e386-4fd8-bd6a-0340262a60ee" xlink:to="loc_us-gaap_VariableRateDomain_8713493c-e386-4fd8-bd6a-0340262a60ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9c867e19-5015-4ea5-bc42-da8f7af1bfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_8713493c-e386-4fd8-bd6a-0340262a60ee" xlink:to="loc_us-gaap_VariableRateDomain_9c867e19-5015-4ea5-bc42-da8f7af1bfbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_SecuredOvernightFinancingRateSOFRMember_9708e8a7-6df4-49bc-8805-cb83b63dc3d5" xlink:href="med-20230331.xsd#med_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9c867e19-5015-4ea5-bc42-da8f7af1bfbf" xlink:to="loc_med_SecuredOvernightFinancingRateSOFRMember_9708e8a7-6df4-49bc-8805-cb83b63dc3d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4117b851-04c4-458b-8ff0-892510596612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_9c867e19-5015-4ea5-bc42-da8f7af1bfbf" xlink:to="loc_us-gaap_BaseRateMember_4117b851-04c4-458b-8ff0-892510596612" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>med-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ebea4200-127d-4056-af39-00ad362d0793,g:908e033e-f9bd-4981-9c22-7aad939362db-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_375cf2d4-95f9-40c2-bc3c-89a03ced83b9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_28543f2d-492f-4af6-aba0-6cfa7fab885a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_16929fa3-4c45-436f-91ee-1033fd79235c_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1857a1e6-8cd3-4a72-9e15-d4733dfde803_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_ad9fd45b-a3fe-4ba3-8954-402010b12c7d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_c61eeb9c-0ed4-44fe-aa7c-b6a3a6a6edf8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5fc00a84-662f-4216-83f6-6333493b1b40_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7c1bbe63-c7a2-4ede-b465-a636ae04b05e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_eff901f7-8a30-474b-8495-12d8264f66d5_terseLabel_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum total net leverage ratio</link:label>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_label_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Total Net Leverage Ratio</link:label>
    <link:label id="lab_med_MaximumTotalNetLeverageRatio_documentation_en-US" xlink:label="lab_med_MaximumTotalNetLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio" xlink:href="med-20230331.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MaximumTotalNetLeverageRatio" xlink:to="lab_med_MaximumTotalNetLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0db30daf-4707-400d-88aa-f4a8a8b7fa50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3f09f0da-666c-42b9-a7ed-af115563e31b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_75904b18-7bd3-4824-a6a5-f92ef1bd1de2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_adca9a42-68bd-4644-a8b4-242ee535f863_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_f5853086-6369-459f-988f-54516af70abb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_97e32758-00f6-4fa7-b8a8-2bcdac2a6497_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_07481303-82d2-46c7-90fc-b53512e84a78_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c3544f07-f5f3-4e3e-af2b-18cbd57b4b4f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_d0cf4569-e3d2-463d-9cf9-7986e00bb536_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_cb1df41f-d061-45f5-bc8e-f7e04cd74f87_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement for Equipment</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_label_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement For Equipment [Member]</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForEquipmentMember_documentation_en-US" xlink:label="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the operating lease arrangement for equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember" xlink:href="med-20230331.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseArrangementForEquipmentMember" xlink:to="lab_med_OperatingLeaseArrangementForEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_dc472605-9269-4d56-a735-a51f2e1e6bed_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_1c4f6e59-e341-4710-8716-6cba58adb254_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_74827b44-ebaf-4097-be81-d8ecac643665_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired from stock repurchases (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesRetired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesRetired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Retired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesRetired" xlink:to="lab_us-gaap_TreasuryStockSharesRetired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_143412dc-cb06-4f7d-abfb-5d2ac0b721a1_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_620448d1-e21c-4958-845a-cf96390314c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_f9dde40d-ceb8-48e2-9c25-2ce474a62e1d_terseLabel_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options and restricted stock</link:label>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_label_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock [Member]</link:label>
    <link:label id="lab_med_OptionsAndRestrictedStockMember_documentation_en-US" xlink:label="lab_med_OptionsAndRestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options And Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember" xlink:href="med-20230331.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OptionsAndRestrictedStockMember" xlink:to="lab_med_OptionsAndRestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_43c21536-0413-46fc-999e-2e50301361ba_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.001 per share: 20,000 shares authorized; 10,887 and 10,928 issued and 10,887 and 10,873 outstanding at March&#160;31, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_f07e845b-d7e9-4a84-94d6-a9dcd3818865_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_7c485e24-e171-4dc0-9e1c-ff96505bd12e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MarketAndPerformanceBasedShareMember_9988134b-fe6d-4020-b356-8d24cf35734d_terseLabel_en-US" xlink:label="lab_med_MarketAndPerformanceBasedShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market and performance-based share awards</link:label>
    <link:label id="lab_med_MarketAndPerformanceBasedShareMember_label_en-US" xlink:label="lab_med_MarketAndPerformanceBasedShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market And Performance-based Share [Member]</link:label>
    <link:label id="lab_med_MarketAndPerformanceBasedShareMember_documentation_en-US" xlink:label="lab_med_MarketAndPerformanceBasedShareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market And Performance-based Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceBasedShareMember" xlink:href="med-20230331.xsd#med_MarketAndPerformanceBasedShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MarketAndPerformanceBasedShareMember" xlink:to="lab_med_MarketAndPerformanceBasedShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5568faff-90eb-4f51-9898-6e0437815b48_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_316e81a0-1eb4-4ec6-a0f9-eb85b282e1ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_fa2924ae-4e09-4800-9575-afd4e6ec6029_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3f3236c4-5e17-4c73-aa39-86c58e7374e0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by directors (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_be0d536b-e455-484d-acb8-cae7fa05904f_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fc815796-6b80-46fb-bce4-050f97700f5f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_88794046-7d5a-4cf5-9bdb-f60623c0f588_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1850e798-47e6-45ff-aec9-44f3d1ab4a5c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2020Member_fd87b948-552a-4759-805b-1696fae4aaa2_terseLabel_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020</link:label>
    <link:label id="lab_med_GrantedIn2020Member_label_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2020Member_documentation_en-US" xlink:label="lab_med_GrantedIn2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member" xlink:href="med-20230331.xsd#med_GrantedIn2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2020Member" xlink:to="lab_med_GrantedIn2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f0b1c69d-ab77-4506-8767-ebce514bf916_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_12ef413f-569e-4f8e-92d8-893e966bbc4a_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents - end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f5bbd01e-621a-41ed-9668-ef8d1e5534d2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_e45d16f2-bb3a-4068-8915-016ef08ae231_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_5a98136c-52b9-4212-b5b1-55eb9a619b63_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_38e01ff8-b39d-4567-96fa-df31ed11d90c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a696de19-e426-405f-ac24-b756198b3b51_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_a8718921-010c-4507-82a6-b26d23d78525_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock from stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_bf209606-6a12-4ce1-bed4-3f263bc10c50_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_c0d978bd-9037-41bf-8fe8-939ae00d7308_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_eb9cc8f6-b3cd-4ec3-9934-d125329c26ee_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_28b2c5d4-bdb7-4da1-8bab-53bd632fc00c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3fe368c0-2dcb-4860-aad2-cd5e18d60362_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive awards</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_adfe0a4a-172c-40a3-972a-21752067c9ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_84e91ed7-fbab-4f7f-9b5d-97bc5f3e21be_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_4d06e605-bbe9-49e2-9e92-ea689698aae1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_3e83ab58-ff51-457c-9e55-302e9feb6b67_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_med_CreditAgreementMember_1837f167-0161-44c3-8b19-76e2f9025286_terseLabel_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_med_CreditAgreementMember_label_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_med_CreditAgreementMember_documentation_en-US" xlink:label="lab_med_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember" xlink:href="med-20230331.xsd#med_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_CreditAgreementMember" xlink:to="lab_med_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_a6987fef-3c0f-4138-b631-88d8ec29833f_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_ef94e579-ccd0-44e2-82bb-ee8be66ac284_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_f069f3c2-60b1-401f-a072-42e37eb24e4a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_37663c09-8408-4ab7-80fe-2a58d892572b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_f585c426-7b3d-4324-ab9e-3b2526d3221e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: treasury stock at cost, 0 and 54 shares at March&#160;31, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_54b1bc46-dc6d-49f4-8b0d-a34e38f0dc12_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9067958d-cbd5-4f12-8752-e8c7338853aa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_304a28da-43ad-4aa1-87a2-3dac78ce1b72_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercisable at end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_713a2564-c275-41fb-b74f-f5ef0e069a36_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8b2a62f2-24cb-4108-80d8-4cce286f2593_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_688ede08-04ba-4dd2-889d-7538bdd6111e_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9ed08ffe-ac97-477c-95e2-50bb72aadb87_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_91fdafae-b23a-4b49-80fe-2e5c9d658a7d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 (excluding the three months ended March&#160;31, 2023)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7cdafcca-0cfa-4fd2-83f4-21623591125d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8c51e67f-7c43-436d-8b4d-8d4a508394c1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_f7ed0dad-230d-4c34-9889-dad2554b84f7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_a90e9998-804a-49d7-b643-4890c8a21db3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2a6534ad-1fc0-463c-ab8c-6e24706700c8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life of options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40038d70-095f-491f-ad0b-5cc371ebc801_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_17a8b486-2647-4be6-97a0-b50345ae738e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding at end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_1047f8f0-928b-4cb9-aa54-f7898585f92c_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5b270e5a-6255-47be-984d-1f0b41b6d1f1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b34bab20-d137-4efe-bb3b-9d2c4947ebf9_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c6dbf4c9-c094-4092-b64e-aa80466269c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6e55cca8-81c9-4687-a789-37e8d86dca2f_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c9d80e44-ef47-4e7c-8457-86235c5e794e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency impact</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_485f9171-d598-4e00-b0f7-59173134e4a2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment - net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_7c7342a8-3f05-4864-83f1-3990c6671c88_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flow used in operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_med_UncommittedIncrementalFacilityMember_550166ff-09e6-4282-b0ee-62cd833b3995_terseLabel_en-US" xlink:label="lab_med_UncommittedIncrementalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted Incremental Facility</link:label>
    <link:label id="lab_med_UncommittedIncrementalFacilityMember_label_en-US" xlink:label="lab_med_UncommittedIncrementalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted Incremental Facility [Member]</link:label>
    <link:label id="lab_med_UncommittedIncrementalFacilityMember_documentation_en-US" xlink:label="lab_med_UncommittedIncrementalFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted Incremental Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_UncommittedIncrementalFacilityMember" xlink:href="med-20230331.xsd#med_UncommittedIncrementalFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_UncommittedIncrementalFacilityMember" xlink:to="lab_med_UncommittedIncrementalFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_dcbfcfaf-341d-44ef-b3f0-0bcef8e1d35b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_dfe50463-ab09-41e1-bc55-d3fd3af0e594_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_f92a3010-cf9a-487b-81c3-685e07c41cb1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by directors</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_14a71735-8202-4366-a3e4-e31f111e3433_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_79c92a7e-241a-4b32-ad11-f3025243d7b2_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_4d920ad3-0aa1-4586-b877-82e8c5c6964b_verboseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Presentation of Financial Statements</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d9f766f7-597e-443f-8294-7c06057fbdee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on investment securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_41a570a3-ce65-4f4b-9699-efac0f38ab88_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_6fb17b5f-21ba-4a2c-af93-bad93d2f8582_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_med_NumeratorAbstract_f846f521-7631-43e6-bff2-d9d369c6ed60_verboseLabel_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_med_NumeratorAbstract_label_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:label id="lab_med_NumeratorAbstract_documentation_en-US" xlink:label="lab_med_NumeratorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_NumeratorAbstract" xlink:href="med-20230331.xsd#med_NumeratorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_NumeratorAbstract" xlink:to="lab_med_NumeratorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fc02c2dc-d973-47f6-b62d-7ca13847ffca_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_27f87050-3962-4213-a66f-76518133801c_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_label_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense, Non-Cash</link:label>
    <link:label id="lab_med_OperatingLeaseExpenseNonCash_documentation_en-US" xlink:label="lab_med_OperatingLeaseExpenseNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash" xlink:href="med-20230331.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseExpenseNonCash" xlink:to="lab_med_OperatingLeaseExpenseNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_17e45042-45ff-4c06-b42f-fcf826911ef8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eb909d0a-b63e-4c63-bf32-831d70985dc4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_5c66f079-278a-429a-855e-110ffead2acb_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ead14142-487a-4439-9946-1f3e95381200_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5bebd5cb-7b78-4685-bac9-dfaf08459429_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_fb5aa2d2-1b11-4472-a1d6-6152222fcb13_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f00b4fb-d5cb-4e8f-9a95-3417d086bbaf_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_c09c6ae5-ce36-4612-9e4f-1012992eb99b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_c03dc867-b5b1-41b6-ad4a-b81936abc862_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_6846ff95-9ee1-43dd-9852-478dec9299e7_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_09ce0607-5a31-49c2-8918-12701dd4fd2c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes (refunded) paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_c38b7acb-c547-4f98-9e8e-013454c553d4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_af1418b6-e986-41ef-80f8-4a0f5b047281_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e7c4b815-2e2c-4470-8d4a-bce28ff3f1bb_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_b75223a3-cd88-4251-a54c-cf10e1224518_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_cea71e80-3b82-400c-a180-26d1a2a43eea_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_ac9cc791-cb89-4889-9a0a-ca8be2e83f73_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_00d27a8f-a460-441f-83ad-8ff6a294b00a_terseLabel_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement for Real Estate</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_label_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Arrangement For Real Estate [Member]</link:label>
    <link:label id="lab_med_OperatingLeaseArrangementForRealEstateMember_documentation_en-US" xlink:label="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the operating lease arrangement for real estate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember" xlink:href="med-20230331.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_OperatingLeaseArrangementForRealEstateMember" xlink:to="lab_med_OperatingLeaseArrangementForRealEstateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_40b61e67-9b52-43a1-81cc-7428263ee8c8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6f5e399a-3ead-450b-b33c-f2c05a3df8ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_23231064-d7ca-4c7a-a7b5-b40a1acf2fdf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_32c9cbde-5398-4d20-99af-5876393fe9a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_12654254-9a67-44c0-a7e8-6de5e5196a0e_verboseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_273b704c-82fd-4cd5-a770-dc006a15a44c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_8f4500eb-e9e7-4126-8388-6e31aba140f5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_5c69bdc9-c5ac-411e-b9a7-8d1813940f29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1a2ac8af-77b8-4af2-ba4d-fd7340655083_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax benefit recognized related to restricted stock awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a935903e-dd8e-4d8e-a048-abdb7f753f25_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_36d87ff7-a7eb-4590-876d-a718b23ba99a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_58fea20c-dd55-432c-a78c-5526c398912a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_med_MinimumInterestCoverageRatio_2a622769-2556-43ca-ae06-d8bba8d73000_terseLabel_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum interest coverage ratio</link:label>
    <link:label id="lab_med_MinimumInterestCoverageRatio_label_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Interest Coverage Ratio</link:label>
    <link:label id="lab_med_MinimumInterestCoverageRatio_documentation_en-US" xlink:label="lab_med_MinimumInterestCoverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Interest Coverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio" xlink:href="med-20230331.xsd#med_MinimumInterestCoverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_MinimumInterestCoverageRatio" xlink:to="lab_med_MinimumInterestCoverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_89048e1c-e3c1-4b4b-b8c1-901778a519ff_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_45e10f58-fc6f-47e4-a6a7-0b313c8523ba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_cb969499-1dca-484b-94fc-0334a73033ee_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_cd9b3ecd-caab-4879-9e95-8c103f80e935_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4026bb8f-47cd-4783-bddf-fe24251dba01_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_cdfed19d-8028-449d-a169-df5c8ee59821_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_6b35426f-4826-453e-b979-f9acef6a1e6e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e3857ebc-542b-40d0-b230-474cd30a6692_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_6724df8c-0627-41bb-83fe-9e6af586098c_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_443bb495-7c77-416b-b854-0542613c0545_verboseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-based share awards</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_05bdf2ba-e2ca-4907-bd7b-bce5703710b9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_738efdc7-858f-472d-8402-9a5c9cd1df51_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_da9dd9e7-174a-4b24-b648-9e520b3714b8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d1cbe20d-cb13-469d-a1ec-bc48bb8757dd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e4cf87c-6253-4302-ab40-b75af6b6c4ea_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flow used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_7788edb3-7221-4eac-b21a-08b05e390a06_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_efb20146-8efa-4d54-9501-b703567293e6_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_6cf7653a-d9f3-4473-95f3-dd7dd713f121_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_62fa6021-1e37-447b-a3c0-c4409c14f91a_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_b0e78ccc-d72a-4495-9cc7-b2147c20bb37_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c387a8e7-16a9-467b-aa75-0ea7c7d8477f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_525c6bd2-7dd0-40fd-8ee1-8d5900d726d1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2e480ed6-835b-4c85-a1c2-6b31b35701c8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d874cfed-6c54-436f-93d9-335c43b0c8a5_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_1b240a59-9590-4b27-aea7-d95a77a0609b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_aeed2af6-2098-4a43-8532-5c6b75c14175_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_3157bc72-b3ef-48af-a72d-c6115a620049_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_90ae45ff-8231-4f23-bf07-8e67feabce33_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e9b5fef-7fe9-4681-992c-e174efa102b1_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c11b7f7-9132-4778-8ebe-0b4f5b3ec583_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_68c12a0f-704a-4477-8634-3c27ae19866b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost recognition weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_23266d11-cc90-45d7-a421-a5d0794717c7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual life of options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_d6cf1e6e-f38b-48c2-b517-c2e14aded88d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_e46991e0-ab2a-4679-9275-e34f7f6d4ae2_negatedLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in share-based payment arrangement, expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_86214d11-6dad-4b9c-9472-2b2f0fd0e7c6_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_e030a954-e95a-4120-9070-fe0b15414592_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_ceb0d838-8416-463a-a6a1-75c26a55b4bf_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ee7a6340-fad0-416a-9da4-2d95bf9e2779_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b9cbd76d-d682-4f1d-9b15-5321b29ce973_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_87a78b49-3331-436d-a856-83d7d8ec970a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Outstanding at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b9e2986a-a93d-43d9-9b33-a9602efff04b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_915334e2-841e-4927-a5f3-7d5b57e89c49_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_8c414ba5-f5ce-422d-baf0-2fe72eb1af7f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Recognition and Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f55d1349-1665-42c6-99d6-582f153bda22_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_230abf81-410d-4e34-bb41-39d2f9868bcd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_86b4e5ed-d37b-486a-a4b7-6e98dfbd5611_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e3f66a2e-4154-4176-bb29-a827f7aaa735_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_36c0fb12-7f32-4f51-b401-8962a39de8ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_med_SecuredOvernightFinancingRateSOFRMember_a095a41b-048a-4066-a642-02db4a085684_terseLabel_en-US" xlink:label="lab_med_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_med_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_med_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_med_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_med_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_SecuredOvernightFinancingRateSOFRMember" xlink:href="med-20230331.xsd#med_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_med_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8c1c4415-e79f-4227-9a1f-5f41c98cc636_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SHARE-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_9d224771-5fc7-4a3f-b089-0d0596e0d24a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_af832072-a347-43dd-9e37-a3fe116839d0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ebc8c808-5f24-4d0e-888e-1a6cde00d396_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5dbdc6a7-c1cf-4003-a784-39eea808a56c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_acd22400-e042-4857-9389-2dd299a8386b_terseLabel_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares earned (percent)</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_label_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_documentation_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:href="med-20230331.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:to="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2023Member_76fd8644-452c-4bdc-ae55-8ab3262054cd_terseLabel_en-US" xlink:label="lab_med_GrantedIn2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2023</link:label>
    <link:label id="lab_med_GrantedIn2023Member_label_en-US" xlink:label="lab_med_GrantedIn2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2023 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2023Member_documentation_en-US" xlink:label="lab_med_GrantedIn2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2023Member" xlink:href="med-20230331.xsd#med_GrantedIn2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2023Member" xlink:to="lab_med_GrantedIn2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_78ccea9b-c52e-491a-a57c-35662d39b8d4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_4cf64bd2-7e4d-4568-8457-74e8de4fa5fd_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_deb81595-2fec-4aab-b22b-80f68c2af231_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investment securities</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a01e2575-af54-44a6-90ea-f895c5450c59_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_0d799b2f-dbb8-4bb4-bbbc-c0872f441d54_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e755da97-087b-4b0c-b299-645c4965a479_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_49e33fd3-e0cb-4bb5-8ea6-f7ab1fc87f0d_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_394a5b47-709d-4539-b50c-ca1f025991aa_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock at cost (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_e11c6a60-22b5-45ed-a787-ec62fc7b7dde_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_57050201-7ddd-410f-af6a-a14182109076_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_18283df5-6955-4240-ac3d-5c6e29355f45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_a07c5864-a3be-4940-b324-e3b1a6cf4396_terseLabel_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Payments Due After Year Four</link:label>
    <link:label id="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Liability Payments Due After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="med-20230331.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_25e0802e-ddda-4702-8825-3b409b0a933f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_48ace9cd-d9ca-428d-8b84-62209860e60c_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_809bd8a8-f304-48e9-996e-42996aa11b3c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_611d2e98-7cbe-4997-8b5a-0910eb44530c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share - diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_8fbc080f-2d60-46b4-84cf-46813ced94d9_verboseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_b37c1b19-f8d5-42bc-85c4-9ad7d38dc14c_terseLabel_en-US" xlink:label="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Packaging</link:label>
    <link:label id="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_label_en-US" xlink:label="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail Related Inventory, Packaging and Other Supplies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:to="lab_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies" xlink:type="arc" order="1"/>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_b65a3097-53c5-468c-89a1-5eee2a44aeeb_verboseLabel_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-food finished goods</link:label>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_label_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Non Food Finished Goods</link:label>
    <link:label id="lab_med_InventoryNonFoodFinishedGoods_documentation_en-US" xlink:label="lab_med_InventoryNonFoodFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods" xlink:href="med-20230331.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_InventoryNonFoodFinishedGoods" xlink:to="lab_med_InventoryNonFoodFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9b053544-98ca-4e6b-bd1e-dc0f4c24cea3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_30033dd3-20bd-47d3-b326-106e74d51bd5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8ca76043-4232-4fe1-bf68-04074a80ead8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2022Member_a935cc7b-4817-4124-8f8e-151e39053ad5_terseLabel_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022</link:label>
    <link:label id="lab_med_GrantedIn2022Member_label_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2022Member_documentation_en-US" xlink:label="lab_med_GrantedIn2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member" xlink:href="med-20230331.xsd#med_GrantedIn2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2022Member" xlink:to="lab_med_GrantedIn2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_16cf330e-ae5a-4b5e-bdf4-b8f93f63e3e6_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared included in accounts payable</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_079514b9-fd5e-4e2e-b1f3-0dad4cb006d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_45bcc215-6c84-4a32-b3e9-8aff006b8cc1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_701db1cd-cfec-4598-86bc-7243f1643b9e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a8c62536-3318-4a99-8496-64a2e2899c0f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d8ce820b-8642-41ae-b777-f59365d59fcd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share - basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_892829be-1be2-477c-83d2-8a6c2bcca66a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_98466f2f-0d12-4db7-b9b0-60ad3e1ec62b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7e0ecd64-24f1-4f51-9ac1-c8d0cbcc8c38_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee (as a percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_6a5fd3fd-f05d-4214-8b14-29aae4661456_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_74ed7316-4b3e-4ade-9d40-d2d59c22aced_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement, fair value of awards vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e69a2334-e642-42c8-854b-fce39613c147_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Company's Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_d9a4b0a9-c90e-402a-8bcb-1567827c3168_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e22d2db9-8323-4455-93b8-3606d06a3e55_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_72f9ff7e-f795-4629-89b6-9de1cec6c3d7_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ec4583da-caac-40c6-a6ba-e6a574155db2_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3a051ea1-fc03-4ced-8f8f-9480d8b0f4ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_c348e1dd-2399-4d5b-998f-3b57e3a8c7dd_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2cff9ad3-122a-4cc7-bf25-b423e0b07425_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_med_DenominatorAbstract_ff625b92-8293-4e34-af48-0d370e17938b_verboseLabel_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_med_DenominatorAbstract_label_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:label id="lab_med_DenominatorAbstract_documentation_en-US" xlink:label="lab_med_DenominatorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_DenominatorAbstract" xlink:href="med-20230331.xsd#med_DenominatorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_DenominatorAbstract" xlink:to="lab_med_DenominatorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e4c287e5-55a0-4001-aedd-23faf54b55a8_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_6413b348-f468-4982-90f9-54dc24839e7d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_med_GrantedIn2021Member_b59ee712-5b23-4c35-97c5-81e18db4e570_terseLabel_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021</link:label>
    <link:label id="lab_med_GrantedIn2021Member_label_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021 [Member]</link:label>
    <link:label id="lab_med_GrantedIn2021Member_documentation_en-US" xlink:label="lab_med_GrantedIn2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted In 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member" xlink:href="med-20230331.xsd#med_GrantedIn2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_GrantedIn2021Member" xlink:to="lab_med_GrantedIn2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_490f8c00-8035-43ed-81cc-198e54efb512_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_847bc668-6a14-4d82-8bc5-ebd6b3d9f870_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve for obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_28a06f8d-443c-4838-a6ba-09215b848e96_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORIES</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_dcc43c48-6a37-4598-991f-bcf0e2d795d7_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_8795dba9-e51f-455a-be67-9e462ca997e1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_10915e91-7013-4ecd-8595-74ac8ae1615e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid to stockholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_04c9be9d-9d05-4fd9-b84e-ac9390e9ad3c_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared to stockholders</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f6d522a5-30ac-4b72-887d-2ee9eaaaaaa8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_251845f5-e573-4ea6-b5ce-3c3aa6dc751a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_8445a9b3-28ee-4220-9420-ed678e66627b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_0e62ad94-a8cf-4872-b6ce-c2b7a40ad012_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and maturities of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6b7391f0-5b8f-4678-90f8-fc0bf5259aeb_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_158dfeec-31b3-49fa-906a-6fc49948a6d4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f95f05e1-525a-4446-a66b-97bcf012f3cd_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ceba9e6a-bded-4040-9129-c344a504b6ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_d5c0283d-03a6-4643-8693-1a373a09c5fb_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_bf71a4fe-0dd9-4234-a61c-c7387ceeaeff_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_45b8e161-6347-4b2f-bb8b-700a6fb56b5d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_03ae44fd-ee0a-4bb3-8ca8-c5055663af18_verboseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5029c927-54c9-4650-ab1d-b62a184fe53b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_13e48327-5304-49d3-b0aa-def78c044abd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in usds per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_68d72e1c-8214-4a5b-b782-0f42d56e7026_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_ea5bc28c-303b-4927-ae42-66d17467a948_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_2121ed3d-9df4-4923-9a06-6e1bee8cb57b_negatedLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for employee taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_74b7f4e9-a148-4f6a-af09-b2d81926f55f_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_6fc8dd05-58a2-4e7f-9dd1-d77e72e772bf_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_85c815d2-36a6-40e8-9e7d-45b063ceb5f7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligations, net of current lease obligations</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_274118f9-13d1-4774-afe0-62348d909849_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3352fd7b-bc65-43d1-943c-744da0a6b4b8_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_71aa2185-9f54-4602-92d2-582f0e3aa265_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive common stock equivalents (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ab94ef55-867b-4c45-be6e-46f4fbd3307f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_med_ProceedsFromStockOptionsExercisedDirectors_a20e3432-b9e2-4ef5-a4ce-989facb97125_terseLabel_en-US" xlink:label="lab_med_ProceedsFromStockOptionsExercisedDirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised by directors</link:label>
    <link:label id="lab_med_ProceedsFromStockOptionsExercisedDirectors_label_en-US" xlink:label="lab_med_ProceedsFromStockOptionsExercisedDirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised, Directors</link:label>
    <link:label id="lab_med_ProceedsFromStockOptionsExercisedDirectors_documentation_en-US" xlink:label="lab_med_ProceedsFromStockOptionsExercisedDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised, Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_ProceedsFromStockOptionsExercisedDirectors" xlink:href="med-20230331.xsd#med_ProceedsFromStockOptionsExercisedDirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_ProceedsFromStockOptionsExercisedDirectors" xlink:to="lab_med_ProceedsFromStockOptionsExercisedDirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_457a8fe7-edac-4485-bdff-543c83634b67_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_c554be35-7d8e-4fc9-9d5f-fab985bd5800_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_711a127c-012c-40d0-ae57-5e6516da5d58_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d1bced49-f884-4236-85db-729e3a752eed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_daed4fa3-2a3c-42bc-9454-3f3ece3e6678_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for employee taxes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_9dd243a7-6b49-4d5f-8687-83f56179c54f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price, Exercisable at end of the period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ce5c837b-5377-4af2-baf7-a4690a1632bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_dee515a2-8088-43d3-b4c2-a49adaa3233f_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1ee5dd72-4ec8-4ae4-93d1-6e7ec0db4a35_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_038ceb79-03c0-4ec5-b88f-331399422335_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c77c70d8-0e13-40a4-a6c7-da1bec503712_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f838e30e-133e-4b4a-9e7d-d9f0380b18e1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8c5e3dcc-d47e-43ff-b33d-f31794244d7a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_5fdfa0c0-f77f-482b-a975-4819119c5fc6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4acd37a5-f22a-4017-9713-f2bff282b54e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e3b3570-682f-4ff5-b83c-23a6e8d915a1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_2aa0bd89-2b93-446b-830b-eb5549557f82_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other (expense) income</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_78e228cd-a479-4e6f-88e3-1a2ae6092d45_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_6ec157d8-a0bf-4461-99f5-f5f6839eea2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_1adae919-1a20-42a2-af49-56430085045b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1d8236e9-4356-4905-b26d-98fe536c5fb1_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_240a5281-2f80-4004-9db3-0a960be8f963_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_49c21ea2-7463-451f-90d9-be19557df69a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_26e0d878-44b6-468a-bdae-953e6ffcdb06_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_29bce77e-2ef3-46f4-a6e4-27a19f562564_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCUMULATED OTHER COMPREHENSIVE INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a1d3fddd-88b0-4783-a693-9fe379d0c582_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f571d19a-cb2a-4daf-81ac-22671674e510_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_b07e374c-b421-46a9-b8ae-b8bdf97143e4_terseLabel_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_label_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</link:label>
    <link:label id="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_documentation_en-US" xlink:label="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:href="med-20230331.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:to="lab_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_8588a09e-5d3f-4aed-8188-4e09d5c947b4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_e9dd0acc-e236-4cb7-adab-c861f9249ed8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock retired from stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockRetiredCostMethodAmount_label_en-US" xlink:label="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Retired, Cost Method, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:to="lab_us-gaap_TreasuryStockRetiredCostMethodAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_329a1efb-47c2-4369-9418-763d126ffbb0_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_439f900f-b038-4e7a-b9a8-6ae1cf7aed9f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5e497f51-a408-4f16-8fd3-476d5550a51b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_93858216-1a33-4ddc-8a5b-bcfbc884f7b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_02c311d0-f6fb-4a90-b9ec-4f38034b3f12_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_d3ea2238-a02a-4bc2-8789-bd20651c133f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c9bcf8ae-a502-42c8-b690-311d869474d5_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_9fb99e65-da61-4c9a-9d9d-392f6e76e330_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the Computation of Basic and Diluted EPS</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity_ec2f9767-93f0-47c0-b0b5-1973f09045ae_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net shares repurchased for taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Other Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfOtherEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_57497048-b6de-4e60-8259-cbb50cfc6500_verboseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d3c81639-ea38-419b-9705-3a252e16d70e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9349e8cf-08f7-4058-84ae-d3a9f0a1bc4d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>med-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ebea4200-127d-4056-af39-00ad362d0793,g:908e033e-f9bd-4981-9c22-7aad939362db-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b5e3974e-6297-4379-93c6-04c27331b6fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_DocumentType_b5e3974e-6297-4379-93c6-04c27331b6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_3a9bf080-4890-44e5-9f10-f125f93bef6d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_DocumentQuarterlyReport_3a9bf080-4890-44e5-9f10-f125f93bef6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d882c97b-1fb0-4985-accb-73cca7989b6a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_DocumentPeriodEndDate_d882c97b-1fb0-4985-accb-73cca7989b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_9cdc157a-0966-4dc8-9e8f-81a791e7290b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_DocumentTransitionReport_9cdc157a-0966-4dc8-9e8f-81a791e7290b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0b8ce7ff-18a4-4a71-9143-41441310acfc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityFileNumber_0b8ce7ff-18a4-4a71-9143-41441310acfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_9c0f206e-39ed-4ed7-b235-7d9814a0c44e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityRegistrantName_9c0f206e-39ed-4ed7-b235-7d9814a0c44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_79635bb4-905a-4f79-9efb-4a051b9a8bc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_79635bb4-905a-4f79-9efb-4a051b9a8bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c2c6c2da-e91c-4244-a7c1-33e77d8538f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityTaxIdentificationNumber_c2c6c2da-e91c-4244-a7c1-33e77d8538f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bc2638f8-c789-443d-b9de-b69d8bc036f8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityAddressAddressLine1_bc2638f8-c789-443d-b9de-b69d8bc036f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1fea20a5-93ef-4319-8d08-324823a697f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityAddressCityOrTown_1fea20a5-93ef-4319-8d08-324823a697f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f12de2f6-7a7c-41bd-ba0b-42f9fa782ae3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityAddressStateOrProvince_f12de2f6-7a7c-41bd-ba0b-42f9fa782ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5d2ba9f1-5219-42fe-9711-65df4c317d58" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityAddressPostalZipCode_5d2ba9f1-5219-42fe-9711-65df4c317d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6c6a3d30-72c1-4d9e-84c6-ae4ed8b879ee" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_CityAreaCode_6c6a3d30-72c1-4d9e-84c6-ae4ed8b879ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_adb834bd-b3ea-4365-91d4-50e284f3cc15" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_LocalPhoneNumber_adb834bd-b3ea-4365-91d4-50e284f3cc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f7cc56b0-0a3b-4de2-8aeb-507a79f1a941" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_Security12bTitle_f7cc56b0-0a3b-4de2-8aeb-507a79f1a941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9c2a6509-5110-4ad2-88fe-1cc898f12aa3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_TradingSymbol_9c2a6509-5110-4ad2-88fe-1cc898f12aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_dacf9602-8669-498f-b4c1-c0ba4bd51f6c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_SecurityExchangeName_dacf9602-8669-498f-b4c1-c0ba4bd51f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b3488fcd-eb95-429c-967e-66539355d7dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityCurrentReportingStatus_b3488fcd-eb95-429c-967e-66539355d7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_12fa0e1e-726c-4807-834d-acf243a01cf8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityInteractiveDataCurrent_12fa0e1e-726c-4807-834d-acf243a01cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2486b5e7-3474-4323-8847-3307893dfdf0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityFilerCategory_2486b5e7-3474-4323-8847-3307893dfdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1741c77e-990d-400e-bc82-786ce860d145" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntitySmallBusiness_1741c77e-990d-400e-bc82-786ce860d145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b304e610-3213-4629-a99a-f5f613861681" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityEmergingGrowthCompany_b304e610-3213-4629-a99a-f5f613861681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b3aeccbd-e12b-47b7-9ed6-26a13f69ce35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityShellCompany_b3aeccbd-e12b-47b7-9ed6-26a13f69ce35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b3aeb0da-a8dc-4ff8-90b7-b9956cccd371" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b3aeb0da-a8dc-4ff8-90b7-b9956cccd371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ee80c368-e47a-4099-ab3c-8c4e67e5e949" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_EntityCentralIndexKey_ee80c368-e47a-4099-ab3c-8c4e67e5e949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f473025e-7c1c-4b09-85dc-f91782ff19ea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_CurrentFiscalYearEndDate_f473025e-7c1c-4b09-85dc-f91782ff19ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3c4bde6d-0e4f-4d63-89cb-a6000d8b893d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_DocumentFiscalYearFocus_3c4bde6d-0e4f-4d63-89cb-a6000d8b893d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_db5cea62-c204-44a5-aaff-0b3cd209528d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_db5cea62-c204-44a5-aaff-0b3cd209528d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ffdb2a75-0e84-4576-b229-286f20533393" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_bdd1ec3c-1610-4f3f-b108-30fa664352b7" xlink:to="loc_dei_AmendmentFlag_ffdb2a75-0e84-4576-b229-286f20533393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9e145e4-daad-46f5-a9d1-ac5b1754fd90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e9e145e4-daad-46f5-a9d1-ac5b1754fd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_39c88cfe-a522-4daa-99f4-2a85628bdb34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_CostOfRevenue_39c88cfe-a522-4daa-99f4-2a85628bdb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a21b84df-4bc0-43c6-a883-5611bb964a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_GrossProfit_a21b84df-4bc0-43c6-a883-5611bb964a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5344f211-5691-42f1-a0ee-debaf44a7560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5344f211-5691-42f1-a0ee-debaf44a7560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_19abe5c9-6b63-4abf-b13e-6dfcabaefa7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_OperatingIncomeLoss_19abe5c9-6b63-4abf-b13e-6dfcabaefa7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6061a83d-f6d6-4033-b436-7a6a84dd37a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6061a83d-f6d6-4033-b436-7a6a84dd37a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a8e9389b-3d9b-411e-b40c-796a95dc7c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6061a83d-f6d6-4033-b436-7a6a84dd37a2" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a8e9389b-3d9b-411e-b40c-796a95dc7c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_83320f03-18a7-4c75-af7a-a0014a7bcd13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6061a83d-f6d6-4033-b436-7a6a84dd37a2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_83320f03-18a7-4c75-af7a-a0014a7bcd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_52b32d8e-10ee-4934-8158-dfdce35d1ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6061a83d-f6d6-4033-b436-7a6a84dd37a2" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_52b32d8e-10ee-4934-8158-dfdce35d1ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d10ce960-3b27-4447-a827-6ef8bacd7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6061a83d-f6d6-4033-b436-7a6a84dd37a2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d10ce960-3b27-4447-a827-6ef8bacd7e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e98601dc-2b2b-4456-ba63-a5f5144e93cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6061a83d-f6d6-4033-b436-7a6a84dd37a2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e98601dc-2b2b-4456-ba63-a5f5144e93cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7ab31c81-c4e7-4f79-bcb8-bf6e0de75562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_6061a83d-f6d6-4033-b436-7a6a84dd37a2" xlink:to="loc_us-gaap_NetIncomeLoss_7ab31c81-c4e7-4f79-bcb8-bf6e0de75562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_614e0e4f-add5-480e-9046-79a84fd19243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_EarningsPerShareAbstract_614e0e4f-add5-480e-9046-79a84fd19243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b3d4b6bf-dd39-4e46-b76b-8ec6231c18c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_614e0e4f-add5-480e-9046-79a84fd19243" xlink:to="loc_us-gaap_EarningsPerShareBasic_b3d4b6bf-dd39-4e46-b76b-8ec6231c18c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e0b1d78c-cec7-4981-b98a-cac86d26ec82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_614e0e4f-add5-480e-9046-79a84fd19243" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e0b1d78c-cec7-4981-b98a-cac86d26ec82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_45d10561-ac2a-4187-9ba1-d3a8fce27000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_45d10561-ac2a-4187-9ba1-d3a8fce27000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3a03b524-1ba1-45a4-b4eb-9ef55e3322d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_45d10561-ac2a-4187-9ba1-d3a8fce27000" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3a03b524-1ba1-45a4-b4eb-9ef55e3322d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3cc68543-1a8c-492a-ae91-e4224f435b9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_45d10561-ac2a-4187-9ba1-d3a8fce27000" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3cc68543-1a8c-492a-ae91-e4224f435b9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_1090a397-bd0b-43e3-b601-c9f3e0a93594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_41a94edb-d433-430f-a3a9-63845c350e1e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_1090a397-bd0b-43e3-b601-c9f3e0a93594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dfc82b02-a66a-43d2-9ce3-c24caea7c072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6dd5503f-d3d5-48c9-b9df-28544802f956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dfc82b02-a66a-43d2-9ce3-c24caea7c072" xlink:to="loc_us-gaap_NetIncomeLoss_6dd5503f-d3d5-48c9-b9df-28544802f956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_182dec2d-0aa2-49c5-a726-61ba395c69d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dfc82b02-a66a-43d2-9ce3-c24caea7c072" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_182dec2d-0aa2-49c5-a726-61ba395c69d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c84ea8d2-fa16-4d7d-b30c-706001bfac45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_182dec2d-0aa2-49c5-a726-61ba395c69d8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_c84ea8d2-fa16-4d7d-b30c-706001bfac45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e3d15881-1030-4b1f-aba5-91113f064cb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_182dec2d-0aa2-49c5-a726-61ba395c69d8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e3d15881-1030-4b1f-aba5-91113f064cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f1e69358-e623-4b63-840e-c122f61ff410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_182dec2d-0aa2-49c5-a726-61ba395c69d8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f1e69358-e623-4b63-840e-c122f61ff410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e5014b71-159e-48dd-848e-eed7b2115b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_dfc82b02-a66a-43d2-9ce3-c24caea7c072" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e5014b71-159e-48dd-848e-eed7b2115b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9d3a3773-12bc-42e6-b10c-7b3e8c04a08d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5cdbab47-bef0-4160-b077-61b897aec01d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9d3a3773-12bc-42e6-b10c-7b3e8c04a08d" xlink:to="loc_us-gaap_AssetsAbstract_5cdbab47-bef0-4160-b077-61b897aec01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_eb69e119-0cb6-4856-9db1-9b431c195531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cdbab47-bef0-4160-b077-61b897aec01d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_eb69e119-0cb6-4856-9db1-9b431c195531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d66e56f-7eda-4e95-8791-04ca68d13a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb69e119-0cb6-4856-9db1-9b431c195531" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0d66e56f-7eda-4e95-8791-04ca68d13a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b138534c-cb76-4dd3-8def-04ac7179baed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb69e119-0cb6-4856-9db1-9b431c195531" xlink:to="loc_us-gaap_InventoryNet_b138534c-cb76-4dd3-8def-04ac7179baed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dc6e7ea8-9822-4307-b6c1-e17cbee7c95e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb69e119-0cb6-4856-9db1-9b431c195531" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_dc6e7ea8-9822-4307-b6c1-e17cbee7c95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0f4b08ce-03a8-4593-92b1-1fde0973c546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_eb69e119-0cb6-4856-9db1-9b431c195531" xlink:to="loc_us-gaap_AssetsCurrent_0f4b08ce-03a8-4593-92b1-1fde0973c546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_794ae8e0-b0b4-42e0-8da9-3aece68faec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cdbab47-bef0-4160-b077-61b897aec01d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_794ae8e0-b0b4-42e0-8da9-3aece68faec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_78b47f0c-ce22-4f75-bb5e-73e0a21d9d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cdbab47-bef0-4160-b077-61b897aec01d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_78b47f0c-ce22-4f75-bb5e-73e0a21d9d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_17132b3b-2778-4246-bbe9-204901017120" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cdbab47-bef0-4160-b077-61b897aec01d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_17132b3b-2778-4246-bbe9-204901017120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_347e63bc-b2aa-4cf7-8e29-98e132757411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cdbab47-bef0-4160-b077-61b897aec01d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_347e63bc-b2aa-4cf7-8e29-98e132757411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fa508cba-8bcf-44e0-8d43-4a1f29569612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5cdbab47-bef0-4160-b077-61b897aec01d" xlink:to="loc_us-gaap_Assets_fa508cba-8bcf-44e0-8d43-4a1f29569612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818f749f-868d-42a3-b47f-eb56d30c1281" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9d3a3773-12bc-42e6-b10c-7b3e8c04a08d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818f749f-868d-42a3-b47f-eb56d30c1281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_aa5a661b-aba5-49da-9dc6-15249959e0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818f749f-868d-42a3-b47f-eb56d30c1281" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_aa5a661b-aba5-49da-9dc6-15249959e0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_f0a43c4a-a3ef-41d6-811c-26197e12272d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aa5a661b-aba5-49da-9dc6-15249959e0f0" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_f0a43c4a-a3ef-41d6-811c-26197e12272d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_5ab74d0c-8f4c-4b82-898d-9bc8138c8bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aa5a661b-aba5-49da-9dc6-15249959e0f0" xlink:to="loc_us-gaap_TaxesPayableCurrent_5ab74d0c-8f4c-4b82-898d-9bc8138c8bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0a2ee406-55a3-47ca-93f5-1ae2103ce58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aa5a661b-aba5-49da-9dc6-15249959e0f0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0a2ee406-55a3-47ca-93f5-1ae2103ce58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a9b1cb6e-bff7-40b2-b93c-34f89dc21232" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_aa5a661b-aba5-49da-9dc6-15249959e0f0" xlink:to="loc_us-gaap_LiabilitiesCurrent_a9b1cb6e-bff7-40b2-b93c-34f89dc21232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8d19a689-0e7e-43d0-b738-477f1b6b8b72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818f749f-868d-42a3-b47f-eb56d30c1281" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8d19a689-0e7e-43d0-b738-477f1b6b8b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a6c59312-0b7f-4c7d-a17c-3251e65505d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818f749f-868d-42a3-b47f-eb56d30c1281" xlink:to="loc_us-gaap_Liabilities_a6c59312-0b7f-4c7d-a17c-3251e65505d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_43c2a108-d8ee-42a0-a5e7-9ada4dd3c80b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818f749f-868d-42a3-b47f-eb56d30c1281" xlink:to="loc_us-gaap_StockholdersEquityAbstract_43c2a108-d8ee-42a0-a5e7-9ada4dd3c80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9bece871-00e5-4f5e-b147-0630e5760938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43c2a108-d8ee-42a0-a5e7-9ada4dd3c80b" xlink:to="loc_us-gaap_CommonStockValue_9bece871-00e5-4f5e-b147-0630e5760938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_272132d9-d95d-4d7c-bdf3-c8f4d0a2f92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43c2a108-d8ee-42a0-a5e7-9ada4dd3c80b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_272132d9-d95d-4d7c-bdf3-c8f4d0a2f92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e0bc32b7-4706-436a-9a81-7fc1ae07b792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43c2a108-d8ee-42a0-a5e7-9ada4dd3c80b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e0bc32b7-4706-436a-9a81-7fc1ae07b792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_380758f8-b685-42d2-a856-a8cfe9de3754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43c2a108-d8ee-42a0-a5e7-9ada4dd3c80b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_380758f8-b685-42d2-a856-a8cfe9de3754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_604642c2-6e29-4132-b79a-353a0ef65378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43c2a108-d8ee-42a0-a5e7-9ada4dd3c80b" xlink:to="loc_us-gaap_TreasuryStockCommonValue_604642c2-6e29-4132-b79a-353a0ef65378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f1ca4b89-1669-4b3a-8136-495eb012d923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_43c2a108-d8ee-42a0-a5e7-9ada4dd3c80b" xlink:to="loc_us-gaap_StockholdersEquity_f1ca4b89-1669-4b3a-8136-495eb012d923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_86c557aa-1778-4482-a194-a7eda909a35a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_818f749f-868d-42a3-b47f-eb56d30c1281" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_86c557aa-1778-4482-a194-a7eda909a35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_7e9c2d10-a46f-4aca-a5f3-08e61a1d595d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4c6720cc-4a00-49e9-8257-7638fe155336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7e9c2d10-a46f-4aca-a5f3-08e61a1d595d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4c6720cc-4a00-49e9-8257-7638fe155336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d0ef0971-70aa-4d89-bd05-14ddfbb88f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7e9c2d10-a46f-4aca-a5f3-08e61a1d595d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d0ef0971-70aa-4d89-bd05-14ddfbb88f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_43201baa-7ffb-4f3a-ba25-20798ee0b477" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7e9c2d10-a46f-4aca-a5f3-08e61a1d595d" xlink:to="loc_us-gaap_CommonStockSharesIssued_43201baa-7ffb-4f3a-ba25-20798ee0b477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_59398453-5c2b-4ee0-bfe0-d08f65bb3d14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7e9c2d10-a46f-4aca-a5f3-08e61a1d595d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_59398453-5c2b-4ee0-bfe0-d08f65bb3d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_59690ef5-1ab1-400f-a4c9-df78475596d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_7e9c2d10-a46f-4aca-a5f3-08e61a1d595d" xlink:to="loc_us-gaap_TreasuryStockCommonShares_59690ef5-1ab1-400f-a4c9-df78475596d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d43157f-774b-46a3-afb9-135a7aee773d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d43157f-774b-46a3-afb9-135a7aee773d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0a5c5bd6-8211-4be0-905d-1d76e7d6bbe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d43157f-774b-46a3-afb9-135a7aee773d" xlink:to="loc_us-gaap_NetIncomeLoss_0a5c5bd6-8211-4be0-905d-1d76e7d6bbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_67d9b339-69f4-4250-addd-5e885fe3d3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3d43157f-774b-46a3-afb9-135a7aee773d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_67d9b339-69f4-4250-addd-5e885fe3d3e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5d19409a-4849-4615-b2c3-1748772af61e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_67d9b339-69f4-4250-addd-5e885fe3d3e9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5d19409a-4849-4615-b2c3-1748772af61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseExpenseNonCash_5cf5b6b4-ffd7-416f-84e8-94e5e7eefdfa" xlink:href="med-20230331.xsd#med_OperatingLeaseExpenseNonCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_67d9b339-69f4-4250-addd-5e885fe3d3e9" xlink:to="loc_med_OperatingLeaseExpenseNonCash_5cf5b6b4-ffd7-416f-84e8-94e5e7eefdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3b7ecb97-c4ed-470d-8079-ad94f10d2bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_67d9b339-69f4-4250-addd-5e885fe3d3e9" xlink:to="loc_us-gaap_ShareBasedCompensation_3b7ecb97-c4ed-470d-8079-ad94f10d2bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_81c3877d-f3d2-49f2-ba1b-a5d25cb6a409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_67d9b339-69f4-4250-addd-5e885fe3d3e9" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_81c3877d-f3d2-49f2-ba1b-a5d25cb6a409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_feee3470-ccc4-4666-bf07-820ae7102324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_67d9b339-69f4-4250-addd-5e885fe3d3e9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_feee3470-ccc4-4666-bf07-820ae7102324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ded938fe-128c-4a1b-8e18-de37dc7a482c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_67d9b339-69f4-4250-addd-5e885fe3d3e9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ded938fe-128c-4a1b-8e18-de37dc7a482c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_4c0ae522-e6a7-4c56-8a19-72fb3d31bd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ded938fe-128c-4a1b-8e18-de37dc7a482c" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_4c0ae522-e6a7-4c56-8a19-72fb3d31bd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_788ad8c1-cbd1-45a4-995d-9b0aee0ae626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ded938fe-128c-4a1b-8e18-de37dc7a482c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_788ad8c1-cbd1-45a4-995d-9b0aee0ae626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_536169dc-dc83-4069-995b-9ff197f87d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ded938fe-128c-4a1b-8e18-de37dc7a482c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_536169dc-dc83-4069-995b-9ff197f87d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6296d76c-2bc8-4910-a6da-f508ac7261d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ded938fe-128c-4a1b-8e18-de37dc7a482c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6296d76c-2bc8-4910-a6da-f508ac7261d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_7c7ad48e-bac1-4b40-af64-d89ad65a1552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ded938fe-128c-4a1b-8e18-de37dc7a482c" xlink:to="loc_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_7c7ad48e-bac1-4b40-af64-d89ad65a1552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_382ec436-420c-4844-bebb-73f43505825d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ded938fe-128c-4a1b-8e18-de37dc7a482c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_382ec436-420c-4844-bebb-73f43505825d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_62ae7864-0854-456d-94e1-3bbd28c48322" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_62ae7864-0854-456d-94e1-3bbd28c48322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_c0cd3866-b5ac-4ee0-8d69-47c5230b6735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_62ae7864-0854-456d-94e1-3bbd28c48322" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_c0cd3866-b5ac-4ee0-8d69-47c5230b6735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_33b6322c-285f-43af-a3f7-f37e705ff04f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_62ae7864-0854-456d-94e1-3bbd28c48322" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_33b6322c-285f-43af-a3f7-f37e705ff04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_21b632e4-d1cd-4ed9-b488-6fa1b5eeb923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_62ae7864-0854-456d-94e1-3bbd28c48322" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_21b632e4-d1cd-4ed9-b488-6fa1b5eeb923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fdfdc5f-4fb3-4d44-92c6-7567eca2dd13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fdfdc5f-4fb3-4d44-92c6-7567eca2dd13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ProceedsFromStockOptionsExercisedDirectors_f6465af9-2df3-4ba9-8881-0b6ff9514dd8" xlink:href="med-20230331.xsd#med_ProceedsFromStockOptionsExercisedDirectors"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fdfdc5f-4fb3-4d44-92c6-7567eca2dd13" xlink:to="loc_med_ProceedsFromStockOptionsExercisedDirectors_f6465af9-2df3-4ba9-8881-0b6ff9514dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_3b5b93f8-d7e4-4961-bdd3-a4f6157710c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfOtherEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fdfdc5f-4fb3-4d44-92c6-7567eca2dd13" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfOtherEquity_3b5b93f8-d7e4-4961-bdd3-a4f6157710c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_ff76ce91-947b-4b27-957e-e0e9b358321a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fdfdc5f-4fb3-4d44-92c6-7567eca2dd13" xlink:to="loc_us-gaap_PaymentsOfDividends_ff76ce91-947b-4b27-957e-e0e9b358321a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c8db7c74-5096-4100-b41b-070153a7be05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fdfdc5f-4fb3-4d44-92c6-7567eca2dd13" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c8db7c74-5096-4100-b41b-070153a7be05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b9e5aa52-193e-4dd9-b9ce-a9e6824d0ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fdfdc5f-4fb3-4d44-92c6-7567eca2dd13" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b9e5aa52-193e-4dd9-b9ce-a9e6824d0ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87cd9328-d562-4bdf-9f95-9020cab494a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87cd9328-d562-4bdf-9f95-9020cab494a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5aaeecaf-fe3c-450d-a69d-508ba23b022e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5aaeecaf-fe3c-450d-a69d-508ba23b022e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1637b37-4cd6-4b07-910f-43a8c2f030d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c1637b37-4cd6-4b07-910f-43a8c2f030d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cdf95ba7-d1f8-48e1-a019-828a976d85dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cdf95ba7-d1f8-48e1-a019-828a976d85dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bb5b8a4-d886-4d10-8a09-a3ab4a4e5f29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a0d06595-2482-4925-aee5-7d8ce5cced27" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bb5b8a4-d886-4d10-8a09-a3ab4a4e5f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_1336115c-bc6e-4b1b-8bfa-96bc67205f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bb5b8a4-d886-4d10-8a09-a3ab4a4e5f29" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_1336115c-bc6e-4b1b-8bfa-96bc67205f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_a9ffeadb-c273-4f7e-b783-1571e655ec92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_7bb5b8a4-d886-4d10-8a09-a3ab4a4e5f29" xlink:to="loc_us-gaap_DividendsCash_a9ffeadb-c273-4f7e-b783-1571e655ec92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="simple" xlink:href="med-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_439372f6-fdb4-4e31-be1a-b7345b08b244" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_13a489aa-880f-4606-a321-3bd942b3390c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_439372f6-fdb4-4e31-be1a-b7345b08b244" xlink:to="loc_us-gaap_StatementTable_13a489aa-880f-4606-a321-3bd942b3390c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_13a489aa-880f-4606-a321-3bd942b3390c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be464dd2-0534-4c0f-a6f5-f1eb5159a6c9" xlink:to="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_53862e55-2c21-4de8-a8c8-42b6b3554c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_CommonStockMember_53862e55-2c21-4de8-a8c8-42b6b3554c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_6b02d742-de17-4793-af7e-0bbdfb5dc3a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_6b02d742-de17-4793-af7e-0bbdfb5dc3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc310c0e-2bbf-41c9-97a1-78c8d404e0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fc310c0e-2bbf-41c9-97a1-78c8d404e0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7cfce479-4992-4e98-8854-41f986a55853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_RetainedEarningsMember_7cfce479-4992-4e98-8854-41f986a55853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_ec9ded9d-8f6d-4287-bdc5-590e99a1a82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0b19d13e-5c88-4721-bbe7-39d4f28efbae" xlink:to="loc_us-gaap_TreasuryStockCommonMember_ec9ded9d-8f6d-4287-bdc5-590e99a1a82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_33b71bb7-481a-4770-a937-66a17397abdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_13a489aa-880f-4606-a321-3bd942b3390c" xlink:to="loc_us-gaap_StatementLineItems_33b71bb7-481a-4770-a937-66a17397abdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_33b71bb7-481a-4770-a937-66a17397abdc" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_bd5bb954-be59-43cb-93de-43f98a024737" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_CommonStockSharesIssued_bd5bb954-be59-43cb-93de-43f98a024737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ccb02334-930f-446b-ac58-ae7747e1c255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_StockholdersEquity_ccb02334-930f-446b-ac58-ae7747e1c255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_100d59a3-861d-49b3-aad4-d44e6a489acb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_NetIncomeLoss_100d59a3-861d-49b3-aad4-d44e6a489acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_77452f10-fec2-40ce-929d-0e2fe54e7bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_77452f10-fec2-40ce-929d-0e2fe54e7bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_ad138d65-5e07-4289-a346-88d75fd4caed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_ad138d65-5e07-4289-a346-88d75fd4caed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_35d0c526-5fae-4c19-8003-18133a53359b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_35d0c526-5fae-4c19-8003-18133a53359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1360013e-0ee4-400c-bfbf-88368a1d5f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1360013e-0ee4-400c-bfbf-88368a1d5f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_be91edca-6bc5-4f39-930c-f1a371675792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_be91edca-6bc5-4f39-930c-f1a371675792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b76195fc-634a-448a-8cd4-de83e3d61360" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b76195fc-634a-448a-8cd4-de83e3d61360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_75edd241-87cc-4566-a307-5e3c07faf5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_75edd241-87cc-4566-a307-5e3c07faf5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesRetired_61453f9a-2d1e-4da0-9aff-973e124b77de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesRetired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_TreasuryStockSharesRetired_61453f9a-2d1e-4da0-9aff-973e124b77de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_69a441da-b600-47e8-a0b9-d57fad10df07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockRetiredCostMethodAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_TreasuryStockRetiredCostMethodAmount_69a441da-b600-47e8-a0b9-d57fad10df07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0a39198e-e53b-4387-a491-be36a09165b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0a39198e-e53b-4387-a491-be36a09165b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_920979db-5523-4ab5-a481-2e352a4d12e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_DividendsCommonStockCash_920979db-5523-4ab5-a481-2e352a4d12e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6ea54088-75ec-410b-9077-d5a07761f203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_CommonStockSharesIssued_6ea54088-75ec-410b-9077-d5a07761f203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_12ab5a5a-3cf0-4254-9235-803434378ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bb560846-c295-4685-8edf-81c19393e4b6" xlink:to="loc_us-gaap_StockholdersEquity_12ab5a5a-3cf0-4254-9235-803434378ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="med-20230331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4e441f92-b4d6-4f07-95e5-4823723d4895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e5684f3f-eb49-40ec-92f8-9a8bdb2cc381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4e441f92-b4d6-4f07-95e5-4823723d4895" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_e5684f3f-eb49-40ec-92f8-9a8bdb2cc381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIES" xlink:type="simple" xlink:href="med-20230331.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_4217a97d-89c2-4419-831f-b71ad2333c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_82feb77e-ea06-4ff4-9ef6-a05678b1f729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_4217a97d-89c2-4419-831f-b71ad2333c78" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_82feb77e-ea06-4ff4-9ef6-a05678b1f729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="med-20230331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b5dc45c4-ed68-466f-ba88-aa16515ea501" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_65d9d76d-ce5c-4baf-9c12-27351b891c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b5dc45c4-ed68-466f-ba88-aa16515ea501" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_65d9d76d-ce5c-4baf-9c12-27351b891c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25ed5346-87d9-4bdc-961c-9892fad8bd74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c8e7855a-b5d0-4d65-a22f-64dc0b3b72e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25ed5346-87d9-4bdc-961c-9892fad8bd74" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_c8e7855a-b5d0-4d65-a22f-64dc0b3b72e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASES" xlink:type="simple" xlink:href="med-20230331.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fadb58eb-ea06-41c1-b557-0865c40bf12f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_6676a5c7-b295-4552-a88b-668969b0f5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fadb58eb-ea06-41c1-b557-0865c40bf12f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_6676a5c7-b295-4552-a88b-668969b0f5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="med-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_8ecfe25d-1467-4ffb-b092-6749993f03d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_db8b4a34-b200-4403-94c3-e7cf6ab3577c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_8ecfe25d-1467-4ffb-b092-6749993f03d2" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_db8b4a34-b200-4403-94c3-e7cf6ab3577c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBT" xlink:type="simple" xlink:href="med-20230331.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_25c72656-e464-496a-a0e1-537be0ada1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_31b3f9f0-804d-449e-b106-08f809181779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_25c72656-e464-496a-a0e1-537be0ada1d5" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_31b3f9f0-804d-449e-b106-08f809181779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="med-20230331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a72b5b48-d83e-482a-9a04-0397d504529e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_60537d0e-7b26-46ca-b3ba-be84602a2b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a72b5b48-d83e-482a-9a04-0397d504529e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_60537d0e-7b26-46ca-b3ba-be84602a2b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_bf61b621-f2a3-44da-92a2-212d44d4d7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a72b5b48-d83e-482a-9a04-0397d504529e" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_bf61b621-f2a3-44da-92a2-212d44d4d7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_f01cac8e-f878-4d0d-875e-024afb298767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a72b5b48-d83e-482a-9a04-0397d504529e" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_f01cac8e-f878-4d0d-875e-024afb298767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_25da33db-6f85-41c8-a71c-67910a605b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a72b5b48-d83e-482a-9a04-0397d504529e" xlink:to="loc_us-gaap_UseOfEstimates_25da33db-6f85-41c8-a71c-67910a605b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_59cdd173-229e-437e-a0b3-7d314c748191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a72b5b48-d83e-482a-9a04-0397d504529e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_59cdd173-229e-437e-a0b3-7d314c748191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="med-20230331.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6c59443b-e4c0-4afb-a9b7-4a0a0d337700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_60dc7ce9-725d-40bd-ad5f-40a70dea36ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6c59443b-e4c0-4afb-a9b7-4a0a0d337700" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_60dc7ce9-725d-40bd-ad5f-40a70dea36ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="med-20230331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_424c50fe-18d4-4de1-89d0-f5d892498abc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b934974e-70a0-436e-a3ad-e19ca58369fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_424c50fe-18d4-4de1-89d0-f5d892498abc" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b934974e-70a0-436e-a3ad-e19ca58369fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_68d2cf65-45c7-4949-8652-585ba88ae889" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_03b2ea37-cdc5-48b7-a516-8aefe84b5051" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_68d2cf65-45c7-4949-8652-585ba88ae889" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_03b2ea37-cdc5-48b7-a516-8aefe84b5051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_bbbb0e8d-e9a4-4012-9cb4-3fff8998f211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_68d2cf65-45c7-4949-8652-585ba88ae889" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_bbbb0e8d-e9a4-4012-9cb4-3fff8998f211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_8639311c-b5af-4194-981a-e839fe40f541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_68d2cf65-45c7-4949-8652-585ba88ae889" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_8639311c-b5af-4194-981a-e839fe40f541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESTables" xlink:type="simple" xlink:href="med-20230331.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d76a11a6-f03e-4408-99be-d423c2a18256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_189d6ef7-030e-43a0-ab7d-a64416bd6ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d76a11a6-f03e-4408-99be-d423c2a18256" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_189d6ef7-030e-43a0-ab7d-a64416bd6ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b229881c-1563-47c4-a864-68ad92edee2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d76a11a6-f03e-4408-99be-d423c2a18256" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b229881c-1563-47c4-a864-68ad92edee2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="med-20230331.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_35dbdcda-b6dc-4ace-bca5-4856a130a225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_5efe1670-e6df-49c9-8583-6f197955e542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_35dbdcda-b6dc-4ace-bca5-4856a130a225" xlink:to="loc_us-gaap_InventoryRawMaterials_5efe1670-e6df-49c9-8583-6f197955e542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_24c16720-e4ff-412a-ad43-41ab01ddf94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_35dbdcda-b6dc-4ace-bca5-4856a130a225" xlink:to="loc_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies_24c16720-e4ff-412a-ad43-41ab01ddf94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_InventoryNonFoodFinishedGoods_1e5ea7e0-33ed-4f60-b806-711c9528d3ec" xlink:href="med-20230331.xsd#med_InventoryNonFoodFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_35dbdcda-b6dc-4ace-bca5-4856a130a225" xlink:to="loc_med_InventoryNonFoodFinishedGoods_1e5ea7e0-33ed-4f60-b806-711c9528d3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_f663c5be-e0e8-47a2-8338-edcf59cf6e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_35dbdcda-b6dc-4ace-bca5-4856a130a225" xlink:to="loc_us-gaap_InventoryFinishedGoods_f663c5be-e0e8-47a2-8338-edcf59cf6e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_c3691c94-84ac-4684-8bb7-80aae4db59d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_35dbdcda-b6dc-4ace-bca5-4856a130a225" xlink:to="loc_us-gaap_InventoryValuationReserves_c3691c94-84ac-4684-8bb7-80aae4db59d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_36534760-63b0-4b70-b602-92ef5664efd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_35dbdcda-b6dc-4ace-bca5-4856a130a225" xlink:to="loc_us-gaap_InventoryNet_36534760-63b0-4b70-b602-92ef5664efd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="simple" xlink:href="med-20230331.xsd#EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a73e24c4-f747-4d65-becf-2311cc49dcda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_NumeratorAbstract_32533c20-3b5b-495b-a28c-ebeacb55360b" xlink:href="med-20230331.xsd#med_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a73e24c4-f747-4d65-becf-2311cc49dcda" xlink:to="loc_med_NumeratorAbstract_32533c20-3b5b-495b-a28c-ebeacb55360b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a25dd503-63fd-4e31-8ff8-e79f0520fd61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_NumeratorAbstract_32533c20-3b5b-495b-a28c-ebeacb55360b" xlink:to="loc_us-gaap_NetIncomeLoss_a25dd503-63fd-4e31-8ff8-e79f0520fd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_DenominatorAbstract_481dd569-658e-4e04-96bd-07e6f3b1df2c" xlink:href="med-20230331.xsd#med_DenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a73e24c4-f747-4d65-becf-2311cc49dcda" xlink:to="loc_med_DenominatorAbstract_481dd569-658e-4e04-96bd-07e6f3b1df2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18ce237f-bf98-4d03-9905-36fc1cbf479d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_481dd569-658e-4e04-96bd-07e6f3b1df2c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18ce237f-bf98-4d03-9905-36fc1cbf479d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_44e01710-71c0-4d02-bce6-9ee45e0a4e00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_481dd569-658e-4e04-96bd-07e6f3b1df2c" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_44e01710-71c0-4d02-bce6-9ee45e0a4e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_03cbcc98-8859-40a1-8be5-e3b9a595f0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_med_DenominatorAbstract_481dd569-658e-4e04-96bd-07e6f3b1df2c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_03cbcc98-8859-40a1-8be5-e3b9a595f0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2d81b4bc-cca4-41cb-94e9-8d8c0c4b16d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a73e24c4-f747-4d65-becf-2311cc49dcda" xlink:to="loc_us-gaap_EarningsPerShareBasic_2d81b4bc-cca4-41cb-94e9-8d8c0c4b16d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_78ae7ec3-7510-4d09-a047-9fd259d67506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a73e24c4-f747-4d65-becf-2311cc49dcda" xlink:to="loc_us-gaap_EarningsPerShareDiluted_78ae7ec3-7510-4d09-a047-9fd259d67506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="simple" xlink:href="med-20230331.xsd#EARNINGSPERSHARENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_43c3289d-4923-484a-9b92-a520f43eb18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c4fe40f0-10ad-401f-8d88-4e58b26282a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_43c3289d-4923-484a-9b92-a520f43eb18a" xlink:to="loc_us-gaap_StatementTable_c4fe40f0-10ad-401f-8d88-4e58b26282a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c4fe40f0-10ad-401f-8d88-4e58b26282a9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_336d6da0-a31f-4187-ae57-2f329242d913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_efaf21e2-8b6c-4e39-a6e1-eb16da0cd3bc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_336d6da0-a31f-4187-ae57-2f329242d913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_32b35d21-f3d9-473b-9ee9-cdd7dc37c8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_336d6da0-a31f-4187-ae57-2f329242d913" xlink:to="loc_us-gaap_RestrictedStockMember_32b35d21-f3d9-473b-9ee9-cdd7dc37c8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c422e704-9f07-4998-bf52-36ac0a115bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c4fe40f0-10ad-401f-8d88-4e58b26282a9" xlink:to="loc_us-gaap_StatementLineItems_c422e704-9f07-4998-bf52-36ac0a115bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_17c72ac5-3c45-4648-9dbf-2aac2be2f8df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c422e704-9f07-4998-bf52-36ac0a115bf3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_17c72ac5-3c45-4648-9dbf-2aac2be2f8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88c4cc23-d25e-4bad-80a7-731f5dbe3f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_88c4cc23-d25e-4bad-80a7-731f5dbe3f9a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:to="loc_us-gaap_AwardTypeAxis_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2de0e70a-e9d4-44b7-8b3d-c8cc1a3d9b6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_610e24f1-0561-45f3-a8cd-057427ed157a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:to="loc_us-gaap_EmployeeStockOptionMember_610e24f1-0561-45f3-a8cd-057427ed157a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9819da95-9c83-4888-9480-e0e67bbe37a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:to="loc_us-gaap_RestrictedStockMember_9819da95-9c83-4888-9480-e0e67bbe37a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3e51e9d3-d74f-4a8d-995b-f083fcecfcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:to="loc_us-gaap_PerformanceSharesMember_3e51e9d3-d74f-4a8d-995b-f083fcecfcf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceBasedShareMember_69890925-4a07-4e57-ab61-95638034a3c2" xlink:href="med-20230331.xsd#med_MarketAndPerformanceBasedShareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7c7b95b0-e412-4071-9227-2b37c75db833" xlink:to="loc_med_MarketAndPerformanceBasedShareMember_69890925-4a07-4e57-ab61-95638034a3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5252c7cf-225b-424a-8cb7-c9f71653dff2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:to="loc_srt_RangeAxis_5252c7cf-225b-424a-8cb7-c9f71653dff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47ebb973-7204-43fe-849f-c13e5cf5f5c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5252c7cf-225b-424a-8cb7-c9f71653dff2" xlink:to="loc_srt_RangeMember_47ebb973-7204-43fe-849f-c13e5cf5f5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_19cc551f-4f44-46d2-aae9-8dbcd11a20de" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_47ebb973-7204-43fe-849f-c13e5cf5f5c1" xlink:to="loc_srt_MinimumMember_19cc551f-4f44-46d2-aae9-8dbcd11a20de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3fe4e62f-954e-48cc-9325-778502e6f289" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_47ebb973-7204-43fe-849f-c13e5cf5f5c1" xlink:to="loc_srt_MaximumMember_3fe4e62f-954e-48cc-9325-778502e6f289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_bf3c6a77-414d-4767-8891-2a9777a35f49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:to="loc_us-gaap_AwardDateAxis_bf3c6a77-414d-4767-8891-2a9777a35f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_e424e09e-c794-49a9-8869-cc144e27efce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_bf3c6a77-414d-4767-8891-2a9777a35f49" xlink:to="loc_us-gaap_AwardDateDomain_e424e09e-c794-49a9-8869-cc144e27efce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member_666041a9-f91c-4cbe-a772-8bf7d2103063" xlink:href="med-20230331.xsd#med_GrantedIn2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_e424e09e-c794-49a9-8869-cc144e27efce" xlink:to="loc_med_GrantedIn2022Member_666041a9-f91c-4cbe-a772-8bf7d2103063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e8b3d442-609c-4f9f-8191-92c4efe88b3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_71a968ee-0bc4-41d5-8c48-81716cc89680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_71a968ee-0bc4-41d5-8c48-81716cc89680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dcef8842-b3cc-46e7-8aeb-ab39faacbd99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_dcef8842-b3cc-46e7-8aeb-ab39faacbd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_35a25aa0-8eeb-400a-b30a-07d8807857d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_35a25aa0-8eeb-400a-b30a-07d8807857d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_6ea8a15c-154d-479c-b04c-553bd27e8b40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_6ea8a15c-154d-479c-b04c-553bd27e8b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_87808962-2939-4cc6-88c9-bc6e7bb7e989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_87808962-2939-4cc6-88c9-bc6e7bb7e989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2a4aba66-5748-46f1-a7ab-719cfd2c2bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2a4aba66-5748-46f1-a7ab-719cfd2c2bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e856b366-1a48-4bf9-99a7-58dd83364761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_e856b366-1a48-4bf9-99a7-58dd83364761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e876563a-3893-42ec-b7c5-f932cad9eaa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e876563a-3893-42ec-b7c5-f932cad9eaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0463df0b-b94f-48db-8e89-bc18ac400bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0463df0b-b94f-48db-8e89-bc18ac400bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1b247551-172f-4b3a-9f98-bf521309eec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1b247551-172f-4b3a-9f98-bf521309eec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a6c1e4aa-a740-44e2-a66a-8ac435baed7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a6c1e4aa-a740-44e2-a66a-8ac435baed7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0a27f6c8-c5a4-4ff8-84f0-2a540a39f8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_0a27f6c8-c5a4-4ff8-84f0-2a540a39f8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_499108f1-c9d9-4814-afbd-fdca6250ef26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_499108f1-c9d9-4814-afbd-fdca6250ef26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_54330195-6928-43cb-b735-ec2462ae81cc" xlink:href="med-20230331.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage_54330195-6928-43cb-b735-ec2462ae81cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_8bf130aa-fd4d-4458-b9d9-6c277e2d642f" xlink:href="med-20230331.xsd#med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod_8bf130aa-fd4d-4458-b9d9-6c277e2d642f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_774ff544-23a6-45ae-9a75-e080088aee40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_774ff544-23a6-45ae-9a75-e080088aee40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_261862ff-931e-4166-926a-1ed74914c1db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_261862ff-931e-4166-926a-1ed74914c1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cd6ef992-ae2c-41fa-995e-a624b8ae7ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_cd6ef992-ae2c-41fa-995e-a624b8ae7ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e83181ab-fb28-4a05-b520-95ca690bae8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e83181ab-fb28-4a05-b520-95ca690bae8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d535c0de-2edc-4308-94ea-8af8223ce99a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d535c0de-2edc-4308-94ea-8af8223ce99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_14a5c2c5-ee2b-416a-b3f2-e64ab843056e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3680b08b-7515-45b7-8a05-ac9b322da1ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_14a5c2c5-ee2b-416a-b3f2-e64ab843056e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a17e3462-d937-4ebc-9f46-34710d463d83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_db30672c-81b7-46ef-90d3-ccec7a76ed82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a17e3462-d937-4ebc-9f46-34710d463d83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_db30672c-81b7-46ef-90d3-ccec7a76ed82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e89157b6-83e8-4fc6-bb84-2247495c25b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_db30672c-81b7-46ef-90d3-ccec7a76ed82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e89157b6-83e8-4fc6-bb84-2247495c25b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_92399f1f-6c58-4cc7-8e59-5555506e2fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_db30672c-81b7-46ef-90d3-ccec7a76ed82" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_92399f1f-6c58-4cc7-8e59-5555506e2fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7d98060c-a45b-4689-9fe8-36818cd888f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_db30672c-81b7-46ef-90d3-ccec7a76ed82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7d98060c-a45b-4689-9fe8-36818cd888f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9ebc4092-3826-4870-a4ee-0bf9ac00f0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_db30672c-81b7-46ef-90d3-ccec7a76ed82" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9ebc4092-3826-4870-a4ee-0bf9ac00f0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1aa10a81-b1ec-4dc0-9961-34ea34c7eeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a17e3462-d937-4ebc-9f46-34710d463d83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_1aa10a81-b1ec-4dc0-9961-34ea34c7eeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_52eea4e8-c969-4e8b-93cf-08651d813163" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a17e3462-d937-4ebc-9f46-34710d463d83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_52eea4e8-c969-4e8b-93cf-08651d813163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_be022e6b-8eda-4dff-9961-efed741f05ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_52eea4e8-c969-4e8b-93cf-08651d813163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_be022e6b-8eda-4dff-9961-efed741f05ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90628f1d-6cd0-48f6-9072-b45baa7dfeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_52eea4e8-c969-4e8b-93cf-08651d813163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90628f1d-6cd0-48f6-9072-b45baa7dfeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1bc5c5d9-c6a6-47db-8619-8c2a5a91d75c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_52eea4e8-c969-4e8b-93cf-08651d813163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1bc5c5d9-c6a6-47db-8619-8c2a5a91d75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_eb061623-0ca1-4ab6-a7c2-e5446f69e9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_52eea4e8-c969-4e8b-93cf-08651d813163" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_eb061623-0ca1-4ab6-a7c2-e5446f69e9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_24d4af56-eef8-4cc4-ba59-e1600553f8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a17e3462-d937-4ebc-9f46-34710d463d83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_24d4af56-eef8-4cc4-ba59-e1600553f8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47f85f63-454c-4aaa-8b80-0b2846632a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82869a23-4c74-43b1-9037-d9eb5460ca88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47f85f63-454c-4aaa-8b80-0b2846632a06" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82869a23-4c74-43b1-9037-d9eb5460ca88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f9d76acf-809f-47d3-b6e5-6629ae34e53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82869a23-4c74-43b1-9037-d9eb5460ca88" xlink:to="loc_us-gaap_AwardTypeAxis_f9d76acf-809f-47d3-b6e5-6629ae34e53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d44b045e-74d8-4107-892a-6ad6d7accbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f9d76acf-809f-47d3-b6e5-6629ae34e53c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d44b045e-74d8-4107-892a-6ad6d7accbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_bdea4b42-5173-475f-b1ad-a43895230073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d44b045e-74d8-4107-892a-6ad6d7accbd7" xlink:to="loc_us-gaap_RestrictedStockMember_bdea4b42-5173-475f-b1ad-a43895230073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12b3032a-95c2-4777-9fff-6ca180942f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82869a23-4c74-43b1-9037-d9eb5460ca88" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12b3032a-95c2-4777-9fff-6ca180942f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12b3032a-95c2-4777-9fff-6ca180942f51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f970d304-cab9-42c2-8777-ed1739f92326" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f970d304-cab9-42c2-8777-ed1739f92326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_45342bf8-d424-4a96-993d-eb5a01308bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_45342bf8-d424-4a96-993d-eb5a01308bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3e19f72c-a9ea-485e-82ca-4523384ae5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3e19f72c-a9ea-485e-82ca-4523384ae5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b79007a0-e531-41d7-93c9-614002917d35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b79007a0-e531-41d7-93c9-614002917d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_074e257c-bf85-4194-9a16-25a12f34f420" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_fb217452-eece-4790-83d2-31b9ff63cb8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_074e257c-bf85-4194-9a16-25a12f34f420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_12b3032a-95c2-4777-9fff-6ca180942f51" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6ea9aac-50ac-4c46-b596-48bf30a8f929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b6ea9aac-50ac-4c46-b596-48bf30a8f929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ffb87adb-1cb1-414b-81db-2bdedc078131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ffb87adb-1cb1-414b-81db-2bdedc078131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_abd855db-38a0-4ed6-84af-e9a4bd53af6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_abd855db-38a0-4ed6-84af-e9a4bd53af6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e83fac7b-8afd-4882-a09e-40ad3cdd066a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e83fac7b-8afd-4882-a09e-40ad3cdd066a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_64e6f1b5-669f-463d-98f0-49d41b9b1f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_63a3f934-af9c-4e07-989d-d981f7535b50" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_64e6f1b5-669f-463d-98f0-49d41b9b1f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="simple" xlink:href="med-20230331.xsd#SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f67b7cb-be37-441d-aeb6-616bfbce08d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6f67b7cb-be37-441d-aeb6-616bfbce08d3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9fd0af59-f426-4cc6-a6e8-808daf4c38cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:to="loc_us-gaap_AwardTypeAxis_9fd0af59-f426-4cc6-a6e8-808daf4c38cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9fd0af59-f426-4cc6-a6e8-808daf4c38cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OptionsAndRestrictedStockMember_5b8ec7b9-058f-4646-921f-fad94a8f2b1d" xlink:href="med-20230331.xsd#med_OptionsAndRestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:to="loc_med_OptionsAndRestrictedStockMember_5b8ec7b9-058f-4646-921f-fad94a8f2b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MarketAndPerformanceBasedShareMember_51b74b50-e976-4fb6-b9dd-62193cd4d677" xlink:href="med-20230331.xsd#med_MarketAndPerformanceBasedShareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:to="loc_med_MarketAndPerformanceBasedShareMember_51b74b50-e976-4fb6-b9dd-62193cd4d677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_3a7d3154-fe9b-4049-adde-0fb9c2cc8cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d9f1962-326d-4edb-ad54-d640ee6982ff" xlink:to="loc_us-gaap_PerformanceSharesMember_3a7d3154-fe9b-4049-adde-0fb9c2cc8cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_b2c5a7ef-60f5-4553-923d-389024eb52af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:to="loc_us-gaap_AwardDateAxis_b2c5a7ef-60f5-4553-923d-389024eb52af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_b2c5a7ef-60f5-4553-923d-389024eb52af" xlink:to="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2023Member_3ccd19cf-883a-445c-bd25-7e9ecba632e7" xlink:href="med-20230331.xsd#med_GrantedIn2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:to="loc_med_GrantedIn2023Member_3ccd19cf-883a-445c-bd25-7e9ecba632e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2022Member_d7422236-a5de-48dc-8ac6-509cca7c9505" xlink:href="med-20230331.xsd#med_GrantedIn2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:to="loc_med_GrantedIn2022Member_d7422236-a5de-48dc-8ac6-509cca7c9505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2021Member_bfa9b7fc-872c-4b2e-9672-851bea6838ca" xlink:href="med-20230331.xsd#med_GrantedIn2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:to="loc_med_GrantedIn2021Member_bfa9b7fc-872c-4b2e-9672-851bea6838ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_GrantedIn2020Member_a0ec5623-54ca-4d31-a4d4-a3f930efa943" xlink:href="med-20230331.xsd#med_GrantedIn2020Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_321eaf74-ec7d-4b83-af8f-61538d7368c6" xlink:to="loc_med_GrantedIn2020Member_a0ec5623-54ca-4d31-a4d4-a3f930efa943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fdffc6ca-6dc9-4daf-9057-8026c85a1af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_53d4484f-01a0-4ba5-a676-50d0ff9aea99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fdffc6ca-6dc9-4daf-9057-8026c85a1af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e48527ae-34ac-46b1-98fa-e2f77dc1894b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fdffc6ca-6dc9-4daf-9057-8026c85a1af5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e48527ae-34ac-46b1-98fa-e2f77dc1894b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7ac60563-8a38-42a8-9c0f-2739c8cc7ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fdffc6ca-6dc9-4daf-9057-8026c85a1af5" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7ac60563-8a38-42a8-9c0f-2739c8cc7ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="med-20230331.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_2c1f1139-6ee7-49a5-84e3-80f803ead0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_2c1f1139-6ee7-49a5-84e3-80f803ead0ed" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f87b7c5a-bad3-4206-9497-1cc50310de70" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:to="loc_srt_RangeAxis_f87b7c5a-bad3-4206-9497-1cc50310de70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4b391e7c-eba9-4b08-b976-3aabfd21f8bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f87b7c5a-bad3-4206-9497-1cc50310de70" xlink:to="loc_srt_RangeMember_4b391e7c-eba9-4b08-b976-3aabfd21f8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_42a5af51-b336-4e9e-9b5c-0b29ceec0b89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4b391e7c-eba9-4b08-b976-3aabfd21f8bf" xlink:to="loc_srt_MinimumMember_42a5af51-b336-4e9e-9b5c-0b29ceec0b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_065f14b3-a2ab-4b34-ab39-2b11ca0d2d14" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4b391e7c-eba9-4b08-b976-3aabfd21f8bf" xlink:to="loc_srt_MaximumMember_065f14b3-a2ab-4b34-ab39-2b11ca0d2d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7042f4c1-e74c-43e8-9658-22ea016e71a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7042f4c1-e74c-43e8-9658-22ea016e71a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3783b23-8922-41bd-bdbf-ccb18a7be198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7042f4c1-e74c-43e8-9658-22ea016e71a3" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3783b23-8922-41bd-bdbf-ccb18a7be198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForRealEstateMember_bcd4c428-83dd-4780-acc0-1b79b687fcb6" xlink:href="med-20230331.xsd#med_OperatingLeaseArrangementForRealEstateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3783b23-8922-41bd-bdbf-ccb18a7be198" xlink:to="loc_med_OperatingLeaseArrangementForRealEstateMember_bcd4c428-83dd-4780-acc0-1b79b687fcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_OperatingLeaseArrangementForEquipmentMember_29507567-c339-45c2-a724-3e6296197873" xlink:href="med-20230331.xsd#med_OperatingLeaseArrangementForEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f3783b23-8922-41bd-bdbf-ccb18a7be198" xlink:to="loc_med_OperatingLeaseArrangementForEquipmentMember_29507567-c339-45c2-a724-3e6296197873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d7a85928-a2be-491a-b497-bd40551a6344" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e063fed4-e17c-4e08-82a5-a4383b9ab3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_e063fed4-e17c-4e08-82a5-a4383b9ab3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_91299667-8b8a-4d6e-9c8f-2e38ff58c8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_OperatingLeaseExpense_91299667-8b8a-4d6e-9c8f-2e38ff58c8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c11c0d8f-47a1-45ac-a7a4-1ba36ed97a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c11c0d8f-47a1-45ac-a7a4-1ba36ed97a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_482b315d-3a34-4e00-9fa3-f0af6fcabc2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e08ab453-9c2e-4ec9-b41e-0d278154d6de" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_482b315d-3a34-4e00-9fa3-f0af6fcabc2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="med-20230331.xsd#LEASESSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c1a1b3a0-eb37-4f34-901b-e8b132848e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_bf884add-2ac9-45ec-967a-7f85041eccd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c1a1b3a0-eb37-4f34-901b-e8b132848e5d" xlink:to="loc_us-gaap_OperatingLeasePayments_bf884add-2ac9-45ec-967a-7f85041eccd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_882129b2-d844-4c38-8784-271583de2eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c1a1b3a0-eb37-4f34-901b-e8b132848e5d" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_882129b2-d844-4c38-8784-271583de2eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="med-20230331.xsd#LEASESFutureMinimumLeaseCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3a6efe29-38ed-47da-88a8-906550c5510e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3a6efe29-38ed-47da-88a8-906550c5510e" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ce9a325a-2189-4c43-9ddd-cf6ffed17c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ce9a325a-2189-4c43-9ddd-cf6ffed17c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_17f04f9f-0d89-463f-9286-1b89feb200c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_17f04f9f-0d89-463f-9286-1b89feb200c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cf1e8f79-e4a2-46c3-a95a-e71c4fb61374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_cf1e8f79-e4a2-46c3-a95a-e71c4fb61374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1c4f20b9-30d2-480b-a6a1-4b5fbbae4dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1c4f20b9-30d2-480b-a6a1-4b5fbbae4dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_92c75143-493b-468a-bb35-d3460c3d7f34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_92c75143-493b-468a-bb35-d3460c3d7f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_b4934177-910d-48ce-971d-44722652c72c" xlink:href="med-20230331.xsd#med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_b4934177-910d-48ce-971d-44722652c72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_886b1783-ded0-407c-b363-9e8ad36cbda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_886b1783-ded0-407c-b363-9e8ad36cbda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_683b8cd9-f435-4c09-bf88-b556bd8b948b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_683b8cd9-f435-4c09-bf88-b556bd8b948b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_087a8bc3-ec97-4ac1-aa2b-0eaf34563ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_39830a03-6d2b-4fde-8a49-f5fd994df6de" xlink:to="loc_us-gaap_OperatingLeaseLiability_087a8bc3-ec97-4ac1-aa2b-0eaf34563ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="simple" xlink:href="med-20230331.xsd#LEASESFutureMinimumLeaseCommitmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" xlink:type="simple" xlink:href="med-20230331.xsd#ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_0c6187d2-259c-48ba-b4c8-670f53091caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_6db315a4-859f-45a1-ad07-ee1cbc404ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract_0c6187d2-259c-48ba-b4c8-670f53091caf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_6db315a4-859f-45a1-ad07-ee1cbc404ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.medifast1.com/role/DEBTDetails" xlink:type="simple" xlink:href="med-20230331.xsd#DEBTDetails"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/DEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_253d47ec-5c0c-4a94-b848-51f5fc382eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_253d47ec-5c0c-4a94-b848-51f5fc382eb8" xlink:to="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_CreditFacilityAxis_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_14302daf-0e0b-4aa4-aed3-fae3ed8f34f6" xlink:to="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_666bd25d-3925-4659-8057-d4faaca7ed3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_666bd25d-3925-4659-8057-d4faaca7ed3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_25355d5e-5b80-40c5-98a2-742d174bf51d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:to="loc_us-gaap_LetterOfCreditMember_25355d5e-5b80-40c5-98a2-742d174bf51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_UncommittedIncrementalFacilityMember_3d74ba4b-e5b0-4b4b-a85b-fdd69d541b53" xlink:href="med-20230331.xsd#med_UncommittedIncrementalFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c712213a-0277-4f10-a2ed-2b33a807c0c7" xlink:to="loc_med_UncommittedIncrementalFacilityMember_3d74ba4b-e5b0-4b4b-a85b-fdd69d541b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ad02d068-f23d-4651-aecc-1af9212d3963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_DebtInstrumentAxis_ad02d068-f23d-4651-aecc-1af9212d3963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc57210c-c475-4d2c-b797-e070d7d49df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ad02d068-f23d-4651-aecc-1af9212d3963" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc57210c-c475-4d2c-b797-e070d7d49df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_CreditAgreementMember_22e5bd55-ce58-48f2-9081-608fcfa0e6d2" xlink:href="med-20230331.xsd#med_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc57210c-c475-4d2c-b797-e070d7d49df4" xlink:to="loc_med_CreditAgreementMember_22e5bd55-ce58-48f2-9081-608fcfa0e6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_02f8a658-3f42-4d4f-9de0-c55831ebb4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_02f8a658-3f42-4d4f-9de0-c55831ebb4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4decd117-7aed-4659-95bd-56b3868e7bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_02f8a658-3f42-4d4f-9de0-c55831ebb4cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4decd117-7aed-4659-95bd-56b3868e7bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e8aefc3f-1ce8-490d-b3bc-2555211386ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4decd117-7aed-4659-95bd-56b3868e7bc7" xlink:to="loc_us-gaap_LineOfCreditMember_e8aefc3f-1ce8-490d-b3bc-2555211386ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bda61963-4cdd-4939-b875-8c23a831d88d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_srt_RangeAxis_bda61963-4cdd-4939-b875-8c23a831d88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4abea239-70e5-4358-8926-d43d0df1f355" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bda61963-4cdd-4939-b875-8c23a831d88d" xlink:to="loc_srt_RangeMember_4abea239-70e5-4358-8926-d43d0df1f355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fa4ea4e2-d83e-40f1-ace6-25800cfdcfeb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4abea239-70e5-4358-8926-d43d0df1f355" xlink:to="loc_srt_MinimumMember_fa4ea4e2-d83e-40f1-ace6-25800cfdcfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2c064561-1fc4-403e-97e5-58d4fc5ba3fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4abea239-70e5-4358-8926-d43d0df1f355" xlink:to="loc_srt_MaximumMember_2c064561-1fc4-403e-97e5-58d4fc5ba3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_8713493c-e386-4fd8-bd6a-0340262a60ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_VariableRateAxis_8713493c-e386-4fd8-bd6a-0340262a60ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9c867e19-5015-4ea5-bc42-da8f7af1bfbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_8713493c-e386-4fd8-bd6a-0340262a60ee" xlink:to="loc_us-gaap_VariableRateDomain_9c867e19-5015-4ea5-bc42-da8f7af1bfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_SecuredOvernightFinancingRateSOFRMember_9708e8a7-6df4-49bc-8805-cb83b63dc3d5" xlink:href="med-20230331.xsd#med_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9c867e19-5015-4ea5-bc42-da8f7af1bfbf" xlink:to="loc_med_SecuredOvernightFinancingRateSOFRMember_9708e8a7-6df4-49bc-8805-cb83b63dc3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_4117b851-04c4-458b-8ff0-892510596612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_9c867e19-5015-4ea5-bc42-da8f7af1bfbf" xlink:to="loc_us-gaap_BaseRateMember_4117b851-04c4-458b-8ff0-892510596612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_10358d86-96bd-4879-a142-c58580cfedba" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0827b100-999c-4f47-8b32-da691885b4ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0827b100-999c-4f47-8b32-da691885b4ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_9b947f7a-89b9-4597-b342-fe72b5d30bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_9b947f7a-89b9-4597-b342-fe72b5d30bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8d3e0923-8cb5-4c22-83bf-4654118c6986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8d3e0923-8cb5-4c22-83bf-4654118c6986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MaximumTotalNetLeverageRatio_b752c591-052c-4b44-bc56-41bd0a5ff200" xlink:href="med-20230331.xsd#med_MaximumTotalNetLeverageRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_med_MaximumTotalNetLeverageRatio_b752c591-052c-4b44-bc56-41bd0a5ff200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_med_MinimumInterestCoverageRatio_2c59faa4-4607-49bf-8670-b6e8e910d55e" xlink:href="med-20230331.xsd#med_MinimumInterestCoverageRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_med_MinimumInterestCoverageRatio_2c59faa4-4607-49bf-8670-b6e8e910d55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_01b01d96-cf31-43f7-9b92-687a990c1dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3a3cc72d-5340-49dd-8e7c-972110cef016" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_01b01d96-cf31-43f7-9b92-687a990c1dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879404035456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 24, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Medifast, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3714405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 International Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Baltimore<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">581-8042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,887,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000910329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879402786960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 348,983<span></span>
</td>
<td class="nump">$ 417,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">102,593<span></span>
</td>
<td class="nump">115,314<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">246,390<span></span>
</td>
<td class="nump">302,286<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative</a></td>
<td class="nump">192,879<span></span>
</td>
<td class="nump">247,199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">53,511<span></span>
</td>
<td class="nump">55,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest expense</a></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense) income</a></td>
<td class="num">(182)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from operations before income taxes</a></td>
<td class="nump">53,329<span></span>
</td>
<td class="nump">54,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">13,361<span></span>
</td>
<td class="nump">13,195<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 39,968<span></span>
</td>
<td class="nump">$ 41,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 3.68<span></span>
</td>
<td class="nump">$ 3.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 3.67<span></span>
</td>
<td class="nump">$ 3.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">10,864<span></span>
</td>
<td class="nump">11,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">10,899<span></span>
</td>
<td class="nump">11,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared per share (in usd per share)</a></td>
<td class="nump">$ 1.65<span></span>
</td>
<td class="nump">$ 1.64<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879404493952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 39,968<span></span>
</td>
<td class="nump">$ 41,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized losses on investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 39,977<span></span>
</td>
<td class="nump">$ 41,797<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879404174176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 123,748<span></span>
</td>
<td class="nump">$ 87,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">96,896<span></span>
</td>
<td class="nump">118,856<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">9,674<span></span>
</td>
<td class="nump">16,237<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">230,318<span></span>
</td>
<td class="nump">222,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment - net of accumulated depreciation</a></td>
<td class="nump">55,960<span></span>
</td>
<td class="nump">57,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">17,091<span></span>
</td>
<td class="nump">18,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">13,709<span></span>
</td>
<td class="nump">12,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">4,528<span></span>
</td>
<td class="nump">5,328<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">321,606<span></span>
</td>
<td class="nump">316,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">113,300<span></span>
</td>
<td class="nump">134,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income taxes payable</a></td>
<td class="nump">13,031<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current lease obligations</a></td>
<td class="nump">5,411<span></span>
</td>
<td class="nump">5,776<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">131,742<span></span>
</td>
<td class="nump">140,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease obligations, net of current lease obligations</a></td>
<td class="nump">18,964<span></span>
</td>
<td class="nump">20,275<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">150,706<span></span>
</td>
<td class="nump">161,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.001 per share: 20,000 shares authorized; 10,887 and 10,928 issued and 10,887 and 10,873 outstanding at March&#160;31, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">19,030<span></span>
</td>
<td class="nump">21,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">151,826<span></span>
</td>
<td class="nump">139,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Less: treasury stock at cost, 0 and 54 shares at March&#160;31, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(6,398)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">170,900<span></span>
</td>
<td class="nump">155,044<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</a></td>
<td class="nump">$ 321,606<span></span>
</td>
<td class="nump">$ 316,213<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879407169744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">10,887,000<span></span>
</td>
<td class="nump">10,928,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">10,887,000<span></span>
</td>
<td class="nump">10,873,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock at cost (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879403748624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 39,968<span></span>
</td>
<td class="nump">$ 41,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to cash provided by operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,974<span></span>
</td>
<td class="nump">2,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_OperatingLeaseExpenseNonCash', window );">Non-cash lease expense</a></td>
<td class="nump">1,369<span></span>
</td>
<td class="nump">1,619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">606<span></span>
</td>
<td class="nump">2,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization of premium on investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">21,960<span></span>
</td>
<td class="num">(8,929)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,563<span></span>
</td>
<td class="nump">3,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(887)<span></span>
</td>
<td class="num">(6,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(21,897)<span></span>
</td>
<td class="num">(6,084)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes payable</a></td>
<td class="nump">12,603<span></span>
</td>
<td class="nump">14,081<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flow provided by operating activities</a></td>
<td class="nump">64,059<span></span>
</td>
<td class="nump">43,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Sale and maturities of investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(2,115)<span></span>
</td>
<td class="num">(3,009)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flow used in investing activities</a></td>
<td class="num">(2,115)<span></span>
</td>
<td class="num">(1,764)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_ProceedsFromStockOptionsExercisedDirectors', window );">Options exercised by directors</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfOtherEquity', window );">Net shares repurchased for taxes</a></td>
<td class="num">(3,236)<span></span>
</td>
<td class="num">(1,459)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash dividends paid to stockholders</a></td>
<td class="num">(19,163)<span></span>
</td>
<td class="num">(16,660)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Stock repurchases</a></td>
<td class="num">(3,602)<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flow used in financing activities</a></td>
<td class="num">(25,896)<span></span>
</td>
<td class="num">(28,119)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Foreign currency impact</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash and cash equivalents</a></td>
<td class="nump">36,057<span></span>
</td>
<td class="nump">13,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - beginning of the period</a></td>
<td class="nump">87,691<span></span>
</td>
<td class="nump">104,183<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">123,748<span></span>
</td>
<td class="nump">118,003<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes (refunded) paid</a></td>
<td class="num">(46)<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Dividends declared included in accounts payable</a></td>
<td class="nump">$ 18,653<span></span>
</td>
<td class="nump">$ 19,663<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_OperatingLeaseExpenseNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Expense, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_OperatingLeaseExpenseNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_ProceedsFromStockOptionsExercisedDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Stock Options Exercised, Directors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_ProceedsFromStockOptionsExercisedDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to reacquire equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879404120576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 202,474<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 12,018<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">$ 190,333<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">41,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">$ 2,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by directors (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for employee taxes</a></td>
<td class="num">$ (1,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(10,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired from stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">(19,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,063)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 216,024<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">12,834<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">203,051<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">10,928<span></span>
</td>
<td class="nump">10,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 155,044<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">21,555<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">139,852<span></span>
</td>
<td class="num">(6,398)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">39,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions', window );">Share-based compensation</a></td>
<td class="nump">$ 606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised by directors (in shares)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised by directors</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for employee taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net shares repurchased for employee taxes</a></td>
<td class="num">(3,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,236)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock from stock repurchases</a></td>
<td class="num">(3,602)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,602)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesRetired', window );">Treasury stock retired from stock repurchases (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockRetiredCostMethodAmount', window );">Treasury stock retired from stock repurchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared to stockholders</a></td>
<td class="num">$ (17,994)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,994)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">10,887<span></span>
</td>
<td class="nump">10,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 170,900<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 19,030<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 151,826<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockRetiredCostMethodAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockRetiredCostMethodAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesRetired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common and preferred stock retired from treasury during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesRetired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879407502144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2022 has been derived from the 2022 audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (&#8220;2022 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2023. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2022 Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not adopted any new accounting standards during the three months ended March 31, 2023. There are no recently issued accounting pronouncements that are expected to have a material effect on the Company&#8217;s financial position, results of operations, cash flows, or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879485095184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text">INVENTORIES<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#8217;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,932</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,670</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4,296</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,611</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7,032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">8,738</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">78,825</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">97,675</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6,189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3,838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">96,896</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">118,856</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879407584144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share (&#8220;EPS&#8221;) computations are calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#8217;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.776%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The calculation of diluted EPS excluded 13 thousand and 0 thousand antidilutive restricted stock awards for the three months ended March 31, 2023 and 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879406353072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">SHARE-BASED COMPENSATION</a></td>
<td class="text">SHARE-BASED COMPENSATION<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#8217;s common stock, and dividend yield. Options outstanding as of March&#160;31, 2023 generally vest over a period of 3 years and expire 10 years from the date of grant. The exercise price of these options ranges from $26.52 to $66.68. Due to the Company&#8217;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#8217;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the three months ended March 31, 2023 and 2022, the Company did not grant stock options. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.65&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.65&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the weighted-average remaining contractual life for both the outstanding stock options and exercisable stock options was 4.3 years with an aggregate intrinsic value of $1.3 million. The compensation expense calculated under the fair value method for stock options was fully recognized as of March&#160;31, 2023. For the three months ended March 31, 2023, the Company received $0.1 million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the three months ended March 31, 2022 was $0.3 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to 5 years after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#8217;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company withheld approximately 9 thousand shares and 8 thousand shares of the Company&#8217;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the three months ended March 31, 2023 and 2022, respectively. The total fair value of restricted stock awards vested during the three months ended March 31, 2023 and 2022 was $2.4 million and $3.2 million, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Performance-based Share Awards</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between 0% and 250% of the target number depending upon both the Company&#8217;s total stockholder return (&#8220;TSR&#8221;) and the Company&#8217;s performance against predetermined performance goals over a three-year performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#8217;s TSR are valued using the Monte Carlo method and are recognized ratably as expense over the award&#8217;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#8217;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period. In the event that management determines that the Company will not reach the lower threshold of the predetermined performance goals established in the grant agreement, any previously recognized expense is reversed in the </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period in which such a determination is made. As of March 31, 2023, management determined that the market and performance-based share awards granted in 2022 would not reach the lower threshold of the predetermined performance goal resulting in a $1.4&#160;million decrease in the Company&#8217;s share-based compensation expense for the three months ended March 31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for all types of awards granted is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. The total expense during the three months ended March 31, 2023 and 2022  as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,275&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company withheld approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21 thousand shares</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company&#8217;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of market and performance-based share awards for the three months ended March 31, 2023. No market and performance-based share awards vested and no shares were withheld to cover minimum tax liability withholding obligations for the three months ended March 31, 2022. The total fair value of market and performance-based share awards vested during the three months ended March 31, 2023 and 2022 was </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and $0, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was $0.1 million and $0.5 million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was $11.7 million of total unrecognized compensation cost related to restricted stock awards as of March&#160;31, 2023, which is expected to be recognized over a weighted-average period of 2.4 years. There was $10.5 million of unrecognized compensation costs related to the 91 thousand market and performance-based shares presented in the table above as of March&#160;31, 2023, which is expected to be recognized over a weighted-average period of 2.2 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879406288528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#8217;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of March&#160;31, 2023 and 2022, respectively, or for the three-month periods then ended, respectively.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leases relating to office and warehouse space have lease terms of 19 months to 122 months. Our leases relating to equipment have lease terms of 24 months to 203 months, with certain of them having automatic renewal clauses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are recognized as expenses when they are incurred.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease expense was $1.5&#160;million and $1.8&#160;million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:63.780%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the weighted average remaining lease term was 4 years, 7 months and the weighted average discount rate was 2.00%.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of March&#160;31, 2023 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:81.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023 (excluding the three months ended March&#160;31, 2023)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879407415568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">ACCUMULATED OTHER COMPREHENSIVE INCOME</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOMEAccumulated other comprehensive income, net of tax, was comprised of $33 thousand of foreign currency translation as of March&#160;31, 2023 and $24 thousand of foreign currency translation as of December&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879407511920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Agreement</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#8220;Guarantors&#8221;) entered into a credit agreement (the &#8220;Credit Agreement&#8221;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (&#8220;SOFR&#8221;), from London Inter-Bank Offered Rate (LIBOR) (the &#8220;Amended Credit Agreement&#8221;). The Amended Credit Agreement provides for a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$225.0 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> senior secured revolving credit facility with a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$20.0 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$100.0 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The Amended Credit Agreement matures on April&#160;13, 2026.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from 0.20% to 0.40% per annum depending on the Company&#8217;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#8217;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#8217;s Total Net Leverage Ratio. As of March&#160;31, 2023, the Applicable Rate for Term SOFR Loans is 1.25% per annum and the Applicable Rate for ABR Loans is 0.25% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than 2.75 to 1.00 and an Interest Coverage Ratio of at least 3.50 to 1.00.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no borrowings outstanding under the Amended Credit Agreement as of March&#160;31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879402812512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#8220;Medifast,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;GAAP&#8221;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2022 has been derived from the 2022 audited consolidated financial statements at that date included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (&#8220;2022 Form 10-K&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2023. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2022 Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Presentation of Financial Statements</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Statements -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not adopted any new accounting standards during the three months ended March 31, 2023. There are no recently issued accounting pronouncements that are expected to have a material effect on the Company&#8217;s financial position, results of operations, cash flows, or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879406333696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories consisted of the following (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.638%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,932</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,670</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Packaging</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4,296</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,611</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-food finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7,032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">8,738</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finished goods</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">78,825</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">97,675</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Reserve for obsolete inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6,189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3,838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">96,896</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">118,856</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879406341056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of the Computation of Basic and Diluted EPS</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.776%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Effect of dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879402615456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our stock option activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Awards</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.65&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.98&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Exercisable at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.65&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52.76&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our restricted stock activity (in thousands, except per share data):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.617%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted-Average Grant Date Fair Value</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">163.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Outstanding at end of the period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.33&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.20&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Share-based Compensation Expense</a></td>
<td class="text">The total expense during the three months ended March 31, 2023 and 2022  as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Share-Based Compensation Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options and restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,087&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market and performance-based share awards granted in 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">640&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Performance-based share awards granted in 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">606&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">152&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,275&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879407446688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Supplemental Cash Flow Information</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to the Company&#8217;s operating leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:63.780%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for amounts included in the measurements of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating cash flow used in operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets obtained in exchange for lease obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Company's Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the maturity of the Company&#8217;s operating lease liabilities as of March&#160;31, 2023 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"><tr><td style="width:1.0%"/><td style="width:81.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.415%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2023 (excluding the three months ended March&#160;31, 2023)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,375&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879401069568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 12,932<span></span>
</td>
<td class="nump">$ 12,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies', window );">Packaging</a></td>
<td class="nump">4,296<span></span>
</td>
<td class="nump">3,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_InventoryNonFoodFinishedGoods', window );">Non-food finished goods</a></td>
<td class="nump">7,032<span></span>
</td>
<td class="nump">8,738<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">78,825<span></span>
</td>
<td class="nump">97,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Reserve for obsolete inventory</a></td>
<td class="num">(6,189)<span></span>
</td>
<td class="num">(3,838)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total</a></td>
<td class="nump">$ 96,896<span></span>
</td>
<td class="nump">$ 118,856<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_InventoryNonFoodFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_InventoryNonFoodFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of items used in storage, presentation or transportation of physical goods that are targeted for sale to end users.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879404040576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_NumeratorAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 39,968<span></span>
</td>
<td class="nump">$ 41,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_DenominatorAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding (in shares)</a></td>
<td class="nump">10,864<span></span>
</td>
<td class="nump">11,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive common stock equivalents (in shares)</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding (in shares)</a></td>
<td class="nump">10,899<span></span>
</td>
<td class="nump">11,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share - basic (in usd per share)</a></td>
<td class="nump">$ 3.68<span></span>
</td>
<td class="nump">$ 3.62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share - diluted (in usd per share)</a></td>
<td class="nump">$ 3.67<span></span>
</td>
<td class="nump">$ 3.59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_DenominatorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Denominator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_DenominatorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_NumeratorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Numerator [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_NumeratorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879402612848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Narrative (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive awards</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879401920640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit (in usd per share)</a></td>
<td class="nump">$ 26.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit (in usd per share)</a></td>
<td class="nump">$ 66.68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Awards granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual life of options outstanding</a></td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual life of options exercisable</a></td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of options outstanding</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of options exercisable</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Decrease in share-based payment arrangement, expense</a></td>
<td class="num">$ (606)<span></span>
</td>
<td class="num">$ (2,275)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for employee taxes</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based compensation arrangement, fair value of awards vested</a></td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period</a></td>
<td class="nump">22,000<span></span>
</td>
<td class="nump">18,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Total income tax benefit recognized related to restricted stock awards</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs</a></td>
<td class="nump">$ 11,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost recognition weighted average period</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted in period</a></td>
<td class="nump">67,000<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod', window );">Performance period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs</a></td>
<td class="nump">$ 10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost recognition weighted average period</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted in period</a></td>
<td class="nump">91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage', window );">Additional shares earned (percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-Based Shares | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage', window );">Additional shares earned (percent)</a></td>
<td class="nump">250.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceBasedShareMember', window );">Market and performance-based share awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld for employee taxes</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Share-based compensation arrangement, fair value of awards vested</a></td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares vested in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceBasedShareMember', window );">Market and performance-based share awards | Granted In 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Decrease in share-based payment arrangement, expense</a></td>
<td class="nump">$ 1,388<span></span>
</td>
<td class="num">$ (79)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceBasedShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=med_MarketAndPerformanceBasedShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879404145840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Stock Options Activity (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at beginning of period (in shares)</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares, Exercised (in shares)</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares, Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at end of the period (in shares)</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable at end of the period (in shares)</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding at beginning of period (in usd per share)</a></td>
<td class="nump">$ 54.98<span></span>
</td>
<td class="nump">$ 54.98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercised (in usd per share)</a></td>
<td class="nump">27.18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Forfeited (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding at beginning of period (in usd per share)</a></td>
<td class="nump">58.65<span></span>
</td>
<td class="nump">54.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercisable at end of the period (in usd per share)</a></td>
<td class="nump">$ 58.65<span></span>
</td>
<td class="nump">$ 52.76<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879404447056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Restricted Stock Activity (Details) - Restricted Stock - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding at end of period (in shares)</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (in usd per share)</a></td>
<td class="nump">$ 187.94<span></span>
</td>
<td class="nump">$ 183.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">102.83<span></span>
</td>
<td class="nump">175.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usds per share)</a></td>
<td class="nump">163.81<span></span>
</td>
<td class="nump">149.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in usd per share)</a></td>
<td class="nump">190.76<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Outstanding at beginning of period (in usd per share)</a></td>
<td class="nump">$ 138.33<span></span>
</td>
<td class="nump">$ 190.20<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879398180368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">225<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 606<span></span>
</td>
<td class="nump">$ 2,275<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember', window );">Options and restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 1,226<span></span>
</td>
<td class="nump">$ 1,087<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceBasedShareMember', window );">Market and performance-based share awards | Granted In 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceBasedShareMember', window );">Market and performance-based share awards | Granted In 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="num">$ (1,388)<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-based share awards | Granted In 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 640<span></span>
</td>
<td class="nump">$ 640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance-based share awards | Granted In 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-Based Compensation Expense</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 469<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=med_OptionsAndRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=med_MarketAndPerformanceBasedShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=med_MarketAndPerformanceBasedShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=med_GrantedIn2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=med_GrantedIn2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879403126176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease expense</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">4 years 7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Operating Lease Arrangement for Real Estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">19 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Operating Lease Arrangement for Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">24 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Operating Lease Arrangement for Real Estate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">122 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Operating Lease Arrangement for Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">203 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForRealEstateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForRealEstateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=med_OperatingLeaseArrangementForEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879407705280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flow used in operating leases</a></td>
<td class="nump">$ 1,804<span></span>
</td>
<td class="nump">$ 1,756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 103<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879404020736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Future Minimum Lease Commitments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023 (excluding the three months ended March&#160;31, 2023)</a></td>
<td class="nump">$ 4,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">5,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">5,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">4,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">2,553<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">2,858<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">25,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1,154)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">$ 24,375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Liability Payments Due After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879402789648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCUMULATED OTHER COMPREHENSIVE INCOME (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139879399127440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Details) - Credit Agreement<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 13, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_MaximumTotalNetLeverageRatio', window );">Maximum total net leverage ratio</a></td>
<td class="nump">2.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_med_MinimumInterestCoverageRatio', window );">Minimum interest coverage ratio</a></td>
<td class="nump">3.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee (as a percent)</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee (as a percent)</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Borrowings outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=med_UncommittedIncrementalFacilityMember', window );">Uncommitted Incremental Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_MaximumTotalNetLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_MaximumTotalNetLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_med_MinimumInterestCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum Interest Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">med_MinimumInterestCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>med_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=med_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=med_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=med_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=med_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=med_UncommittedIncrementalFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=med_UncommittedIncrementalFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>med-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:med="http://www.medifast1.com/20230331"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="med-20230331.xsd" xlink:type="simple"/>
    <context id="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i73efc58548364e9da276fb4aee70585f_I20230424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2023-04-24</instant>
        </period>
    </context>
    <context id="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ef290f1cdac4ec68f177f8490b8503a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3d62bc40011a4e969ffff01db87cd897_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14276493cdda4b5297135c9e43430126_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fbf2e6d85424505bb1df89b807899f0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i37fc307c3fff4012b03412aba9187bf6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic21acf6f41c44ed8a91b90def6137e1b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib645712f743642f7b14f17858412b113_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib7a98f37c1e44fa184ad39aef19462ae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4f0ba66dcb054c298b2f1218f9d34e61_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id9003a88c4844e8cbd52972e24a1d8e7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i760c27790b4a43b18f0947b1de071b7c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i25bf64baa4f84f3c91994cf68921d605_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iff775d4fc8d945b78ba54e784502dc6f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i31b8f688eea24545a396eeb0611d6e1b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i90030857661f4a4dbc4ccc740b7b79c0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8914dfcaa1404cf9af3e00a8b215faad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i892b2a6455a84efea48207042eb47ebc_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0c9ff89193a54598a41c53bc8a2c8707_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iddbcc131b7564ee995939796a3d726ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16778ba2b0e747a695b14af615208230_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ad93c89a7e443da95e864cdcaff958e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i021a1b09c09b4f149bc661efb55a8579_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae2a9532cbe94c05a12c15c043307bc3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3245c01aff3346e8b0e93c38786ba422_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib09b1a76e8224a0f8f66a0f0d89c5f8e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia03cb5ed3f53442c810b63d75610adee_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iefab9b282eab46b6b9feb116dacd81f1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9aa7a26927a042ddb0c4efddb86c5947_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifc4d87af6ad34ece906c185c57bc0f27_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0d859544afec4409b2dc5203bc73948f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i63601fd2318848348fc1c8b45cb1f3a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i13e17fd77c1a47b9b50510f8f141dfae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic44f166aec324147a4cca9c573b540dd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieba1e7bde05646528901c22163e8367a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if9b32ff21de445638831a1796f077b25_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7ae296ff6c0a4ed29838c825beaa94bb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id59c14c148de496880d6652176a2c999_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id3a735cd0fee4e528a997870d8f0f709_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibb9683758726458fb14c1d50b204c772_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia309ad2ca0aa4222af27696fc0425511_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6188f0dd58ad41dfb34e2a2f9bee3259_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic3dd7f52bc934c60b57c8561a32e45d5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9a5bf52113ef41b2935708b735e9ee0f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i91137ee67f7f41ce9748d8db7d981c22_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iffbabdce70a34f2d8c8f4369464e6bf9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib5a00a160b774d91807d91918cf7ee46_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9b24326b642845e8b3857f0d21d79d19_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:OptionsAndRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie316187f7c484420a923ed9f350e11ca_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i720156933c7242888d839f8f81c4decf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2f68ff9d37804516a004fa3fefa6e941_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia4b5d53cd7024ad8b562648072669881_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if84394c44eed4092ac896bf455a72df7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia665c39f19eb4a6a9d485acd05a18124_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3f1aab26e7984ccaba10e7aa1ad24c41_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">med:GrantedIn2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iab840a0209b94086be8b0d816f977bc2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6dba0507dc5141659a87360e36adc332_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">med:MarketAndPerformanceBasedShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7752400214154be7a3da22c4ede6da41_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i584845803f224e90963b306cfaa8a708_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iaca1e5bf2df0432fbcfc2e5ee7e5e7d6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForRealEstateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i17778c8c21984c959271d0d7cbc7d47a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if51850419cba458da16f0e96e36a1e6c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">med:OperatingLeaseArrangementForEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7c0fd591c6d54c788d05c4d43bfe45e2_I20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-13</instant>
        </period>
    </context>
    <context id="i813dd19e7bc04cd4b34c1ac0e2f5b4fc_I20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-13</instant>
        </period>
    </context>
    <context id="i7e4639f404b746da9129538a34b70a01_I20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">med:UncommittedIncrementalFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-13</instant>
        </period>
    </context>
    <context id="ie0292eae6d68435581e1a1cb655cb025_D20210413-20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-13</startDate>
            <endDate>2021-04-13</endDate>
        </period>
    </context>
    <context id="idcfc7ba03ed44069a73caf1bc4436006_D20210413-20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-13</startDate>
            <endDate>2021-04-13</endDate>
        </period>
    </context>
    <context id="ia9c24ad6f6bc453d97165b16303e0845_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">med:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i87cc27821ccd42ed968755b54c044371_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i55a3deca29144b558d038563d063d0e5_I20210413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-13</instant>
        </period>
    </context>
    <context id="idf71ad0c5ed640be905a819b87cf32f5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">med:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8yNi0xLTEtMS02Mzk5Mg_7d59d532-8aa0-4c2c-8f9c-59eacdcadf6a">0000910329</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8yNy0xLTEtMS02Mzk5Mg_df7a4d75-554b-4bcd-9629-f24318334143">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8yOC0xLTEtMS02Mzk5Mg_b14ea012-8b55-46c6-ba4b-3a24b8d88429">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8yOS0xLTEtMS02Mzk5Mg_87424297-bbee-4f5e-b865-ab518f2e55c0">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80L2ZyYWc6YTg0ODk3OWFjMDQxNDk0YTkyYzU2NWRmNmRkMzRhYWQvdGFibGU6YTZiYTA1NmYzYTMxNDA4NzkzZTMxYTNmZWVmYzQ2YjYvdGFibGVyYW5nZTphNmJhMDU2ZjNhMzE0MDg3OTNlMzFhM2ZlZWZjNDZiNl8zMC0xLTEtMS02Mzk5Mg_7271a5a7-53cf-4b57-9c39-dc57e964e4d8">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzI4_73de853a-8123-4601-9a72-9e5a1bbed852">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE5_9314749c-ab07-4ca8-ba78-d4c625b739b7">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMTk5MDIzMjU3OTI3_02e9b07f-7499-42aa-b40b-46baeef864f2">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE0_9c37b092-8fd2-495f-ba7b-33f785331dda">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE1_210130d2-1b8e-449c-b7a4-19ae7f22c560">001-31573</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzI2_608172ba-98ef-4f7a-9bad-14fd3585a567">Medifast, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6MmQ2ZWYxM2RhMDA1NGE5OWEyNGFjNzAyYTUxY2U4NzYvdGFibGVyYW5nZToyZDZlZjEzZGEwMDU0YTk5YTI0YWM3MDJhNTFjZTg3Nl8wLTAtMS0xLTYzOTky_8775ffae-d185-4027-90e7-8ae0110a64cf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6MmQ2ZWYxM2RhMDA1NGE5OWEyNGFjNzAyYTUxY2U4NzYvdGFibGVyYW5nZToyZDZlZjEzZGEwMDU0YTk5YTI0YWM3MDJhNTFjZTg3Nl8wLTItMS0xLTYzOTky_34a65007-bf92-49a9-80e6-5d5c1a56cb8f">13-3714405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzIx_e2ad1c01-86de-4aa7-ad2f-abc18ce13cbe">100 International Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzIw_a0630ebf-67c9-46ee-a6c5-44d33ff5b319">Baltimore</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzIy_55cc72a2-b25b-4e53-9222-4702da197281">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzI3_eee42992-50bc-47c9-94a5-b95577b4512c">21202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzIz_d723f645-fbe2-4db2-96d5-528826de4aa0">410</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE2_f9ee492b-1c49-42bf-ba10-f7618b86723a">581-8042</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6NzVhYWFhYTIwNWE3NGIwY2I5ODcwZDVmYjc5NWVhOTAvdGFibGVyYW5nZTo3NWFhYWFhMjA1YTc0YjBjYjk4NzBkNWZiNzk1ZWE5MF8xLTAtMS0xLTYzOTky_92005520-a506-4e54-b0e1-a6c4896ac9a4">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6NzVhYWFhYTIwNWE3NGIwY2I5ODcwZDVmYjc5NWVhOTAvdGFibGVyYW5nZTo3NWFhYWFhMjA1YTc0YjBjYjk4NzBkNWZiNzk1ZWE5MF8xLTItMS0xLTYzOTky_59ba41b7-94ca-44f8-8963-9d588f12c50c">MED</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6NzVhYWFhYTIwNWE3NGIwY2I5ODcwZDVmYjc5NWVhOTAvdGFibGVyYW5nZTo3NWFhYWFhMjA1YTc0YjBjYjk4NzBkNWZiNzk1ZWE5MF8xLTQtMS0xLTYzOTky_9abcc6b0-a884-4518-a025-e3b459befd6c">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE3_a1024229-8d82-4158-acb8-417b348bfed9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzE4_bc5b342d-2c3e-435f-8e74-250e4d19b4f3">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6ODhkOTMxOGRhYWUxNGYzNmIyMWNjMGU4MDc4ZjdjMGQvdGFibGVyYW5nZTo4OGQ5MzE4ZGFhZTE0ZjM2YjIxY2MwZTgwNzhmN2MwZF8wLTAtMS0xLTYzOTky_8618b89a-4454-4faa-b7b9-e9628a422097">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6ODhkOTMxOGRhYWUxNGYzNmIyMWNjMGU4MDc4ZjdjMGQvdGFibGVyYW5nZTo4OGQ5MzE4ZGFhZTE0ZjM2YjIxY2MwZTgwNzhmN2MwZF8xLTMtMS0xLTYzOTky_bf21a535-7351-418d-b144-032aea609cb0">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGFibGU6ODhkOTMxOGRhYWUxNGYzNmIyMWNjMGU4MDc4ZjdjMGQvdGFibGVyYW5nZTo4OGQ5MzE4ZGFhZTE0ZjM2YjIxY2MwZTgwNzhmN2MwZF8yLTEtMS0xLTYzOTky_70c127bc-8d81-4010-bff0-ffdac8d7c51e">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yMzI1_81c992ed-3231-4446-8ff3-d20dcff71177">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i73efc58548364e9da276fb4aee70585f_I20230424"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xL2ZyYWc6NWMzMmY5MjYzNzI5NDFhMDgwNDg1ODU0MzUwNzc2NmIvdGV4dHJlZ2lvbjo1YzMyZjkyNjM3Mjk0MWEwODA0ODU4NTQzNTA3NzY2Yl8yNzQ4Nzc5MDcxNzk0_e2e3e16f-df5c-479a-99d4-dac9997c6d74"
      unitRef="shares">10887193</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMy0xLTEtMS02Mzk5Mg_3d3a8270-bf8a-48fe-8ca5-021cf4b5c3e0"
      unitRef="usd">348983000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMy0zLTEtMS02Mzk5Mg_df0ccb29-9921-4818-93e4-af4c1f845964"
      unitRef="usd">417600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNC0xLTEtMS02Mzk5Mg_478cd8d2-9b77-48ae-9575-9e5cc6b30a96"
      unitRef="usd">102593000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNC0zLTEtMS02Mzk5Mg_5f675a83-623f-48d0-ba09-7550e2372965"
      unitRef="usd">115314000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNS0xLTEtMS02Mzk5Mg_637e3f14-31e8-413e-b470-b48b7f9428c2"
      unitRef="usd">246390000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNS0zLTEtMS02Mzk5Mg_938c6ee4-0b51-4a43-b744-4b5596b62135"
      unitRef="usd">302286000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNy0xLTEtMS02Mzk5Mg_b990372f-65ff-4f29-b4d4-0f787806509f"
      unitRef="usd">192879000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfNy0zLTEtMS02Mzk5Mg_b5d54661-4b93-4307-a627-6d99623cf218"
      unitRef="usd">247199000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfOS0xLTEtMS02Mzk5Mg_d90b3836-670a-4186-b5e1-16164b77b558"
      unitRef="usd">53511000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfOS0zLTEtMS02Mzk5Mg_7c4af8b6-fd76-4ccc-b574-5d75438c894a"
      unitRef="usd">55087000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTItMS0xLTEtNjM5OTI_8b24865c-80b9-49ee-88ac-9e58d901a2ce"
      unitRef="usd">-181000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTItMy0xLTEtNjM5OTI_921ec4c0-411d-489a-b66a-bf38c5230d86"
      unitRef="usd">-95000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTMtMS0xLTEtNjM5OTI_030a933e-8863-480c-a251-5442a02249b6"
      unitRef="usd">-1000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTMtMy0xLTEtNjM5OTI_d843f77c-657c-4e65-bf58-b023efad8d8a"
      unitRef="usd">-16000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTQtMS0xLTEtNjM5OTI_289a875d-c1b6-4996-9871-dfd6274ac048"
      unitRef="usd">-182000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTQtMy0xLTEtNjM5OTI_1c7ab039-1a2e-4a5d-a4c9-34d9d3819f71"
      unitRef="usd">-111000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTYtMS0xLTEtNjM5OTI_14c1acc4-19ca-406b-bc1d-930bffdf7a84"
      unitRef="usd">53329000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTYtMy0xLTEtNjM5OTI_b34a1770-8974-4f28-962f-636fad04b72a"
      unitRef="usd">54976000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTgtMS0xLTEtNjM5OTI_1b79cbf3-309a-47e1-b0af-b89d3fcafc5e"
      unitRef="usd">13361000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMTgtMy0xLTEtNjM5OTI_65accea5-3b40-422b-b403-d253884f3c12"
      unitRef="usd">13195000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjAtMS0xLTEtNjM5OTI_31bd1787-9090-454a-b1ca-a50813b8339f"
      unitRef="usd">39968000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjAtMy0xLTEtNjM5OTI_4584fb0a-4671-4421-8757-7a7080ab0e83"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjItMS0xLTEtNjM5OTI_9551a1d4-775f-43e1-932f-d16245db4593"
      unitRef="usdPerShare">3.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjItMy0xLTEtNjM5OTI_231644da-ffb0-4e4c-8685-f5d8e04c65b6"
      unitRef="usdPerShare">3.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjQtMS0xLTEtNjM5OTI_4efc5fbf-b521-4a5f-b826-169048c51514"
      unitRef="usdPerShare">3.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjQtMy0xLTEtNjM5OTI_66175a81-5dab-457d-9952-5e76882579ef"
      unitRef="usdPerShare">3.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjctMS0xLTEtNjM5OTI_7a7ef509-8a68-41f9-961d-52fd0320ba41"
      unitRef="shares">10864000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjctMy0xLTEtNjM5OTI_bcda701f-c36d-4fa5-bc50-5bb0057d35b5"
      unitRef="shares">11557000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjgtMS0xLTEtNjM5OTI_3aef1bb5-3fc5-4407-b37b-d007b3bba388"
      unitRef="shares">10899000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMjgtMy0xLTEtNjM5OTI_b3e93f9a-44cb-4c82-a38a-3a40089e1334"
      unitRef="shares">11638000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMzAtMS0xLTEtNjM5OTI_317c59b5-f332-48a9-9ef0-437b9be0211e"
      unitRef="usdPerShare">1.65</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xNi9mcmFnOjU4YjBkN2JiNDE4MDRlMzhhNzMwYWZmYzJlYmQ4NDA2L3RhYmxlOmIyODkxYTViYzI1YjQwZTc5OGUyMzBjZmE3MmY1ZDYzL3RhYmxlcmFuZ2U6YjI4OTFhNWJjMjViNDBlNzk4ZTIzMGNmYTcyZjVkNjNfMzAtMy0xLTEtNjM5OTI_5703fcb7-f75c-497f-8b41-59d1e6cb72ea"
      unitRef="usdPerShare">1.64</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:NetIncomeLoss
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfMy0xLTEtMS02Mzk5Mg_0a72357a-f0b3-4bd4-92fa-106282798265"
      unitRef="usd">39968000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfMy0zLTEtMS02Mzk5Mg_b2788f62-0095-4f08-8c03-e88224ae37a0"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfNi0xLTEtMS02Mzk5Mg_10adf817-f636-4561-ba13-fd2be34852ec"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfNi0zLTEtMS02Mzk5Mg_5f11737d-96d1-4a99-b408-7ede65a02ba6"
      unitRef="usd">30000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfNy0xLTEtMS02Mzk5Mg_8a5d796e-afa8-4942-8725-a040d159f256"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfNy0zLTEtMS02Mzk5Mg_416c9423-5b0b-4ccc-9085-dc5afed31577"
      unitRef="usd">-14000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfOC0xLTEtMS02Mzk5Mg_f86f5aad-ad13-4b02-980e-b8030d520592"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfOC0zLTEtMS02Mzk5Mg_eb9100ab-8569-42eb-a068-05c413cde11c"
      unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfMTAtMS0xLTEtNjM5OTI_1fe250bf-699b-4945-90eb-1c75c1d6bf81"
      unitRef="usd">39977000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8xOS9mcmFnOjBlNDM0MDE0ZDBjMzQxN2FhNzRiYzQxMGYzYWMxMjI5L3RhYmxlOjcwOWZjMDExOWQxOTRhNzk4MWU0NTNlYzQwNDRiZjdiL3RhYmxlcmFuZ2U6NzA5ZmMwMTE5ZDE5NGE3OTgxZTQ1M2VjNDA0NGJmN2JfMTAtMy0xLTEtNjM5OTI_4b1773c4-e3bf-42b8-b519-36d2e19fae71"
      unitRef="usd">41797000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNC0xLTEtMS02Mzk5Mg_9a7a820f-8aa6-4fda-9f06-df1dffef501a"
      unitRef="usd">123748000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNC0zLTEtMS02Mzk5Mg_ff783136-0cff-4572-a432-0ef369d81f2d"
      unitRef="usd">87691000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:InventoryNet
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNS0xLTEtMS02Mzk5Mg_963fd2ca-1244-4786-a684-0e4c081168b3"
      unitRef="usd">96896000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNS0zLTEtMS02Mzk5Mg_26e29e0c-37ee-4cba-94c3-9eaa06d637a2"
      unitRef="usd">118856000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfOC0xLTEtMS02Mzk5Mg_054469f0-1d7f-402f-b4eb-be2d6ab02e95"
      unitRef="usd">9674000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfOC0zLTEtMS02Mzk5Mg_8bbb05ae-fa16-4f9c-8db6-4aef1edc7ecb"
      unitRef="usd">16237000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfOS0xLTEtMS02Mzk5Mg_d0aab91c-fbd3-40bc-a887-8a06113bf05a"
      unitRef="usd">230318000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfOS0zLTEtMS02Mzk5Mg_b554e86e-0662-4ec2-bc3b-54b2bced9f87"
      unitRef="usd">222784000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTEtMS0xLTEtNjM5OTI_88743e38-9613-4d19-9409-48e076bb35a7"
      unitRef="usd">55960000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTEtMy0xLTEtNjM5OTI_3ed2b7df-8d67-463c-81e3-b6cb000aceac"
      unitRef="usd">57185000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTItMS0xLTEtNjM5OTI_71850aab-b420-479d-9995-3d6e93e722fb"
      unitRef="usd">17091000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTItMy0xLTEtNjM5OTI_577177bc-5c22-4b5e-abc7-c354dd54edf0"
      unitRef="usd">18460000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTMtMS0xLTEtNjM5OTI_92cd8066-de0e-4a79-817d-57b8735f0d68"
      unitRef="usd">13709000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTMtMy0xLTEtNjM5OTI_f7b30885-3e4c-4157-bdf9-6e3d32c87485"
      unitRef="usd">12456000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTQtMS0xLTEtNjM5OTI_8282350d-2e3b-440d-88c2-d2a9b8e6fcab"
      unitRef="usd">4528000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTQtMy0xLTEtNjM5OTI_0191bc8d-9f64-48e9-b285-3ec1c90dcbc2"
      unitRef="usd">5328000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:Assets
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTctMS0xLTEtNjM5OTI_a2e25404-2a49-4a32-be44-e570e3459db6"
      unitRef="usd">321606000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMTctMy0xLTEtNjM5OTI_74ddaeea-5988-4e33-b346-3abb88337d95"
      unitRef="usd">316213000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjEtMS0xLTEtNjM5OTI_b307491f-cc12-4f2f-a278-4330f2f7e0bd"
      unitRef="usd">113300000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjEtMy0xLTEtNjM5OTI_e904bbff-1ae4-4f7b-a7f5-d0db04ff728c"
      unitRef="usd">134690000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjItMS0xLTEtNjM5OTI_512b3214-a831-451a-a765-08f4765013cb"
      unitRef="usd">13031000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjItMy0xLTEtNjM5OTI_88b63932-f6db-4b07-b399-c0b0828ac012"
      unitRef="usd">428000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjMtMS0xLTEtNjM5OTI_3c61553b-9532-4607-967f-ae3a97378f13"
      unitRef="usd">5411000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjMtMy0xLTEtNjM5OTI_ffb24791-14df-4558-be53-1b464117f94d"
      unitRef="usd">5776000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjQtMS0xLTEtNjM5OTI_a9c7a19a-db56-4114-81a7-d7076698e3cd"
      unitRef="usd">131742000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjQtMy0xLTEtNjM5OTI_5d2b401c-45b2-41a6-bdcb-db47fc2c0743"
      unitRef="usd">140894000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjYtMS0xLTEtNjM5OTI_f30594be-2836-4d9e-aab7-42159cf110a4"
      unitRef="usd">18964000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjYtMy0xLTEtNjM5OTI_c1bc0b10-d16d-48ca-8725-34ab230f8d30"
      unitRef="usd">20275000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjktMS0xLTEtNjM5OTI_a0e06746-f4b3-4d93-9351-d7a2ae91c853"
      unitRef="usd">150706000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMjktMy0xLTEtNjM5OTI_09c19af2-8ea2-44a4-9c1d-924affa98c62"
      unitRef="usd">161169000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzItMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo4N2QzMDQwMGM0OTE0NWY0YmRlZGM2YmRjZDFiMmNhN18yNzQ4Nzc5MDY5NTA0_12500503-ecfd-411c-ad26-4cefec08323a"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzItMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo4N2QzMDQwMGM0OTE0NWY0YmRlZGM2YmRjZDFiMmNhN18yNzQ4Nzc5MDY5NTA0_51e1baa2-ddac-48a2-93c2-486c18533c2c"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzItMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo4N2QzMDQwMGM0OTE0NWY0YmRlZGM2YmRjZDFiMmNhN18yNzQ4Nzc5MDY5NTA4_43d7dd85-3dad-4012-ae0f-f4c6a7ede8cf"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzItMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo4N2QzMDQwMGM0OTE0NWY0YmRlZGM2YmRjZDFiMmNhN18yNzQ4Nzc5MDY5NTA4_96d1439e-deb6-4a80-8a67-ff4f6fcddf97"
      unitRef="shares">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzMtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo0MDVlYzJkZGE5MGY0Yzk1YmQwODhlMDNmMWRjOTkwZl8yNzQ4Nzc5MDY5NDg3_31b300a6-06c2-4efc-859c-934e44eb7bcf"
      unitRef="shares">10887000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzMtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo0MDVlYzJkZGE5MGY0Yzk1YmQwODhlMDNmMWRjOTkwZl8yNzQ4Nzc5MDY5NDkx_7d2f9bc6-79cf-48ba-b8e6-be11332fa484"
      unitRef="shares">10928000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzMtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo0MDVlYzJkZGE5MGY0Yzk1YmQwODhlMDNmMWRjOTkwZl8yNzQ4Nzc5MDY5NDk1_fcfa163d-ab9b-419c-99e1-051cca402425"
      unitRef="shares">10887000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzMtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjo0MDVlYzJkZGE5MGY0Yzk1YmQwODhlMDNmMWRjOTkwZl8yNzQ4Nzc5MDY5NDk5_4e312e5b-6b6c-451d-b7bf-9aece52661a9"
      unitRef="shares">10873000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzQtMS0xLTEtNjM5OTI_cc426644-64d8-4fcd-b262-b0094810898d"
      unitRef="usd">11000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzQtMy0xLTEtNjM5OTI_6ff8e73e-a57c-4cd1-9999-c8e502f8f757"
      unitRef="usd">11000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzUtMS0xLTEtNjM5OTI_f5442d5b-4340-465d-8902-11b7dfa0ee1e"
      unitRef="usd">19030000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzUtMy0xLTEtNjM5OTI_de9facc0-39de-45a6-9eb3-a5d97e5a3e45"
      unitRef="usd">21555000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzYtMS0xLTEtNjM5OTI_8fdc6bd2-97bd-4200-b3af-bd6380deaf25"
      unitRef="usd">33000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzYtMy0xLTEtNjM5OTI_2ee6f1eb-1119-43ae-a6d1-33990c840a8a"
      unitRef="usd">24000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzctMS0xLTEtNjM5OTI_853886a3-ac0f-4082-bc9c-0f3f5f4e8e4a"
      unitRef="usd">151826000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzctMy0xLTEtNjM5OTI_e3e25bc6-494c-477e-9e15-f1a271aa7f9d"
      unitRef="usd">139852000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzgtMC0xLTEtNjM5OTIvdGV4dHJlZ2lvbjphMjUxMjMyNjY5OTc0NzZmODk1N2UyOGJmZTk1NDA0NV8yNzQ4Nzc5MDY5NTQw_5991846f-bfd8-4fcc-b4d9-254d7c502443"
      unitRef="shares">54000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzgtMS0xLTEtNjM5OTI_01a3750b-5ee6-486f-8f17-93b61c937b35"
      unitRef="usd">0</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzgtMy0xLTEtNjM5OTI_123f9c50-16b0-4002-b375-b0e44015158e"
      unitRef="usd">6398000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzktMS0xLTEtNjM5OTI_861088e2-6825-485d-92de-c7e8d65cbfef"
      unitRef="usd">170900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfMzktMy0xLTEtNjM5OTI_d654e57a-c3d9-48ba-9b48-97dfcd3b1725"
      unitRef="usd">155044000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNDEtMS0xLTEtNjM5OTI_f26defd5-e62f-40fd-acce-5e9f23a98459"
      unitRef="usd">321606000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yMi9mcmFnOjg2ZTQzYjI3NDU0MDRmYmE5ZGE5OTg2NmNlZDNkMmJkL3RhYmxlOmJlNTUyNzg0Y2MxZDQ5ZDA5NjExYzA5ZTdjZWFkMmFhL3RhYmxlcmFuZ2U6YmU1NTI3ODRjYzFkNDlkMDk2MTFjMDllN2NlYWQyYWFfNDEtMy0xLTEtNjM5OTI_ed5cbf86-e4e3-4d04-855b-bcd82ac2b9cc"
      unitRef="usd">316213000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNC0xLTEtMS02Mzk5Mg_b0ccff7a-6ead-45f3-b704-b0c1e53da282"
      unitRef="usd">39968000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNC0zLTEtMS02Mzk5Mg_84d1d39a-875f-48ba-b0c1-f8914d3d4971"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNi0xLTEtMS02Mzk5Mg_43e9b1ce-7197-4ea2-9682-f9aa60f0e361"
      unitRef="usd">2974000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNi0zLTEtMS02Mzk5Mg_978f7c78-fde8-4918-bf37-5d73f9310305"
      unitRef="usd">2444000</us-gaap:DepreciationDepletionAndAmortization>
    <med:OperatingLeaseExpenseNonCash
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNy0xLTEtMS02Mzk5Mg_3f7e0757-5de4-4530-bfd0-9ede5be979b5"
      unitRef="usd">1369000</med:OperatingLeaseExpenseNonCash>
    <med:OperatingLeaseExpenseNonCash
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNy0zLTEtMS02Mzk5Mg_304bc540-7605-4e3a-b0b0-eb819ef2943d"
      unitRef="usd">1619000</med:OperatingLeaseExpenseNonCash>
    <us-gaap:ShareBasedCompensation
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfOC0xLTEtMS02Mzk5Mg_c37f886b-0f82-48e7-bd03-b2f288e59777"
      unitRef="usd">606000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfOC0zLTEtMS02Mzk5Mg_7701b607-3d87-426c-883b-22928bdace4a"
      unitRef="usd">2275000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTAtMS0xLTEtNjM5OTI_8a144b96-db41-4582-857e-a2ad08ae2dfa"
      unitRef="usd">0</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTAtMy0xLTEtNjM5OTI_e667710a-6c22-488f-beb9-816dd0acb9de"
      unitRef="usd">11000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTEtMS0xLTEtNjM5OTI_4d6c749b-9b3f-46f5-9bac-34d30c1fe173"
      unitRef="usd">800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTEtMy0xLTEtNjM5OTI_a18b9c05-5319-4f09-8d3f-40c202ec44f9"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTQtMS0xLTEtNjM5OTI_1777d0d6-2ab4-4cfe-ad54-7b3b07f0b11b"
      unitRef="usd">-21960000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTQtMy0xLTEtNjM5OTI_6846ac6d-64e6-4627-9627-63e3396eb364"
      unitRef="usd">8929000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTYtMS0xLTEtNjM5OTI_75a183e9-766b-4ba5-9839-4aa78ca1c226"
      unitRef="usd">-6563000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTYtMy0xLTEtNjM5OTI_6f4a74a7-7bb9-4431-9ce3-779310df1aea"
      unitRef="usd">-3107000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTctMS0xLTEtNjM5OTI_f8227183-5f0d-4712-83dc-28eb6a067c3b"
      unitRef="usd">887000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTctMy0xLTEtNjM5OTI_de58e2a9-c5a9-414a-82b8-3d366bcf99c5"
      unitRef="usd">6632000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTgtMS0xLTEtNjM5OTI_0aadea2c-8116-45f0-95d1-8ee1474b2d49"
      unitRef="usd">-21897000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTgtMy0xLTEtNjM5OTI_71682c55-27a1-4bbe-aa80-76824e69c521"
      unitRef="usd">-6084000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTktMS0xLTEtNzY2NTU_f8ead574-66e5-428e-b624-1cdfc0424fbd"
      unitRef="usd">-12603000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTktMy0xLTEtNzY2NTU_47866b21-82aa-4386-8d77-485a501f4707"
      unitRef="usd">-14081000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTktMS0xLTEtNjM5OTI_f88e4897-4524-497b-9804-405899fd81ca"
      unitRef="usd">64059000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMTktMy0xLTEtNjM5OTI_33099b27-57c8-4dac-ac25-e1bb2b94de6b"
      unitRef="usd">43673000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjItMS0xLTEtNjM5OTI_b2c459ea-a086-4319-b721-8f23b8b001db"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjItMy0xLTEtNjM5OTI_3f71ef3d-d05a-4d2b-a5ff-167432d8bb09"
      unitRef="usd">1245000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjMtMS0xLTEtNjM5OTI_a8852608-bd47-43fa-b667-b2b0ee59ce17"
      unitRef="usd">2115000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjMtMy0xLTEtNjM5OTI_25418300-a1c4-4ff3-bbbb-c240d26e6455"
      unitRef="usd">3009000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjQtMS0xLTEtNjM5OTI_79098ceb-f41c-4613-b0af-e15f68a4967e"
      unitRef="usd">-2115000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjQtMy0xLTEtNjM5OTI_e6600952-564d-4310-933d-6e0f1aa0d225"
      unitRef="usd">-1764000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <med:ProceedsFromStockOptionsExercisedDirectors
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjgtMS0xLTEtNjM5OTI_95223a8d-09db-42a5-b816-3564d5d374d9"
      unitRef="usd">105000</med:ProceedsFromStockOptionsExercisedDirectors>
    <med:ProceedsFromStockOptionsExercisedDirectors
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjgtMy0xLTEtNjM5OTI_25a8e1f7-f300-49d6-a25b-cfa9fd595a23"
      unitRef="usd">0</med:ProceedsFromStockOptionsExercisedDirectors>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjktMS0xLTEtNjM5OTI_00f5abe2-fa73-4fb5-9417-8ba96a9f7071"
      unitRef="usd">3236000</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <us-gaap:PaymentsForRepurchaseOfOtherEquity
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMjktMy0xLTEtNjM5OTI_bdbb00f1-27b9-4ecf-908a-8e54f015d8ff"
      unitRef="usd">1459000</us-gaap:PaymentsForRepurchaseOfOtherEquity>
    <us-gaap:PaymentsOfDividends
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzAtMS0xLTEtNjM5OTI_8a5e67e1-5605-4e72-8809-f4eae5b6d761"
      unitRef="usd">19163000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzAtMy0xLTEtNjM5OTI_a71e9a7b-d4b3-47b4-9563-32017e903c66"
      unitRef="usd">16660000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzEtMS0xLTEtNjM5OTI_2ba40afc-2f48-4eaa-889d-aa6855df69da"
      unitRef="usd">3602000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzEtMy0xLTEtNjM5OTI_d15257c2-f8e6-40eb-a5e6-64c9730cb634"
      unitRef="usd">10000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzMtMS0xLTEtNjM5OTI_11c5586c-92ef-428b-be13-9279577fdc4e"
      unitRef="usd">-25896000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzMtMy0xLTEtNjM5OTI_20a3b045-24a8-4466-8c2e-a607a7656673"
      unitRef="usd">-28119000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzUtMS0xLTEtNjM5OTI_fbaa2ba1-3cba-4240-a526-8ed919bcc4e3"
      unitRef="usd">9000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzUtMy0xLTEtNjM5OTI_4ac2e723-f6c7-4d03-b710-afe5f843c869"
      unitRef="usd">30000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzctMS0xLTEtNjM5OTI_49ca4a65-7c56-405e-aed2-f7ddbee1c762"
      unitRef="usd">36057000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzctMy0xLTEtNjM5OTI_2afc89bd-555d-402a-b8f6-356c2f203eeb"
      unitRef="usd">13820000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzgtMS0xLTEtNjM5OTI_4b21977d-4a0c-4010-9ecd-7533a5de6995"
      unitRef="usd">87691000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i14276493cdda4b5297135c9e43430126_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzgtMy0xLTEtNjM5OTI_9c075dfc-6dea-4b91-a72f-6e906ecd6857"
      unitRef="usd">104183000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzktMS0xLTEtNjM5OTI_3cc8edb3-b29c-4289-bd7d-7940e0e67fe0"
      unitRef="usd">123748000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfMzktMy0xLTEtNjM5OTI_ef8ed78b-a45e-4591-96a4-c1e59ce5e700"
      unitRef="usd">118003000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNDItMS0xLTEtNjM5OTI_e7450ae4-0e2f-4d23-b097-1fc6caea474f"
      unitRef="usd">-46000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNDItMy0xLTEtNjM5OTI_dd4f97c7-253d-4506-a900-15687a3f7854"
      unitRef="usd">62000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DividendsCash
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNDMtMS0xLTEtNjM5OTI_2dad5770-f76a-4e27-ae0c-be7a63022d87"
      unitRef="usd">18653000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yNS9mcmFnOjM2YTA0NDkyMGMzMTQwODc5NDg0YjJlNWQwZTE1ZTU2L3RhYmxlOmJmOWU5YTYyNWExYjQ5MjhhZjRhODZjNWMyYmU5YzBlL3RhYmxlcmFuZ2U6YmY5ZTlhNjI1YTFiNDkyOGFmNGE4NmM1YzJiZTljMGVfNDMtMy0xLTEtNjM5OTI_f1ff7976-1726-4cbf-8551-8d75d447655f"
      unitRef="usd">19663000</us-gaap:DividendsCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="i37fc307c3fff4012b03412aba9187bf6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy0xLTEtMS02Mzk5Mg_4677a4c8-9aeb-4189-97f1-41662e6e1019"
      unitRef="shares">10928000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i37fc307c3fff4012b03412aba9187bf6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy0zLTEtMS02Mzk5Mg_6405a5c5-a437-414d-a973-9bb5671976a0"
      unitRef="usd">11000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic21acf6f41c44ed8a91b90def6137e1b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy01LTEtMS02Mzk5Mg_e618c08e-9e5f-4b48-8602-d38db2124ee5"
      unitRef="usd">21555000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib645712f743642f7b14f17858412b113_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy03LTEtMS02Mzk5Mg_24594794-5c05-4e7a-9157-73f20746d441"
      unitRef="usd">24000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib7a98f37c1e44fa184ad39aef19462ae_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy05LTEtMS02Mzk5Mg_89580fd7-94b9-4bbe-9cc4-6452590ea32d"
      unitRef="usd">139852000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f0ba66dcb054c298b2f1218f9d34e61_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy0xMS0xLTEtNjM5OTI_b98d876c-ecd4-4a16-a8b0-c83716a68a73"
      unitRef="usd">-6398000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMy0xMy0xLTEtNjM5OTI_81a69ea0-1022-4fff-8649-bb107d1b1ecf"
      unitRef="usd">155044000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="id9003a88c4844e8cbd52972e24a1d8e7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNC05LTEtMS02Mzk5Mg_32ef50f0-a991-4d9c-ad87-c7d9a9faf30b"
      unitRef="usd">39968000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNC0xMy0xLTEtNjM5OTI_e781d84c-0675-4872-8e33-1bfcdc88acb4"
      unitRef="usd">39968000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNS0xLTEtMS02Mzk5Mg_029d9c5a-0c8e-4208-9c78-85136ac05159"
      unitRef="shares">69000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="i760c27790b4a43b18f0947b1de071b7c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNS01LTEtMS02Mzk5Mg_bb9fdeff-8c63-4d01-a8ef-35f84f933984"
      unitRef="usd">606000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNS0xMy0xLTEtNjM5OTI_95e4ddb2-c2bc-4783-bfc1-7831dcfd1c8a"
      unitRef="usd">606000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi0xLTEtMS03MDA3NA_379c606f-8a5a-4be6-9fa9-cbaf98b8e575"
      unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i760c27790b4a43b18f0947b1de071b7c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi01LTEtMS03MDA3NA_40769683-e0e4-478c-8b74-fbc6439df8ad"
      unitRef="usd">105000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi0xMy0xLTEtNzAwNzQ_e6fb8a97-97d7-4a27-86a6-790bd48731a0"
      unitRef="usd">105000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi0xLTEtMS02Mzk5Mg_4b02c1a0-fb5b-4e6c-bbc8-811037cc7ff3"
      unitRef="shares">30000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i760c27790b4a43b18f0947b1de071b7c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi01LTEtMS02Mzk5Mg_158b1284-3a2e-4b43-bc8b-df945394ab89"
      unitRef="usd">3236000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNi0xMy0xLTEtNjM5OTI_f98091ad-f712-4519-9f91-742674df68da"
      unitRef="usd">3236000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i25bf64baa4f84f3c91994cf68921d605_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNy0xMS0xLTEtNjM5OTI_f7128d7e-2916-4ec8-9923-b5286437e116"
      unitRef="usd">3602000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfNy0xMy0xLTEtNjM5OTI_5c787114-26e1-4d67-89cb-26b31e2e1827"
      unitRef="usd">3602000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="i86015706b09b4ffd83576dd36d66d362_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOC0xLTEtMS02Mzk5Mg_cdc17470-9e29-4b9f-84c8-504d0d4318a5"
      unitRef="shares">84000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="id9003a88c4844e8cbd52972e24a1d8e7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOC05LTEtMS02Mzk5Mg_43b286fa-ef41-4c13-9f45-dbd065dbc83a"
      unitRef="usd">10000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i25bf64baa4f84f3c91994cf68921d605_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOC0xMS0xLTEtNjM5OTI_bc0298cc-8ea4-43d2-90ec-e150fc6bb3aa"
      unitRef="usd">-10000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOC0xMy0xLTEtNjM5OTI_41103495-13ff-4e0f-be5d-174eabe67709"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iff775d4fc8d945b78ba54e784502dc6f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOS03LTEtMS02Mzk5Mg_3e1bffe8-0ed8-495b-ad91-7a7824a48653"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfOS0xMy0xLTEtNjM5OTI_6931d6b1-64ae-486a-83a3-6b6b267f1c29"
      unitRef="usd">9000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:DividendsCommonStockCash
      contextRef="id9003a88c4844e8cbd52972e24a1d8e7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTAtOS0xLTEtNjM5OTI_fe033119-0325-4010-be5d-2acfa3a9bd76"
      unitRef="usd">17994000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTAtMTMtMS0xLTYzOTky_2ce9551c-2893-4e85-b73d-12deb54eae36"
      unitRef="usd">17994000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="i31b8f688eea24545a396eeb0611d6e1b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItMS0xLTEtNjM5OTI_cb4597e1-259f-4039-83cd-2e47fdd9aa11"
      unitRef="shares">10887000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i31b8f688eea24545a396eeb0611d6e1b_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItMy0xLTEtNjM5OTI_e18ce72d-b4fa-4c88-91f2-78c73dd9ebbf"
      unitRef="usd">11000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i90030857661f4a4dbc4ccc740b7b79c0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItNS0xLTEtNjM5OTI_6add389d-1fd0-49c0-a95e-57cad15d8c51"
      unitRef="usd">19030000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8914dfcaa1404cf9af3e00a8b215faad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItNy0xLTEtNjM5OTI_bac5aad6-5a49-47d8-b960-df0d9895ea43"
      unitRef="usd">33000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i892b2a6455a84efea48207042eb47ebc_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItOS0xLTEtNjM5OTI_67df1006-a099-4a6e-9a60-b00d97f59011"
      unitRef="usd">151826000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0c9ff89193a54598a41c53bc8a2c8707_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItMTEtMS0xLTYzOTky_033a68e0-1948-41cf-945c-cd3f7c1da03a"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjVlZTNkZWM2NTU4YzQ4ZWVhOWUzMWZkMmUwNmUyOWFkL3RhYmxlcmFuZ2U6NWVlM2RlYzY1NThjNDhlZWE5ZTMxZmQyZTA2ZTI5YWRfMTItMTMtMS0xLTYzOTky_a4b42104-4f92-431d-9ac2-2972858a0c60"
      unitRef="usd">170900000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="iddbcc131b7564ee995939796a3d726ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy0xLTEtMS02Mzk5Mg_a562ce85-15ad-4a16-9537-ca646b2695c3"
      unitRef="shares">11594000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iddbcc131b7564ee995939796a3d726ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy0zLTEtMS02Mzk5Mg_98980542-cfa4-41a8-bb4e-f0fbe21e6d24"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i16778ba2b0e747a695b14af615208230_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy01LTEtMS02Mzk5Mg_97402bde-dac1-4fc7-b7a9-ba2fad696338"
      unitRef="usd">12018000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9ad93c89a7e443da95e864cdcaff958e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy03LTEtMS02Mzk5Mg_e77354c7-daa2-4a4f-ba10-4b2f9370af48"
      unitRef="usd">111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i021a1b09c09b4f149bc661efb55a8579_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy05LTEtMS02Mzk5Mg_c39cd724-aadc-4032-9cfd-3c9261359ca6"
      unitRef="usd">190333000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iae2a9532cbe94c05a12c15c043307bc3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy0xMS0xLTEtNjM5OTI_f31b1d84-221e-4d3d-93cd-cc1fe400f7a2"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14276493cdda4b5297135c9e43430126_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMy0xMy0xLTEtNjM5OTI_d35d8c91-8f66-4a04-98ef-d234fc4648b3"
      unitRef="usd">202474000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i3245c01aff3346e8b0e93c38786ba422_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNC05LTEtMS02Mzk5Mg_9ac36722-e849-47de-95d4-2ca402767e69"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNC0xMy0xLTEtNjM5OTI_d5edf2a4-d679-45f7-a5d6-63cefdcba6a0"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="ib09b1a76e8224a0f8f66a0f0d89c5f8e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNS0xLTEtMS02Mzk5Mg_72d3a75e-7140-4c7a-810e-10199f52bf92"
      unitRef="shares">18000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="ia03cb5ed3f53442c810b63d75610adee_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNS01LTEtMS02Mzk5Mg_9446d89f-2764-4864-b962-456f241382e3"
      unitRef="usd">2275000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNS0xMy0xLTEtNjM5OTI_a1929e53-32f8-42e1-a495-72586ac9223e"
      unitRef="usd">2275000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ib09b1a76e8224a0f8f66a0f0d89c5f8e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNi0xLTEtMS02Mzk5Mg_2c364179-9fcb-44b2-96c3-dcf23ccbfbb5"
      unitRef="shares">8000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia03cb5ed3f53442c810b63d75610adee_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNi01LTEtMS02Mzk5Mg_694ea316-7537-4816-be43-39b4824531c8"
      unitRef="usd">1459000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNi0xMy0xLTEtNjM5OTI_89c54c36-cc3e-4508-87e9-f27a2d011248"
      unitRef="usd">1459000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iefab9b282eab46b6b9feb116dacd81f1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNy0xMS0xLTEtNjM5OTI_311fddb9-f161-4605-8143-e67a7c90ce98"
      unitRef="usd">10000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfNy0xMy0xLTEtNjM5OTI_f8fbaef6-836d-4ca7-b70f-2f06cb1287be"
      unitRef="usd">10000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesRetired
      contextRef="ib09b1a76e8224a0f8f66a0f0d89c5f8e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOC0xLTEtMS02Mzk5Mg_32b88def-0998-4d12-9f60-db5f929a4183"
      unitRef="shares">51000</us-gaap:TreasuryStockSharesRetired>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="i3245c01aff3346e8b0e93c38786ba422_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOC05LTEtMS02Mzk5Mg_f825c24d-81c0-43de-b0b9-e50ce1334bf7"
      unitRef="usd">10000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="iefab9b282eab46b6b9feb116dacd81f1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOC0xMS0xLTEtNjM5OTI_3225903b-8eec-4ffd-ba8e-e29be318acf6"
      unitRef="usd">-10000000</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:TreasuryStockRetiredCostMethodAmount
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOC0xMy0xLTEtNjM5OTI_da337b19-073b-435c-b3f0-1a449eb0d388"
      unitRef="usd">0</us-gaap:TreasuryStockRetiredCostMethodAmount>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9aa7a26927a042ddb0c4efddb86c5947_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOS03LTEtMS03MDI4MA_28ef177c-658b-4596-a21d-20cb12b955fb"
      unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOS0xMy0xLTEtNzAyODA_d638b980-ed2c-4309-9d94-a1cecf8bd98b"
      unitRef="usd">16000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:DividendsCommonStockCash
      contextRef="i3245c01aff3346e8b0e93c38786ba422_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOS05LTEtMS02Mzk5Mg_632e8fc4-5780-4be2-bac2-8dbcb55f50f2"
      unitRef="usd">19063000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfOS0xMy0xLTEtNjM5OTI_9766fb65-04ae-4f21-ad06-d5d264c93486"
      unitRef="usd">19063000</us-gaap:DividendsCommonStockCash>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifc4d87af6ad34ece906c185c57bc0f27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItMS0xLTEtNjM5OTI_4b6e339e-9052-440e-826d-cc969052af23"
      unitRef="shares">11553000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ifc4d87af6ad34ece906c185c57bc0f27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItMy0xLTEtNjM5OTI_bdacbab6-3542-4a27-be91-70b9e55c2d45"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d859544afec4409b2dc5203bc73948f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItNS0xLTEtNjM5OTI_c99b9bba-ed8b-464a-a871-06cf7489bd53"
      unitRef="usd">12834000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i63601fd2318848348fc1c8b45cb1f3a2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItNy0xLTEtNjM5OTI_cac3c333-d1ac-4551-907b-57d22093e163"
      unitRef="usd">127000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i13e17fd77c1a47b9b50510f8f141dfae_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItOS0xLTEtNjM5OTI_7d87ce73-60da-4abe-b643-7200dab3a8ae"
      unitRef="usd">203051000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic44f166aec324147a4cca9c573b540dd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItMTEtMS0xLTYzOTky_7fe12809-86ab-4edf-9527-5eaff7bb0362"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8yOC9mcmFnOjQwNDFiNzZiZjY4ZjQxYmQ5YThhNmZlZDg5OGMwNDJlL3RhYmxlOjMwMDQ3OGI2MGQxYzQwMDViZThjNDNlMjcyOThlMGRhL3RhYmxlcmFuZ2U6MzAwNDc4YjYwZDFjNDAwNWJlOGM0M2UyNzI5OGUwZGFfMTItMTMtMS0xLTYzOTky_7fe3ffa8-ecfb-46dc-a996-33fb20c60721"
      unitRef="usd">216024000</us-gaap:StockholdersEquity>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwMw_d3c34013-98f4-4eeb-b744-b949151e8651">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#x201c;Medifast,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2022 has been derived from the 2022 audited consolidated financial statements at that date included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (&#x201c;2022 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2023. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Presentation of Financial Statements -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassification -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not adopted any new accounting standards during the three months ended March 31, 2023. There are no recently issued accounting pronouncements that are expected to have a material effect on the Company&#x2019;s financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwNA_a59e548a-e5ae-452e-adfe-9cf32280bd8d">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The accompanying unaudited condensed consolidated financial statements of Medifast, Inc. and its wholly-owned subsidiaries (&#x201c;Medifast,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) included herein have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;GAAP&#x201d;) for interim reporting and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Accordingly, certain information and notes that are normally required by GAAP have been condensed or omitted. However, in the opinion of management, all adjustments consisting of normal, recurring adjustments considered necessary for a fair presentation of the financial position and results of operations have been included and management believes the disclosures that are made are adequate to make the information presented not misleading. The condensed consolidated balance sheet at December&#160;31, 2022 has been derived from the 2022 audited consolidated financial statements at that date included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2022 (&#x201c;2022 Form 10-K&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three months ended March 31, 2023 are not necessarily indicative of results that may be expected for the fiscal year ending December&#160;31, 2023. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the 2022 Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzQ5OQ_4db03143-752c-4256-b658-a5d338846e47">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Presentation of Financial Statements -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated financial statements included herein include the accounts of the Company. All significant intercompany accounts and transactions have been eliminated.&lt;/span&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwMA_364beb42-62b1-4bb9-9f12-db53f8ac6fbd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassification -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Certain amounts reported for prior periods have been reclassified to be consistent with the current period presentation. No reclassification in the condensed consolidated financial statements had a material impact on the presentation.&lt;/span&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwMQ_015393d6-c4ba-4ec1-a257-0c5dc88ff65e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNC9mcmFnOjEzZDdjMDJhZTFlYjRmYTdhOTg2OThhZDE3MmRlZGVjL3RleHRyZWdpb246MTNkN2MwMmFlMWViNGZhN2E5ODY5OGFkMTcyZGVkZWNfMzUwMg_c3869add-dc95-412f-a9ee-4e31791a7964">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not adopted any new accounting standards during the three months ended March 31, 2023. There are no recently issued accounting pronouncements that are expected to have a material effect on the Company&#x2019;s financial position, results of operations, cash flows, or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RleHRyZWdpb246MzZiMTM2NTkwYmRhNDcxYzg1ZDM4Mzc5ZjgxMDNkODRfOTYy_66addeec-2695-4797-8579-c85d87b5a808">INVENTORIES&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consist principally of raw materials, non-food finished goods and packaged meal replacements held in the Company&#x2019;s warehouses and outsourced distribution centers. Inventories are stated at the lower of cost or net realizable value, utilizing the first-in, first-out method. The cost of finished goods includes the cost of raw materials, packaging supplies, direct and indirect labor and other indirect manufacturing costs. On a quarterly basis, management reviews inventories for unsalable or obsolete inventories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12,932&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12,670&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4,296&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3,611&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non-food finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7,032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;8,738&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;78,825&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;97,675&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Reserve for obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(6,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;96,896&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;118,856&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RleHRyZWdpb246MzZiMTM2NTkwYmRhNDcxYzg1ZDM4Mzc5ZjgxMDNkODRfOTYx_cb0786aa-ad51-4caf-b3fc-0360de380da2">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12,932&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;12,670&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Packaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4,296&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;3,611&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Non-food finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;7,032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;8,738&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;78,825&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;97,675&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Reserve for obsolete inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(6,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(3,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;96,896&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;118,856&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfMi0xLTEtMS02Mzk5Mg_354d5120-cbf9-4bf1-94ec-592c3538f6ae"
      unitRef="usd">12932000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfMi0zLTEtMS02Mzk5Mg_4f60997b-1d1f-4d20-ade5-8bd35b5c500b"
      unitRef="usd">12670000</us-gaap:InventoryRawMaterials>
    <us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfMy0xLTEtMS02Mzk5Mg_3e226d2c-a6ea-4ccf-9726-c2e036fcdaed"
      unitRef="usd">4296000</us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies>
    <us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfMy0zLTEtMS02Mzk5Mg_2123c8f9-7e6a-4358-8659-f2b0ce604d26"
      unitRef="usd">3611000</us-gaap:RetailRelatedInventoryPackagingAndOtherSupplies>
    <med:InventoryNonFoodFinishedGoods
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNC0xLTEtMS02Mzk5Mg_52db9456-928e-4e4f-ba85-75553694d3b2"
      unitRef="usd">7032000</med:InventoryNonFoodFinishedGoods>
    <med:InventoryNonFoodFinishedGoods
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNC0zLTEtMS02Mzk5Mg_d597cc3b-bec8-4221-bc53-cae0fad40de0"
      unitRef="usd">8738000</med:InventoryNonFoodFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNS0xLTEtMS02Mzk5Mg_04c929a9-a402-4263-aeff-c87b7b5ad97e"
      unitRef="usd">78825000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNS0zLTEtMS02Mzk5Mg_715e551f-a354-4a66-82d7-100c17d0e2d0"
      unitRef="usd">97675000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryValuationReserves
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNi0xLTEtMS02Mzk5Mg_5be3dbc1-d478-4f85-9246-5d801ed4a864"
      unitRef="usd">6189000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNi0zLTEtMS02Mzk5Mg_dc070661-6a30-45e2-9753-5d4258985331"
      unitRef="usd">3838000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryNet
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNy0xLTEtMS02Mzk5Mg_bb48ca6e-0d85-49d6-9bc4-53e639b8368b"
      unitRef="usd">96896000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml8zNy9mcmFnOjM2YjEzNjU5MGJkYTQ3MWM4NWQzODM3OWY4MTAzZDg0L3RhYmxlOmI4Y2FlYjAyMDBmMjQzMDU5MDNhZjRmNzJmMzI2OTc3L3RhYmxlcmFuZ2U6YjhjYWViMDIwMGYyNDMwNTkwM2FmNGY3MmYzMjY5NzdfNy0zLTEtMS02Mzk5Mg_da67312b-add8-4be2-9d6f-efa95c83cb07"
      unitRef="usd">118856000</us-gaap:InventoryNet>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RleHRyZWdpb246NGFjNGIyYTc5MWNlNDM0NTlmZGYwODdmNjUxM2Y2ZGRfOTI0_b627ce7b-49d8-4929-8f03-4da4d188926f">EARNINGS PER SHARE&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share (&#x201c;EPS&#x201d;) computations are calculated utilizing the weighted average number of shares of the Company&#x2019;s common stock outstanding during the periods presented. Diluted EPS is calculated utilizing the weighted average number of shares of the Company&#x2019;s common stock outstanding adjusted for the effect of dilutive common stock equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Effect of dilutive common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The calculation of diluted EPS excluded 13 thousand and 0 thousand antidilutive restricted stock awards for the three months ended March 31, 2023 and 2022, respectively.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RleHRyZWdpb246NGFjNGIyYTc5MWNlNDM0NTlmZGYwODdmNjUxM2Y2ZGRfOTIz_39a534bd-e3ac-4918-95d8-c6ce4b6dbf09">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted EPS (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.670%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Effect of dilutive common stock equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Earnings per share - diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfNC0xLTEtMS02Mzk5Mg_f4bbc9ec-5f7a-40c0-b57d-51aa37fa39fb"
      unitRef="usd">39968000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfNC0zLTEtMS02Mzk5Mg_11aaddd7-aa59-481b-bb7f-171855ed1290"
      unitRef="usd">41781000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfNy0xLTEtMS02Mzk5Mg_3c18fa10-50ed-4f2b-a3f5-2476724465d9"
      unitRef="shares">10864000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfNy0zLTEtMS02Mzk5Mg_085122ee-ecd1-4a46-836b-6325d795b1e2"
      unitRef="shares">11557000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfOC0xLTEtMS02Mzk5Mg_ca00e473-49f0-40b8-aad6-0dcefc93219e"
      unitRef="shares">35000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfOC0zLTEtMS02Mzk5Mg_c4d2a3d1-21cc-4aeb-b163-6e3bfebb9cac"
      unitRef="shares">81000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfOS0xLTEtMS02Mzk5Mg_4bb25aea-f751-46b8-9575-5a1a8918857c"
      unitRef="shares">10899000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfOS0zLTEtMS02Mzk5Mg_c1a27197-0f32-453f-87f3-a5f4efcc291b"
      unitRef="shares">11638000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfMTEtMS0xLTEtNjM5OTI_b4af2bf5-9b4e-47ad-b96f-26d71986fab9"
      unitRef="usdPerShare">3.68</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfMTEtMy0xLTEtNjM5OTI_6c2bca71-8cae-431a-87bc-8920cf384fb3"
      unitRef="usdPerShare">3.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfMTMtMS0xLTEtNjM5OTI_173a58bb-f9fa-4189-af9d-ebd80064b368"
      unitRef="usdPerShare">3.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RhYmxlOjViMmI5MWYzNDM1MTRkZWFhOTlkMzE1MmExMjhjZmJmL3RhYmxlcmFuZ2U6NWIyYjkxZjM0MzUxNGRlYWE5OWQzMTUyYTEyOGNmYmZfMTMtMy0xLTEtNjM5OTI_2def848c-1b0d-47ce-a0e4-4f988163e449"
      unitRef="usdPerShare">3.59</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ieba1e7bde05646528901c22163e8367a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RleHRyZWdpb246NGFjNGIyYTc5MWNlNDM0NTlmZGYwODdmNjUxM2Y2ZGRfMjc0ODc3OTA3MDY2NQ_70488a0c-94ac-4dde-b827-86da997d5bce"
      unitRef="shares">13000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if9b32ff21de445638831a1796f077b25_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80MC9mcmFnOjRhYzRiMmE3OTFjZTQzNDU5ZmRmMDg3ZjY1MTNmNmRkL3RleHRyZWdpb246NGFjNGIyYTc5MWNlNDM0NTlmZGYwODdmNjUxM2Y2ZGRfMjc0ODc3OTA3MDY2OQ_8204db4a-efb1-4254-88ca-ffa1fff74139"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1Nw_956e7c5c-a1a2-482f-ac09-4acfb6067464">SHARE-BASED COMPENSATION&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued non-qualified and incentive stock options to employees and non-employee directors. The fair value of these options are estimated on the date of grant using the Black-Scholes option pricing model, which requires estimates of the expected term of the option, the risk-free interest rate, the expected volatility of the price of the Company&#x2019;s common stock, and dividend yield. Options outstanding as of March&#160;31, 2023 generally vest over a period of 3 years and expire 10 years from the date of grant. The exercise price of these options ranges from $26.52 to $66.68. Due to the Company&#x2019;s lack of option exercise history on the date of grant, the expected term is calculated using the simplified method defined as the midpoint between the vesting period and the contractual term of each option. The risk free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant that most closely corresponds to the expected term of the option. The expected volatility is based on the historical volatility of the Company&#x2019;s common stock over the period of time equivalent to the expected term for each award. The dividend yield is computed as the annualized dividend rate at the grant date divided by the strike price of the stock option. For the three months ended March 31, 2023 and 2022, the Company did not grant stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our stock option activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the weighted-average remaining contractual life for both the outstanding stock options and exercisable stock options was 4.3 years with an aggregate intrinsic value of $1.3 million. The compensation expense calculated under the fair value method for stock options was fully recognized as of March&#160;31, 2023. For the three months ended March 31, 2023, the Company received $0.1 million in cash proceeds from the exercise of stock options. The total intrinsic value for stock options exercised during the three months ended March 31, 2022 was $0.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued restricted stock to employees and non-employee directors generally with vesting terms up to 5 years after the date of grant. The fair value of the restricted stock is equal to the market price of the Company&#x2019;s common stock on the date of grant. Expense for restricted stock is amortized ratably over the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our restricted stock activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company withheld approximately 9 thousand shares and 8 thousand shares of the Company&#x2019;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of restricted stock for the three months ended March 31, 2023 and 2022, respectively. The total fair value of restricted stock awards vested during the three months ended March 31, 2023 and 2022 was $2.4 million and $3.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Market and Performance-based Share Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has issued market and performance-based share awards to certain key executives who were granted deferred shares and may earn between 0% and 250% of the target number depending upon both the Company&#x2019;s total stockholder return (&#x201c;TSR&#x201d;) and the Company&#x2019;s performance against predetermined performance goals over a three-year performance period after the date of grant. Market and performance-based share awards that are tied to the Company&#x2019;s TSR are valued using the Monte Carlo method and are recognized ratably as expense over the award&#x2019;s performance period. The fair value of the performance-based share awards is equal to the market price of the Company&#x2019;s common stock on the date of grant adjusted by expected level of achievement over the performance period. Expense for performance-based share awards is amortized ratably over the performance period. In the event that management determines that the Company will not reach the lower threshold of the predetermined performance goals established in the grant agreement, any previously recognized expense is reversed in the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period in which such a determination is made. As of March 31, 2023, management determined that the market and performance-based share awards granted in 2022 would not reach the lower threshold of the predetermined performance goal resulting in a $1.4&#160;million decrease in the Company&#x2019;s share-based compensation expense for the three months ended March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for all types of awards granted is recorded in selling, general, and administrative expense in the accompanying Condensed Consolidated Statements of Income. The total expense during the three months ended March 31, 2023 and 2022  as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company withheld approximately &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21 thousand shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Company&#x2019;s common stock to cover minimum tax liability withholding obligations upon the vesting of shares of market and performance-based share awards for the three months ended March 31, 2023. No market and performance-based share awards vested and no shares were withheld to cover minimum tax liability withholding obligations for the three months ended March 31, 2022. The total fair value of market and performance-based share awards vested during the three months ended March 31, 2023 and 2022 was &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5.3 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and $0, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total income tax benefit recognized in the accompanying Condensed Consolidated Statements of Income for restricted stock awards was $0.1 million and $0.5 million for the three months ended March 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was $11.7 million of total unrecognized compensation cost related to restricted stock awards as of March&#160;31, 2023, which is expected to be recognized over a weighted-average period of 2.4 years. There was $10.5 million of unrecognized compensation costs related to the 91 thousand market and performance-based shares presented in the table above as of March&#160;31, 2023, which is expected to be recognized over a weighted-average period of 2.2 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7ae296ff6c0a4ed29838c825beaa94bb_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzQz_13823048-211d-412d-b9eb-024cb8f83ab1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i7ae296ff6c0a4ed29838c825beaa94bb_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzQ3_5e8be6a0-da3f-42b4-9066-cf76e7bbea54">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzUx_caa73177-03b8-45e7-8894-a50d13a3547f"
      unitRef="usdPerShare">26.52</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzU1_211830ef-c109-4c38-9a21-92f3468b8dc8"
      unitRef="usdPerShare">66.68</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMTMyNw_bb7b5284-8e18-4b47-ad49-eb3550e69724"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMTMyNw_bc1a1ee7-9919-4182-8f8f-8605531b5e0d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1OA_9d2a79c5-38f8-4790-8f46-e6f47405bce7">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our stock option activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.056%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;27.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Exercisable at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNC0xLTEtMS02Mzk5Mg_1704be9d-324c-4549-8589-0ef2f0124f14"
      unitRef="shares">33000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNC0zLTEtMS02Mzk5Mg_1f44176a-81c0-4918-b30f-d208e33e4625"
      unitRef="usdPerShare">54.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i14276493cdda4b5297135c9e43430126_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNC01LTEtMS02Mzk5Mg_8262a643-f8e1-478b-a860-4a3eb98362f2"
      unitRef="shares">32000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i14276493cdda4b5297135c9e43430126_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNC03LTEtMS02Mzk5Mg_020439f7-e22a-4118-b65b-f8a445a2bb0e"
      unitRef="usdPerShare">54.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNS0xLTEtMS02Mzk5Mg_deedf08f-fca7-427f-b701-1603d3a57cd7"
      unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNS0zLTEtMS02Mzk5Mg_e3c1af7b-3c1b-479d-9770-6f20d0ed1922"
      unitRef="usdPerShare">27.18</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNS01LTEtMS02Mzk5Mg_44b720b0-239a-4834-bfe0-2a18e43930c0"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNS03LTEtMS02Mzk5Mg_768c628a-29d5-423a-a833-4c8a1a8d22ea"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNi0xLTEtMS02Mzk5Mg_15905334-5296-467d-9072-e34ab7725892"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNi0zLTEtMS02Mzk5Mg_5f2216c5-c697-443f-a5a6-0f3ab2722c88"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNi01LTEtMS02Mzk5Mg_3658f182-45d7-4d04-a3d4-b6287616ce85"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNi03LTEtMS02Mzk5Mg_26d50138-0d7c-47a5-a516-d07f4e71ffdf"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNy0xLTEtMS02Mzk5Mg_73b80b2f-ddf5-4c6a-95d1-d0d2fbde38cb"
      unitRef="shares">29000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNy0zLTEtMS02Mzk5Mg_a30ca2f2-e788-4775-a603-6707d1c608a5"
      unitRef="usdPerShare">58.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNy01LTEtMS02Mzk5Mg_3b4be272-f992-40cc-b7d4-c290cb1da8ce"
      unitRef="shares">32000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfNy03LTEtMS02Mzk5Mg_98bea1ae-5397-419b-8459-74879ee1c224"
      unitRef="usdPerShare">54.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfOC0xLTEtMS02Mzk5Mg_8ea91b31-5305-4900-9913-e3259488e9ae"
      unitRef="shares">29000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfOC0zLTEtMS02Mzk5Mg_70116585-8c44-4437-90ea-7b7750eb876b"
      unitRef="usdPerShare">58.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfOC01LTEtMS02Mzk5Mg_a8a152ee-9e1e-4e88-b283-dbbc8aaf1ea6"
      unitRef="shares">28000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i2fbf2e6d85424505bb1df89b807899f0_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOmEwNDI1NDFmODdmYjRlMTY4OGE3YTU3OTc4YTgwOTRlL3RhYmxlcmFuZ2U6YTA0MjU0MWY4N2ZiNGUxNjg4YTdhNTc5NzhhODA5NGVfOC03LTEtMS02Mzk5Mg_95ac87d2-6559-42aa-8a14-4932f39a38f7"
      unitRef="usdPerShare">52.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzY4_eb2d3463-0b50-4d2a-a3d8-7dabff25bf69">P4Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzY4_eed523e7-9b2b-45a3-9bf2-be0165594b77">P4Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzcy_29fbe8c2-9b07-428c-b910-112c5adec660"
      unitRef="usd">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwMzcy_aa852117-a50b-4aa4-819c-da9fc78a67ac"
      unitRef="usd">1300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDUy_d19ee621-ea39-4253-9487-e859e29c85b9"
      unitRef="usd">100000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDU2_1fbb28b1-63de-4ea3-83cb-8efdba6f5dde"
      unitRef="usd">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDcw_ae3b6a06-7a0c-467d-a7b2-410c3d92febd">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1Mw_27513e4a-82df-4ee5-b863-70ef957aa73c">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our restricted stock activity (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.617%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;163.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Outstanding at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id3a735cd0fee4e528a997870d8f0f709_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNC0xLTEtMS02Mzk5Mg_39d57b66-a1bc-45d2-9074-f313518b8f6a"
      unitRef="shares">60000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="id3a735cd0fee4e528a997870d8f0f709_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNC0zLTEtMS02Mzk5Mg_17e4e69e-55a9-4023-84bc-3bf3f15ec09b"
      unitRef="usdPerShare">187.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ibb9683758726458fb14c1d50b204c772_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNC01LTEtMS02Mzk5Mg_b4cea386-64fe-4fff-80f6-e05a80fb96c6"
      unitRef="shares">43000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ibb9683758726458fb14c1d50b204c772_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNC03LTEtMS02Mzk5Mg_f20089ba-a110-4c9c-a2e8-a24c4ea0375f"
      unitRef="usdPerShare">183.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNS0xLTEtMS02Mzk5Mg_af025444-3732-4822-bf16-c17ac9fc1991"
      unitRef="shares">67000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNS0zLTEtMS02Mzk5Mg_aa8e903f-9ebf-44a2-b7b9-c6880f7c628e"
      unitRef="usdPerShare">102.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNS01LTEtMS02Mzk5Mg_960b7779-6087-41f1-9541-c2e4eab240d3"
      unitRef="shares">29000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNS03LTEtMS02Mzk5Mg_177d5ce8-7a63-46e7-974e-07425e94b06e"
      unitRef="usdPerShare">175.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNi0xLTEtMS02Mzk5Mg_d83f5a09-d4b3-4850-b29d-13e8c2bb900c"
      unitRef="shares">22000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNi0zLTEtMS02Mzk5Mg_09b18f6d-d806-4955-a9e8-ee6176f9b331"
      unitRef="usdPerShare">163.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNi01LTEtMS02Mzk5Mg_50e588ae-9e7b-4c37-b40c-30151f40c1db"
      unitRef="shares">18000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNi03LTEtMS02Mzk5Mg_aa8d5adf-8b47-49ba-bb3b-7933a48edc38"
      unitRef="usdPerShare">149.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNy0xLTEtMS02Mzk5Mg_91c13cee-4b8f-421d-8a8c-18190a1df1a7"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNy0zLTEtMS02Mzk5Mg_7ec113f6-ce21-4229-aabc-80a347bbe57f"
      unitRef="usdPerShare">190.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNy01LTEtMS02Mzk5Mg_cd709c73-5f1f-4cec-8668-032e66cf0729"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfNy03LTEtMS02Mzk5Mg_cb6a1bb3-a2ea-43af-a1fb-02ad3756e90f"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia309ad2ca0aa4222af27696fc0425511_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfOC0xLTEtMS02Mzk5Mg_bfb3b322-a0a2-41ba-9e79-96e90c62f639"
      unitRef="shares">105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia309ad2ca0aa4222af27696fc0425511_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfOC0zLTEtMS02Mzk5Mg_ed877922-e4f2-4a75-b011-36d33eb86d73"
      unitRef="usdPerShare">138.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6188f0dd58ad41dfb34e2a2f9bee3259_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfOC01LTEtMS02Mzk5Mg_62dddfeb-8e12-4f21-81de-237ee24213d0"
      unitRef="shares">54000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6188f0dd58ad41dfb34e2a2f9bee3259_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjFkNTlhMTIzMjZmNjRhMzE4NzFjNWJjOGJiMzE1NjA1L3RhYmxlcmFuZ2U6MWQ1OWExMjMyNmY2NGEzMTg3MWM1YmM4YmIzMTU2MDVfOC03LTEtMS02Mzk5Mg_bf822a5f-1d24-468a-94bd-da3b1337c259"
      unitRef="usdPerShare">190.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDc0_e7e95f8c-50bb-4e71-9f4a-194f783145bd"
      unitRef="shares">9000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDgy_df5caeed-6e9f-4ce1-83fb-d597901ac123"
      unitRef="shares">8000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNDkw_5baa649e-0597-45f0-abac-cc6a48c4f0f7"
      unitRef="usd">2400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNTAz_b372e6eb-faf7-42bd-8520-ca3a729745f7"
      unitRef="usd">3200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage
      contextRef="ic3dd7f52bc934c60b57c8561a32e45d5_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMzEyMg_3aa6a5fd-7a13-4ef6-9e26-7871a1dc5c69"
      unitRef="number">0</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage
      contextRef="i9a5bf52113ef41b2935708b735e9ee0f_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMzEyOQ_c042b390-cab2-462a-b62e-142743122292"
      unitRef="number">2.50</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage>
    <med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod
      contextRef="i91137ee67f7f41ce9748d8db7d981c22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1NA_b4539acc-919f-46df-8ee1-57822c19231e">P3Y</med:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iffbabdce70a34f2d8c8f4369464e6bf9_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMTA5OTUxMTYzOTQ5Nw_a52cc90a-c786-4ca4-b998-5c089457fd13"
      unitRef="usd">-1400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNDc1NQ_a887929d-4caf-4a4a-98ac-7de6e6990f48">The total expense during the three months ended March 31, 2023 and 2022  as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Share-Based Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options and restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Market and performance-based share awards granted in 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;(1,388)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Performance-based share awards granted in 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib5a00a160b774d91807d91918cf7ee46_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfMy0xLTEtMS02Mzk5Mg_2a6c5c18-5808-437b-9aec-4a9faa886764"
      unitRef="shares">134000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib5a00a160b774d91807d91918cf7ee46_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfMy0zLTEtMS02Mzk5Mg_078b00fc-ace5-41e7-a1c5-bfc5541f710f"
      unitRef="usd">1226000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9b24326b642845e8b3857f0d21d79d19_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfMy01LTEtMS02Mzk5Mg_cd8b0935-d169-4c74-aef3-bdeb10769b1d"
      unitRef="shares">86000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9b24326b642845e8b3857f0d21d79d19_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfMy03LTEtMS02Mzk5Mg_51bac862-dd4a-451f-880a-3bc52951252e"
      unitRef="usd">1087000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie316187f7c484420a923ed9f350e11ca_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNC0xLTEtMS02Mzk5Mg_e22f48b3-8e81-42d8-9b21-d5c71b2c5e72"
      unitRef="shares">47000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie316187f7c484420a923ed9f350e11ca_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNC0zLTEtMS02Mzk5Mg_a7869d11-d6fd-42df-8cad-1af830a85ff4"
      unitRef="usd">79000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i720156933c7242888d839f8f81c4decf_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNC01LTEtMS02Mzk5Mg_9e8851e8-82c9-4f05-99b0-e92cb134a58c"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i720156933c7242888d839f8f81c4decf_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNC03LTEtMS02Mzk5Mg_b8ecf4c2-e714-41fd-a73b-162d207a1cc5"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iffbabdce70a34f2d8c8f4369464e6bf9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNS0xLTEtMS02Mzk5Mg_9ab6962b-d8cb-47ad-abf9-8f2e203c9b91"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iffbabdce70a34f2d8c8f4369464e6bf9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNS0zLTEtMS02Mzk5Mg_32bb01ff-7578-42d8-81d9-0884101e623c"
      unitRef="usd">-1388000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2f68ff9d37804516a004fa3fefa6e941_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNS01LTEtMS02Mzk5Mg_43673f1f-5a31-4fde-ad10-8022d78d5f56"
      unitRef="shares">25000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2f68ff9d37804516a004fa3fefa6e941_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNS03LTEtMS02Mzk5Mg_3291b098-5c53-4797-a932-63fc99ba6139"
      unitRef="usd">79000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia4b5d53cd7024ad8b562648072669881_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNi0xLTEtMS02Mzk5Mg_38b2dba5-5747-4d96-9cf7-d057de4eb056"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia4b5d53cd7024ad8b562648072669881_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNi0zLTEtMS02Mzk5Mg_ec589d79-002b-4837-a80a-aa1728e18887"
      unitRef="usd">640000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="if84394c44eed4092ac896bf455a72df7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNi01LTEtMS02Mzk5Mg_ac8befbf-b8cf-496c-9b66-36892339a3eb"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if84394c44eed4092ac896bf455a72df7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNi03LTEtMS02Mzk5Mg_48513b63-d4e7-4dd4-bb24-ec4f534b45bb"
      unitRef="usd">640000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia665c39f19eb4a6a9d485acd05a18124_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNy0xLTEtMS02Mzk5Mg_3bade896-aed0-4c95-bc5f-8e9b3df9f993"
      unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia665c39f19eb4a6a9d485acd05a18124_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNy0zLTEtMS02Mzk5Mg_fb481938-4601-4195-a8da-51928468c8b0"
      unitRef="usd">49000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i3f1aab26e7984ccaba10e7aa1ad24c41_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNy01LTEtMS02Mzk5Mg_c9f0d78b-d249-469c-9755-7c5e17fcd310"
      unitRef="shares">26000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3f1aab26e7984ccaba10e7aa1ad24c41_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfNy03LTEtMS02Mzk5Mg_d8cdd3c5-5f34-48ca-b094-716583e44491"
      unitRef="usd">469000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfOC0xLTEtMS02Mzk5Mg_d2407c31-fda7-4da6-932d-cd5aed6e4676"
      unitRef="shares">225000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfOC0zLTEtMS02Mzk5Mg_19e76b58-ce1b-46ed-922e-726d5c74046e"
      unitRef="usd">606000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfOC01LTEtMS02Mzk5Mg_5d104555-f34c-4b82-b4b7-e90b7f59b725"
      unitRef="shares">152000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RhYmxlOjlmZjFmMTI4YWViZDQ2YjdiNzY1ZWVhNWU1MmNmZDk2L3RhYmxlcmFuZ2U6OWZmMWYxMjhhZWJkNDZiN2I3NjVlZWE1ZTUyY2ZkOTZfOC03LTEtMS02Mzk5Mg_e5a2c696-7bdc-442d-b5d2-e606936b984e"
      unitRef="usd">2275000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="iab840a0209b94086be8b0d816f977bc2_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjc0ODc3OTA4MDUxMg_8a107ab8-07b6-4dcc-a582-e4068f521c4a"
      unitRef="shares">21000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i6dba0507dc5141659a87360e36adc332_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjE5OTAyMzI2NzI0OA_ffe7f003-6ad7-4419-98ac-eaa1d9f417af"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i6dba0507dc5141659a87360e36adc332_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjE5OTAyMzI2NzIzOA_c770babf-9b86-4f34-925e-96c41ba4ba4d"
      unitRef="shares">0</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="iab840a0209b94086be8b0d816f977bc2_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjc0ODc3OTA4MDUyNQ_04723b81-1053-49bf-8cb2-9188e3f3e0f0"
      unitRef="usd">5300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i6dba0507dc5141659a87360e36adc332_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfMjc0ODc3OTA4MDUzMw_dcab1ba7-1d3d-495d-936a-5c8bea9d1ce0"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIyNTg3_cf1db5f7-1116-4684-bcec-980f1e28218a"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ib33e6966117d4a62b5660a751fb28021_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIyNTc5_bc36fa5c-6418-4e64-90e1-4d6ed1817d3e"
      unitRef="usd">500000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="ia309ad2ca0aa4222af27696fc0425511_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjMz_3af864b2-bd38-4a0e-a906-8bc997293b33"
      unitRef="usd">11700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id59c14c148de496880d6652176a2c999_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjQ5_1819a1e4-b6c2-4a71-a2bc-13bbf0b7abeb">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i7752400214154be7a3da22c4ede6da41_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjY1_96c3d790-49d4-4c74-829f-267c1e565efa"
      unitRef="usd">10500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i91137ee67f7f41ce9748d8db7d981c22_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjY5_3788c82e-ea6a-411d-a5ce-715141994636"
      unitRef="shares">91000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i91137ee67f7f41ce9748d8db7d981c22_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80My9mcmFnOmU2Njk0MGJjZWMwZjRiNGY4YjRlODk1NTM0MjM5ZTY3L3RleHRyZWdpb246ZTY2OTQwYmNlYzBmNGI0ZjhiNGU4OTU1MzQyMzllNjdfNTQ5NzU1ODIwNjYx_cab9d7d0-847d-4d34-b691-af42edcb6c23">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMTM4Mg_1ea2f3c9-c2ad-4d6c-be2f-a0f4d2de1d5b">LEASES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for office and warehouse space and certain equipment. In certain of the Company&#x2019;s lease agreements, the rental payments are adjusted periodically based on defined terms within the lease. The Company did not have any finance leases as of March&#160;31, 2023 and 2022, respectively, or for the three-month periods then ended, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our leases relating to office and warehouse space have lease terms of 19 months to 122 months. Our leases relating to equipment have lease terms of 24 months to 203 months, with certain of them having automatic renewal clauses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s warehouse agreements also contain non-lease components, in the form of payments towards variable logistics services and labor charges, which the Company is obligated to pay based on the services consumed by it. Such amounts are not included in the measurement of the lease liability but are recognized as expenses when they are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease expense was $1.5&#160;million and $1.8&#160;million for the three months ended March 31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to the Company&#x2019;s operating leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash paid for amounts included in the measurements of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flow used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the weighted average remaining lease term was 4 years, 7 months and the weighted average discount rate was 2.00%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturity of the Company&#x2019;s operating lease liabilities as of March&#160;31, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2023 (excluding the three months ended March&#160;31, 2023)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i584845803f224e90963b306cfaa8a708_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg1MQ_82fe2616-b494-43e6-8a34-1abed71521a9">P19M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="iaca1e5bf2df0432fbcfc2e5ee7e5e7d6_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg1NQ_5be92ac0-f46d-47b8-a500-317d4573dc3e">P122M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i17778c8c21984c959271d0d7cbc7d47a_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg1OQ_b70864ad-acf9-4f33-8c8b-34cf36e5496a">P24M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="if51850419cba458da16f0e96e36a1e6c_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg2Mw_ad7e46c9-1e98-4f37-8ad9-c6c6def4bb5f">P203M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg2Nw_eb398716-08ef-40ef-a23c-7a6c9a07bed9"
      unitRef="usd">1500000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDg3MQ_bcbe1ee7-77b4-44d6-ad5d-c3dac97bacab"
      unitRef="usd">1800000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMTM4NA_61bef8cf-e89e-4dbc-91f4-e7a2f8f83427">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to the Company&#x2019;s operating leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.780%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.420%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Cash paid for amounts included in the measurements of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating cash flow used in operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOmE5MzViNDAwNjFjODQ4YWJhZjlhMTZlNWZjNDY0OTk3L3RhYmxlcmFuZ2U6YTkzNWI0MDA2MWM4NDhhYmFmOWExNmU1ZmM0NjQ5OTdfNC0xLTEtMS02Mzk5Mg_d9703362-b703-4633-86e6-91c5da143e3b"
      unitRef="usd">1804000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOmE5MzViNDAwNjFjODQ4YWJhZjlhMTZlNWZjNDY0OTk3L3RhYmxlcmFuZ2U6YTkzNWI0MDA2MWM4NDhhYmFmOWExNmU1ZmM0NjQ5OTdfNC0zLTEtMS02Mzk5Mg_01d5c35e-1b83-4935-8cdd-83a7914dde8b"
      unitRef="usd">1756000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOmE5MzViNDAwNjFjODQ4YWJhZjlhMTZlNWZjNDY0OTk3L3RhYmxlcmFuZ2U6YTkzNWI0MDA2MWM4NDhhYmFmOWExNmU1ZmM0NjQ5OTdfNy0xLTEtMS02Mzk5Mg_558eb29b-aba9-48fd-ac07-43e2ed574d2f"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic4eaf82003714db188ad9980e7f6ceaa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOmE5MzViNDAwNjFjODQ4YWJhZjlhMTZlNWZjNDY0OTk3L3RhYmxlcmFuZ2U6YTkzNWI0MDA2MWM4NDhhYmFmOWExNmU1ZmM0NjQ5OTdfNy0zLTEtMS02Mzk5Mg_5ec2bed0-0d44-4c36-bb38-b121ec6480db"
      unitRef="usd">103000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDkzMA_59da69de-63ed-4fa3-9e45-40a8bf216bf1">P4Y7M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMjc0ODc3OTA3MDk1NQ_8e7229df-0f77-41e7-86a3-4978efc2ee8d"
      unitRef="number">0.0200</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RleHRyZWdpb246MGFkNDM0YzU1ODI1NDA3Njk5NTNmOGQ5NzA1ZGE0ZDJfMTM4NQ_c8b21171-9fbc-4c25-bcf1-6201a16415cd">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the maturity of the Company&#x2019;s operating lease liabilities as of March&#160;31, 2023 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.415%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2023 (excluding the three months ended March&#160;31, 2023)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfMC0xLTEtMS02Mzk5Mg_2b9b611b-b501-49ac-8c4e-e7b1a5c6fb28"
      unitRef="usd">4440000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfMS0xLTEtMS02Mzk5Mg_2f89c93b-874f-4b38-a850-0d2105d9479b"
      unitRef="usd">5693000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfMi0xLTEtMS02Mzk5Mg_cb909eb8-991c-4066-9bfd-1c09694adaac"
      unitRef="usd">5825000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfMy0xLTEtMS02Mzk5Mg_6250f3fb-be56-4276-aeed-0eab644f51cb"
      unitRef="usd">4160000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfNC0xLTEtMS02Mzk5Mg_2c1f2081-815b-4367-8dd1-fd126dd613bc"
      unitRef="usd">2553000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <med:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfNS0xLTEtMS02Mzk5Mg_79da8014-91e8-4ef3-9bae-8a32f65bfd05"
      unitRef="usd">2858000</med:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfNi0xLTEtMS02Mzk5Mg_e63d8b20-1570-4dad-b361-cddd02b2f667"
      unitRef="usd">25529000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfNy0xLTEtMS02Mzk5Mg_fdea9399-f676-4294-9397-ca740d7b7d61"
      unitRef="usd">1154000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80Ni9mcmFnOjBhZDQzNGM1NTgyNTQwNzY5OTUzZjhkOTcwNWRhNGQyL3RhYmxlOjAwN2ZkYmI0Nzg5YTQyNTc5MmY4NDlhMTVmNWIzZDk2L3RhYmxlcmFuZ2U6MDA3ZmRiYjQ3ODlhNDI1NzkyZjg0OWExNWY1YjNkOTZfOC0xLTEtMS02Mzk5Mg_361f7dea-c2cc-4aff-a449-3a22b8a3ed4d"
      unitRef="usd">24375000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80OS9mcmFnOjlhN2RmM2IyOGM1NTQxMGM4ODE2Mzg0NjNmY2QyNDE1L3RleHRyZWdpb246OWE3ZGYzYjI4YzU1NDEwYzg4MTYzODQ2M2ZjZDI0MTVfMTgw_813ce9b1-1dc8-4a5a-bdd9-b46630c68246">ACCUMULATED OTHER COMPREHENSIVE INCOMEAccumulated other comprehensive income, net of tax, was comprised of $33 thousand of foreign currency translation as of March&#160;31, 2023 and $24 thousand of foreign currency translation as of December&#160;31, 2022.</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i9ef290f1cdac4ec68f177f8490b8503a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80OS9mcmFnOjlhN2RmM2IyOGM1NTQxMGM4ODE2Mzg0NjNmY2QyNDE1L3RleHRyZWdpb246OWE3ZGYzYjI4YzU1NDEwYzg4MTYzODQ2M2ZjZDI0MTVfMTIwOTQ2Mjc5MDYxMDE_ba453692-97f7-4893-8310-0a60e404d95c"
      unitRef="usd">33000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i3d62bc40011a4e969ffff01db87cd897_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml80OS9mcmFnOjlhN2RmM2IyOGM1NTQxMGM4ODE2Mzg0NjNmY2QyNDE1L3RleHRyZWdpb246OWE3ZGYzYjI4YzU1NDEwYzg4MTYzODQ2M2ZjZDI0MTVfMTIwOTQ2Mjc5MDYwNzM_8e6af25c-57d7-42d7-ae9b-ec6486fe3e54"
      unitRef="usd">24000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMzQ0MA_9b52ca52-dfdd-4d78-8fc4-fa9a1c0c658c">DEBT&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April&#160;13, 2021, the Company and certain of its subsidiaries (collectively, the &#x201c;Guarantors&#x201d;) entered into a credit agreement (the &#x201c;Credit Agreement&#x201d;) among the Company, the Guarantors, the lenders party thereto and Citibank, N.A., in its capacity as administrative agent. On May&#160;31, 2022, the Credit Agreement was amended to increase the borrowing capacity and convert the interest rate to be based on Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), from London Inter-Bank Offered Rate (LIBOR) (the &#x201c;Amended Credit Agreement&#x201d;). The Amended Credit Agreement provides for a &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$225.0 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; senior secured revolving credit facility with a &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$20.0 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; letter of credit sublimit. The Amended Credit Agreement also provides for an uncommitted incremental facility that permits the Company, subject to certain conditions, to increase the senior secured revolving credit facility by up to &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$100.0 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;. The Amended Credit Agreement matures on April&#160;13, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s obligations under the Amended Credit Agreement are guaranteed by the Guarantors. The obligations of the Company and the Guarantors are secured by first-priority liens on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Amended Credit Agreement, the Company will pay to the administrative agent for the account of each revolving lender a commitment fee on a quarterly basis based on amounts committed but unused under the revolving facility from 0.20% to 0.40% per annum depending on the Company&#x2019;s Total Net Leverage Ratio (as defined in the Amended Credit Agreement). The Company is also obligated to pay the administrative agent customary fees for credit facilities of this size and type.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving borrowings under the Amended Credit Agreement bear interest at a rate per annum equal to (i) the Term SOFR Rate for the interest period plus the Applicable Rate (as defined in the Amended Credit Agreement) based on the Company&#x2019;s Total Net Leverage Ratio or (ii) the Alternate Base Rate (as defined in the Amended Credit Agreement) as in effect from time to time plus the Applicable Rate based on the Company&#x2019;s Total Net Leverage Ratio. As of March&#160;31, 2023, the Applicable Rate for Term SOFR Loans is 1.25% per annum and the Applicable Rate for ABR Loans is 0.25% per annum. SOFR based loans also include a Credit Spread Adjustment based on the duration of the borrowing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amended Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants that, among other things, limit or restrict the ability of the Company and its subsidiaries, subject to negotiated exceptions, to incur additional indebtedness and additional liens on their assets, engage in mergers or acquisitions or dispose of assets, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments and change the nature of their businesses. The Amended Credit Agreement also contains customary events of default, subject to thresholds and grace periods, including, among others, payment default, covenant default, cross default to other material indebtedness and judgment default. In addition, the Amended Credit Agreement requires the Company to maintain a Total Net Leverage Ratio of no more than 2.75 to 1.00 and an Interest Coverage Ratio of at least 3.50 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has no borrowings outstanding under the Amended Credit Agreement as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7c0fd591c6d54c788d05c4d43bfe45e2_I20210413"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzAyNw_b5652277-8c3c-4c2e-8ed6-2de668f8a8ea"
      unitRef="usd">225000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i813dd19e7bc04cd4b34c1ac0e2f5b4fc_I20210413"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA0MQ_ff4c8891-1867-440c-be1f-f3e23d4c49d1"
      unitRef="usd">20000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7e4639f404b746da9129538a34b70a01_I20210413"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA0OQ_fcc2b213-5a63-468b-9e8a-53fd4b55462e"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ie0292eae6d68435581e1a1cb655cb025_D20210413-20210413"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA1Nw_f888990f-6440-41b2-be9e-638905c545c6"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="idcfc7ba03ed44069a73caf1bc4436006_D20210413-20210413"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA2OA_4da8f3eb-b4d1-43b9-b184-843f388ae30d"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia9c24ad6f6bc453d97165b16303e0845_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA3Mg_6e02750d-3050-40b5-aeaa-27ecb6f9e279"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i87cc27821ccd42ed968755b54c044371_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA3Ng_c3c9b51d-6c26-4618-b673-dc4c561267eb"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <med:MaximumTotalNetLeverageRatio
      contextRef="i55a3deca29144b558d038563d063d0e5_I20210413"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA4MA_1a7929eb-9690-465c-b2b5-8242e3d5d643"
      unitRef="number">2.75</med:MaximumTotalNetLeverageRatio>
    <med:MinimumInterestCoverageRatio
      contextRef="i55a3deca29144b558d038563d063d0e5_I20210413"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMjc0ODc3OTA3MzA4OA_28206700-ed69-46ad-835c-fb8976be1371"
      unitRef="number">3.50</med:MinimumInterestCoverageRatio>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idf71ad0c5ed640be905a819b87cf32f5_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjcyMzcyMDY3OTNkNTRlMWJhODUzMTNlZDAyYmQxZjgyL3NlYzo3MjM3MjA2NzkzZDU0ZTFiYTg1MzEzZWQwMmJkMWY4Ml81NS9mcmFnOjljZjE3N2JlODEwMTRlNDQ5MTlmNjk0Yjk5YmE0M2I1L3RleHRyZWdpb246OWNmMTc3YmU4MTAxNGU0NDkxOWY2OTRiOTliYTQzYjVfMzM2OQ_62dcfe8d-2ec2-42c7-b9a4-fb45a4ed8c49"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>42
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MXLBTN-$RR4\=%U)K&>67:\%]H<P'\'XII=[?F!\H#Z['_P)02P,$%     @
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M(>J]_!5[S:'06?F.?B1P329Q+]^'8U'X'\,UT70V'=,/DPJ-]*(]<T4CQ#/
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M!O!\Q;EZ;Z0O*,^@)O\!4$L#!!0    ( .Z%H58](-  /@,  (0)   8
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&ULK59M;]HP$/XK5E9-K=0V(>&U@T@4
MJ(HT:%5*]V':!S<YB+7$9K:!=K]^9X=FO*1L'_HE\<L]3YZ[B^_<7@OY4R4
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MH=59NDTTZ%.4 K_Q-7! F"593!5;0>F&?1)&5).#R1^_ =1U!YY5<\<@Y>/
M-7L3E-X$G=[DW'C*UZ>99!T1#YJ?V[<.-E"!T" 5. =^'"$<E @'G0AO\K1M
MAS9H+FH#MAHT@Q1QVK89MBJ&LCK!3=B:0;:ND*+/'1CW5@Z7=UQ2SU>#E&L?
M2!UC/&!1W+VK;I:C.1HM%L"61G"XL:Q-H)C72Y5)#C8]MEL 5MR&?XS<YA%]
MB.)(M114_*X4]U[6CGVN2 YWL]PH#'D&I(:V](4^Q"PO(U S1,:JLFV,@FU@
M#-NVZM7")&<[WJ!E-^**]?!;M!?RA.F$9R5Z(U #M>DJ7<?9%'-:<[[B/]Q-
M@*\I%3-HHQ%_B*/'O/J:0]HD,]?!#: &*=]OJR 5Y>&?X;SXC2W0I#1L8]\A
M=:P&.<<*!BW4ARONP]WD-Z_'\^25[\*?BGB3RS#T1O4FPR &_;3?0GFXXCS<
M37I%S-^*M8'-7,MOED6#G(>Q-VA!6?$>'G26Q87BX;<-CU=,R-_0%%H,]6($
MVLF?/UT7W\G:\3&G(E323:ACGB1P@I;:=^BPJ$#0_6<,?;#.+ LCZ+R0W%#!
MSN%D=6)95C&#!C=3&VC%_V6KSPA;)T'@YQ45A@,2H$A*75?W3PY>!KZ->*:D
M@GF4/B*J$)S\PDWAT>OY+Y>&(QU+'I@X>D5.$*R^9?F!/S9^'M)D]49MZ98Y
M#F7%^Z2;]T>K5:1W(*2Z/@R<PH$XI-L(4M\(L\GN>&#9=5HQB!'LNBU;DAR<
M;SOY5O-AV2[O#RH\@0S;Z%N9'8/3O&8=(W#2;$OL.NJF#&FIA:2B<-)-X7=,
M47@$=$U%"LEC/I8;:-C% :E7$9.</0A<TH*RHFO23==S)N4Y4@+*<B9>BHVE
MTSSD4IT@*T]MURFWT?^0_TV";R154^34 ^];?*^Z -+=!11U7A[54=9:1XGA
M3 L'B49G99)S7<MI2ZBJ%2!OM )YHSZ?C:YF\]ER-EV@T?4$+98WX]^_WLPG
MT[L%T,"?][/E/T;X7N.2P]C&F^1,;7S_X.).WYI"7CQ&J02"7X.B=>9# $1Q
M$5E,%-_F=WD/7"F>Y,,-HQ!U+0#OUYRKUXF^'BRO@X?_ 5!+ P04    " #N
MA:%6ZB+C@=@"   ["   &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM;*V6
M76_:,!2&_XJ535,K=22$C[ .(E&@:J6.HM)N%],N3'(@5I,XLQUH]^MW[- (
M1H BC0OPQWE?/^?$L>FNN'B6$8 B+TF<RIX5*95=VK8,(DBHK/$,4IR9<Y%0
MA5VQL&4F@(9&E,2VZSAM.Z$LM?RN&9L(O\MS%;,4)H+(/$FH>+V"F*]Z5MUZ
M&WA@BTCI =OO9G0!4U!/V41@SRY=0I9 *AE/B8!YS^K7+P>>CC<!WQFLY$:;
MZ$QFG#_KSFW8LQP-!#$$2CM0_%G" .)8&R'&[[6G52ZIA9OM-_=KDSOF,J,2
M!CS^P4(5]:R.14*8TSQ6#WQU ^M\6MHOX+$TWV15Q'I?+!+D4O%D+4:"A*7%
M+WU9UV%#4&_N$;AK@?M>06,M:)A$"S*3UI JZG<%7Q&AH]%--TQMC!JS8:E^
MBE,E<):A3OF#^_%P-)Z.A@1;T_N[VV'_$3M7_;O^># BTYO1Z'%*SI[&_:?A
M+<Z<D[,)%9"J"!0+:'Q./I./Q"8RPE'9M14R:6<[6*]_5:SO[EG_&Q4UTJA?
M$-=Q&Q7RP6'Y$()2[F[+;:Q$60ZW+(=K_!I[_*:**L!-J@B?DVN6TC1@-"83
M+IG9=3_[,ZD$[KU?5:D6WLUJ;_T^7LJ,!M"S\(63()9@^9\^U-O.UZK$_Y/9
M5AD:91D:A]S] 4\2S!9W7_!\03(JR)+&.9 SEI)<AB0#43SQ\ZHR%-X=XZU/
MD:7OU!RGWK67F_D=B]H";Y;@S1/ ::XB+M@?" UYL4<KD0O7U@8,'H/F\P_U
M.P*WP%LE>.L$<"9E?ARZM<-2=SH=;Q>Z*O"+V]D+W2ZAVR= XQTA%4U#EBZ.
MD;??2UX9Z#7VDGLEN7>0_!%O/)F+UX*=4$4"+M4Q[(.>I[[?WDYJK>9N7O;&
MT:ZO53PO%RR5)(8YZIR:AP:BN*J*CN*9.>UG7.'=89H1WNX@= #.SSE7;QU]
M@93_%_R_4$L#!!0    ( .Z%H5;/^@V'O08  #4<   8    >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&ULK9EM;Z,X$,>_BI5;G7:ERP;;A)!>&RE-6FVE[8,V
M[>UK%YS$MX Y&_IPG_YL()" <79/>=, '4_^8WOF-P[GKUS\D%M*,_ 61XF\
M&&RS+#T;C62PI3&1GWE*$_6?-1<QR=2MV(QD*B@)BT%Q-$*.XXUBPI+![+QX
M]B!FYSS/(I;0!P%D'L=$O%_2B+]>#.!@]^ ;VVPS_6 T.T_)AJYH]I0^"'4W
MJKV$+*:)9#P!@JXO!G-XML"N'E!8_,7HJ]R[!CJ49\Y_Z)N;\&+@:$4THD&F
M71#U\4(7-(JT)Z7CG\KIH/Y./7#_>N?]N@A>!?-,)%WPZ#L+L^W%P!^ D*Y)
M'F7?^.L76@4TUOX"'LGB+WBM;)T!"'*9\;@:K!3$+"D_R5LU$7L#E!_S %0-
M0.T!;L\ 7 W 1:"ELB*L)<G([%SP5R"TM?*F+XJY*4:K:%BBEW&5"?5?IL9E
ML\7]W?+J;G6U!.IJ=?_U9CE_5#>K1_5Q>W7WN +WUV Q7WT!UU_OOZ_ QZ>[
M^=/R1ME\ D/PM%J"CQ\^@0^ )>!QRW-)DE">CS*E3/L?!96*RU(%ZE&!P2U/
MLJT$5TE(P\/Q(Q51'1;:A76)K YOB?@,,/P#( =A@Y[%SP]'%CFXGF5<^,,]
M_NY3*DC&D@V8ZVW+,D:-LU1Z<<U>=$:?R90$]&*@4E92\4('L]]_@Y[SIRG$
M$SD["-BM W9MWF=WJ@"Q). Q-859CO6*L;K.O,SP=.KYYZ.7??U=*Q=.?%A;
M'0@;U\+&UI68AW^KI%)U*),@XZH0!3P)6$1!4BO6SP,BMR 5_(6I_0B>WP&O
M5Y!85W!\RA4\D;.#B?+JB?*L*[BDRFG 2%ELDQ"0F(N,_5L\,$5>NAOO+1>:
M3MS6FAJ,7-<U+^FD5CJQ[S6>#(OUBJBJYX"^*<1)X[Z;=+X=8F_:DF@P\N#4
M+-&O)?I6B:LM$72H<1,"M<6TP-YY]#O?[SE>2V/7!J')V*QQ6FN<6C7.]]87
M\+7:_31F>0S4'4M>:)DT0-(@%[V[?]K1Y;24=RU@3T9#IT&8<V2KKJD0:FIW
M^4O>S/(J/_O?[CMMA08CIT?A'F2AM>HLMB394 W)O3HB)55%2*=6Q,@SBXI9
M/3/JAJ>L*J?R=C@7J)D+9%VM&[69DHR+GBU4C3[8VW#J=5:I:S;TIZ@G3V$#
M:FC%XNQ!T)2P<%=%RO7AV98*U8VI3:92H%PXHW;<S=VQA]O2NU88.I,>Y0UQ
MH1VY]X5(BSC7,&/^I"W.8.5Y&/6H:[ +K;":S8. YQJZ*7DGSXJW!5*"0.2T
MF6RC['%7$(+^M"/<8.<Y?@];8(-!:.?@S5Y-V8DWZNRB#2+/Z2R^P<QU^KH:
MV# 0'H&@:E\*"*[5P>Q_=2ZP"S[/=<9M/!K,7.Q-<$\ #2&A;RV1-P5CCK?(
MT$K:7ZZ%)_)V&'2#7&AG[HI4F:#.HQ56-7I_FK?P.' -)A"Y/;T":IB+[,Q]
MR$6PU>U6T2GH/9:]%Y'0?W*6:NDFO:C+5I7,<-S2;#+#CM-3W%&#861%6RM)
M<EFT#-5L'T^0ROE1\08S./%Z"A%JN(F0-4&N64+44>5H@B K?G\U04[E[3#H
M!L?(CN/[5+>C4A&"BH#)LJ*%3)U,5 =A#K]+5^ATUJAKU-/CH8:_Z/B15^H^
M7ZI395JE1PC67/0WI,A 6XQPN]TWF4%WW)</#921'<H+G0LATZA(0DTWU?BH
MPZ_,>/!CRZ.0]DRQ ;5P"CN-CM'.\[R^J6Z8C.Q,7FF!>[-L5MDE[1![#FJ+
M-)A!QW'Z1#9$1K]"Y%VQ6==9?*38=#$[1&-_VMD:)CL?]AU84<-C9#^R7G-!
MV2:INM[@';!8Y;FYJG>/H^VNP6""^V:XH2>RTU.U9J(X\JMY+69:\Z>XT!!Z
M46Q-S*TPZC)1[8QQNZ4TF$'LHQ[=N&$GMK-ST:<5#,$SW; DT?M#@55U]$"1
ME?'0% 4VG&8GWA2VHC"80<>%?D_'AAN:8CM-;6%0?6I:V\1W*0D1GKCM'P%-
M=E =VOO4-SC%=IRN\C2-J&Y42*1JH PB+G-1]#--UK*D?%&B&&0\F..3LO94
MW@YG9.\W:CMK#TXZ'P5=Y_K'^$\%%HS!=R$Z=-OUR6#D]1PF<8-:;$?MLD96
M2(.(5#_]1'E8UEC2.FL:Q7=_78:^-VXCS&0V];SV[AOMO8")J=@4[Z4D*&24
M+RWJI_6[KWGQQJ?U_!*>+<HW6(V;\H7:+1&J,D@0T;5RZ7R>J"D5Y3NJ\B;C
M:?&:YYEG&8^+RRTEBN':0/U_S7FVN]%?4+\IG/T'4$L#!!0    ( .Z%H582
M%P]$0P@  !]$   8    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULO5QK;]LV
M%/TKA%=L+3#7(F7YT24&4DMB@[5)%R<;AF$?5(N)A>KA2G+2_/M1LFJ9#]-6
M>[%\B"7[WG-IGDM2.KS6V5.6?RY6C)7H:Q*GQ7EO59;K-X-!L5RQ)"A>9VN6
M\D_NLSP)2GZ:/PR*=<Z"L'9*X@&QK-$@":*T-SNKW_N8S\ZR31E'*?N8HV*3
M)$'^_);%V=-Y#_>^O7$3/:S*ZHW![&P=/+ %*^_6'W-^-MBAA%'"TB+*4I2S
M^_/>!7Y#[6'E4%O\&;&G8N\855_E4Y9]KDXNP_.>5;6(Q6Q95A !?WED<Q;'
M%1)OQY<&M+>+63GN'W]#]^LOS[_,IZ!@\RS^*PK+U7EOTD,ANP\V<7F3/;UC
MS1=R*KQE%A?U?_34V%H]M-P4998TSKP%291N7X.O34?L.6#[@ -I',BI#G;C
M8$L.9'S 8=@X#"4'>WK P6D<'+E)DP,.H\9A)#LX!QS&C<.X)FO;NS4U;E &
ML[,\>T)Y9<W1JH.:W]J;,Q*E52HNRIQ_&G&_<C:_OG*]JX7G(GZTN'Y_Z5[<
M\I/%+7_YX%W=+M"UC^;O+JZHMT"75_R#Z_GO[Z[?N][-XA?D_7%W>?LW>GEW
M=7'G7G+'5ZB/[A8N>OGB%2I60<X*%*7H=I5MBB -BU_1"^'\;%#R[U"U9+!L
MVOMVVUYRH+VW61G$&K>YV6V>)0E/_$69+3]KO%VS]T481M7 "6+T,8C"_F6*
MYL$ZTK?$.X*U7&Z231R4+$37Y8KEB+>-SR*K:G@_,G29+K.$:7!],^X-*_G$
MPT&]($^C]$'7M_1(W_*YK-CDS[IN&O"\VB47V247J0&'!P#?!G&0+AEZR3G?
M9L,K%)3(9<O7R,:_(F(1K$L!(VHU.;\IUL&2G?=XOQ4L?V2]V<\_X9'UFRXQ
MMF!.#59-S(\SC)WI\&SPN)\ D"$]2# ?$HP"@0G98.^RP3XI&T[)@"W2:(\T
M;CD<2ZS-53-,)&)U)A:>B%:>Q@ICT<;7V$PMV[9%,ZJ:63L+H=^&NWX;UB[V
M@7[C,T(U,/DPXMU6'[VJ)M%ZD*ZR.&1YP6?B+YNH?$;_W&1QC/@B_13DX;^Z
MGAU"CBU(,!<2S(,$\R'!*!"8D$K.+I4<XQ"\XM>VT:$%YJVCS)1#/)Y(PV!N
MC-"5<T@P#Q+,/ZDS*%!(@<S1CLR1D<Q%M:+VJ^OP$'%*^<U)$=27]WO+K8YF
M(VK7&6"DKJ[2W.I"QO,@P7Q(, H$)J3">)<*X^]*!1W]8W5I)6-'&N3&<%T'
M^5C)$36B!QG1AP2C0& "L9,=L1,CL=?KBL8"L:\L7T85O9^>41CE_$8^RXMC
M(WVB=+PE\6R,WI5G2# /$LR'!*- 8$(^3'?Y,#VZ@#?WU3E;;_+EJA[S]UF.
M6+*.LV?&4!E\94=3PQBFZR(P5?*L+R\"D/$\2# ?$HP"@0FY@:U6R[%@LD.K
MNUC*PM#'0V<JS1CF)G2=,AHTQQS4 PWJ@Z)1*#21\SW]#ALYWXDV174_B.[S
M+&D.VQ30\XTU76_Q/YEP8_S.A$.B>:!H/B@:/=Z_(N.MJ(;-JIK$>,Y*?CT0
M'F#^V#I@CM5U(<"JV-9WI'LF%S2D!XKF@Z)1*#0Q45J]#9L%MTZ)HDT.^^@%
MI+D)G6<'2#0/%,W7=(9NOJ0:.].P;U5 ;%2&9MO-@J6P67!8RVG A%:,9.Y
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MTRBV)V6VKA^&\"DKRRRI#U<LX)-B9< _O\^R\MM)]7R%W3-!9O\!4$L#!!0
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M*G/#A4#=IVD!WL^4LM4#'5#_^\3%_P!02P,$%     @ [H6A5FYD ,L1!0
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MD@#>+XSQW0TYZ#]"7?T#4$L#!!0    ( .Z%H5:6O'2RFP8  #\2   9
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M'LEA0VN.J6P>H--S;?DRR;7[DJ;UO0T\DM4:9=F!300E$^U*G[L\' $,SVE
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M\ RM(GY'UE^P N1)>SZ)6/H_6*NR5@_X*\9)K"H+#^(PR?ZB%T5$H0+T&BI
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M>1WRQ0)' 9@1"G"\C,@KQH"C%UP[\<&JOAI;%8%54VID-8D+J(43- NGI@V
MLJJ8H9!J986R):_LR'I5!:LZ"+I51#5J"38BTG()FN62ZH3,.ZF9#('F5#B%
ML(;Z:C';P+V61- LB;X3+A:782)X3\,#/.($ST(N5J$^F2?II@O%$9(X.!&/
M^?":J?>L'VJ!N=6%5Q56M9#7"$HK'VC>47I("MZ7(LHGC-=[ZU6]M8=5?P^A
M4:#6*- L+J;;6#;=E'Y8JYT$L-E),$2=N1VH]@?<S?X =!OW!\RFVE*B50TT
M:Q&5:IN]+W.N#2M)-!C6Y%JU&!PWYYK6)M"L36XQ3<^P$A\?7Z:C7>9\K:N=
M:I2NK)6!:XT"WUNCP$XU2E?6RN<M6J,X9G%1B!-#,.\P8EB'F&NVA:<5BF-6
M*"U&9V6Q/)=XE<0U-]P6F-8QCEG'=#8Z[VAG,SK#?/<6-H[.9E-M*2F<'>XE
MA/8:G9VJQ!G;U='9W&);1%HP.6;!U#2(@W_!39B$\2JNQ=;IQE)7ULH4:'GE
MO/?&DM/IQE)7ULIT:='F[-A8"H)T!! Z6QUHBNQ-Y#F=R 5?D%)[2J>,C@W'
M=.9VV^+2RLLQ*R]3)J"7QDSH:'](47"(W29'*SIG]-Z9T*D.[,I:F2ZM YT=
MQWGM,F%<R01XXFWGPB$DFZLEFVM66S>(/F$.4))>+,C3(NOQ%*MAI6RV_=8^
M[LI:F0FM[ES[G5/"[4CE*;H.H1E=K1G=/?:^WKQ=IXR65J@U4JFF6,,BUM6*
MSMU#T76]6>=6#_R\ZN%U3:DF.(4;6WM<V=IOI\YLZ<UQY^[=-UJ8N>9]K[U'
M(3%%_Z8D^752<U%0 >Y4A75EK<R-5F'NX+W'I8[DF*+K$.+.U>+.-8N[K@[\
M53/EZS>CT79F5TL=#\=;Z= OW!B.,9VG%ZF9&(16"<]NU^9?\\O:%^D5Y:WO
ME_;I-+MRK<UD-\!% LW#A($(SX1)ZV0H8I9FEZJS%TZ6Z;WD1\(YB=/'!48!
MIK* ^'U&"-^\R ;RJ^V3_P!02P,$%     @ [H6A5H!%EN.' P  WPT  !D
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M2_ZF%J',+J_"Y C&<Z,6\+%,%)J)>PUQ[VR#^*D/(\@ZHS4P>;@B79=(-GQ
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M3 G(_V>4BNU";=!\_@S_ %!+ P04    " #NA:%6^4_X,'@$   P&   &0
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ [H6A5I^Z6,@L P  "Q4
M  \   !X;"]W;W)K8F]O:RYX;6S%F%MOVC 4@/^*E:?MH8,$2B\JE=(02B1(
M4!*0]C298(I5)T:VTV[]]7-(V8Q*C_;B\11\D?E\[)S/\=TK%\\KSI_1SY)5
M<NALE=K==CJRV)(2RV]\1RK=LN&BQ$H7Q5-'[@3!:[DE1)6LXW6[@TZ):>7<
MWQW&FHN.6>"*%(KR2E<V%4M*7N7?]J:(7JBD*\JH^C5T]K\9<5!)*UK2-[(>
M.ET'R2U_G7!!WWBE,,L*P1D;.F[;L"1"T>)#==9 YG@E]S4*KU*L08;.H*L'
MW% AU;['?GRL&5^([MR6:L7'E"DB1EB11\'K':V>FF'T+#K&-/9Q.#S;(-Z*
M?PDCWVQH04:\J$M2J3:.@K &L));NI,.JG!)AD[ 7XAHYJ/_(%JW<U,:RHB4
MN*6Z043K/9Y%E"0>A7$6CI#^E273:.3GNI#E^C$+8P/2 R"],T+^\ S('@#9
M.POD@S_UXR!$!F0?@.R?$?(HDI< Y.4YE[MG0 X R,$Y(?L&Y!4 >647,EO,
M9G[Z'25CE$6/<32. C_.D1\$R2+.(P/R&H"\M@L9Q<LPSI,T"C,#Z 8 NK$+
M%/II',6/&9J'*<HF?AJ:N;H+)>NNY?5L8"X>_';;S>9Z _IYE)AIV@5E8MDF
MTU"CF:OH0M9P+6M#;_/%;#'=OY=)/M&+V<0L#2<Z;-'R:%$A;[B6Q3$*'W*3
M!=*#:]D/8,(X\H,+"<*U; @C9: O^H#'B/QJLD%><"V+X6/V.(D(6<&UK85/
MTL@[J(D)><&U+(8VFYR,'F0'U[(>CC;?B"A,V1&<!QG"LVR($[OO @6\W-6J
MZ6QB0J+P+(OB)&:,A<#-)YMY6/; [P[+!OGT16EA34S(()YE@P"8F>*%B0G)
MQ;,ME\\Q4R*5B0G)Q;,L%RB:=5F:F)!G/,N>><^.YFMS,AM!HO$LB^8/8U;O
M=HPTO3%# 99;-&;\U<2$1./]']%<H'&M:D'0K+FFJDLT)5@2%)B8D'@\R^(!
MS[/'UR"0@GJ6%=2<9T]NQ1YDG%Y[#W>X?%N3#:W(.M8C2EU?8%;,!6H>[6=%
M_[(Y VQJQ@)=EU13CM>'N[S#/>3];U!+ P04    " #NA:%6CWJT85T!   D
M$P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=C-CH(P%(;A6R&]
M ,LY5=2)N)J-VXDW0+" D;_03D;O?@@N\".SF(WI69&6</J&Q1/"X<O6F;]V
MK:NNO8ON3=VZ5%7>]Q]:N[RR3>9676_;\4[1#4WFQ^50ZC[+;UEI-<=QHH?7
M&>IX>)T9G1^]_<_$KBBNN?WL\N_&MOZ/P?JG&VZNLM:KZ)P-I?6ITO=ZWG9Z
MNM!JG*RBTR55P^E"2H<.8@CB\$$&@DSXH#4$K<,';2!H$SXH@: D?- 6@K;A
M@W80M L?M(>@??@@BE'&6$#2 FL!6A-R30*\)@2;!(A-2#8),)L0;1*@-B';
M),!M0KA)@-R$=), NPGQ)@%Z,^K- O1FU)L%Z,V+CVT!>C/JS0+T9M2;!>C-
MJ#<+T)M1;Q:@-Z/>+$!O1KU9@-Z,>K, O0WJ;03H;5!O\TZ]G7_4ULT]SS6>
M_TZJ_?BLG8^?EL_-Q4N8<-;P4^SX"U!+ P04    " #NA:%6[UO*"88!  #5
M$P  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-F,U.PS 0A%\ERA4UKETH/VI[
M :[0 R]@DDT3U;$MVRWMV^.D/Q*H1%1%8BZQ$N_.C+W2=\CD;6O))YM&:3]-
MJQ#L V,^KZB1/C.6=-PIC6MDB*]NP:S,EW)!3 R'8Y8;'4B'06@UTMGDB4JY
M4B%YWL3/OC9ZFCI2/DT>=X6MUS25UJHZER'NL[4NOKD,]@Y9[.QJ?%5;?Q4+
M4G;2H=WYV6#?][HFY^J"DKETX44VL8IM%/-AJ\AG_1(G,IJRK',J3+YJ8DOF
MK2-9^(HH-"K;B5[U.X=XP[1[\HO].YD^PU@Y=\;Z.#%'Y]L=1M)V#VP4(A?J
M_B,>':/TQ>>C=MH%%;_TCM?[8=RRFX=GW7+Y'7^=\5'_S!P"),<(),<U2(X;
MD!QCD!RW(#GN0'+<@^3@0Y0@*$3E*$CE*$SE*%#E*%3E*%CE*%SE*&#E*&05
M*&05*&05*&05*&05*&05*&05*&05*&05*&05*&0=H9!U])]D?3=F^=<_FMHU
M:V2M#_ZL^YLW^P102P$"% ,4    " #NA:%6!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .Z%H5:N
MJ6D3[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( .Z%H5:97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ [H6A5ORZG>3"!0
MQ!X  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( .Z%H58]I[O_SP0  (\2   8              " @08.
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #NA:%6/2#0
M #X#  "$"0  &               @($+$P  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ [H6A5M;5)(SG!0  &A8  !@
M ("!?Q8  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( .Z%
MH5;J(N.!V (  #L(   8              " @9P<  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    " #NA:%6S_H-A[T&   U'   &
M        @(&J'P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ [H6A5A(7#T1#"   'T0  !@              ("!G28  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( .Z%H58[I*>J7 8  #<0   8
M              " @18O  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    " #NA:%6Y3)4AZ #  "Z!P  &               @(&H-0  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ [H6A5LARZ[M8 P
M"P@  !D              ("!?CD  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    " #NA:%6W-9VWC$*  !*(0  &0              @($-
M/0  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( .Z%H59N
M9 #+$04  "8,   9              " @75'  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ [H6A5F/K'FJ) @  W@4  !D
M     ("!O4P  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M" #NA:%66H))+P0'  "0$@  &0              @(%]3P  >&PO=V]R:W-H
M965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( .Z%H5:6O'2RFP8  #\2   9
M              " @;A6  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L!
M A0#%     @ [H6A5DT</B^W @  K@4  !D              ("!BET  'AL
M+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " #NA:%6JE,7&00#
M  "D!@  &0              @(%X8   >&PO=V]R:W-H965T<R]S:&5E=#$W
M+GAM;%!+ 0(4 Q0    ( .Z%H594"9S>3@0  !D,   9              "
M@;-C  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ [H6A
M5IQ,>PJ" P  0 @  !D              ("!.&@  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    " #NA:%62&]3LM "   ,"   &0
M        @('Q:P  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( .Z%H5:E;51-7P,  )<*   9              " @?AN  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ [H6A5M1_"Z90 @  GP4
M !D              ("!CG(  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    " #NA:%6"K\]Q9,'  #F+@  &0              @($5=0
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( .Z%H5: 19;C
MAP,  -\-   9              " @=]\  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ [H6A5M E(ZN9 P  "@T  !D
M ("!G8   'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " #N
MA:%6^4_X,'@$   P&   &0              @(%MA   >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( .Z%H5;Y0R.%P ,  $83   9
M          " @1R)  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#
M%     @ [H6A5JMW1!F' @  7P8  !D              ("!$XT  'AL+W=O
M<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " #NA:%64FBV >L"   (
M"   &0              @('1CP  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM
M;%!+ 0(4 Q0    ( .Z%H58R=NBL8@(  #P%   9              " @?.2
M  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ [H6A5KDT
ML3R1!   LQP  !D              ("!C)4  'AL+W=O<FMS:&5E=',O<VAE
M970S,2YX;6Q02P$"% ,4    " #NA:%6$1<RRCH#  #L$P  #0
M    @ %4F@  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .Z%H5:7BKL<P
M !,"   +              "  ;F=  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M .Z%H5:?NEC(+ ,   L5   /              "  :*>  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " #NA:%6CWJT85T!   D$P  &@
M@ '[H0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #N
MA:%6[UO*"88!  #5$P  $P              @ &0HP  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     )P G (@*  !'I0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>75</ContextCount>
  <ElementCount>192</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>26</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - SHARE-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATION</Role>
      <ShortName>SHARE-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/INVENTORIES</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - SHARE-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables</Role>
      <ShortName>SHARE-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/SHAREBASEDCOMPENSATION</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/LEASES</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/INVENTORIESTables</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails</Role>
      <ShortName>EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - EARNINGS PER SHARE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails</Role>
      <ShortName>EARNINGS PER SHARE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails</Role>
      <ShortName>SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails</Role>
      <ShortName>LEASES - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails</Role>
      <ShortName>LEASES - Future Minimum Lease Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails</Role>
      <ShortName>ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="med-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/DEBTDetails</Role>
      <ShortName>DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.medifast1.com/role/DEBT</ParentRole>
      <Position>31</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="med-20230331.htm">med-20230331.htm</File>
    <File>med-20230131xexx311.htm</File>
    <File>med-20230131xexx312.htm</File>
    <File>med-20230131xexx321.htm</File>
    <File>med-20230331.xsd</File>
    <File>med-20230331_cal.xml</File>
    <File>med-20230331_def.xml</File>
    <File>med-20230331_lab.xml</File>
    <File>med-20230331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="377">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>47
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "med-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 10,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 377,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 75,
   "dts": {
    "calculationLink": {
     "local": [
      "med-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "med-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "med-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "med-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "med-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "med-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 280,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 8,
   "keyStandard": 184,
   "memberCustom": 11,
   "memberStandard": 14,
   "nsprefix": "med",
   "nsuri": "http://www.medifast1.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.medifast1.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - EARNINGS PER SHARE",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - SHARE-BASED COMPENSATION",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATION",
     "shortName": "SHARE-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - LEASES",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.medifast1.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - DEBT",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.medifast1.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "15",
     "role": "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - INVENTORIES (Tables)",
     "menuCat": "Tables",
     "order": "16",
     "role": "http://www.medifast1.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - EARNINGS PER SHARE (Tables)",
     "menuCat": "Tables",
     "order": "17",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - SHARE-BASED COMPENSATION (Tables)",
     "menuCat": "Tables",
     "order": "18",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables",
     "shortName": "SHARE-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - LEASES (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://www.medifast1.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - INVENTORIES (Details)",
     "menuCat": "Details",
     "order": "20",
     "role": "http://www.medifast1.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)",
     "menuCat": "Details",
     "order": "21",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails",
     "shortName": "EARNINGS PER SHARE - Computation of Basic and Diluted EPS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ieba1e7bde05646528901c22163e8367a_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - EARNINGS PER SHARE - Narrative (Details)",
     "menuCat": "Details",
     "order": "22",
     "role": "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails",
     "shortName": "EARNINGS PER SHARE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ieba1e7bde05646528901c22163e8367a_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details)",
     "menuCat": "Details",
     "order": "23",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "SHARE-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i3d62bc40011a4e969ffff01db87cd897_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - SHARE-BASED COMPENSATION - Stock Options Activity (Details)",
     "menuCat": "Details",
     "order": "24",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Stock Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i3d62bc40011a4e969ffff01db87cd897_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "id3a735cd0fee4e528a997870d8f0f709_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)",
     "menuCat": "Details",
     "order": "25",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
     "shortName": "SHARE-BASED COMPENSATION - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "id3a735cd0fee4e528a997870d8f0f709_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails",
     "shortName": "SHARE-BASED COMPENSATION - Summary of Performance-based Share Awards (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - LEASES - Narrative (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.medifast1.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - LEASES - Supplemental Cash Flow Information (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails",
     "shortName": "LEASES - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - LEASES - Future Minimum Lease Commitments (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails",
     "shortName": "LEASES - Future Minimum Lease Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails",
     "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i55a3deca29144b558d038563d063d0e5_I20210413",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "med:MaximumTotalNetLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - DEBT (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.medifast1.com/role/DEBTDetails",
     "shortName": "DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i55a3deca29144b558d038563d063d0e5_I20210413",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "med:MaximumTotalNetLeverageRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "i9ef290f1cdac4ec68f177f8490b8503a_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "iddbcc131b7564ee995939796a3d726ad_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "iddbcc131b7564ee995939796a3d726ad_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - INVENTORIES",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.medifast1.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "med-20230331.htm",
      "contextRef": "ic6b3c6572aa54d498ac033896c2093bc_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 26,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "med_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_DenominatorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Denominator [Abstract]",
        "label": "Denominator [Abstract]",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "DenominatorAbstract",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_GrantedIn2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2020",
        "label": "Granted In 2020 [Member]",
        "terseLabel": "Granted In 2020"
       }
      }
     },
     "localname": "GrantedIn2020Member",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2021",
        "label": "Granted In 2021 [Member]",
        "terseLabel": "Granted In 2021"
       }
      }
     },
     "localname": "GrantedIn2021Member",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2022",
        "label": "Granted In 2022 [Member]",
        "terseLabel": "Granted In 2022"
       }
      }
     },
     "localname": "GrantedIn2022Member",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_GrantedIn2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Granted In 2023",
        "label": "Granted In 2023 [Member]",
        "terseLabel": "Granted In 2023"
       }
      }
     },
     "localname": "GrantedIn2023Member",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_InventoryNonFoodFinishedGoods": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before last-in first-out (LIFO) and valuation reserves of (Non-food) merchandise or goods held by the entity that are readily available for sale.",
        "label": "Inventory Non Food Finished Goods",
        "verboseLabel": "Non-food finished goods"
       }
      }
     },
     "localname": "InventoryNonFoodFinishedGoods",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Liability Payments Due After Year Four",
        "label": "Lessee Operating Lease Liability Payments Due After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_MarketAndPerformanceBasedShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market And Performance-based Share",
        "label": "Market And Performance-based Share [Member]",
        "terseLabel": "Market and performance-based share awards"
       }
      }
     },
     "localname": "MarketAndPerformanceBasedShareMember",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_MaximumTotalNetLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum ratio as of any date, of (a) Total Net Funded Indebtedness on such date to (b) Consolidated EBITDA for the Reference Period ended on such date under credit facility.",
        "label": "Maximum Total Net Leverage Ratio",
        "terseLabel": "Maximum total net leverage ratio"
       }
      }
     },
     "localname": "MaximumTotalNetLeverageRatio",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "med_MinimumInterestCoverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum Interest Coverage Ratio",
        "label": "Minimum Interest Coverage Ratio",
        "terseLabel": "Minimum interest coverage ratio"
       }
      }
     },
     "localname": "MinimumInterestCoverageRatio",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "med_NumeratorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Numerator [Abstract]",
        "label": "Numerator [Abstract]",
        "verboseLabel": "Numerator:"
       }
      }
     },
     "localname": "NumeratorAbstract",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "med_OperatingLeaseArrangementForEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the operating lease arrangement for equipment.",
        "label": "Operating Lease Arrangement For Equipment [Member]",
        "terseLabel": "Operating Lease Arrangement for Equipment"
       }
      }
     },
     "localname": "OperatingLeaseArrangementForEquipmentMember",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_OperatingLeaseArrangementForRealEstateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the operating lease arrangement for real estate.",
        "label": "Operating Lease Arrangement For Real Estate [Member]",
        "terseLabel": "Operating Lease Arrangement for Real Estate"
       }
      }
     },
     "localname": "OperatingLeaseArrangementForRealEstateMember",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_OperatingLeaseExpenseNonCash": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Expense, Non-Cash",
        "label": "Operating Lease, Expense, Non-Cash",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpenseNonCash",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_OptionsAndRestrictedStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options And Restricted Stock",
        "label": "Options And Restricted Stock [Member]",
        "terseLabel": "Options and restricted stock"
       }
      }
     },
     "localname": "OptionsAndRestrictedStockMember",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_ProceedsFromStockOptionsExercisedDirectors": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Stock Options Exercised, Directors",
        "label": "Proceeds from Stock Options Exercised, Directors",
        "terseLabel": "Options exercised by directors"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercisedDirectors",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "med_SecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Percentage",
        "terseLabel": "Additional shares earned (percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPercentage",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "med_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Additional Shares Earned, Performance Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesEarnedPerformancePeriod",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "med_UncommittedIncrementalFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uncommitted Incremental Facility",
        "label": "Uncommitted Incremental Facility [Member]",
        "terseLabel": "Uncommitted Incremental Facility"
       }
      }
     },
     "localname": "UncommittedIncrementalFacilityMember",
     "nsuri": "http://www.medifast1.com/20230331",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r230",
      "r308",
      "r320",
      "r327",
      "r328",
      "r339",
      "r340",
      "r345",
      "r372",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r230",
      "r308",
      "r320",
      "r327",
      "r328",
      "r339",
      "r340",
      "r345",
      "r372",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r229",
      "r230",
      "r256",
      "r257",
      "r258",
      "r307",
      "r308",
      "r320",
      "r327",
      "r328",
      "r339",
      "r340",
      "r345",
      "r369",
      "r372",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r229",
      "r230",
      "r256",
      "r257",
      "r258",
      "r307",
      "r308",
      "r320",
      "r327",
      "r328",
      "r339",
      "r340",
      "r345",
      "r369",
      "r372",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails",
      "http://www.medifast1.com/role/LEASESNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r113",
      "r116",
      "r117",
      "r118",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOMEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r110",
      "r315",
      "r325",
      "r326"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r21",
      "r24",
      "r81",
      "r306",
      "r321",
      "r322",
      "r358",
      "r359",
      "r360",
      "r364",
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r6",
      "r344"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r364",
      "r365",
      "r366",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Net shares repurchased for employee taxes"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Recognition and Exercise",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "negatedLabel": "Decrease in share-based payment arrangement, expense",
        "terseLabel": "Share-Based Compensation Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Anti-dilutive awards"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r88",
      "r97",
      "r109",
      "r133",
      "r170",
      "r173",
      "r177",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r279",
      "r281",
      "r287",
      "r344",
      "r370",
      "r371",
      "r407"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "TOTAL ASSETS"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r105",
      "r112",
      "r133",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r279",
      "r281",
      "r287",
      "r344",
      "r370",
      "r371",
      "r407"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r44",
      "r107",
      "r329"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r39",
      "r44",
      "r46"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents - end of period",
        "periodStartLabel": "Cash and cash equivalents - beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r39",
      "r83"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Cash dividends declared per share (in usd per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r364",
      "r365",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r344"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, par value $0.001 per share: 20,000 shares authorized; 10,887 and 10,928 issued and 10,887 and 10,873 outstanding at March\u00a031, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r25",
      "r121",
      "r123",
      "r128",
      "r311",
      "r317"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r34",
      "r127",
      "r310",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "ACCUMULATED OTHER COMPREHENSIVE INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/ACCUMULATEDOTHERCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r29",
      "r133",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r287",
      "r370"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r58",
      "r132",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r214",
      "r221",
      "r222",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r89",
      "r90",
      "r96",
      "r135",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r204",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r295",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r90",
      "r96",
      "r225"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Borrowings outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r18",
      "r135",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r204",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r295",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r18",
      "r60",
      "r61",
      "r62",
      "r63",
      "r84",
      "r85",
      "r86",
      "r95",
      "r135",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r204",
      "r210",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r223",
      "r295",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r269",
      "r270"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r42",
      "r77",
      "r272",
      "r276",
      "r277",
      "r363"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r42",
      "r168"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r233",
      "r261",
      "r262",
      "r264",
      "r268",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "SHARE-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r68",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation Expense"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r64",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "verboseLabel": "Dividends declared included in accounts payable"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared to stockholders"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "Earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r129",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r149",
      "r151",
      "r153",
      "r154",
      "r155",
      "r159",
      "r284",
      "r285",
      "r312",
      "r318",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share - basic (in usd per share)",
        "verboseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r129",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r151",
      "r153",
      "r154",
      "r155",
      "r159",
      "r284",
      "r285",
      "r312",
      "r318",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)",
        "verboseLabel": "Earnings per share - diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Foreign currency impact"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation cost recognition weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r399"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r260"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Total income tax benefit recognized related to restricted stock awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r59",
      "r103",
      "r124",
      "r125",
      "r126",
      "r136",
      "r137",
      "r138",
      "r140",
      "r146",
      "r148",
      "r161",
      "r183",
      "r226",
      "r265",
      "r266",
      "r267",
      "r273",
      "r274",
      "r283",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r306",
      "r321",
      "r322",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r28",
      "r133",
      "r170",
      "r172",
      "r176",
      "r178",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r287",
      "r333",
      "r370"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r26",
      "r87",
      "r92",
      "r102",
      "r170",
      "r172",
      "r176",
      "r178",
      "r313",
      "r333"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r134",
      "r147",
      "r148",
      "r169",
      "r271",
      "r275",
      "r278",
      "r319"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes (refunded) paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.",
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedTerseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoods": {
     "auth_ref": [
      "r353"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.",
        "label": "Inventory, Finished Goods, Gross",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoods",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r111",
      "r330",
      "r344"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r55",
      "r356"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "negatedLabel": "Reserve for obsolete inventory"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Cash Flow Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Company's Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2023 (excluding the three months ended March\u00a031, 2023)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r304"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "verboseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r16",
      "r133",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r280",
      "r281",
      "r282",
      "r287",
      "r332",
      "r370",
      "r407",
      "r408"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r91",
      "r99",
      "r344",
      "r362",
      "r368",
      "r402"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r106",
      "r133",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r280",
      "r281",
      "r282",
      "r287",
      "r344",
      "r370",
      "r407",
      "r408"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee (as a percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-Term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r18",
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-Term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash flow used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r130"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash flow used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r39",
      "r40",
      "r43"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash flow provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r27",
      "r43",
      "r93",
      "r101",
      "r104",
      "r119",
      "r122",
      "r126",
      "r133",
      "r139",
      "r141",
      "r142",
      "r143",
      "r144",
      "r147",
      "r148",
      "r152",
      "r170",
      "r172",
      "r176",
      "r178",
      "r182",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r285",
      "r287",
      "r333",
      "r370"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other (expense) income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r170",
      "r172",
      "r176",
      "r178",
      "r333"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r403"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "verboseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r297"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease obligations, net of current lease obligations"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r298",
      "r300"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flow used in operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r303",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r302",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r47",
      "r48",
      "r53",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "verboseLabel": "Presentation of Financial Statements"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "auth_ref": [
      "r30",
      "r42"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement.",
        "label": "Amortization of Other Deferred Charges",
        "terseLabel": "Amortization of premium on investment securities"
       }
      }
     },
     "localname": "OtherAmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r78",
      "r79",
      "r80"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r114",
      "r115",
      "r116"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized losses on investment securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "verboseLabel": "Other comprehensive income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r78",
      "r79",
      "r80",
      "r120",
      "r123"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other expense"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfOtherEquity": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to reacquire equity classified as other.",
        "label": "Payments for Repurchase of Other Equity",
        "negatedLabel": "Net shares repurchased for taxes"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfOtherEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Cash dividends paid to stockholders"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance-Based Shares",
        "verboseLabel": "Performance-based share awards"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r357"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "verboseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-Term Investments",
        "terseLabel": "Sale and maturities of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r56",
      "r100",
      "r314",
      "r344"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment - net of accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetailRelatedInventoryPackagingAndOtherSupplies": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.medifast1.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of items used in storage, presentation or transportation of physical goods that are targeted for sale to end users.",
        "label": "Retail Related Inventory, Packaging and Other Supplies",
        "terseLabel": "Packaging"
       }
      }
     },
     "localname": "RetailRelatedInventoryPackagingAndOtherSupplies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r64",
      "r98",
      "r324",
      "r326",
      "r344"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r103",
      "r136",
      "r137",
      "r138",
      "r140",
      "r146",
      "r148",
      "r183",
      "r265",
      "r266",
      "r267",
      "r273",
      "r274",
      "r283",
      "r321",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r166",
      "r167",
      "r171",
      "r174",
      "r175",
      "r179",
      "r180",
      "r181",
      "r227",
      "r228",
      "r309"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r301",
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "verboseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of the Computation of Basic and Diluted EPS"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r0",
      "r11",
      "r12",
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r231",
      "r232",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r69",
      "r71",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general, and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "verboseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Shares granted in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r245",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "periodStartLabel": "Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r245",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Outstanding at beginning of period (in usd per share)",
        "periodStartLabel": "Outstanding at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)",
        "terseLabel": "Shares vested in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Share-based compensation arrangement, fair value of awards vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in usds per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Shares, Exercisable at end of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-Average Exercise Price, Exercisable at end of the period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Shares, Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Awards granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Outstanding at end of the period (in shares)",
        "periodStartLabel": "Shares, Outstanding at beginning of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r237",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-Average Exercise Price, Outstanding at beginning of period (in usd per share)",
        "periodStartLabel": "Weighted-Average Exercise Price, Outstanding at beginning of period (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "verboseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONRestrictedStockActivityDetails",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Weighted-Average Exercise Price, Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "verboseLabel": "Share-based compensation, shares authorized under stock option plans, exercise price range, lower range limit (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "verboseLabel": "Share-based compensation, shares authorized under stock option plans, exercise price range, upper range limit (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life of options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual life of options outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedLabel": "Net shares repurchased for employee taxes (in shares)",
        "terseLabel": "Shares withheld for employee taxes"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r47",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r19",
      "r59",
      "r103",
      "r124",
      "r125",
      "r126",
      "r136",
      "r137",
      "r138",
      "r140",
      "r146",
      "r148",
      "r161",
      "r183",
      "r226",
      "r265",
      "r266",
      "r267",
      "r273",
      "r274",
      "r283",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r306",
      "r321",
      "r322",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r136",
      "r137",
      "r138",
      "r161",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHARENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r4",
      "r5",
      "r59",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONSummaryofPerformancebasedShareAwardsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r4",
      "r5",
      "r59",
      "r64",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Shares, Exercised (in shares)",
        "terseLabel": "Options exercised by directors (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED",
      "http://www.medifast1.com/role/SHAREBASEDCOMPENSATIONStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r59",
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Options exercised by directors"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r54",
      "r344",
      "r362",
      "r368",
      "r402"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock at cost (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r20",
      "r66",
      "r67"
     ],
     "calculation": {
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedTerseLabel": "Less: treasury stock at cost, 0 and 54 shares at March\u00a031, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockRetiredCostMethodAmount": {
     "auth_ref": [
      "r5",
      "r59",
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease of par value, additional paid in capital (APIC) and retained earnings of common and preferred stock retired from treasury when treasury stock is accounted for under the cost method.",
        "label": "Treasury Stock, Retired, Cost Method, Amount",
        "negatedTerseLabel": "Treasury stock retired from stock repurchases"
       }
      }
     },
     "localname": "TreasuryStockRetiredCostMethodAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockSharesRetired": {
     "auth_ref": [
      "r5",
      "r59",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common and preferred stock retired from treasury during the period.",
        "label": "Treasury Stock, Shares, Retired",
        "negatedTerseLabel": "Treasury stock retired from stock repurchases (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesRetired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r59",
      "r64",
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Treasury stock from stock repurchases"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSTOCKHOLDERSEQUITYUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r50",
      "r51",
      "r52",
      "r162",
      "r163",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "verboseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/DEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r367"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive common stock equivalents (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r150",
      "r155"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares of common stock outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r149",
      "r155"
     ],
     "calculation": {
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.medifast1.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED",
      "http://www.medifast1.com/role/EARNINGSPERSHAREComputationofBasicandDilutedEPSDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r346": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r347": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r348": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r349": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r351": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>48
<FILENAME>0001628280-23-014622-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-014622-xbrl.zip
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M]MXRCCK6&^ONDWUX )5%H;R7\@\2PMB@G*!VH6!?4+('+(-_'?$[_E(UO5B
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MV2JZ"W!C!KIK$#;UASW $>57-QH>N5\/G+4;@]?O'1E0JZLW:P73.^N&M:$
MBH.C6XR.C;ZG>TS<[ZS0YIL7#(/?U;W=RGWN=5.KP2='E:)12;BW1"GCM58X
MR)B[8$RAU72DU706M9K>7ZOI8[3ZN@R *.PFX5WU!42F\ [73RV SO0[W5\4
MU\3UZ<=*:'=:C?9MM[VO2MVXQ9N;K?^9MN@0J<:1.&] <5RN(I$R*JZQ50(S
M,[3EV5"2F[9\7>X/L^4;/<!\3JWC&!-B ,UR'>%_F'BKI/-*RZ('**&SU@,I
M,3B='B < )QKYKP']BZ [!$FG Z<<?!^-"]Z@,Q>#Y"I]0"-%JAL[L&G42ZP
ML);XJ+156"JM(Q[HP.Q9 9V>%<CH&):.@?)S$+K%$*!38XTF2MJ8/Y\5#%$O
M'":&/_CJX6'GI\V&:_2KH67A$;X!1P>#!L,$\.IN'X _7;/Q[[.4R.NT3CMM
M^-I;/V^ NQZ=!K^W.NW=?L>=#.[UQYM;'W'5:U<M>2GS=)08%_/(B>,\> 4B
ML1K[$'/"9"!V842S[GTCC1= U&X:?JO]WIPV^J8Y)V*R.1>2T"@YL&+X8PD'
M7ZJ$ CNRA+#%$9-S9ZVS9AJ0V^X?A6XZKQN.TMV^AJVVZ[3"O(A,&JTBDXX$
MSJ,ABAO/M F1:)Y3$Q9&9#NA;QKMX#=,M]UH'_;F1#X\8FORW#N+!7=4*TLC
MH41%[1D/.5D8^=2[!:V_*-S2P$/-B8B\AD#3*.6X N>DG/6)/]) N2%>!?D"
M.92YMZ67S_"H'!,A<6ZQMCQ&KYB0N?<L]V"-+*>+)]4GI84O+U"98T>EA*B>
M&\XL0"C6'"B*#U@2*U\BU;DH9/+EA4L%!&C<&L.CXI$Y3;3F$#$H38G/L5@\
MX3Z+OWQYP<8HI? \.N4U%U8J:P0/4G&!J7=Y7#S!ODAL\?*"9L0JL%<5@J%<
M<&&8SD.P."=@P*,0?Q'D^US9E^FEAQ._Q0KH3TXB^$YO'7?.28ZMM%([O#"B
M>8GLR_3$I#3A/CIC",?@^[2)+&!L(&(D(AKC%T=,+YQ]F:;(J*4FYT(8Q4,,
MABN*)>8T6"Z#=0LCLF?-ODQ//MCI&,&N- /6(;0RG#C!K%.&.B6Q7!CY/'?V
M97HB\N".' 'V($7.0]!::*:ES@WSDN9#U'N6D;L%X0W3&U(DN4Q\G5H<))<F
MU\(2;F).!,4*S&9A1/,2O&%Z8M)I48]3VLC .?-&BZ!RGB:IQZB%"HLCIA?F
M#=,3&=S+$(N!>Z?D).':.B#G(=I$)(34"R.R9^4-TY./"13,B%%G@^8."T.H
M(\)ASAB6UK&%D<]S\X;IB8A1#@(A@'&,\3PH<%* @DQ)E5O#*7V!.8)S;TLO
M,H/QYG V "(Q$N1)*3<XJICG\ =[I9V(X,L63JK/-VKS(@(UF#DK@F=1,,XA
MZB+8YD#M14ZP\6$!!?HRHS8O(MP0C=66*AJ,Y;G-K8[!$I)[X[PBD2R><)]_
MU.9%!*N-D8;FFDJ#.840'3L>(OQ5N1.:R\43[,N/VKR(H*/C7DF(Z4V:CN2"
MQKDC2C@!+!='*I]OUO \N]DGF<X,G$=HP;F)P7$.O(AZ)T 4UDFFN8H+(YJ7
MF3,[+3'E+,<D>@@%E>**@6 <<<I"<&))9(8NCIA>?,[LM$1&6" R>BD=,5P"
M@Q%8D!1K$$Y\',V970"1/?.<V6G)!^ N$HC[@H,@GW!IN',&XC_)K.#8^X61
MS_//F9V6B((U)$CK Q8YSP55&A-'*<E94"R79HZF]:S#'7RC>=8'&-L-[JP+
MSBCT-LY=\\P'O]GMM)+XSOI%':CM.+*ET6++=Q>WWV#<$GO];L,!=B[L_,RH
M+:,Q4N(#YR)G2C%BB-1YQ%):*N8H9EA E7B1Z$*:0$'^,7?8\."I5DPY184-
MQFAN[3RAQ#?3]:E@V$TA;K1.FYV+$ H1;I\F?5A$V_9".\+A_PJ,6^=*89\#
MZA.9&^JTUO,OR%< T)X9R83S.(;  _ALH[54$N+,B*/$>O:7(KV4[)YFY9X%
M0V)2*$ES+E2TR<"\P)9B[J2DLS_&. /BF-YXHF4LY#K/"9&>FYQ:D>?82$&B
MI0H>-$_T918@[F5&FQC6QE-GL$ECP-1$*D&HT6%.A2!D]N?[S8!-36]N7TX4
M^!;OA3(^I58LXX$:"I%""(P*/?N!_ R(8XIY%>:]C():IQEW.;9".B5R8A@-
M7/AY6F1UAUP@ BM*Z;5=*"*QGV6\?OJ\7K>_NF/:A\/GI*_51KO1.FLM"$.\
MJA_5/DL-OZ,FV"E\'-W@WE6\M!$6M(T0%B(GEFHF)%86.&C0(>!Y6OKUDNIF
MSA=(W6XJ"$G57T(NHTR588*6$%\J;Z77*F437Y^"S*488[3&>A<D-HQ'ZI53
MD;-<\YR'W,8Y3@ZT@@?[ZYZ$_GK;7Y/E.],#SY\$^EB#O_'@)(#O#_[0!3<?
M_%8[<8!%U!LK#,:&  ^1DGM-% ;#)_#714 %GL^WW@R2@3U0G%>06M*6<D9S
MFW.JN C*,B4D,']*O-2>Z/D-GE]2E"\SIX\1"-O )1?E<"@VFK+@=60"!T+<
M7(WLS2B:LT6$ )EVR,DU8TY20 $%3([IJ"(P.>Z#B_,- :]";UX$;VC,54S5
MT*3"7) <. &/AL4031XTG^.\Z\SHS5.SQY=)]7(KO&#.2TRY\<J*G.8<."3-
M<ZT4F3<_=;?XR%35Y+4&J8HSS5/UV> YUM0XI2$X394;)/5QGF:TOS)U>1ET
MR7/A@+\0'2PWN=&>*V&<3TM!%:%\WM#E&7*7]U1/O(CHPB(QQM(\2*W29%5K
M" [2&&(\!="98Q*SZ.KR,NAB%<<&7DY;S;'*;5J^[!7)HY;2NCE.?#^:\\ZE
M^>?>&BRP]$X03G*AC9(LQX'EQCO&YFDM^JS)\V7FK4I!.08JQ8G@%H"<>4.I
MX\&'W!L^O]-(GH&[/<E$$J&XXD)A%BGE06.=,\MP[J(QRDBL9E\@21;;<;W;
M3:.[Z=KKZ>6TI5*C??@Q@%5=.V6ST]T)IKG12ZM)YFDFPY/H@'&&!&$C1&N8
M,QJMBXX&$8*$?Z3/9U<'?GE4?V:T:U9T@$@IE5..DL2SM=!4$H^]=-9)S^4S
M;O7US#B0UI&=IL^O'@:B($I@3K2S!ER"-\":<=!Y(ELDY#-<<G-F8>"^RC4K
M*B =CEYHXG(ON)-*>2P<]YS9&+@(PYGSH"-LUE3@JAI!-_A&?].X1A.:-3ZW
M]&NG^14D=?.D:>E()=C^%O1]]^RF@@R>MG[8#>')58&D74P)FX(J*,*\)SJD
M<A7<>6X9=\0X'&@4ED<W^ZHP'7E,1?,^AGX_=+?CX)PYT0 9>,YTY)A;R2$Z
MTX1JP91A\!T;3$H-N(<&I,?MI1(.K4:_R+RY;O%,T[PG_,R*-@1,-0T&PO1<
M<2:$(H$8XFPNA+-XN BYT 94JL7+SG ?$_J/,CMCISYF#20$C=(:S(+G'.?:
M2.9,)-9QSG*,\SG0CZ>GD2]&$5Y>/XQV:39!'G-0"<&\EB07EN004 2L^#PM
MD?G;=!O&-L/.C;&5HAI!\-M?0[?=.#SJ;S;:INV ;:;3=K<W=Q9+B5YFZSGI
M')6*$@>,E :O<R6%L!"K8( 9.4]34R:5:'0DC0#L3"$O6>I+0PC#?'"&:L*Y
M!=+B,5,B9QZG_X)X+11V5DBDCY(8CYT(/N?8!HV%441;L.O((+"<W133"X44
M'SOM0X@<6^FQDX-.'QOM\"Q!Y2]FF-XTSE>[H=<YZ[K0&WP]"L87[?&-KVM_
MP#^C.<Y,4IQ+S;S@@5BC!"- )3&UGD1%OR2%^'Y-KW_1!-&W&FUT%)*S7>7B
MM/_V6\/WCU8)QO^U=/,\TSV$4_N=TU5*5O+3/ASNG9KVZ+CK-#O=U7\DC8GQ
M;83FHVA:C>;%ZO_402:]K!:^93N=EFG_SW+/M'NH!R\\/+'7N SP2'AZ\?7;
ML#D8OVV"=$;-(T3\U]O4*0C@J-,MRANMGK6A*])9T!PS,VW)CKHA_G/I'S^7
MB5Q:JR<7EG5B]C[)O-WO_?'&@*!2YX[D-2FU<6D,&F.:C</VJH.;%(ME^\6=
MAY?83A>:AZ!OFN:T%U9''][Z1N^T:2Y (XLW+"YZ.WR [?3[G=9J4@S@9/V&
M,\WA0XKG#0Y_UYD5/-";/FAGWX^>/#R\4AQZT_>3Q[1:T?CNPWB%7!U[4]R[
M.SIAI+J%/L)U\%:IX_ZYQ);&7GSX*NRTG_G.6>J8I"!O3XWW0#!7<4:*>WQ_
MR)NB)W[<^>R.GK_#,N!YOZ*-^9@VRG%MI*GO]FI;]8U*MEM?KV_LWM2?:XV?
ME=;N;KS?V]FJ;VWL9NNU2K;Q?^__M5[[L)&]WZY6MW9WM[9K=[["M?Z_2_.G
M^T;D7F_T>7WW7UNU#_7MVG)667F_DE$LN)Z=M[B?7#:W=ZK9'^!EVIUV#1QT
MM^&RH3/:29C6<+EE+A>2&B.XYUH9!V1#Z=Q1K)F]=:?CK&T2S?"AL5KIN,+M
M)T^\-"K]]/>%K72^?J0[7_=9]<P?;WP]^*"/MX_=1?42_JOLL^UZ[:16WVE6
M/_]YM%W9NZS6:\V#ROK%?NO3^<'QX<5'5FON7W98];@*_ZW3VN7)Y4%E#Q_4
M-QO[]4-2O=RX//C\Z5NU]>=)]?,^KS;5^4=Z<+'_V>6US]7+:FM?5(_W+VN7
M6Z)6V3RJ5@Z_U2J'!)Z%JY=[WVJ7CM9:6U_]A[^Y_]>?S0/:_&J/.V3_LGIQ
M<'QR42N>>X*KGS>^;5?6,5S':_5/E[7Z.JM=[M/]IH)WV>)?))!I< (&*0*4
M@.?03=I(BG00AE@;O!)T:8U@]*GP]=^EL'9?31HB&FJ&V%_5UW[H%F+6MRG;
MX)=&.[&[5434C]S[N/I]AGNG^_?N4#Q]+[U[!I7[= ;Q$GCHBYUPVNGVE[)B
MME$?'G#>7XV-\^ 1<-+7IY4;XHMFA$NN'3(62\2=4<@:J9#G+J?"2J8M,)7S
MNU3RGIJR#N%Z\U%:DF4/?.3]L/%^#_^TM[Y3W]CYN)_M;/RUO5//_MK;V=U;
MK]6S^G8&_JP.3BLC+-O>R8CXS?^>;6]F]7]M9-=<W96;6W]?3X>)9GQ6[?K7
MNFZ"*0^\2J>;]8]"]N^1"6:#>"<+T#3_'/[FK^)Y&X,\R$W3]_ +:L$SC])E
MR)L+=!%,%X7V:X."^HFH5K8NJ\=[\#Y;[ NF00,@1 38H!$'$2#+L06W94T(
M4>4\@K.JFJX[RAA9SI( YL5M35.]MW=F]2WGQCG7N]"\8J>%N[US-,W>*W3/
M^(MV3%JL*5+14\2UB,D]6\18E$ F&?'>+*UU7K=[KN^LUW:W"B=<^N=?],_]
M*RL<.>C8[;2^#/^7]3O9Z//*S 2V]WO#M(%!HY<RP]EFHQFR6E%1;O4IJ<=&
MD1A.3QL\[/4A%_E"H7,8!M B5@7$4XAAI>&(:!-DI-2)'*=Q!H(8$?*7R<.L
M9$^>7)MVPF&CEZRT7X,CKTZCMNB7'"LBJ35(JQ 1CQ(^6>,1X=$SH801.82J
MU> ;T?3ZR]E6VZW,K%K=S[/]MG%N7+_0A31.T+W2@<STLMYI<&E SF>-=M;H
M]S)W5,18O]_S)>=IG("KE1S+>XT3/.P84_R7KOQI8_5#!C7N&L$8C5'0T_,T
M2G$+C1CO],[ILVLJX<^!?VDKK^[I<,2MV,CH?>>LW>]>O._XFV$]O(%;+98/
MG78[7]-]YC2>WVS8#WMYM?6)'GS>/Z_2'3AWG0!)%=N?-RYJ'S:/:Y?0KOK>
M^3X%S+S<'U[S-SQ+M _JG8N#RD'SX!C:\V'C6Q7NOP]Q_GY]"^]_AK97_CRJ
MU3>/#^J'\$;JV\?Z>K^ZB\\_UO<OM^LG%U^4E")&$Y G2B".J40:!XF4"9@0
M;'+NXM):)33--Y/J\-Z!M$,3^(%VWQB!*PWA)X90-^=;P[D8KC"&.>:8SZWA
M6S<UG'&3"XPELE&GZ-IHI'#(D?#"$: 3SBK0<,(0DX1S+'ZHXS^!\J%W3;X7
MKTCPEUFOTVSX;*20LZ#A\EX:_EN!OAD$CIVTX6)V?-9M]'S#%<$CL)3&=:0N
M3NL>FG;CLOC^^W1Q88%Z=6ME9V5W)1MNW=3-;AIY5NNL_#ZI;_>9JC!#?/;)
MP7'=^V[H]89_TA0O,I? ^*A0Z?Q+H,83!SVE<@_!MS$2&4\C,M81Y0)ASH8T
MUHPA2 )E:)O!1K=9I=OX>K<G?_89);.E5._AXW:WWODVGVSR42KU[8O!.</!
M1I1+IQ'/0T F=\ +N6<L1F$9T4MK[TRSWVAU)NG@\M/GVX9B*KS3=O<OX/[@
MB18T-'B4,"^^".$<=#9%E@J+>! ,:4J! DE,O2%:4D6*X;V+IFG[<5D^FRC_
MZH"LF@>-TT&,]]KDQ+Z$$#C5P$T%M@ZD Y:GN1'(:B&DM%P0ZI;6*. @G3?4
MKH=F.#WJM+\GY'][0K5*V+W>#>9U*M+E%R\IBSD7*-H 9NXM13KW @FJ% 6.
M !0!+ZUQ@L?5Z/>G-/:/'2#>?R4EF.,8]E'C)/1+U&#CFEI$'$\S+6P:X248
M19D3954.@C-+:T(!E\/\_E8^F_S_MR&PIS#QKRZXY\8IL,Z-\^"*/8FS[0CQ
M3N@M9X#Y6;+5#-Q/-@X516J_>98"NRP9=7'F [+>4WUQ=:]!R.^[+0^3^*$;
M?'9ZUNV=I6Q^OY/!&46<1^AO]O?4/VE4=MWU5Q\CXKG)[S.](CB;D_P^R5?X
MW#2VZ-E\VH,1;(6JGT]KD"MT4F\&*O/49GA[DJ7>Z ]6W 3CCC+7-+W>XN6I
M[]D575, Z.Y%RW::+]P++ZD3M>'@:J$2X=P=I2(&&2#QMZ,&_/(=KI\JV_L(
M6WH&[;EM =R3YER&KO*"4%N8ZUR2PL' 1NWR[Z/]SYM'^_6M;[7/&ZSV8>O;
M/MT2VQ7W[:#R=VO_V(G:Y[^/MNOKXP,;K):N@_^@G62_[O#^\;OC_>,37KM\
M=U+[?-" MI.#SQNBN@EM'!^ZTQ1C(2A&1N \Q?<<61Q(RMAP$(1QVO#!S"C0
M\V+/J.7LU'2SKZ9Y%K+_3&Z<I'E@6>_HR8?VYB&%_W.C>.*AOR%:#\"ZM(A[
M6,384)_0UG!B)=+<&<1Y5 @ZGR'MA5*14">P6UJK;E1*99\9#[ Q=,:#"6_C
M:=SDJN<X@_O<]O!IS$,8ZT!,X"&4XH@+HI#!5*# + =;"='G8 ])5?8[W9.!
MC\A& OGY./@]QR5?)AC?:OLTJAHR>Y&YH^!.H%$G0/=",9R=XNYK$^U^([]G
M1Z:7Q483(G;3;,+!M$PA!?+_/FND,!ZB=QN&)\ MKR)YE@:_B<C2C/-A0'\M
M#S#JS!3DI\-IQGGFX2B0\G3J:3>X4%!T0K-BD5(O^PUN"':0]<Z F?:..FFZ
MWVB^=O_(],<;_\W<;&9JX^#BX4O\OEQD6'ZC@Y>T8$UPW![#*Z3SBU/AHM2*
MX7W2DHU>T8BBD:;7SS3.O+GHK60SDXVZGQX\^3#&^[-N%]YOL*XEN>^^Z9_U
MYA*N'I7E9%\,P913JI'RBB).!,"-LPH^2<NXLC%XO;2V'WJ38TT/6U?RLV5/
M]].,\R=9S7*_9V>USLN\=&>F,Z@3H)W]"+43F &.#>J&9J$)>-;MM!-O:EYD
M 3C4Q6#F@W%%WKEB^F:P.F0,U+_?XWJN=N<,SN18)-C>"8=GS<$4G5U4SW[[
M[W^07+ZEC*X,3^@?-8JIV:=I:O93 _R@O5>X'7J_EZ@\.9/X2O!)[D.0?GVH
MS+]8)P!]J4?4L8 X$Q&I(#FB @?NB;8\LA*52U2>%BH#$)JL"<T.F7$.4+EK
M$K0FH.HF(GKKKQGH';KE0*\%8 [/Z([8%4!%"WK@8CG1;K@94-7408?98;?S
MK7\T.KP")#P4+?,A-MK%FL=B0/*__Z$HA9>\HWW%8?)V=-I/3[B[?:,3$_,>
MGGQ'6T=G-MH#GT.H17042UP/(.Z[*'.>Q@0INW=ML/*VCUI+E!8NO\ "BF=/
M+'U?E]M]#X9[V.E>W))7*DXJ3-H-3YKK%--VY>ADNUX]W_ZP<[3_>>^\]@&N
M;6U=5#\#3_BPQZL5QP^./7S^-)YBXML?/HG$% X^;!X=U#?PP7&5[A]OG>_3
MZK>#.CSW\JA52Y\W;UL_5$Q@T2G;*CCB,=40D5:CH'.J#$2#6,NEM8^WP^V=
MC./7AAT?K>$/*9%PNU[_]S^TY/G;%WZ/:5EJ&N]8GQ3:B[[;0TN>W/Y6A9SX
MVX>,]LZ#P)(*UFYC4@MB67R1+&OW+NZX$!;VY!Z^Z+YW9SUX<J^W6/6$GM6G
M@R^OWO3I-E)B!!-(,D$0)\HC2SA'F%$33(ZUL_B:0?[Z<LEYL-2$/1NW!V[S
M#ZI/;J2CGOM0=-S[0;^5QOK+QGKQL;YQTU@E=H1*Z]*@"Q@KR /9&#&*T1NG
MO'2"A/L9Z]1F!/Y:L>V72V_%'R22EK/&[=FO1KQM.*(8A #2U>X48PAGO4$2
M"HQJ4 KSE@I<G6[QK.9%>OBW!CPZ04L;7JV3N,'71J\@<<56.::9@JA4$B.=
MG+88\*;K>UE:Z-;P=TTV9[^9WW^83WJ!@EUEGO57IBSLC*59>T>AV;QR1[^!
M A;ISD&UH!\G$^=OS&@?[O2R6O.:AB2>GK\GW5U(1O"H97SDBR).:PH]P"@#
MC\YYCE2,#'F*O8M1$B)_5*U[MJ$MP5"[6."50*F8>=S+.F?]PI<EIS::I#^$
MK$:O=Q:Z:8B$R+>]P6J.4(SDN,'$YMY@8K/IC:YHPF-Z?7"):?37%>,@J03T
M P9/7J!_ZK=VRSC%^-X-U][]1N^9?K9^VFTTTP0%_);R0='F8@;!T* WBWZ!
MB\_:C8$Y#YZV=-/$)0O1"26X8CD/VALJ\VBY"4%B^#D.]Z'BE"^!SW$-",9[
M_US:JFW>,D&J:&PQN7"W>-3V]P;?-'SH >0[Q:X[Z89 +"$R@GOA5P8#M<M/
M'.XC(&@XA_;A+X$&%D@>D8\B+1'7!FGM.0**K[66+O>2IU(?RTK)9:*O"FV.
MA+UV+^V_:[N;N1E,G*^-AJ[ORW7:&40%J]V0YAE]#7?NU#5\/OY^B;&]3O.L
M?_<E3U\^]3X;:EWC_->WO7KH-F=R:73-4?=[X'D8D.T&<X),A/=;-<UOYJ*W
M]*;<"VV1]D(C]%EJ 8_WR.VKW&^6H"VF>>R>V5[#-TRW$7KWP=N9>A]@:.'\
MOJV>*Z? 5K"@TZ__NB*Y>H$I&U>K:%\4X.\HTG4;+CWA$R=P"2C/0R")X*6U
MOTRWGY%BBA8A;[/-JT3;5GM 3>&^M\#4KV1!)^B&_@'=F$K>=0:>2,33/W*J
M@R^%?)^9'CVY]=SVQ$=;#P.OT0^M6ZVG*-#6NL/'SZDJ/\,3IZW)8]</=B_Y
M\48D3\4C;].XE^*T/V[+ TP@3POL4_&&-$@#GXJ%OL6TF^\&D AO*FS>"MEO
M9VUSYAMP_/>KU75U>%K("BN9URZH#M:U; QV>YOK-TF;G<WU&V1LKIM/YKKU
M1;IUKM]@OK6G",,IGNMWF&_]H;]$]Z83^Q8[L3U_;G,^R?L/9%6RWY+]WDN'
M]#W9;QKE[X8C."^MPUY@+JP7A@OKN>?">KZYL)YK+JSGG@OKN>;">@&XL)YK
M+JQ++CPW7/C*UDLN_/(V-I_V3NF=7/B=:9JV"]GN40C AZ_SWL&LQ;D%N?32
M\\T2TQO,,4M,S9]?EIA:/]\L,;W!?&M/P1(KP85B[C$CR_-,&=,+S;<RE91Q
M/BACDA4O*>.,V-B<VKNX;_K4](ZRS6;G6^_6I.G\ IY("U^Z(<SU&V2+D?%-
MKS+G7%[,-Y<7<\WEQ=QS>3'77%[,?\8WO<-\ZT])W^>$OH.L1$G?9\3&YM3>
MU7WI>U%SHY=*<A2+H(\Z37A:;[B8.]OX]UFC?[%@S%[-/;-7B\/LU=PS>S7?
MS%[--;-7<\_LU5PS>[4 S%[--;-7);.?&V8/LLI+9C\C-C:?]LY(JJ+=AS;U
M.]D=%/^VE:[7.7P)%W,!%TG4<M'AH@2%*8!"3H:KW>G5:O>J:9O#PO2O"K-5
M&CUWUNNE^FJ)LJVW3?.BURC2 -\1(T'*H 9L.F<G],Z:@TS!]FD8M/#7%LV7
M\/'<\)&4@BS\U-$2/Z: 'TH,\8-=X<>G5*FYT2_JO150 #\T1]\3DC0[O;-4
M"-+8SED?X*9[$OK93J-W4L+#7,!#DCE1)3R4\/!S55%#>.!7\)"*Y'5!3 4T
M_-7MN. 3&I2V/Q^VKUZ#[=^B)#^K0#<E2[Q7/;AG0H4'MN7^2J3)L$#=UM85
M+&P7NP$L1G6ZTA7-H"O2?**NV\=P"'%KX8.*S<Q+)S0?3BB)DNA%=T*EU4_#
MZN7(ZM>OS#Z%FMFF<?U.M[3X.;%X65I\:?'WK'Z,)U+:>^W!;B.AFZ:QF>9@
M%Y+A%+7=X,ZZC7XC#$+2O5Y1RWW("DJ F ^ **1>(D2)$/?2E5&)Y_P*(3;.
MCQJV\8MEG4MS?WYS!Q$.9X[=8>[E!C6C#6K(-#:H29L*E#O4O((=:J:MH_=2
MT5LV[;RG6K*E^6U[OG0+/$V@QD )&FF^5G^5/<%>?O=*_"ZM53<J6YOKN_7E
M;*OV?B5;KU6RW;UWNUN5K?6=K8W=.S?9>7X8O+W][[=KE8W:[D8E@T^[VQ^W
M*NMU^+);AS_5C5I]-]O>3*^V7=W(?MNKK>]5MN#X[S/_7K_MK>RN9#[M3=0M
MEN/TCSIG<$/?6\["N0NG_;0I\V#WQ<RTTC;+O>R_3>OT;09OTP"U\FDK27/W
MF]YG<Z?GW3A)BQ5,]:_LFR3TBJ)LZOLF$;5"V/WVZ'O8,3[8T7[ZC;W?WE'W
MC&/N#)/T?<CR$.?NHLM3-:KQ?;PG;(KP_QJN\LI:G6*AU&"/\V*M42HE=&-W
M^<?VS\1&C(61@<D6<W)O;L(XZSU7$+JT?^J-'OK5MWU5749O4ZJQ@(7\:!O/
M:?3: WO_21_Y$[NRQIT<=L&5>304DG,A !/_U9#\2<4^R1L3QNR$KZ%]%L:-
MY2%OB+/9?L]"O?_S46_X=CQ#,DNO=N?FTV<]/[;S]"]M+O]]"VK$1CM0G_70
MH3&GJT/UV>QV6L64*FC"YT;_Z/U9#[HC=#?.7?,L=>-ZVEF\%WS=G-]O6VKV
MPMM2UQJZY5J;[>WC/;Y__.ZD1O]L '/GU0H\Y_+HJ'99_;;_^:"U?_EG$Y[#
M:Y5U^I'M'.VWSIO;K:V+[<K)^7[][\;^Y1;9/_[T[:#NQ/:'/6CSN^.#U@:K
MMO;)067_<G0-/.OL@.[E^\=;?+N^>53[_.=Q]?AO>.:[)K27']2W+JL?:JW]
MNKLX./[[I'9<B]4+?/ZQOM&O[F):O3P1U<,OS#.CJ,3(1F405S$@Y8Q F!(7
MN16.!;RTQKA:UFIR)^O!SN:/L90$K ^TF!\A]L\>.8[Z)6PM)FSQ8**B&#-)
MN+=$*>.U5CC(F+M@3 %;= 1;M(2M68>MRS'8\A$[9ZE&6E,"L$44TBQP9")W
M)"HN=,Z7UCB1RSG&,P1;#R:(L?C?K<\F?$7,+!@57/%]I]=/^=M>&KN^,[RB
M#WO]6V%XKL%JVAPK=?MV'$)6"4/3@J':^PGVQ*5R7GF*M)428,@$I(442 ?A
MDEBQT6D;14R7A7XT>_H!%#P5>QI[Y)TQ\ZLWX6GSC=*$G\J$QYF$B+D41C&4
M4Q;!A#V$0@9K)(7 (8V%Z3PM'"-BF1$^0R:\4*FFV]/9'[J=7B\[[79BH_]+
M[&'XRO?*X\TB+MV>>'U):E&(Y*]"(B4J30V5=B>(1<YD8)%PQ$A0B!,6D.4I
M2\.5E5%SJES:H(#GRTQ/QC<C8WD!I_EKH=6]+?2%TT4EZKP(&RI1YVE09YP+
M::9<'@)'V J"N.$,6<DYXE8(G=N<$I;J<D,X0U5>HLY].=I#1D1_/0:;]WM,
MB=#.26IL-S3AQ\/E[#"T0]<TEXM5',:W&NU&K]\M9O4^AO/.LH.9O8S94!H?
M!K)8;_OU&X+8.#]-5>=*WS,UWS,Y$&FU!KY (\I%A#@\4@UDUX,KBE))A7.!
M=4QK9>BRDGJ&,OHOP"P7V[:G31Y+VWYVVQ[GE59XP?,<**75#'&&)3(YE2@'
MR>:4N4A)JNK+Y3+1LV3;L\;?IC4';L8:^0I2F5MMUVF%+'8[K:QSK;#D8A*\
MV<M;#HMYM@\'@OC8Z?5*Q)\6XF]/YB^]QI8IEJ-<8H,X43FR(A!$<I)S*Z45
M A!?L&5!R/PG$DH>.8,0,FT>64+(TT+(.&F4CH, ;8ZBESGBSCF $,F1\%)P
MIIS2W "$B&6L9 DALTA79_H>"T4Z;\\Q#HH3AD& >Y_53;_L;%[R'J]K2N56
M6@86>OV?BG4AIV3]]KPQ1 _>%SZ-,X&1# 9$8)A JG7:G1%#J(5^Z?T?,L&[
MOI4\?Q%$U(ZK8KN^]459RE4N'%+8:L1U" @HG$M3*Q5$%\10%U)1W\GPX?=R
M1N4BF._C^7MIOL]HOA<WS5=3$AQW&&)_XA%7VB";Y_!/!.HN &Z]RI?6M)@-
MZWU=8\_WXX5SGD"890)1". ZXMR HA)['H0]U0GJ@-.Z"\828<@98 ]VR%!!
MD."<&O 57-N\J"_VR]!3YOUFV&R?C#B49CM=LQVC#%YQ%J5T"##7(1YR 6Q!
M*&0!7$,T7GEEP&PG)QZ^B-T^-NWP&.8_MU.+9]DIEX8]'</^-.&/*;!_)05H
M,;$YA/(Z1UI)@GST.94<),B+_7GHXX.!F5E(4%K[;/ORTMJG9NUC;IPX:2QF
M&A%# ^(&[-YPIQ'C7GNFB(XR;=1YR[C_[%G[5$;4IC@ \G03P%ZTD5,:PIF-
MG,M#)H!E-L1.-V2-P=&^.5_<.AFS-RGL^T2.45V?1OL,NN_[SL_O"O$,SJLG
MX6R<][L&]+O1-MV+5(R_!XXDM;+;*689CW++Y<R0Z;F8_0E"2;@CQCF.B'8&
M<9Q;9!WQ2#-L8_11&L6+V66,3DXGGI^I(>7PU.QBT;1GEY58-"]8-$9W+>.&
M2(F1TI*G=4L*Z3PM8V)Y-!YS"_X*L(@O:SG/2V:G/]@V,Z1ZIN_QNF8W_=7M
M?&WT$O8"9+T*5CQ[:V&O/,PP(?(NM$-9>&&J7N1PDM%:J9V-##&L@='*0)#%
M)B*KM&?1F>A$FNT$C#:?S)N4M')AC/EI:&5IS$]KS&.4,!<0G 8C$+,<(TXI
MA*<<,^2I8$KQR!RAA3&36^8_E;QL+N[Q"E*6M= ?4K GR\O/6$GUV],"]R^I
M_N#7GQ&_-7NI6="]<IG=$WBKX_4)ZLF(]40JB336X*T$-\@29Y 16!%F%6.I
M\ K3RSI7\Y_ F)<) B7$EA#[M*%!";%/![%C 0$7P/IM*H202X(XIP0I*222
M1F*%C<5!L;1;Q;*\93E3";&S'JA<>V$&K^0[9VE3T1F>EG'?5BY4D'-[QGG#
M=-O0U-ZUS6919DVOX1X3@L^8TWWL5E&WO>&,^-6'I]S^"MW=).?IAC!TW+V.
M%&OTN'=)IZX\*2X]Z3T\Z>2J8"T$,<1S)*6(B+- D&8T(D]RRH6W7&CPI&SE
MEE!E[K/D)0 M-@ ]CN"7 /0T #1&Y2DC.>?>H B$'O' '5*Y$B@*KP+FX$'2
MVD( H,G%#&5FOR3,"TJ8?:-YU@^^I,RORV,],66N#+2J]%D/\EF3Z^]XB$Y$
M&Y$5:;-4(]*\$IHCDFO,E1-$$%[XK,DZ>B5I+B%HIB'HB4ES"4&_"$'C4V)R
MDG99)$AX8Q$7TB.M!44BR%PI*J0.:9!Q13RZ_'M)FTO:/%LCG 5M_EQ\"3XS
MT"AS& ;4N9=USOJ]OFFGU_BE"IWWG5E9EEI]TJCHW6TC!O>:UCJW-7GN]-8#
MS7[J&4(C@UH?V%/MK&5#=SL67KNW_=VJAFFO<GA[6L[=3<07TL@0!=9(F3QM
M5AHUTCGQ2-#H,:/8&IY6_.-EE3]Z!^6R\M9,6_FT)ZF45OYR5CZ^T-%Y(S&)
MR+'<(QZ-0-8)C(2U& .A9\(6&Z4O"_'H/,(,U>F: _)1N3W[^I!5-0M68V@V
MN<E03A/@5>+6]'!K<FD=,R$2:P5BT0G$.9;(,FF1QUA:9JUA2@W8R>/WGINS
M2<8E0LP8KRD1XED08J*$0] LIG6WW%G$G:((0,$@9D!WE Z$,5XPFYQ-:UI1
M.4>VS%W.#;]\;WI'F6]\;?C0]KV$:TW )_]]!L O:O_@G7[4TXL[*O>P+IA/
M5_ID,P>V:IOC#O5]I]7JM'?['7=2&6GJU2#>4&'+4;R'.,K+VY8*2B<T4.G(
M&$5<&8UTB!AQX-/:!DP)254J5O)I+6M_D)7,^$R#$O1>.^@]+H@H0>^90&\L
M.A 2L^BL1%$*A[B6$2G+"1+:DY## 1I, 7J/'MMX3M K:.N;OH'[PE\@=VM_
MP#^CMK5,][#1'H0G]"8(N9#*"D[;Z C^F=719'7UHY 9YSHM>/8%=$'6[O3A
M[FD2*C2F 2T[[)IF=FJZ_:P3L_Y1Z(5DA#[5ODDPWRXB+9,&XF.C;=JN :=#
ME-T/+7BOWLJ5K,9[9-@,G@JHG79ZC23?U6YHFG[C:WC[K>'[1R-DN';54(;X
M^R7&0@L@QK_SDAGH:B*@3?1F5US_-[6V@!))F:0XEYIYP0.Q1@E&6/"86D\
MZKX0O32ZZ.@J%CTUAP'9;C GR$1XP573_&8N>DMO;JH@Z-_U3K^KOZZI*@4C
M+%SR'?T5XY/UU\!" *P[@VJ=JV#6H9O.@N:8F6E+=M1-KN@?/Y><!&-+X)#,
M*%4C3=;QQQNS=IM6O*CV3DRW*8"BNE'9VES?K2]G6[7W*]EZK9+M[KW;W:IL
MK>]L;>S>:>:STO[WV^ ::[L;E0P^[6Y_W*JLU^'+;AW^5#=J]=UL>Q,.5?_:
MV?@7G+?U]T9ZT>WJ1O;;7FU]K[(%9_\^\V_YV][*[@IXMR8PE1[ -P!VYPQN
MZ'MWM_T^KJEP:]\QN'"G+CWEM!=61Q_>^D;OM&DN5AOMHF7%16^'MQ\"=P*>
M,3=:/&]P>(A)FJXP+1,L#=- PP</$6NE0*PQYS\X)O0*X^S.PWB%W'GL1[<E
M:H7E])=N^^-CG/W:77_:V/OUP4]2;3]- .J)4V\)L@9*-"-3!_& ]'1#R(#H
M]X]Z&5!\X"Y5TW5'&2/+-[CE8_OG6O#[@/3T;'=>2A_=9V+EM#;66*2.H[=I
MUT-&%*;=<?>XSY,^\A5,9/V%HG_WG=LV0Z_ZP/35;6\XM]FILG3?1&IJ>W>4
MFGK7K%6JN%K9P >5=\?5RT_G-;IY5+O<:>S#Y^J'_<O]S]7SZO&6N$I-';MO
MVY\/CN&:\^W/G\ZWZSM'*;U4_;R':_74ED_?:I6=QL&Q;XRGIFJ7Z^*@5?U6
MK6^(@\J&J'W8@/<[/#^H?R)5^O=QK;*.:Q_^;-7HGW&4EJKN8EJ]/!'5PR_8
M0!@GI$$16X:X]1QI&@TB.*>*2JUH+NZLW#?W\VY+/%I,/"KKW,T+'EV.X9&E
M4JF84X2Q%HA'K) "9X*"4I1R$Y@T^,XR=R\^0_AQ4V6FN(;J3EXZ,ZN\'MC"
M5T";BZW!LS0PT0U'H=UK?!UMZK><M<-@,,*<K_[2$K]75 Y]3K:IV>QTX6L[
M<V?=;FB[BZS?A9LUBVQ[N5'-<P4:A<V]OVYR S\_E,[[H7#J23:#YJVW??V[
MI-;]\5FOG\;]@")LQ[HY_ZO3+0[T^]V&/2L2PO7.7P9NTR^YP0.X0:TQ$:L0
M;'Q41**8LQQQD1-D#6$H>FH#XTK0X);69FGU?[FWS8P3^]+^9]C^QV,#$0F1
M+)7]R'VJ0:1UVA-'(1E\R(7!U)I4-P_/$ !,B;;.":?9:W<#M.(R^*P)@7(J
M39%FU'P- Q/)>@'83J/?^,6M^!9O ?0+,IR4R5C_:AK-A%  =[N 3+M7\IG$
MM9M9C]@X#QY=AFZG!+6'@-ID E89X:7. S+1*,0UITA)*I#!''LB=*0B3U7T
M%27T[0QE/,K*!_<P_-^>E]OTX'WAT]-!0&GJ#S'U<?["2>[ OAD2%J<U@LXA
MC95 W@D3@V=$2+FT1B;G /\^@T4/RO7 <^/FR]!DNJ:]_7["BT>51V&,1\:3
M-(R**4K0C:S"#'M!L=!T>JF)LC; 0F'!<R4U2BQX$BP8=_/!:M !8Y$2N4:<
M!@MD/E<("\<)<SX0XL#-Y_,"!C-<!N!Q\RQGJY'WY%NS/9!98-_[6X8PR^7]
MY4K7EV'&MSC"VW-:Y4R>1\SDJ4^N]"<Q4(%M1+G6-F6V!(2[X R)D\(1G]NH
MR&!JH9S6I@'E6O\2 ><? :<=#Y0(^%P(.+YGKR52,L=18 "#G%J%K" :L=S3
M0'0T09+!9$8]5PA8+OPO%_[_<.$_F\;"?TK+A?_EPO]RX?^T%OZ_6_^X7GN_
MD>W^:V.COKL@B_R7LW#N O@Q@.WLJVF>A7LO^W_^1?YR)<_Q+RWR5RM2W7WX
ME]?-ZQ6"]1,L\F=:/<4B?TJ>9Y'_O;)N,[7<>H!;5ROZ;??-?5>M+VIG5((+
MJ2#R]?Z8B<7HS[T2_16LI[E]NZSUW5WP<^5RF7M,:Y6S+<G!-.Q^MM[KA?[=
M<T?+/<ZN319FLR+2']2#!@*7N?0A_/NL >1M$">4)2->P1)M'2+5.!+GC>/!
MY2H2*:/B&ELE,#-?MNXYN@/JL][VZ<_&=R5:[[\WW6Y*\OR=0H*YR')>5*^*
MFQ[2@_JGR_WC+5:#:ZJ5G=9^:T,<?-@0V_5#6FNE9]5.TK7?BYO^V:S5]RYJ
MEX=XGU;/#RJ?!+1'U(XWSO=3%K/NCP\^;\(UFT<3Q4U;>Z16WV+;E9WC_<O-
MDUJE>5*MG-!J??.X6FDV:Q3>Y?.GB_W/F[$V.?5)&VD4Q1$I8W+$HS=(1YPC
M'XF/,6WJ1E)M4\J6)5^4$A*#1S52:K"_BL@*T659B<7'+.9S:AW<AA##@\YU
M<N68>*ND\TK+ K,H:'J)63.&6>-3M&*4BA&6(^QB3%M)4V0XHPB'R'+M%8G4
M+ZTIN9SK&:PR,9T5\C-.$+?:7\$J.MU?72SV&I;#3HM$C?KZHA;Z)>Y,#7=V
M)[E2SJ*GSB!".4=<JAR97'' '>ZP(B17EBVMZ7Q9Z6E-#YVA&2^EW4Z92)1V
M^T1V.\X7:!ZH#M@A)D- W%F(<;AC2 =C<.YS)@U-N[NI925FR7!_0AA& UO0
MV/!C6W^N,Q>MP0N5L_NK&TY-PV?A_#1-B>D5^;O.H&K5,$-K?IRA7<A%OB]
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MRXC*F%/?286T\0[^=(Q$&HFF:JF4^A7$\$PY+GIQD#5BD0Z,%^A]?9HXGBN
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ME2SW*/<H]WC\>[P"U^.?MF4[/J[7ZK;GCVJ,K-?RRO@05Z/K]D+LH=%;_<X
M4$-WZ%JQEE]F<G70/?X]8VV_VVJ&T975HR;S'25EQ.DDM8[14BZXL,S(&!V6
MA 09B?NR>S=.<HF*C,Z/CJI6%$JR.$JR.YB.W?:."Z,B\$9A$IB S"#-/)B
MD:L4@K&6D"IV6VNUH"C/1>C1,ULFSP852P2S%5+\SW-,_AR3ODS@.6O6+0HY
M#RYMINW\=]@<G!9<G!<7I_:3(]$^*AJ0X\DB[K5&AB2*E/9@L 43G4N BZ1@
M8L'$@HD+Q,2\LX"U4%*2Q"T/SG/OO>+8*:>,QP_!Q$(D%P>8C2DB*4$8F38!
MD10PXC!3R!H1D5#>!B*"]B(32;..KZDK5$"S@&8!S?N#IC:$A^3!6..8^V1L
M8A%CJQTE(ED;"I%\.ER<(I(@P )F0")AN4%<!8V<D1B%A(/1@)"6YUIKK&!B
MP<2"B0O%1.JHE5P(JWE,H&>:8H4YC8ZKZ'PADLL!F--!*5*%!),MD<4& -/*
MB(P%P'08 %,E87#ED11D7=/9DB$%-0MJ%M2\/VIB;U(".FF8%5P8;3GQ@CFO
M+?5:8;4HU"R9.N[OJAP=#+V(*H'9L%)'C(CA&L&$)62X\,@'EI0GP>*<76NQ
MJ3H*8A;$+(A9.2QCH@8GXH/U/'JI$U$J:6ZPTP(TK_#,98'-J6 \RQVG!'/$
MDZ&(,Q* :'J*<B2[%MIB+W$.QL/K9F%YRYX3-F^)^@G-_G'+GN:7C+]&VM*R
MM"Q"55H6H2HM5Z=E$:K2L@A5:;G\+8M0E99%J$K+Y6]9A*JT+$)56BY_RR)4
MI641JM)R^5L6H2HMBU"5ELO?L@A5:5F$JK1<_I9%J$K+(E2EY?*W+$)56A:A
M*BV7OV41JM+R<83JGU5I)/AO:/[8_%_X9_*+MNU];79&\?'TZID:'SN#V%L;
M'1;9_%_7^^?F>6S^+;>!'U4/G%P>1^%#CUOVN!]_GWSX8]+A9J<Z,%+]Z(_Q
MS<81_>)X)@B_ZN3H\A\GS3 XRD=,-O#HF,E8?\9/'E_>J"Y-1N[*-6HVN! W
M7L8;Y,9KO[JMWI#F?G?]]36F^<+[*C<,O_GJ<O55;U A5Z2OA&Q(8E:DLVI#
MJOOVY^G[JHE>F;Y23N]TUUN6_]MS%YN9MM<<E1S!^O.<#%37)A8^/.K%6&M#
MNZ-^+79"#%=3#-,K1\(>/$KG32^=#<,;2EPY'G;-";'E'L3&L.UBK]9-M6JE
M'J7[K8WR_=Z8HGG^L7AMPSK*H%RK3I*68;SW,&Y!7_,93]NJO;?-@'8[(S%]
M8X^; ]LJ(WO_D?5^V!ZV[ !0LZJ8.AK7RV53:Z.ZJ660[SW(^W%@X<LP$MH=
MV^M UV\NLED&]-8EOQ=M?]@[+<#ZT('L3L/G/<K+W&_P;CA/?X>;E.>5YRW'
M\UY3V9;MZ&-E(XS-*O*ZBD3/5X$E!.<]8<0I(7F,Q@C#C#+2LJ"H'*=_)826
M"BPWYJ&IG]2W_V)[[W9I_1VT/X-[;__=_%SEE6FTZM#WO<.C5OW=_M%T'IKZ
MV1;<R_-/WSZ=?-Y^"^WA[X__;L$S<)U^.&V<[<+S/IQ\?O<V3:H,U \PK9]]
M%_6O7ZR0U.="<$38@+@E$AG!%/)6\ERZW@C/<J&!=7%-2;B5+_'X8,U=(@"[
M7RZM%YD3:U& ]&+S43\9W)Q-P8W11F/!*?+)<L2)U<@Y'E'"R45*H@R4 ]S0
M C4%:E8":HA42CM+'8Z**POKI2/<)DD$Q9HR_!"H*;1G83A$IG%(<4Q=B"A8
M3Q!/7B&GK$$PD\D&:21C.N/0.B:Z8%'!HI7 (F.#85X;JR+G+.3Z-UIR'[Q-
MR0@="^UY*KAA4W 3E6*" \@$:RE863P!TA",N*/),(5MXAEN%E;/K6!-P9I'
M3M1.B24.&X^-XXEPX[R4)":7ZUT(90KO60H@$E- Y)GQ8 -S9&WPN=XN1<:G
M@)@W5!(FC+<RETG#ZVQA-8$*&!4P>EPPLI$"V6'4NVBXQ\(2ZHGPF#.&E?-L
M46#TXJI&/)W;>;KP=V+$D: YHI1$Q ,+R.3"W]Z3%$$@DK)TT44C"A 5('ID
M;Q"G2O(LR,%R)ZA1L*9Z$SGC#!,J"RM:$C2:JI(86*X0:PC224JPSS!'1L>$
M F4\>2ZY=FQM$^9NG:MEV@:;>TL^5?];I2WY1AS4FK^.R?O5%OPU+[P:6_#C
MI6].V;I^?A]UI9MZY(UQ)V66RBR562JS5&9II6=I#C;,* <CG-B4&.,R:H<C
M4&.FE9;.<DJ_;.<#2YA@@JH/M]8H RXP"L__3[??+XQX48RX\6;&3VBL9U)1
MBJ(>E0V/R(@ UKJW'(.-HZ(T:YN<K"O]X#V+HL$%9\LL/0!G/8\V:8HQ4X0'
M1[2VP1B-HTK21VL+SBX-SLYZ'D0,B5J.@E0 M"(I9$602#(?4_#.2HN7$&A?
MP5F *@0=.=N/^17;Q['3MWG4RTF FT\".&P<L0JX'J7<XI3=:? ?'+3Q(NDX
M-Q)5D_!GGH,WEZ9@J]>SG:^Q'3N#/T\OFKRWI_FKK1/;"Y</$.QVWL.[=T,!
MJWG ZF#FK("B@5DE(H)E!B/NE46:X(A@.HU)@KIDZ-KF2PR8>]DZ?C]"6&9I
M29#XFOUPS+P#8L&28)Q3#UKJ) M*2()MB//#\%;X-NP/,KCV#[L7^0ER>H+=
MSC@O086X;@:J.V'G9^SY9C_NI6I;:^\X?U]HY2*1>B:\F7,):VY">3L2<0W_
M.",I\$N9*"=,TYCWL]:I$@6L5PL&"EB762JS5&;I]<S2<WK""O%9;N(SXT^S
MQ% 3!4.,)HTXC019;@125&AIO:&4Q>5C/J\DCF?D,ZKUXO&PYX\JSQKH0BVV
MCUO=TQAK _LSWIPIZD6Z^7];!@=;/^/9VV[OT/[\V!P<Y<!#&$7XXGKW6P&I
M>4"J.>-'HYY)3I1!)GF'.'<4&>D9"CY1YKU+SHFUS5DWVC_*9MV2:G'94EV%
M6;H9:Y_6A;8?JQ24A]T[XVUAC L#XVE7F31@,S BD<IIC[B&3RYRX(_&<4VY
M8,3GH[GK7)@"R"NCZ@60RRR562JS]'IF:1YR\YANLD)NGM/2G':'9;< !W,3
M><\BX@)KI%4T*%%E:<"$4+Y<[.85!):=Y_/N9Z]P+?6Z[?''"\?8_;Q@*^OB
M+QLQ99;*+)59*K-49JG,4IFEQS-]8K+..*IIM(Y+)YU)T1$B@_5!DT3F-GTF
M;*[:XO_;MH9QR_]WV.QE*Z<_J,?!4;=DL%^<C7--*B%&2 K!@5%#)$%<8H$T
MX0Q%J:SR!OMHLHV#UT$('V#D%*U>7JU>N$.C:/63:_64YR+IY&Q,$FDF ^+>
MY@S-."&:L/2.4*U<7"ZM?@5!/%.NBUX<9)58I OC!?I?GR:0YPIBC:)Z]D?3
M4Z!H#BC:>S,3KL.HTSK$A# L*8@'0I%)$J/@1#+46$XT6]L4L\=SR_;PLBIK
MV=(JLU1FJ<S2ZYFE>:RIA>=MNL)-QJSDPH[::L,(#XHUM4 *,YW."6QCX2D/
M2!./$6<A(H>=05%@'PG,LDMJ <944>JE/1FU +]G'UX7/A7E?F[[9,8!2JDP
MF#FD8_2(IQ20LSJB2(V+C&CKD[Q1N\NZ_5)4_'&=H'?2[%(@X?Y*/9T8S#*F
M'#$(*]!LSH1'CB6,B.7<1(<#TWIA!1)* -<\7M"]P5'L53G!>O$H=OK-'_$A
M*<I7=H>F[(Z762JS5&;I]<S27,4XK;)4&JHLYC0$AX&?Y3@%+;TP7,W-QJI5
MY\WE1><B1VLC#O;2H?WYOMNK<D\,!KVF&PZL:\7#[GO;BYFH%4)V=T)V<%["
MD]6W=WE]ZPO5,1&E/))" Q\31B)+28#)R[O1S@B1'!A9<HFR2A25+L!;9JG,
MTC(NCPMW5I3E\4F7QPM_Q=G6Z=[VUI<@F78P@2@&ZA%GV" 3#$>6^.B3=L'H
M95L?7T' UAO;/ZJ%YH]FB)W0SPK4LCEB:] =Q6N-:PR^KE"MLF-=9JG,4IFE
M,DMEEI9IEIXU1F=[0A* 0[>[G6K/+[.'LG6_0-8\'9<C&8TZ>8Z$ N;,7:0(
MY)DB'9QW0B2!4ZZH8=:Q9"4N9V44N<#M*LS2LQXP*W#[I$Z*<5"%45(F)P7"
MW$;$$R7(!BQ1$(%*[@WC6BX7WHY]%)-G30285GJZ:*=DN4>Y1[G'X]_C%3@>
M_[0MV_%QO5:W/7]48V2]EA?&AS@:7;<78@^-WNIW!H :ND/7BK7\,I.K@^[Q
M[QEK^]U6,XRNK!XSF>\H*=@/02N;I V,1Q\-EIYHX85R'NP']67W;I3D$A.Y
M7#VQ,))%,9+ZX>Y@.G:;.QD9,Q$9+"CB'$>DJ031]T;FKVRB#!@)61=BEI'<
MS\!8A!X]LV'R;%"Q1#!;(<7_/,?DSS'IRP2>LU;=HI#SX-)6VLY_A\W!:<'%
M>7%QRE)SP7IGG41,<,!%2Q5RT1"DL#-1"$\#%X"+M&!BP<2"B0O$1!RT,()S
MFZ('.F(<#5X !CJOF.$Z/003"Y%<'& VIHBD-\89YRR*(<>G2FZ1U8H@6-*2
MXMJX(#*1I.N:\0*:!30+:"X0-"63F*1 &=&:@X+IY(G7C@OO2&*6%B+Y=+@X
M122]]<PSQE @UB,N! %36SDD5( 9,2P26>&B*J!80+& X@)!D8!NJ124\L1R
M!>1$8$%RICO"24@V%B:Y'(BY-\4D5=#*1\60Q,&"Z>TB<I(SI"B&+QRSVN82
MNIBMXVN2WA74+*A94/,A!V-X(E+:Z!GEA"O+O;?&"\6<X#B$1:%F2=5Q?U_E
M*(@/0//3V=[A]],O*D5"-39(2PNV=PP)&4$5$M&FI)S#3-)%Y^HHB%D0LR!F
M1DR:7*)1!BTXY< QG0-ZJ8W36&EC$BX\<UE@LSX#FRPEJU'T*;LL@T?6&(D8
M2XYB+[&B!(@FD>N8O@2?Y2UA/Z'9/V[9T_R2\==(6UJ6ED6H2LLB5*7EZK0L
M0E5:%J$J+9>_91&JTK((56FY_"V+4)661:A*R^5O682JM"Q"55HN?\LB5*5E
M$:K2<OE;%J$J+8M0E9;+W[((56E9A*JT7/Z61:A*RR)4I>7RMRQ"55H^CE#]
MLRJ-!/\-S1^;_PO_3'[1MKVOS<XH/IY>/5/C8V<0>VL+/BQ"\&VG16@^+7)X
M%&O6YXJ\MG/:['RM=;H#N+OMP=>=6A-Z]K5G6[5CVQO4NJDV.(K]""/2";'3
MCWEL.E6HOQW 'ZG9L1W?A.;] 7S1AO?J;YP?,Y@>D7$WN(!^'G?[S7PTX?=>
M;-E!\T?\XZ09!D>3$RV7?C4^?H O?F(=]& XN/DG2S#41$"?Y-6AN/QO[FUU
M$D91IBB6RK @>"3.:L$(BP%3%TC2] LC:Y,?'9WG-CZV7R-RO6B_(YO@!7^W
MK1-[VE_[YU41!/F[/.@WC=<E4:5D0U8'SVX8KY0>;;Q&&A*B[_9L-<]#D+E>
M;@7=L4O3E]I1+Q^E^G^WSYP"9<O@D-7H33Z%!=KQO_^TF]=)Q;-*K[H6*.H[
MV[MOMPX.UVN[C3<;M:W&=NW@PY\'N]N[6_N[.P<WJOFR]+^Q=[AS4#O<J[W9
M:VSO- YVMO.G@[W_[&YO'<(?;W<;6XTWNUO_J1T<PA?UG<;A0>VW#XVM#]N[
M</T?LR]X1X7E:_,M!]^&_4$SG3[3,)&-VO@ 86/8AEOXVM4SUM(Q+X6BU@H>
MN-'68\:TD3YGA'&^RN;/)MG\V>CHX-1A07C)9FIZVQELP<(S[ Q@V7D/BXAO
MQOXA/.G/5M=_?]Z3@6>-\Y.!<&T[?*MO__L(VK<^?=MO?SH,1WN'7^G>X='1
MY^T=5F_OMSZ_^_O;?]A^*_YK__3SQW#L*)?UW"]:A_N^A;[]W6R\^WS4H#MB
M;_N3V'OW]GO]T)_"[[Y__MA(];,/)_63+X%YQC%AR.C$$8_1(:<X1\YP0P2)
M6@HR.L/9[ QCV,KG*V4@0B5A#6:8<Z>-B4)[30-1A%GMUFJQ[^UQ5L7>$,#S
MX$.]OK7_J;;WMG:P^ZZQ^W;WS5;CL+;UYLW>A\;A;N-=[3THQ9M*IZ](PA12
MP;5Q1RI,',W7K9W9?&3I^M/VF_V]-"59IZ-_7[-T-;:^6 &SP;5%4>0:#H)&
M9$.*R/C$*-78!1VFI64E0*N:]+RNON\!/>T,1@*))O+Z'+RZ-D.LAQT[#,W!
MB#3?E3[GEZK'T$RV/X"5M^,W@):'6A.NG!QU6ZU3U#WIP&_[0]=OAJ;M 8;6
M?LOY$BC^X_R'U=_DC\S>:^-K;T8=.[\T_OHD3G\S[)]_T^U-ONP.>^,O_P$V
M@F\- _3A*/9BLU,[LC]BS<78J1WWXG%5,Q.^S4/1"SFQ?>VD.3BJ?8V="(9%
MZS1?B<?Y_>VYSL(OX:[-XQ:\#/PV=_M#IQJZ@SPRU:AL5?AASU_VW=;6^_,^
M)>AJMEUZS78-.I&+U\)=\\@=#WO](2P]N8YGOF]OF!^2K_3BUV&KDIS^V-*I
M'40_[(&5,6ZQ\],?V<[76,OYWIO]?A:RWRZ-Z<'.FTD/@"!5+PR/;9VNUWSL
M#6PSVU.C8_'YE_F.(V-K<&0'E<75R1?SF/3B?X?-/'+NM)9?[-*@7@@/O&.W
MW1S L&S4_M4]B3]B;WTR7-WC9B<_!%X$1!G,@RQ-ZS6X><V&K*PCZ<KRU^Q7
M@P,M1X]?AZ?#:_>J$9MN"[07GMR)/O;[MG=:#;2M)=OLY=F^T+WQ %Z(],1<
M&P]U?]@:"7?W./;&@W[QCN<BE1M?]!\NMIKPFOWJWF"#^U:W/^Q='L&V#7%D
MO 880I"5/,]M^SU6/[D\_./NQFH2:C"=K6CS=&U4FGN#BKI1;89:_RA&>."@
MM@TCT7:Q-SI2/ZG5 *_2'[T)C!=8LZ#;O6Z[ZD)U^1(0W*+^\(CJW7*3BV$9
M3_)8AZOL*.J/?FVK VMQJ[9?"7P-WO$MO&V-8/1_U3R-)B2G7JB=1MNKQ4Z^
MUPUO,%&KZH_S^YR+]XUT?PG6B)L='=?+W61L!F#*@03!G8[ZX\&Y4H*#C75T
M<"[_T$N8BP PE'T6^;:3)U23UK:G( 6U^/,X^FJ&KY^$K&C7S@+;6-0JTC_J
M#ELA=Z8'4I[E!W[S;=@990BI #EW; ZYO 1>  F#[CJL1TT8JSQ$TW)Z58:F
M9&>:8\XK2X]+)_=Z7VVG>59)RIOS48$_QCSS,N'X<]@'J>OWMX%!]9K'5;WT
M3B@VS@4+_4OL_?6%!X<9R5GQ1"YW3H5$3@J-K @P.9K+R-4,"WT.5OE^:D%[
M>ZX(!Q>*\/PD\WZ(,,W:QG^/8& DLN<T:+S. *<!^M"_,-]'%&L,3A>_RM@P
MZ,%KC=+-7%[88?UN0V\R93E'@6D;\UXKRN.BP/M>L]M[#[?NAOU<!QZH7ZI
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M#H\#5[DK@]QK#$'?J4GF6RV47D[D(3SY^$SFW^4!*<=.)%V;2/JP*)+2,$K
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M3734HFDPI?>I!E+Z"]/+B_(;H)$$Q4>-*;4DF2JD&D6JE6+[X5QRH3W]\^2
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M9M'4ALIJO0XO7+0[,M9QZH992HES.AMIO>MT3JT!5^PF%?#6YZ!J/M2^(<;
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M8.>+7M- 8Y5$KP=]J5Y 3:%<.YNT27F<EE5KV-[8!#NO&#XB+U%K8Y)]"]B
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M%_9@G0;L*6P3[;1")[/LZ#N]Z(*K;/(%C6=/%G\=E868X-YGX_.."U<<1,\
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M9ATD<@"'#/"49^@&'OM5LVQ-OM,2F-["P:W]Y@!W)R.=_3__\I>\(GK%8!U
M/6F:E0--?T >0WE2M]<!\YD/F](<G6XP&N59TOC69A9$B&YO57'7+"NC:QYD
M8$.CE1*#*O(_]YKDD.>5RAP"B9Z1<%7'GN>U)$#Y.EWT$@FX9OS&6R-^<U>Y
M,F,Y,)R^\0[4RYBBN_K0X ]Y_?O+K$KR0M4W\+B8D%?Q&Y@^[[/JV^[I!;WX
M$A:/>:+DN6E4?HXI+D"855/HP04(-^"CEC-NH.] <($\OUC)A&GTJ/&)KEI2
ML#;^YHH+5;! W6K6;!$%?&=8C)5"4>H$*#G[KO*]*/(IT8TD?ZA%S8(,-)3(
M5:=-%7@K8,MQ.5$JGVSODE,.#,H$4/T398^@K086QY8G?5T>I(-#!<NOT(E#
M@]9Q+_>M+CDM_24\5[)=F\P?!&MSTF3%X1$HP[\ P]18K"V=BE);L.I8EOOJ
MFZSC4D]0!05=3'*AR(/,6Q)54VM5)6[1[1O#M=**F%.FB'I_ JAP;ED*PG>(
M=1LHR>OPM\HI43G.FL:F=#_5-+M)**5&S+&40U09#>"M:0*V!\^Y33E$4.A$
M ,$ JF)Y'.;J*B+<J1 _:0VW3U9A6>A4G[=ED4B!2F+WB.* #P$I(R/V=*RT
MYO47IYE,C5=-KM,11A,Q#()PG#Y[W4A9_5F/&&1"C(:I7\JPU,;>3,(6N<+T
M'P$7HDA7B;XZ=:2V#D6C@ EE-5L^:K:\IY)_0>(K%^_["<86F,--YCV63^AJ
MY@G]VQ08[25C^JI&_+W5E?1@1*RU$@.CH>IEE*"10[J<L&PV!"DV4.^F[5NA
M99.^L_(_3YKR;Q6HKII8;(IQ851;DQA0\>R;&!385ME^/;6DJL(?R2PO@1X$
M+5;=4U)X98(R/U>($".FY!C(SU7A6M_XLS9=*&K>.DHX(GP5M=L8B2K%%$,J
MR)F15#% P@.XS:K3:9S?MIAC[*/60?>FYB*R@QA[1A^<E*2G7I=P,.@;( ^
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M7YN40S*A!NA0FMF**_LOHF '9<Q>GQS8QFM5ZK&3\F4=5Q81/[YH7=.">4U
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MKM1]-,0%I! 0ER[\?3-CYT(A*5<1@I_:A\2QA^C,9'Q\CD/_3P\"P-46=P"
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M7> 0?Y=$H3EBO^>,Y/4;5#@4;$7S_[O[-G;SN@\J=NC^+;QWR#2O]Z!"?7J
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MV<E:6%A=Q/4R"^BN&'N5I&3HIDE2E!-IC2*!.T7 EM*54R[:VF;A&@%]+FQ
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MFQ^O1!169:*Y*AO!E",6,'5TR UC*84L:INYA[#<FR6+^@A84P&;!(+1R;J
M(5?RF)E)@4;=*>Y)YHFZE P3H7;06]^H;:<T*CKVXP,_0O>RX\]&G1\/$VCM
M)6857)<][RR5)(,+DC*D'-%A,5,;Y?>0TB=CMR8*;B7Y%81?#>&'T/G1!-+
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M!7\[_!-'YU_U3_N3GC(@#9 _1N,SUE/A0%+2/]QE[[GSQN5.*-V1/$^3Y;M
MC@[V^)O*]ONG3S=DLP@>A$E,&)UKR4MBD>O$C%$Q2X<^ZLUX)&WD^4'\;9%C
MEYJO733]^#M]<#*^[,CU]U'M)^>=Y^1I22:#HC YI=K&* 46$ZUG,3H,?C,3
M_5IB_*#YAJG008>VE1VS"Y$.SR:U_7]M_O OK#<A8-[[C"/X@$=834H_?SD<
M3$:0)F=P\AY'I[(G04,$:YEQ%'AH6P0#!V01$5+),LF8.HG@-ROFTQP=.TRE
M+IK"K2GRQ>)7]RD7%%GTT!L;%8DLH(H<2V A@&/&Y^R5LMI9L6.C9P4Q?XR>
M':-2%ZWNUEQ.KTT8;TBR_F#<3],.,B28L\8J8,H'Q;1$<AE=,JP$)1/D@  [
MT^+V/F&>YDC8.BVZZKK79HC?%$STN+8J%QY9#+HP[7-D'GWU(H6'I#F/I?D!
M]<ZD>9J,WSXQ.FC]]VXT3(AY7(L6[NB$&:5VQ@@FG"2 D49G*!<UA4+Q@)A:
MNS/W@GIR!&QKI@[Z]ZV[)EP*\BWX?C^<P,G,\@ V"=0 %$)HSK1&R2BT %8'
MBC(1,+O6G<4W(=>38_/.D:6+EH0K-8+E(%VQR;-D0#-=BF=>%\YD[=T#*A2/
MS3N2/X@6OKO V"Z-V47/PY5U=GXX[LU@/!E-;UL=3T^WOO\(@XL!6$L6KBZQ
MF(Z^U] ?G0\\'8+@O@B60BTQ\T(S*#&SDA-8:3@6V?I ^G8D?9JC8+<)U;+Y
MXRFY52N+?'!637E8KEH)G,\AM1B8/DD+&'T2/F#/:*6X"(;9(/WYW671*<,P
M26TEH!>SR?9;A8X; ?IDV+Y[9F_90;);Z<IP=%KOFKZH!?*Q4.Q!/EC)=6=8
M&XI'ZABV23J',ELMRU:Y?1/O#XIOFP1=-,3<.YE^!O-\B?>_U"^QWL15BM&:
M2066] C( C@:D-QS[CT@-B]Q60S9DV%EAP:;PZLV>XL;\(9ZT@IO96V6KFKO
M=&$M"Y(B64$AK Y")Y$["0HW(-N3X_9.DF;.Z%A[[W#_]-/)\"OB,8X^]Q/.
MEYLBZ5]Q0%:?7!Z:FQWD*5LLM7,.H*Q=BPNP$ PR<OQUI#'NL+1N8=4&^9-C
M]A8,/H>W:^\!+B3&P7#P>3K<IOH;3^/5Z[^O]Q<<#"?_C9,C3,,/@UI<>?6D
M\S^:';\]]$IX 9&56"."JO=H)&?!4)@;>*28H/46X=:$_3$Z=I)6<P;4VCN,
MG4E^OM"]'HXN?E0_)WK9*)-X1B8QT_RAN&=!8TW[%R^E2K7CUD,917,E_#%T
M=H= <\;+]G92[_40;U8W]X0&DV2B@ EEK!YB/:]2)$.K(7H2W-C6W:(W)=N3
M&R,[29HYAYS6WU5-'S&?G=2[I^\3>7R7S.=MA]!'E;66S/) X[R$>N]+$!0E
M)8T%/?VZ.?U;@=]8=[$MLWHKQMZ91F93^/3A:5\8F9&CX\ P9,VTKGHDF5CR
M*0E0.43;O/78=0!;:Q:V'0[,IB17ML7&CC@OHH@K,0:Y'NZ[UFIF$9DZZB;6
MA3Q;ZD"V.DV67= W9>.'PE^77 PF<H9:2*:YJP-;.B:CHE^9'+UJWDGWP?#V
MOGYFNTW;94S;Q5T[E_'G5=WMY440@J/413#R>@7Y-D75>T$R?>NT=)B%<9WE
M&F;![&#(T[FM[TH4K&6H#GKJS&_%%LC[R! ,"\DKIKVOB09/DG.T+D94#DQC
M]NQ(W[N=8\[Z!NI@WKE627%>8''9P@^-H*E9L>SJB1'PN>Z01%:X5R5A*JDT
M/Y Q'\H/YC0Q4L-F,+6PYS<8_8&3*N85MJDZI@ O9\3@ P_2U T!5ULM.P:1
MYL9@K*J7IH)*<H'*K$7>]819THDY&K90&8\FO6DCEZGC9Z21R:7"I"2F:JF!
M^43>7PK%"6M4+D4N,K'04Z]-*O3=U81RXX5/,Z6PNLX;SA/?0%S><+< C&6B
M_T4HT'YVN#]07T/YL^9;0W,-G859.-IAC,$IYB2GX$T59%X3+9.@%2D54\QB
MIS6W;< [(M;V]EM&88WM]AMIZO3L] *(""D94]L\%TU ;)8,  /S.:8L!$B>
M%]J/N,=R-UZZN:5Y+;4/6^BL85PW!0)?K@$A_!JM++1@:Z10(246%"WGSGG#
M)=HB%^L7=I_QKK_T 1IO99UU<=M!7<9?P>1\*HE%)0N.?"\Q[6%G'?.>5G()
MP3D'RA3=NN';#0!/TQ=:WQ8=]!/\!N;RRN\%X'1US\I-*%O<U%C-.'>9>0W-
M=CD37%['0IX$\H LN4#36P!:4+P-+"51CY$[I #^(1IZD5V 3NR\C$(;VK=&
MW]/RE5H67U5^&6Q;R[4@$"4(FJD2S90D:+UQI;@L!5?<SFP5S<U]S'GT%JX0
M64?5PW9ZVNI=(3/IV[TTZ7_N3[ZVOCGDGM=T=X_(,O+-W"K"HR!K*0!IA9;!
M@<PR:FN%JAEL@#MN%;GGC5N_8T3(2-:24*N8)<U.-$^%4@JS"83G0<MB.NFQ
MN!;JW:T,_58]>S0\.7D]'-4_ZI4HA=-&,L2$M:TS9UY1A*5$)%U;E6+S\PB;
ME7 '$]-MF;^Y*M&U"=3532;=2GM^%+I7@N-942B<( :F)1G&5\-@%DZ%$J1Z
M0!U/9H1[0(-D RS=_(!:@6+;*-EJ55^NC=(R%L\R.;),0[ L!)491@-<*.YC
MVIG&L(_W4,)C&DEK$&QCM[1T</Y;H0C%R<0@(##M#3(O$WUEI%)> YKF5U7_
M:!KPJ ?2&@3;I5M?[I63K%"P?UW42!;@#CA#HT2]DH]\;I4"HY":<QF$RZIU
MI=X&Q?LQG+8RG-:C65<WS6S$F>5.HS0N,5J'#0D:- L@+),&A"Q*%RUWYG[3
M]>*EG;3"S/434P>III"_=5R\/GBL E6"JBT7Z[8><B*E#YGEX$5Q1IEH'J"M
MEE'! YH?'TR:J#,*/JC8=W%U]*)%" ")&0YU+T9;%@W%+MK'HCCX$N3.7$C7
M4.X'-/9V@?P[.)"78NZ#&KTW$POW*Z*4Z!WDR$2*U;W3D7E!W\J8,2?NO% [
MLV?56O@?XW@WQW&7''[ V;/[%0$Q>V-(<N4I8-.8+?,:"L, .F:CH-B=N8JD
MM? _!O-N#N8N.?P0,WAG(QS?KP7TJD!RL3;XRO64IV10"Z@TAZQ2SMS:UH>X
M=T/R'\-X-X=Q9^Q]F#G#^W5@-=HBHF'6AL+J?7IDQD(S6LA:Q!!%T:U[!.^"
MW+O32LU+;P-(1=&=J^=!R#4,7#D:1QB-MCR!;[YI_P1;J:V5T]N*L7>SE5H)
MV5E(A9'2:+YP6;%HL4X?,@ JC4;]:*76C@/?;:6VC"T>2BNJ163ZT4IMJ59J
M2]%D$SVI5K'Q0^%OUCIR;9 YG3W3@MQB'VC9L9!M=I!2S!OWIW:&MTNU4MLY
MVBYCV@[H.K_/4LP(.FK)C'"TI#A36!20&6CE@Y&*<]>Z==]C;H2UE(T7:H2U
MC(&V>A#L^.ST%$9?A^5:KYWXK=?.>6OXUJ?"EGEG=T?$5I9\YKP89I\#F5.J
M>F!0.Z^*2< EAJ#H&WG'>;%E7K_UPV,EEY(H:&(VI\!TAD+>JZ%1PJ5-WH"
MLC/E?&^;'1ZKX_G->'R&^=79J#_X<)XEGKYU/!]>#[4WT@$RI>O6K:UNOB_
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M&!^9+X57'\4(;H*UHO5APIL('JS-&RATV=/I%S^N_T1ZZ]_^\O\!4$L#!!0
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M%Q30TMO8R.!%V.I8'5[/02.OKZ]^&\1N!EDPX'IFA5W,IFO,P.^UL$$=WQU
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MQB;]PZ*PF>P>[=^;RTO!(ZE)I*%$:01)HA/(!5509PH1(3.BJ=,NV+/?L9'
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M;,\9I7J.X>]&(<$P?9WR/4T^U97,9JMNI :UV#W5\CD!4A]5?8YU^7KU?4Z
MT%KIY]2[W3CIDUI>S\7B07U<E.6$:XSR%*4P9<:6)D)%D"M)8*QQ&G-A&"E!
MD^5BR69NU+/5NI<9O>ZCOTEAA /32CH_&MF&3""99Y1+F*,X@R3B&E*M*,SC
MG"F$9!8CZI=:NS-HP^35#@.;V: )0;59UV(A;8*4&.9Y3*",<!+C7.!4>:4
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MWR^^_6S>J6>H^<O+Q-QO:9#)>%2!U00\_D#GRT8;JG!;++Y-S:[F[?-OI8T
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M\)3@=RLMJ,0-[BET"I>@SD)'.WL%?Z%3BA]V&3KY5D>O(6$LT*<JR5U5+.H
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M#G.)!<E)IKC._1S'6OL;FW'2N$-MR;SA%-5(#JSHOIYD[;BW<U4/:/9,4"&
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MDS@52/,(PTS;Q)TZB2 G*((T3S$S]K"B2GF5 ]GO8VR3<;.DQ\?%_!Z:3A^
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MF#+5I3.KQ0;JNST']SU^Z3@^K@>S?:/>^\EM+3AXLU+A)VM2KL?A=F,<&D7
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ME5;SS8MY_?ZIYI^_;)2\-_L^]EE59==L1^.]+SX76E,F(<CRG!F*%B7@.L>
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M;21R.%_OS-_^_=^V/S%_V!I^__YO_Q]02P,$%     @ [H6A5K/N,Q% 2P
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M%%T,E\YPXW8+,.]X^&:XZ/Z8<7?!=H&/CY_Q\/"<^H I17*(*(X&9:,%C]F
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M2@=%+B;&VCI6:Y12B'Q7 <F0(.Q@KQP6+5M"\^&*Z]<ZGMCZZY59,B7CM))
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M-=CL$NJ4,#<?9'T7/0W&'M3/?+^8U[DC^9<?ORUK&>)9PMA>6DV_'1_'G$I
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M5P1?"O>V.)M9ZUX,FU$V;O0]&AAW5E*GX-ND\=O$"&^R-0E$3(Y"MII48G*
MHID+R0K#<^O(>SM*QXW&1P-G<R5VZC:>!'"X)(\=I]\JKQ-+TLIUQF0,J=ZN
M*F*K& 79^9"-#ESKUL>2&Y(V;AP^HBNYJYKZ*87<_+YU(IW I&J9GF"I7AXI
MB!@C6%F4U$P[T;S:97/JQ@VV'PF* RFK@Q++6SBK0=ORMK,($= Z6F#,:45^
ML<GUNHF#C#&3:)63HK59?#B5W12-/$IN62MU=; Y$VL),2]?D5 _AD-\5SY^
MGB]69'B_''.Y/EF;)):R=/5 58=TG'KN<JUIMDD+R:*Q4C<&X6:4=9F-U@P?
MUP<XM596#Q ,/TZ.;_?2?QY-%WCKG*J)E-&0?,CS=;J DJ% D,5"D18MTZ4P
MU;IA[^;4=9E0-A@4AU%:%['UYJ*<"%YY0_)^><JTU+*'J)P#4\CAT8BQ?3N-
MS:D;]X#GD0$YD-+Z]1E/ZH5N%*0ON>145UN)$E0FK]B+9,!J8S$%D3-_)%C>
M064WQ:&/XC.V4M>H>>4U0>Z2$U*KRMY]K3I;[G_'19H2KR]I-TCT]\M),<KH
M4#R(VE%0Q>#!.<>!7)!2O*YEU5?:5=V8N;CY$[OT!IMI?CZX$CKR!E_-%Q_P
MZ]$B?0Y+<G37I_8G_6YDU-'+XB!;,N+*&PZQ#MH.JABNK>4LM;[NNY^J+KV_
MUM ;2$E=>'VG/+TK+Z=5B+-,:Z=8D]!S<D-LI+4C+'AM$9"ACU*3/\);YS3<
M0$:7?MS0T-I6#5UAZ<KZN%#=/TDN1YNL LV\ <49(R>41V"6<2V#C<B:GZC<
M2]6XMVY]&+%ME=0%\#87X21ZU"%H =Q+)-'5*,@GA.#1.%&'/&'K771SZL:]
M<7MD( ZDM Y"U_U2R M]5_:_T^*:?<(/!/1WZU*:^O_J*7P+AW4-?J @?3%-
MM SJ+_9F^?(/+KQSXFS*7@IR++2AV"SF I[\6/!,L!2B\BJT[H$[ !O=]+%I
M&_R.K? . IB=F'V/B^D\7[]F38='M0701;$>BWI"Y@#)P!0H*!,HS3($XS/M
M6"X&(2-AN7GSN$?EL)L&/6U72L<PZ6#CV,UB)&ZDC;*F/&=RVR*C>(&S]=V#
M2Z(PR7+S!GB#;P8#]L/N$>(/4N+6B/VZ7D@D@<6J!]QFVM=BL)!Y<: <<@B,
MU\:F+GAKLM.Y=>;1\+BU_VJX?8 2=\3M_JQ-U/CQZ.O7P[4HP^&I*%_/RGSQ
M)5QN1!>CCB[47#]'2[*VI'.!>0B2W+"@4!?1.GMX0](V0J)[<D@<0C$=N,@7
M$DOK,"J*?R=<2L.Y3A"3H< VUG3!6 )X$]>-GG6QK6\LKU,Q<H>T(91]/<EW
M%\EW@)VS4^%U0X[@R;T-.4(25H(J%B%:)X%KNYZ]B:GY>*]+!(R<]_@(B-E>
MW@UOJA^_;>A?]][^9?_CZ[<?#]Z]^)]_???FY?Z'C_O_Z[?7!_\8MI'H)L]]
MK-:B#Y9!^V:C=\[J\=**8J#DJ$"AY!"1ASJC6>E(8:U0K=LU;$38[D.;3AYR
ML"ZWX#(HYT, YVKP8YBA92MJ3E3V2M0B==:Z]/\R!=VT#6V$A>MSF[:6=P?;
MX1GUQQ*IC8/FLQJ'['V?+B<1E5$Y"V!:DEQ2[?%LBH;",6JN?3"IN<-^%T&=
M8&D+3=\&FIW%W@&&KO#P<OXE3&<3%KG/7"+HY.K0>Y),C&A!^JR*<%AB:'VP
M?",AG6!F=T5?O2K96>H=0.?"9?FO^"7B8J*E,P(UA;N):%<979VR2:R(:*+4
M6B7?>H;\-2+&A4P#Q=X^%6(+*7< DUN&3Y\P8R(3V2H!&7F= .QK8UN*+%B,
MN42=DPRM,Q'N)&C<H*X]?-I)OP<HW3]9^H2QDB1GB2&(&&E_Y\F#MX&#I862
M%5/(4NM;H(V)&S>E;P"(#:*5#N!V=;CT"1<VE82T5D!Y+RC@\(Z\R%JSPHMW
M)FCM=.OCRILI&3>/I#V0&LB[ ]3<,'7GA!%,OE;&9W#%U$&PSD+,28/V#+T/
M/#C1.J/X5F+&S:QHCYTV4N\ /F=!QQM:"J_IY;(645H>(VW0C@>2BV40O+1@
M3.!6D@4E?H:*Y,^HZ*3*OV'XOIV .X#(]=R?Z\=C'^:'AZ_FB]_#(D]BU(8Y
M92 )KTE:3H/#7,#QQ+WT$E4<OD7>G21V$N=OB8A[F^FT4T\'Z+MM\&7,.D:O
M:P\637NU3!&\S$BO:)L.3"@K>YH\^HC=/QNJ?\,AI _113?Y4S=,MT^) E0I
M%5%?[;PR$4+2#@):JRSR)'3K0IGK5/36N',X..VH@6Z0='ER%V<L:Q\D.,/)
M ?110@A9058*S=J/2*U/)1\^-.T1>VT.AY_MY=[%Q+2;9W#L+18UG[KZ![_\
M.'_+20797A7:1=O[>G:<H#VA]:%%X0P*)@I;64+P@L(0AJ*@5FCCU0+X@2:M
M;,E ;UTX!S1[H^F]"]A?ZJ)_RWGQFM-X342S?-ITX.2*_J05P210'.^RH2@;
MF:U!=TTX(NTXEZTN6:6 K;.9!V"CM]Z?PRV!L3'005RSIOUX+;\\6DQGGX[7
M\_$:O['/QD3JS)(6!G0)Y%RGFNE-E %W7,J@I=3-[SL?3F5O74,'=E^'TV"_
M&/U;.#S"FQGDTC!6SU09UE8<C"6()9(\G32NSH\OKOF\MX<2.6XI20<(;:2_
M'@"Z7FMUVR!Q'83O?Y^N/E=)$JOT@UN&W$7T'',*8&(BB1;I:[29H/ @+3=6
MV^:)W-O0.6Z=R:,[Q$-JL8M^&1=\G@^XOKX^F&_,K#7<ZY+ 2!5 *1? I1K;
MHI,HLZG+=CC_]J'D;H1<_QR0^U@Z[0+ E^X\UWO(23]6XFNY^A57GVLXJC%G
MH3@XFVKQMZE79>2/:Y2)V1**;M[J91.Z-CNC9\\!D\W5U!_XCC>,#[BJ7$T,
M5UH6'T!D7AO5! 8^E +>2N1"16MSZ^SAVZG9#&C/XC:HD4KZ&=QQB:$35L[7
MS-Z7.BYG8GQ0BN< D3QE4+:FP[+H(6M:-IFS7%CK>\=-Z-H,=\_BVJBYFOI!
MX&T)C?6"XRVNWA5R+M[7.<FDUM5J,8U'JYJ@<C!_O];2A 7IN7<(J&4$)9V%
MH'RM4)(F,,^-CJUS!7<D>3/</HOKJL=4;@>Q^7DU[WG6P+JPUPOFK<\1M!82
M5(B:^' <!$HM@LJ<7C0&Z6VT;(:^9W'KU$0=7;B"MV6A& Q:,>> G-M4.VA&
M\,Q:,OF!_C&\"-8:5SME!#V+FYP6RNBE-<WU=!0N:#D$'4"FPNIP[MIJ4Y)X
MF%3T7^LPMAX"LV5"$'\^5RK;JZ ID%HW@OCXVZ^_[GWXQ[M7'U__Y>WK5Z]?
M[+T]V'OQXMUO;P]>O_W+^W=O7K]XO?_Q,BL;=7K8\(/;M'+8AHM&O1I.!I;6
M:XSYX31=;(FK4-7R# %1U09NI39PTTCH<T):(;-ROG7BWNW4[&R'II]FTS)-
M=;C1M8<<D#!_.:P-HU$;IXHL@%%Y4(S,K!?%4:#M8HXB)>E:#WO>C+)Q\V$;
MH>2:96JOE(Z;UKQ^^[?]MP?O/FQGD"[^=1NK<RL]C4Q+'=TTH[?\>#E=IL/Y
M\FB!YZ@1W 9O,SA?$ZQ4O;.7O$"T/&0AI4RV=6+='>3L7LQQ[://T>M$P6CK
MM(/ Z@(IM-=B,1"8-M9%7FSSIGMWT3-V8GT;3%ROUVBD@8[MQ_[>A[?D#GQ\
MO__AXU_W/NQO842N?40;2W(W98W,R6E%Z7L\OOP[PTVM<5<Z*<!L'/G&AB 3
M*$@*@1O--<5,K/6>?1LM.W=RN?*YYQ@V.OML38;:<[).@2K@$Q<@K-0\.L^3
M;9VF=BLQ([?G:(&#:\U<F@B^8^.Q7I>_[*W;Q?WZ?O_MQ[V#U^_>;A,8W?Q!
MC0*A#:AL9$[.-XKUR)BS%(*3E(-Z][$\SY8]G35S!C:A,>MU)JS-O@XU()_4
M</KBR#4-F1Q3V[I[W6X4[W[RO.'3+V;87W#BDT/KM Y RY2!JCG%08@"1N7$
MHHQ68.MH<D>2QS5SCXC/ZZ?:CZ?JCDWFFWTR1-N$:B=_V,8DWD1%(Q/XIIX\
MGD.&8!&UPWCB)O/$28': G.&=E46"Q>MSV4O4["KB7J#RR7BNZ^X"/4@X?C#
M+^SDQIJ@DX6X/D/56@"Y!Q&,<=[XR(J.K5MWW$W1N 9F!^U?-1@-!=^Q/=A[
M\>*W7W][4]OLOCOXZ_Z'ZJ)\V/\K>2FO_[;_^BU]NTU(MLFGMK$D#Z:_W1'S
M?;VE+M[6GR'282HH= :NC*UA>X3(O !CE?=>%B9SZY3R+4EM</EZ]3%OYZL+
M04B.+JH@%:V@FGBCF 2OD@2TJ9@0I;:V=?>8^V@:_4!Z<$S=<"O;3DO-<DE:
M6[F7^[\<;&'&UG_6QDY=IZ!5R(=Q=<.YHZ"M21AMH#:#K9.. P2&'+2L\T%#
MKA4ZK2.3&RG9.42[]*GGN)0\RN(+ \=4)EQZA,AIDV>N..:YX]:V/H&^A921
M0ZK=]7\M5&H@\FY-P6;7TJ?W=8-=LI\]X#$OVV_F:OA+]V!%U%$YR*X.B'4B
M@ ], 9/>9LV4%KYUWOUPE^Z_A.5T^:Y<><"/XZ\7X@-&2RTS!!L%A1XF!8@R
MTA=TRC 11'2M \_-*!O=QVF!DJLF:P"E=) 8^V[Q*<RF_[56SHOY;$G<Y/4W
M)^R^OZ"\7XZ6TQF%K"]QF1;3KR<=$.[*0(C%\&@$AR*")'.>2=XD A!<9/I.
M99M;G_8.RM"X[; & G8_$.BB)<S[Q72^.*Y-_X#I,"R7ZU2;-:MG%987^)\4
MQE-(#J$XZT!EEL%9C<"$"B4*[ZQI783S4!K';<,U$&X'55074/RM]I797ZZF
M7RA@7Y+#G8.4.8(I3M>C1@?!\D1!N.<LT,83>>O]_C(%X[;%&@A&.PBY"Y"\
MQ=\O2&8QG]'+M&[=M;S90]$^Y<RM!$%2 24MUFHT"39+KI)5COO6>1\/I7'<
MYE,# 6U0175\_G\A7W+=P7J;B/?Z9S3/Y;R)MD?(Z#1)>Z5D!%2)0=V((/C:
M?#FPP+*4UK+6W30&S.C\F#YC/CHDBWKVD!='B\5I\_*+85).-J$'6T^5%8L9
M0M:%7@7+,@9IL/6EXJ:T]9OI^1"L7,L9'T(SW1[!7<VLW-KPW/)!P^1_#FB"
M;LW^4T(ES0H"=UG5B5H<G,\,BL[."^5=B*VOR(;* CV'^-4GU$@V4:#Z<GIX
M5&OD+R,^>JF\50B6EA'MLP;KA. ,R'T*VDGCRW"VZ$&D=II!^A ,W6Z7AE-:
MMV;JYKS-K8W5G1\W9*;I@(9KQWP^X[)(Q=3TF40;I5<>G-$"M-,UR3F@<\WO
M\$;--SU?3S>W^KK8:G$OK:;?IJL?5Y86DU'0/F\AU5E!RI&'$30W0-(JZ%34
M3#<OYMN9ZB>==?H0E-YN0!]%X1W<69QS_'9.ONR2!/R!OBZFB5ZMV?UM-EW=
MQFRD_S!TM%/X4+N*<@$^106RE.*\=T7PX="]!<'CWCET >RAU=P!IB_*^=Z>
M_,O;FO)?J-TSTDO.$T0=ZKA)K\#7<4[HI"^H6-&J-<H;LS#NG<6(N!\3"MUZ
MRL?I_%M[QI?^O&6!P8">[Y5$\VQ-X#P8**P>/2OFP/N(D)60203NA&[=S+1U
MF0%]6ETX5RPUIUC18+' )*O'W!3.A6@S!*,4-Y%^AZWO3V\AI:O"@H?H^WIA
MP>ZB[F!3O*D^XLTTQ.DA[?>_AM71XH9]7PCO'%D[KHT$99."X(P"XT+V C.B
M:)T(M@69XSIU39$VK(JZW9 NW!R]K+.;#W>\UCK]D.;W6C=2]P@76U+GF-.Z
MZ6E.H$)"B"G4\%(3W"0+0K1.#W^,5B4?PN\$:UQ,P^%RH@F1W%@&:#*Y5CZ1
MFZ>=!%.XMUYKU*IUJ<V-A/1[9?40%-S:G&1KF7>PAZT'NQ^>A UG'+T/Z9_A
M$QG,O=EQ(<['HZ]?#Z<U_T0EXDX0>ZI4;UT$"%F1F>0A,IYS\:KU_O5 $L>>
M"3H,V(;4TX@PI+WA7&1OY[-7\WE^-9U-EY\Q_X5>+R<<-0:+#*2D[4D5PR Z
M9L!2R.BU<%EBNF<;N_<A8X\!;0N9MC+M(HGLC)W+?!1C9-+D"B)#1YY:$."D
M=( Y%>U3,6A:WXS>3,G8 SD'WN"VEWH'.]P9%W6^Q\DAV1(7W\A()FD\(5Z!
M(\'4]JOTJDZ6=RP$5#EJWWP.[.W4C#W1<F ,[2;]+IIIGQM5)*$8+94ERVED
M9* B>7S1, $4(19MC,*26Q\+77S^V*,C!T;+0R6\O9V9K\+A(V9ZU7/RH^//
MG9=U"DDX2R'9?[]#K+[E@X;)%-N&RZ$SR8*52%ZQ@F*5/6Y?%#$5$/7R(2E?
M,=MY)EGU[-X>?:F'6?/%^8(36LI$KKZ,.E+$25^"< DP8DA1:VE8W,!#OO;!
MG69S/42/%UWBW037A1M,5O&\"<8D")VS9I+L8R$O'B4'5PKY8=87I@4KV;0O
ME+A P#CX:*#*:X4/VTIUY,#Y)<[F7Z:S2X)0CH)[;3P8[9#(9PJ\B1F815-D
MY+F(3<+E&SYZW'.5YN9@5^%U81#^CM-/GVE/W:,/#9^0UD7$Q<FU_/+=T6JY
MHGV7Q+;>@B?<)132%HC%KPL,)7C/-$A3$D^Q*.MS8X/Q( +',R@[@V'^6'KI
M%W8G[MTU'L^+72>*I,@M9V!Y+1#)Y,S'A 8\HM+( OVZ=3'1EJ2.8^P>#8J-
M==7!*<\M*^XV1B=,II@2+3?G=!T^$6B;CZ@!9?1!>UU8:'W]]T 2QSF4?D1K
MV$0WS0+_=A'GL5$7V?&H8H*4:H(GV7'P"CVX[!)+*G+3O,WAC82,>[?1U&UK
M)_ .#-95)DY6P\2Z@!:3!*OYVNYZ"(Q$Y$L6VF=C-6N=1W<+*>->:CP*<K81
M>L>E[%>/X=Z&1<U[^H;MCA6O?>0P!XAW4SYXT:E,4CA/X;^O8SZ="N"C%Q!J
M_*\D1NYZ/RH\JU(@=:PSL==);I.DUBG5##@+M7J:EVH?*>A [:(PPHG0NM[L
M,@6='BH^1./7!S%N+>(.]J&]V6J:JQFDQ?814TV(G.)R_WLZ/*(5]HI$>.$P
M_X8JV!\W?\#>]^ER@B44P5&0^V92/4LCLVJ0 ];-.+"49?/B[0'9&1>ZNZ!L
MWJ?*NT7_V_ %7\Z_A.EL(J7)E7 (=6:9XG60.&H+HDCAA1+9\]:#DN^C:>3V
ME;V 9R-0;ZG)#I!YI9;P5ZQ!\T2**'6N[0IEG?]B9:P',AY2SC8G:9,KK4_0
M;B2D1PQNJ^MKF9:["KX#])SM%N2'XVMZN:0=0PBT]=RF#G-5WCN(10N0)B06
M.->QM+9DUZD8]Q*IX1ZZHX [@,B.AGSO2VT5-^$V61&2!IE4G6"N'/@<*1H/
M(8F(HKC<NNEC$\([<>:V1$];AVX+579\"')S"Y@&1R$;?O"0C6P>Y5ADQ]IR
MYY)*B:+H+#36R9JY9G1:L+05ZQQ1%M_Z\*3OEC8;E<.O-R1T46:E!!CFR?\M
MGC8D[CEXD51M=4*_;EU<TXSX)]W@YB&8?6B#FV'4WX,#L::<WKR.W41&1OM7
M /2UR9JJB=S$#B27$@_D-%-(U]H1N$C R!OZ.""XZ@=LK9$.X+2]X,[9GN7W
MAV%V(1 DER9Z'6L9'!?DXMLJ2$&!8*20S=+2=K)YT#, 'R.'V]O#ZJJM'%O'
M'>!\GUS-^0_$"XW/3LX8#&<H5.' M.&@=)$07,KTK57"8N;:-K]VNHV8D<WI
MZ#BY>G'<1&D=H._FTRU/6TP.7H-/KEY_.0K]E&.UPL_82/Z/;9X-M?VQXG#'
M0[VA;G=E=8"X][@H\\67,$MXG.IU>J**FM,60CZW5054<!E\S=LOS,F2,)54
M6I<OW$+*N"E2W:&NA<)&KHSX-2S^B:LJEG->UN);,W1JN;WSS M=^]/;>NAK
M(42RX5X;Z9A40:8K&7HWEDIL\JQQ4ZFZ0=@@JAD1:LO%:O*A"G'M&&NA1;(U
M$TW4&B2A KA$WG'RQ7*C92YEHXQ/^M0+QHR^.S=DEQXX\F8Y:L2[O>1[@,L)
MRI7%&+V58 6C2$H6!*>(^\3)U*:BBTX;[8"; &9,KWX'95U5]Q:2&UGAOTYG
MTR]'7TX(YSXEK>N==%%$N,D"0E@G*<>4.0^"Y8U.>.]1^:6'CJST;50V;R&_
ML14?OE\@G/A5:$2A+4S5R5PI@9>TP5GK-!-HBMBLT?]]BK_XT'$VB&:*WUI^
M'00]Z^WM95@=F[Q89#+!DB?#Z]AP:RPX1SN<"-Y:&Z0NJG76[24"1@YP^CD;
MWTHC/<'IQ/E&VC:1>81D?9UM'\@".N,A):X4"HL4CPT%J&Y.I+=3YFVPV$*R
M(P>Y?Z%ELVX&6'5U&C@9PQ0GHHOGM$)21"#!U(3*8K/@3#)SY;[CQICVAH_N
M1.';J&G>3F8=V()[C>AM-O3-6:Z1-(Y%YF(M=ZHS .H53F :0O)1"I$##ZWO
M:G>G>N0SE"XVL4?6_5-&^_K+WW"YGF:[GL+-)Y96N7&(P&*J):)94^BI',F?
M(L^4'/VR=?9T2_H[OY-KC+U6T-\5"%UTW#C/7;J;^WB5^_WO7Z>+]9N/>9_D
MA,4Y,C]1IMIU$:L.,$*(TI<04LR^>05@*^([OQY\A 7PZ!#H=@LXOIK:.UI]
MGB^F_X7YMQEI_\+U?+VN6.Y_QT6:+O']8IIP?2CQ9OX[+HY?3;],:[?*('0(
M#,@:1%",!9(*?6$V.\>LTS8/LAP&XJ?SJ\PQMH@1@-+/EM%*&K]]_7I)&@:#
M"US7&2GKD)L\V<A4 JUES!1^N:@>QY-JPT_G][-/:-GL I2.E\T&RCB98;H^
M85B^/MEK_[*H/26==8Q\2@'"2P\J)0/.)0\QT=X;HT7??,KO &R,VZ"\RT7R
M>+#HQ0_;Q@$]$<&%%E]7.H)]P'JH1S]_,9^M"S*.PN$!+KZ(B0@JQ& ,:$OA
MF3*%0["!-,A]*EDD$=,@)U6/R^:XS=Q[6%D=P^H9K+R3;;H>/VXH(CY!ITV4
M)"(>JHAB\>!]L*!=SDY*HVSS[M(CL+G1RK/_O?)&@54O*V^';?^"<7I-DIC.
MEM-4)Z'4:P!KM)$!I/,2E$!RC&W24+P4*62/(;2>/3,8,QNM(O><5]'H$.EE
MK;0Q)Y<%P2=,&9D+BQ!]33UW.8)#5SUE[D)2C,72NLO$<-QLM%K\<UXMXX.D
M@^7R?C%/B'E9VW-<.%<Y.U/)$QZ%LEISX%800Y$L@2\G?4&X9!YQL_S@AU3(
MW$?49G>0[)FBMZW..@#AKIO7*>-G)QL'M:WVE7TLF,11A4 QEF)0\W. 8J\
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M>&5X>#,Q,2YH=&U02P$"% ,4    " #NA:%6NJXKHZ@'  #P)0  %P
M        @ 'J!P  ;65D+3(P,C,P,3,Q>&5X>#,Q,BYH=&U02P$"% ,4
M" #NA:%6@=,@1R<%  #?&@  %P              @ ''#P  ;65D+3(P,C,P
M,3,Q>&5X>#,R,2YH=&U02P$"% ,4    " #NA:%6&-,:BQL  0 VFPL $
M            @ $C%0  ;65D+3(P,C,P,S,Q+FAT;5!+ 0(4 Q0    ( .Z%
MH5978IM6' D  *93   0              "  6P5 0!M960M,C R,S S,S$N
M>'-D4$L! A0#%     @ [H6A5M.S.-\6%0  %+\  !0              ( !
MMAX! &UE9"TR,#(S,#,S,5]C86PN>&UL4$L! A0#%     @ [H6A5EZ"L"HH
M(0  F6\! !0              ( !_C,! &UE9"TR,#(S,#,S,5]D968N>&UL
M4$L! A0#%     @ [H6A5ME+B^\L@@  KGH% !0              ( !6%4!
M &UE9"TR,#(S,#,S,5]L86(N>&UL4$L! A0#%     @ [H6A5K/N,Q% 2P
M$F,# !0              ( !MM<! &UE9"TR,#(S,#,S,5]P<F4N>&UL4$L%
3!@     )  D 4P(  "@C @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
